Ligand source activities (1 row/activity)





Ligands (move mouse cursor over ligand name to see structure) Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb
ID
#Vendors

Reference
ligand
Fold
selectivity
# Tested
GPCRs
Species

p-value
(-log)
Activity
Type
Activity
Relation
Activity
Value
AssayType

Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

445643 97389 69 None -1 7 Human 5.0 pAC50 = 5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 803 7 3 12 4.6 C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC 10.1038/s41467-023-40064-9
CHEMBL269732 97389 69 None -1 7 Human 5.0 pAC50 = 5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 803 7 3 12 4.6 C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC 10.1038/s41467-023-40064-9
2398 954 62 None -7413 36 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
2801 954 62 None -7413 36 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
701 954 62 None -7413 36 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
CHEMBL415 954 62 None -7413 36 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
DB01242 954 62 None -7413 36 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 4 0 2 4.5 CN(CCCN1c2ccccc2CCc2c1cc(Cl)cc2)C 10.1038/s41467-023-40064-9
5022 1651 76 None -239 9 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 4 1 4 3.2 O=c1[nH]c2c(n1CCN1CCN(CC1)c1cccc(c1)C(F)(F)F)cccc2 10.1038/s41467-023-40064-9
6918248 1651 76 None -239 9 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 4 1 4 3.2 O=c1[nH]c2c(n1CCN1CCN(CC1)c1cccc(c1)C(F)(F)F)cccc2 10.1038/s41467-023-40064-9
8182 1651 76 None -239 9 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 4 1 4 3.2 O=c1[nH]c2c(n1CCN1CCN(CC1)c1cccc(c1)C(F)(F)F)cccc2 10.1038/s41467-023-40064-9
CHEMBL231068 1651 76 None -239 9 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 4 1 4 3.2 O=c1[nH]c2c(n1CCN1CCN(CC1)c1cccc(c1)C(F)(F)F)cccc2 10.1038/s41467-023-40064-9
DB04908 1651 76 None -239 9 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 390 4 1 4 3.2 O=c1[nH]c2c(n1CCN1CCN(CC1)c1cccc(c1)C(F)(F)F)cccc2 10.1038/s41467-023-40064-9
2247 505 81 None -812 42 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
249 505 81 None -812 42 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
2603 505 81 None -812 42 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
CHEMBL296419 505 81 None -812 42 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
DB00637 505 81 None -812 42 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 458 8 1 5 5.4 COc1ccc(cc1)CCN1CCC(CC1)Nc1nc2c(n1Cc1ccc(cc1)F)cccc2 10.1038/s41467-023-40064-9
2710 84308 31 None -25 9 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 300 3 0 2 3.7 CN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1 10.1038/s41467-023-40064-9
CHEMBL22150 84308 31 None -25 9 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 300 3 0 2 3.7 CN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1 10.1038/s41467-023-40064-9
3351 95002 52 None -1 6 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 388 5 0 5 2.8 O=C(COc1ccc(Cl)cc1)N1CCN(Cc2ccc3c(c2)OCO3)CC1 10.1038/s41467-023-40064-9
CHEMBL254857 95002 52 None -1 6 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 388 5 0 5 2.8 O=C(COc1ccc(Cl)cc1)N1CCN(Cc2ccc3c(c2)OCO3)CC1 10.1038/s41467-023-40064-9
9823820 19166 102 None 1 2 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 6 3 5 4.1 COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O 10.1038/s41467-023-40064-9
CHEMBL1289601 19166 102 None 1 2 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 6 3 5 4.1 COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O 10.1038/s41467-023-40064-9
3035016 12594 50 None 1 3 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 483 3 5 10 0.6 CC(=O)[C@]1(N)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](O)[C@H](O)CO2)C1)C(=O)c1ccccc1C3=O 10.1038/s41467-023-40064-9
CHEMBL1186894 12594 50 None 1 3 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 483 3 5 10 0.6 CC(=O)[C@]1(N)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](O)[C@H](O)CO2)C1)C(=O)c1ccccc1C3=O 10.1038/s41467-023-40064-9
3627 44129 18 None -162 9 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 314 3 0 2 4.1 CN1CCCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1 10.1038/s41467-023-40064-9
CHEMBL1515447 44129 18 None -162 9 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 314 3 0 2 4.1 CN1CCCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1 10.1038/s41467-023-40064-9
196122 112588 55 None -1 4 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 478 13 1 6 4.5 CCOC1O[C@H]([C@@H](COCc2ccccc2)OCc2ccccc2)[C@H](OCc2ccccc2)[C@H]1O 10.1038/s41467-023-40064-9
CHEMBL3301681 112588 55 None -1 4 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 478 13 1 6 4.5 CCOC1O[C@H]([C@@H](COCc2ccccc2)OCc2ccccc2)[C@H](OCc2ccccc2)[C@H]1O 10.1038/s41467-023-40064-9
98941 46950 17 None -58 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 457 7 0 4 6.3 COc1ccc2c(c1)OC(C)(C)C(c1ccccc1)C2c1ccc(OCCN2CCCC2)cc1 10.1038/s41467-023-40064-9
CHEMBL154126 46950 17 None -58 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 457 7 0 4 6.3 COc1ccc2c(c1)OC(C)(C)C(c1ccccc1)C2c1ccc(OCCN2CCCC2)cc1 10.1038/s41467-023-40064-9
4150 788 39 None -19 15 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 6 2 2 5.8 CCCCCc1cc(O)c(c(c1)O)[C@@H]1C=C(C)CC[C@H]1C(=C)C 10.1038/s41467-023-40064-9
5288 788 39 None -19 15 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 6 2 2 5.8 CCCCCc1cc(O)c(c(c1)O)[C@@H]1C=C(C)CC[C@H]1C(=C)C 10.1038/s41467-023-40064-9
644019 788 39 None -19 15 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 6 2 2 5.8 CCCCCc1cc(O)c(c(c1)O)[C@@H]1C=C(C)CC[C@H]1C(=C)C 10.1038/s41467-023-40064-9
CHEMBL190461 788 39 None -19 15 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 6 2 2 5.8 CCCCCc1cc(O)c(c(c1)O)[C@@H]1C=C(C)CC[C@H]1C(=C)C 10.1038/s41467-023-40064-9
DB09061 788 39 None -19 15 Human 5.9 pAC50 = 5.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 6 2 2 5.8 CCCCCc1cc(O)c(c(c1)O)[C@@H]1C=C(C)CC[C@H]1C(=C)C 10.1038/s41467-023-40064-9
9818306 14419 15 None -1 5 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 1 1 3 3.8 CC(=O)Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12 10.1038/s41467-023-40064-9
CHEMBL1200430 14419 15 None -1 5 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 314 1 1 3 3.8 CC(=O)Oc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12 10.1038/s41467-023-40064-9
5568 197500 29 None -4365 13 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 352 4 0 3 5.3 CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21 10.1038/s41467-023-40064-9
66069 197500 29 None -4365 13 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 352 4 0 3 5.3 CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21 10.1038/s41467-023-40064-9
CHEMBL1201102 197500 29 None -4365 13 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 352 4 0 3 5.3 CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21 10.1038/s41467-023-40064-9
CHEMBL570 197500 29 None -4365 13 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 352 4 0 3 5.3 CN(C)CCCN1c2ccccc2Sc2ccc(C(F)(F)F)cc21 10.1038/s41467-023-40064-9
64143 198864 62 None -2 10 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 567 9 4 6 4.7 Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C 10.1038/s41467-023-40064-9
CHEMBL584 198864 62 None -2 10 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 567 9 4 6 4.7 Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C 10.1038/s41467-023-40064-9
2520 204008 70 None -120 20 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC 10.1038/s41467-023-40064-9
CHEMBL1280 204008 70 None -120 20 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC 10.1038/s41467-023-40064-9
CHEMBL6966 204008 70 None -120 20 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 454 13 0 6 5.1 COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC 10.1038/s41467-023-40064-9
10180 98869 47 None -25 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 6 1 4 4.5 CCN(CC)CCNc1ccc(C)c2sc3ccccc3c(=O)c12 10.1038/s41467-023-40064-9
CHEMBL279014 98869 47 None -25 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 6 1 4 4.5 CCN(CC)CCNc1ccc(C)c2sc3ccccc3c(=O)c12 10.1038/s41467-023-40064-9
6077 150698 31 None -4570 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 5 0 4 4.4 CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2 10.1038/s41467-023-40064-9
CHEMBL39560 150698 31 None -4570 11 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 5 0 4 4.4 CC(=O)c1ccc2c(c1)N(CCCN(C)C)c1ccccc1S2 10.1038/s41467-023-40064-9
1662 188705 80 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 162 4 3 3 -0.3 CC(O)(CC(=O)O)CC(=O)O 10.1038/s41467-023-40064-9
CHEMBL50444 188705 80 None -1 3 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 162 4 3 3 -0.3 CC(O)(CC(=O)O)CC(=O)O 10.1038/s41467-023-40064-9
24795069 89048 42 None -9 3 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 418 7 1 6 3.6 COc1cc2c(cc1OC)[C@H]1C[C@@H](OC(=O)[C@@H](N)C(C)C)[C@H](CC(C)C)CN1CC2 10.1038/s41467-023-40064-9
CHEMBL2364639 89048 42 None -9 3 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 418 7 1 6 3.6 COc1cc2c(cc1OC)[C@H]1C[C@@H](OC(=O)[C@@H](N)C(C)C)[C@H](CC(C)C)CN1CC2 10.1038/s41467-023-40064-9
4822 45032 47 None -1995 10 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 293 0 0 2 4.7 CN1CCC(=C2c3ccccc3Sc3ccccc32)CC1 10.1038/s41467-023-40064-9
CHEMBL152408 45032 47 None -1995 10 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 293 0 0 2 4.7 CN1CCC(=C2c3ccccc3Sc3ccccc32)CC1 10.1038/s41467-023-40064-9
3280 48449 28 None -8 8 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 10 0 5 5.4 CCOc1ccc(Cc2nccc3cc(OCC)c(OCC)cc23)cc1OCC 10.1038/s41467-023-40064-9
CHEMBL1555736 48449 28 None -8 8 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 395 10 0 5 5.4 CCOc1ccc(Cc2nccc3cc(OCC)c(OCC)cc23)cc1OCC 10.1038/s41467-023-40064-9
10071196 3124 79 None -1023 9 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.1038/s41467-023-40064-9
5142 3124 79 None -1023 9 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.1038/s41467-023-40064-9
8423 3124 79 None -1023 9 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.1038/s41467-023-40064-9
CHEMBL2111101 3124 79 None -1023 9 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.1038/s41467-023-40064-9
DB05316 3124 79 None -1023 9 Human 4.9 pAC50 = 4.9 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 427 8 1 3 4.7 CC(COc1ccc(cc1)CNC(=O)N(C1CCN(CC1)C)Cc1ccc(cc1)F)C 10.1038/s41467-023-40064-9
49843517 78294 41 None -42 8 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 590 13 2 6 8.5 CCCCCCO[C@@H](C)c1cccc(-c2csc(NC(=O)c3cc(Cl)c(/C=C(\C)C(=O)O)c(Cl)c3)n2)c1OC 10.1038/s41467-023-40064-9
CHEMBL2107831 78294 41 None -42 8 Human 4.9 pAC50 = 4.9 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 590 13 2 6 8.5 CCCCCCO[C@@H](C)c1cccc(-c2csc(NC(=O)c3cc(Cl)c(/C=C(\C)C(=O)O)c(Cl)c3)n2)c1OC 10.1038/s41467-023-40064-9
444795 139999 105 None -40 6 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 300 5 1 1 5.6 CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1 10.1038/s41467-023-40064-9
CHEMBL38 139999 105 None -40 6 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 300 5 1 1 5.6 CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1 10.1038/s41467-023-40064-9
3735 206231 76 None -1 3 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 571 4 2 2 3.7 CCC(Cc1c(I)cc(I)c(N)c1I)C(=O)O 10.1038/s41467-023-40064-9
CHEMBL867 206231 76 None -1 3 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 571 4 2 2 3.7 CCC(Cc1c(I)cc(I)c(N)c1I)C(=O)O 10.1038/s41467-023-40064-9
2583 3776 118 None -9120 16 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
592 3776 118 None -9120 16 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
65999 3776 118 None -9120 16 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
CHEMBL1017 3776 118 None -9120 16 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
DB00966 3776 118 None -9120 16 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
65863 14465 57 None -8 11 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 436 6 0 4 7.0 Clc1ccc(C(Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1201196 14465 57 None -8 11 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 436 6 0 4 7.0 Clc1ccc(C(Cn2ccnc2)OCc2csc3c(Cl)cccc23)c(Cl)c1 10.1038/s41467-023-40064-9
208898 66199 78 None -22 11 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 556 18 1 6 7.0 CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1 10.1038/s41467-023-40064-9
CHEMBL184412 66199 78 None -22 11 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 556 18 1 6 7.0 CCCCc1oc2ccc(NS(C)(=O)=O)cc2c1C(=O)c1ccc(OCCCN(CCCC)CCCC)cc1 10.1038/s41467-023-40064-9
2444 14478 26 None -10 8 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 333 6 0 2 4.1 CN(C)CCOC(c1ccccc1)c1ccc(Br)cc1 10.1038/s41467-023-40064-9
CHEMBL1201245 14478 26 None -10 8 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 333 6 0 2 4.1 CN(C)CCOC(c1ccccc1)c1ccc(Br)cc1 10.1038/s41467-023-40064-9
2749 344 40 None -512 10 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 4 0 3 4.5 CN(CC(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
5574 344 40 None -512 10 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 4 0 3 4.5 CN(CC(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
7237 344 40 None -512 10 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 4 0 3 4.5 CN(CC(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
CHEMBL829 344 40 None -512 10 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 4 0 3 4.5 CN(CC(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
DB01246 344 40 None -512 10 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 4 0 3 4.5 CN(CC(CN1c2ccccc2Sc2c1cccc2)C)C 10.1038/s41467-023-40064-9
50905713 102396 76 None 1 2 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 416 4 2 6 4.5 C[C@H](Nc1ncnc2nc[nH]c12)c1cc2cccc(Cl)c2c(=O)n1-c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL3039502 102396 76 None 1 2 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 416 4 2 6 4.5 C[C@H](Nc1ncnc2nc[nH]c12)c1cc2cccc(Cl)c2c(=O)n1-c1ccccc1 10.1038/s41467-023-40064-9
24821094 67094 93 None 1 8 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 440 5 1 7 4.2 C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1 10.1038/s41467-023-40064-9
CHEMBL1873475 67094 93 None 1 8 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 440 5 1 7 4.2 C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1 10.1038/s41467-023-40064-9
8569 22643 91 None -1 4 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 244 3 2 4 2.3 COc1ccc(C(=O)c2ccccc2O)c(O)c1 10.1038/s41467-023-40064-9
CHEMBL1326877 22643 91 None -1 4 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 244 3 2 4 2.3 COc1ccc(C(=O)c2ccccc2O)c(O)c1 10.1038/s41467-023-40064-9
62867 3129 35 None -5248 9 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 475 8 1 6 4.0 OCCC1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
7557 3129 35 None -5248 9 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 475 8 1 6 4.0 OCCC1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
CHEMBL398880 3129 35 None -5248 9 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 475 8 1 6 4.0 OCCC1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
DB01621 3129 35 None -5248 9 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 475 8 1 6 4.0 OCCC1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)S(=O)(=O)N(C)C 10.1038/s41467-023-40064-9
6917906 67773 21 None -7 5 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 887 35 10 12 1.7 CCCCCCCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O)C(N)=O)C(=O)O 10.1038/s41467-023-40064-9
CHEMBL1908331 67773 21 None -7 5 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 887 35 10 12 1.7 CCCCCCCCCCCCCCCCCC(=O)NCCCC[C@H](NC(=O)CC[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)OC(O)[C@@H]1NC(C)=O)C(N)=O)C(=O)O 10.1038/s41467-023-40064-9
37464 19221 26 None -4466 8 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 291 6 2 3 3.5 CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1 10.1038/s41467-023-40064-9
CHEMBL1290 19221 26 None -4466 8 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 291 6 2 3 3.5 CC(C)(C)NC[C@H](O)COc1ccccc1C1CCCC1 10.1038/s41467-023-40064-9
60151560 167442 39 None -1 5 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 439 11 1 5 5.3 CCO[C@@H](Cc1ccc(OCCn2c(C)ccc2-c2ccc(SC)cc2)cc1)C(=O)O 10.1038/s41467-023-40064-9
CHEMBL4297530 167442 39 None -1 5 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 439 11 1 5 5.3 CCO[C@@H](Cc1ccc(OCCn2c(C)ccc2-c2ccc(SC)cc2)cc1)C(=O)O 10.1038/s41467-023-40064-9
133 2496 52 None -41686 27 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C 10.1038/s41467-023-40064-9
1723 2496 52 None -41686 27 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C 10.1038/s41467-023-40064-9
28693 2496 52 None -41686 27 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C 10.1038/s41467-023-40064-9
CHEMBL19215 2496 52 None -41686 27 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C 10.1038/s41467-023-40064-9
DB13520 2496 52 None -41686 27 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 403 4 1 4 4.1 O=C(OCc1ccccc1)NC[C@H]1CN(C)[C@H]2[C@H](C1)c1cccc3c1c(C2)cn3C 10.1038/s41467-023-40064-9
124087 1389 114 None -380 27 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
7157 1389 114 None -380 27 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
814 1389 114 None -380 27 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
CHEMBL1172 1389 114 None -380 27 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
DB00967 1389 114 None -380 27 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 310 0 1 2 4.0 Clc1ccc2c(c1)CCc1c(C2=C2CCNCC2)nccc1 10.1038/s41467-023-40064-9
3157 1470 71 None -22387 21 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
7170 1470 71 None -22387 21 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
954 1470 71 None -22387 21 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
CHEMBL707 1470 71 None -22387 21 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
DB00590 1470 71 None -22387 21 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 451 4 2 8 1.5 COc1cc2nc([nH]c(=N)c2cc1OC)N1CCN(CC1)C(=O)C1COc2c(O1)cccc2 10.1038/s41467-023-40064-9
2107 3055 50 None -5248 9 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 365 4 1 5 4.0 N#Cc1ccc2c(c1)N(CCCN1CCC(CC1)O)c1c(S2)cccc1 10.1038/s41467-023-40064-9
4747 3055 50 None -5248 9 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 365 4 1 5 4.0 N#Cc1ccc2c(c1)N(CCCN1CCC(CC1)O)c1c(S2)cccc1 10.1038/s41467-023-40064-9
9216 3055 50 None -5248 9 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 365 4 1 5 4.0 N#Cc1ccc2c(c1)N(CCCN1CCC(CC1)O)c1c(S2)cccc1 10.1038/s41467-023-40064-9
CHEMBL251940 3055 50 None -5248 9 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 365 4 1 5 4.0 N#Cc1ccc2c(c1)N(CCCN1CCC(CC1)O)c1c(S2)cccc1 10.1038/s41467-023-40064-9
DB01608 3055 50 None -5248 9 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 365 4 1 5 4.0 N#Cc1ccc2c(c1)N(CCCN1CCC(CC1)O)c1c(S2)cccc1 10.1038/s41467-023-40064-9
3356 2280 73 None -165 2 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1038/s41467-023-40064-9
4326 2280 73 None -165 2 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1038/s41467-023-40064-9
9867642 2280 73 None -165 2 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1038/s41467-023-40064-9
CHEMBL426559 2280 73 None -165 2 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1038/s41467-023-40064-9
DB11629 2280 73 None -165 2 Human 6.8 pAC50 = 6.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1038/s41467-023-40064-9
2805 161890 38 None -51 9 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 329 6 0 2 4.9 Clc1ccc(C(OCCN2CCCCC2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL415087 161890 38 None -51 9 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 329 6 0 2 4.9 Clc1ccc(C(OCCN2CCCCC2)c2ccccc2)cc1 10.1038/s41467-023-40064-9
CHEMBL343448 211700 43 None - 1 Human 5.8 pAC50 = 5.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL None None None C/C=C1\NC(=O)[C@H]2CSSCC/C=C/[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@H](C(C)C)NC1=O 10.1038/s41467-023-40064-9
8609 14444 66 None -1 4 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 229 2 2 4 2.2 Nc1ccc(C(=O)Oc2ccccc2)c(O)c1 10.1038/s41467-023-40064-9
CHEMBL1200868 14444 66 None -1 4 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 229 2 2 4 2.2 Nc1ccc(C(=O)Oc2ccccc2)c(O)c1 10.1038/s41467-023-40064-9
25102847 78221 93 None -8 10 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 501 8 2 6 5.5 COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC 10.1038/s41467-023-40064-9
CHEMBL2105717 78221 93 None -8 10 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 501 8 2 6 5.5 COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC 10.1038/s41467-023-40064-9
16222096 80483 67 None -66 7 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 531 4 3 4 3.8 O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1 10.1038/s41467-023-40064-9
CHEMBL2146883 80483 67 None -66 7 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 531 4 3 4 3.8 O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1 10.1038/s41467-023-40064-9
5591 157531 90 None -10 17 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 441 5 2 6 4.4 Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2 10.1038/s41467-023-40064-9
CHEMBL408 157531 90 None -10 17 Human 4.8 pAC50 = 4.8 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 441 5 2 6 4.4 Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2 10.1038/s41467-023-40064-9
CHEMBL508338 188966 0 None -194 15 Human 4.8 pAC50 = 4.8 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL None None None None 10.1038/s41467-023-40064-9
3598 187821 76 None -25 17 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 404 2 2 2 6.6 Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl 10.1038/s41467-023-40064-9
CHEMBL496 187821 76 None -25 17 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 404 2 2 2 6.6 Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl 10.1038/s41467-023-40064-9
6719 32668 39 None -4 4 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 4 0 3 4.1 O=C1c2ccccc2C(=O)C1C(=O)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1413199 32668 39 None -4 4 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 4 0 3 4.1 O=C1c2ccccc2C(=O)C1C(=O)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
3397 205488 112 None -1 7 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 3 1 3 3.2 CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1 10.1038/s41467-023-40064-9
CHEMBL806 205488 112 None -1 7 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 3 1 3 3.2 CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1 10.1038/s41467-023-40064-9
1613 2348 53 None -2290 34 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
205 2348 53 None -2290 34 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
3964 2348 53 None -2290 34 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
CHEMBL831 2348 53 None -2290 34 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
DB00408 2348 53 None -2290 34 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 327 0 0 4 3.8 CN1CCN(CC1)C1=Nc2ccccc2Oc2c1cc(Cl)cc2 10.1038/s41467-023-40064-9
3476 40286 99 None - 1 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 490 7 3 5 3.1 CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)cc2)C1=O 10.1038/s41467-023-40064-9
CHEMBL1481 40286 99 None - 1 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 490 7 3 5 3.1 CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)cc2)C1=O 10.1038/s41467-023-40064-9
9846332 52059 37 None -1 3 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 444 2 3 5 2.4 C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C(Cl)=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO 10.1038/s41467-023-40064-9
CHEMBL1587228 52059 37 None -1 3 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 444 2 3 5 2.4 C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C(Cl)=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO 10.1038/s41467-023-40064-9
31101 729 40 None -6606 29 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
35 729 40 None -6606 29 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
403 729 40 None -6606 29 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
CHEMBL493 729 40 None -6606 29 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
DB01200 729 40 None -6606 29 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 653 5 3 6 3.2 CC(C[C@H]1C(=O)N2CCC[C@H]2[C@]2(N1C(=O)[C@@](O2)(NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C 10.1038/s41467-023-40064-9
242 470 124 None -758 33 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
34 470 124 None -758 33 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
60795 470 124 None -758 33 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
CHEMBL1112 470 124 None -758 33 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
DB01238 470 124 None -758 33 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
16362 3125 71 None -2089 35 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
2172 3125 71 None -2089 35 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
90 3125 71 None -2089 35 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL1423 3125 71 None -2089 35 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
DB01100 3125 71 None -2089 35 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 7 1 3 5.9 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)n1c(=O)[nH]c2c1cccc2 10.1038/s41467-023-40064-9
135398737 958 93 None -9332 43 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
38 958 93 None -9332 43 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
722 958 93 None -9332 43 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
CHEMBL42 958 93 None -9332 43 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
DB00363 958 93 None -9332 43 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 10.1038/s41467-023-40064-9
16564 204995 32 None -134 6 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 207 2 3 3 0.3 N=C(N)NCC1COc2ccccc2O1 10.1038/s41467-023-40064-9
CHEMBL76725 204995 32 None -134 6 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 207 2 3 3 0.3 N=C(N)NCC1COc2ccccc2O1 10.1038/s41467-023-40064-9
4037 189016 60 None -1 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 295 3 2 2 4.7 Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl 10.1038/s41467-023-40064-9
CHEMBL509 189016 60 None -1 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 295 3 2 2 4.7 Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl 10.1038/s41467-023-40064-9
CHEMBL876 189016 60 None -1 4 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 295 3 2 2 4.7 Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl 10.1038/s41467-023-40064-9
441383 20333 57 None -208 19 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 10.1038/s41467-023-40064-9
CHEMBL1306 20333 57 None -208 19 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 531 8 0 8 4.5 CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 10.1038/s41467-023-40064-9
446156 39825 29 None 1 3 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 459 11 3 5 4.9 COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1 10.1038/s41467-023-40064-9
CHEMBL1477 39825 29 None 1 3 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 459 11 3 5 4.9 COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1 10.1038/s41467-023-40064-9
11057 176149 23 None -3 25 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 10.1038/s41467-023-40064-9
3468 176149 23 None -3 25 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 10.1038/s41467-023-40064-9
CHEMBL459265 176149 23 None -3 25 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 10.1038/s41467-023-40064-9
CHEMBL64894 176149 23 None -3 25 Human 5.7 pAC50 = 5.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 372 4 0 2 4.5 CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1 10.1038/s41467-023-40064-9
3336 95001 30 None -4265 14 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 315 7 1 1 5.6 CC(NCCC(c1ccccc1)c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1405922 95001 30 None -4265 14 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 315 7 1 1 5.6 CC(NCCC(c1ccccc1)c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL254832 95001 30 None -4265 14 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 315 7 1 1 5.6 CC(NCCC(c1ccccc1)c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
3606 203488 60 None -2 8 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 270 5 2 2 4.8 CCC(c1ccc(O)cc1)C(CC)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL6615 203488 60 None -2 8 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 270 5 2 2 4.8 CCC(c1ccc(O)cc1)C(CC)c1ccc(O)cc1 10.1038/s41467-023-40064-9
667492 43905 43 None -1 4 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 234 1 2 3 0.2 CN1C(=O)/C(=N\NC(N)=S)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL1512080 43905 43 None -1 4 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 234 1 2 3 0.2 CN1C(=O)/C(=N\NC(N)=S)c2ccccc21 10.1038/s41467-023-40064-9
60663 175669 42 None -29 12 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 495 11 1 5 5.3 COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C 10.1038/s41467-023-40064-9
CHEMBL1421212 175669 42 None -29 12 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 495 11 1 5 5.3 COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C 10.1038/s41467-023-40064-9
CHEMBL1534525 175669 42 None -29 12 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 495 11 1 5 5.3 COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C 10.1038/s41467-023-40064-9
CHEMBL45816 175669 42 None -29 12 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 495 11 1 5 5.3 COCC(=O)O[C@]1(CCN(C)CCCc2nc3ccccc3[nH]2)CCc2cc(F)ccc2[C@@H]1C(C)C 10.1038/s41467-023-40064-9
CHEMBL4743867 214033 14 None -4466 15 Human 4.7 pAC50 = 4.7 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL None None None OCCN1CCN(CCC=C2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1 10.1038/s41467-023-40064-9
3952 1888 38 None -2570 21 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 10.1038/s41467-023-40064-9
5353646 1888 38 None -2570 21 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 10.1038/s41467-023-40064-9
5443 1888 38 None -2570 21 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 10.1038/s41467-023-40064-9
5702063 1888 38 None -2570 21 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 10.1038/s41467-023-40064-9
CHEMBL1331786 1888 38 None -2570 21 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 10.1038/s41467-023-40064-9
CHEMBL420 1888 38 None -2570 21 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 230 2 2 2 1.6 NC(=N/N=C\c1c(Cl)cccc1Cl)N 10.1038/s41467-023-40064-9
5280795 4829 69 None -1 3 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 384 6 1 1 7.6 C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12 10.1038/s41467-023-40064-9
CHEMBL1042 4829 69 None -1 3 Human 4.7 pAC50 = 4.7 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 384 6 1 1 7.6 C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12 10.1038/s41467-023-40064-9
213046 2385 59 None -1445 17 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
4168 2385 59 None -1445 17 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
7461 2385 59 None -1445 17 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
CHEMBL1237021 2385 59 None -1445 17 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
DB08815 2385 59 None -1445 17 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 492 5 0 6 4.3 O=C1N(C[C@@H]2CCCC[C@H]2CN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1[C@H]1CC[C@@H]2C1 10.1038/s41467-023-40064-9
13791 43791 67 None -3 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 356 4 1 3 5.4 CCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@]12C 10.1038/s41467-023-40064-9
CHEMBL1511 43791 67 None -3 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 356 4 1 3 5.4 CCCCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@]12C 10.1038/s41467-023-40064-9
3634 84108 51 None -16 9 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 356 7 2 5 3.7 CCN(CC)CCNc1ccc(CO)c2sc3ccccc3c(=O)c12 10.1038/s41467-023-40064-9
CHEMBL22077 84108 51 None -16 9 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 356 7 2 5 3.7 CCN(CC)CCNc1ccc(CO)c2sc3ccccc3c(=O)c12 10.1038/s41467-023-40064-9
5625 199668 72 None -1 5 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 456 6 3 6 2.7 CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1 10.1038/s41467-023-40064-9
CHEMBL593 199668 72 None -1 5 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 456 6 3 6 2.7 CC(C)Nc1cccnc1N1CCN(C(=O)c2cc3cc(NS(C)(=O)=O)ccc3[nH]2)CC1 10.1038/s41467-023-40064-9
6231 29770 33 None -8 4 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 0 1 2 3.6 C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
CHEMBL1387 29770 33 None -8 4 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 298 0 1 2 3.6 C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=C(CCC(=O)C4)[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
277 1301 62 None -25118 29 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 10.1038/s41467-023-40064-9
2913 1301 62 None -25118 29 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 10.1038/s41467-023-40064-9
765 1301 62 None -25118 29 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 10.1038/s41467-023-40064-9
CHEMBL516 1301 62 None -25118 29 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 10.1038/s41467-023-40064-9
DB00434 1301 62 None -25118 29 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 287 0 0 1 4.7 CN1CCC(=C2c3ccccc3C=Cc3c2cccc3)CC1 10.1038/s41467-023-40064-9
2580 78395 18 None -1174 10 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 446 6 1 4 4.1 NC(=O)C1(N2CCCCC2)CCN(CCCN2c3ccccc3CCc3ccccc32)CC1 10.1038/s41467-023-40064-9
CHEMBL2110775 78395 18 None -1174 10 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 446 6 1 4 4.1 NC(=O)C1(N2CCCCC2)CCN(CCCN2c3ccccc3CCc3ccccc32)CC1 10.1038/s41467-023-40064-9
31703 194717 63 None -38 8 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 543 5 6 12 0.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
CHEMBL359744 194717 63 None -38 8 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 543 5 6 12 0.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
CHEMBL53463 194717 63 None -38 8 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 543 5 6 12 0.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
222528 1368 81 None -144 2 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 4 3 3 4.5 O[C@@H]1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2C[C@H](O)[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)C 10.1038/s41467-023-40064-9
4988 1368 81 None -144 2 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 4 3 3 4.5 O[C@@H]1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2C[C@H](O)[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)C 10.1038/s41467-023-40064-9
610 1368 81 None -144 2 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 4 3 3 4.5 O[C@@H]1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2C[C@H](O)[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)C 10.1038/s41467-023-40064-9
CHEMBL406393 1368 81 None -144 2 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 4 3 3 4.5 O[C@@H]1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2C[C@H](O)[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)C 10.1038/s41467-023-40064-9
DB03619 1368 81 None -144 2 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 392 4 3 3 4.5 O[C@@H]1CC[C@]2([C@@H](C1)CC[C@@H]1[C@@H]2C[C@H](O)[C@]2([C@H]1CC[C@@H]2[C@@H](CCC(=O)O)C)C)C 10.1038/s41467-023-40064-9
21700 593 53 None -4897 5 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 520 6 1 7 4.1 CCC(=O)O[C@@]1([C@@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2CCC2=CC(=O)C=C[C@]12C)Cl)C(=O)COC(=O)CC 10.1038/s41467-023-40064-9
294 593 53 None -4897 5 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 520 6 1 7 4.1 CCC(=O)O[C@@]1([C@@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2CCC2=CC(=O)C=C[C@]12C)Cl)C(=O)COC(=O)CC 10.1038/s41467-023-40064-9
5894 593 53 None -4897 5 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 520 6 1 7 4.1 CCC(=O)O[C@@]1([C@@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2CCC2=CC(=O)C=C[C@]12C)Cl)C(=O)COC(=O)CC 10.1038/s41467-023-40064-9
CHEMBL1200500 593 53 None -4897 5 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 520 6 1 7 4.1 CCC(=O)O[C@@]1([C@@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2CCC2=CC(=O)C=C[C@]12C)Cl)C(=O)COC(=O)CC 10.1038/s41467-023-40064-9
DB00394 593 53 None -4897 5 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 520 6 1 7 4.1 CCC(=O)O[C@@]1([C@@H](C)C[C@@H]2[C@]1(C)C[C@H](O)[C@]1([C@H]2CCC2=CC(=O)C=C[C@]12C)Cl)C(=O)COC(=O)CC 10.1038/s41467-023-40064-9
65646 121301 26 None -2 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 6 2 9 0.8 Cc1oc(=O)oc1COC(=O)[C@@H]1N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1(C)C 10.1038/s41467-023-40064-9
CHEMBL3580454 121301 26 None -2 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 461 6 2 9 0.8 Cc1oc(=O)oc1COC(=O)[C@@H]1N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1(C)C 10.1038/s41467-023-40064-9
4167 14500 43 None -4677 10 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 309 2 0 2 5.0 CN1CCCC(CC2c3ccccc3Sc3ccccc32)C1 10.1038/s41467-023-40064-9
CHEMBL1201342 14500 43 None -4677 10 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 309 2 0 2 5.0 CN1CCCC(CC2c3ccccc3Sc3ccccc32)C1 10.1038/s41467-023-40064-9
9051 14442 67 None -5 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 1 0 2 4.5 CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C 10.1038/s41467-023-40064-9
CHEMBL1200853 14442 67 None -5 3 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 312 1 0 2 4.5 CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C 10.1038/s41467-023-40064-9
1054 2917 85 None -83 5 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 282 15 1 1 6.1 CCCCCCCC/C=C\CCCCCCCC(=O)O 10.1038/s41467-023-40064-9
3400 2917 85 None -83 5 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 282 15 1 1 6.1 CCCCCCCC/C=C\CCCCCCCC(=O)O 10.1038/s41467-023-40064-9
445639 2917 85 None -83 5 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 282 15 1 1 6.1 CCCCCCCC/C=C\CCCCCCCC(=O)O 10.1038/s41467-023-40064-9
CHEMBL8659 2917 85 None -83 5 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 282 15 1 1 6.1 CCCCCCCC/C=C\CCCCCCCC(=O)O 10.1038/s41467-023-40064-9
2749 32643 101 None -1 3 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 207 1 1 3 2.4 Cc1cc(C2CCCCC2)n(O)c(=O)c1 10.1038/s41467-023-40064-9
CHEMBL1413 32643 101 None -1 3 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 207 1 1 3 2.4 Cc1cc(C2CCCCC2)n(O)c(=O)c1 10.1038/s41467-023-40064-9
72287 61061 38 None -1862 9 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 328 5 0 4 4.5 COc1ccc2c(c1)N(C[C@H](C)CN(C)C)c1ccccc1S2 10.1038/s41467-023-40064-9
CHEMBL1764 61061 38 None -1862 9 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 328 5 0 4 4.5 COc1ccc2c(c1)N(C[C@H](C)CN(C)C)c1ccccc1S2 10.1038/s41467-023-40064-9
180 401 56 None -56234 38 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
200 401 56 None -56234 38 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
2160 401 56 None -56234 38 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
CHEMBL629 401 56 None -56234 38 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
DB00321 401 56 None -56234 38 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 277 3 0 1 4.2 CN(CCC=C1c2ccccc2CCc2c1cccc2)C 10.1038/s41467-023-40064-9
134780 168368 131 None - 1 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 273 1 2 5 -0.3 Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O 10.1038/s41467-023-40064-9
CHEMBL43452 168368 131 None - 1 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 273 1 2 5 -0.3 Nc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O 10.1038/s41467-023-40064-9
2406 100404 89 None -162 17 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 354 2 2 3 5.9 Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O 10.1038/s41467-023-40064-9
CHEMBL290106 100404 89 None -162 17 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 354 2 2 3 5.9 Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O 10.1038/s41467-023-40064-9
1884 3083 52 None -331 9 Human 5.6 pAC50 = 5.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O 10.1038/s41467-023-40064-9
5280363 3083 52 None -331 9 Human 5.6 pAC50 = 5.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O 10.1038/s41467-023-40064-9
912 3083 52 None -331 9 Human 5.6 pAC50 = 5.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O 10.1038/s41467-023-40064-9
CHEMBL815 3083 52 None -331 9 Human 5.6 pAC50 = 5.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O 10.1038/s41467-023-40064-9
DB12789 3083 52 None -331 9 Human 5.6 pAC50 = 5.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O 10.1038/s41467-023-40064-9
1440 2027 119 None -72 7 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 357 4 1 4 3.9 COc1ccc2c(c1)c(CC(=O)O)c(n2C(=O)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
1909 2027 119 None -72 7 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 357 4 1 4 3.9 COc1ccc2c(c1)c(CC(=O)O)c(n2C(=O)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
3715 2027 119 None -72 7 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 357 4 1 4 3.9 COc1ccc2c(c1)c(CC(=O)O)c(n2C(=O)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
CHEMBL6 2027 119 None -72 7 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 357 4 1 4 3.9 COc1ccc2c(c1)c(CC(=O)O)c(n2C(=O)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
DB00328 2027 119 None -72 7 Human 4.6 pAC50 = 4.6 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 357 4 1 4 3.9 COc1ccc2c(c1)c(CC(=O)O)c(n2C(=O)c1ccc(cc1)Cl)C 10.1038/s41467-023-40064-9
2723 154046 108 None -15 4 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 156 0 1 1 2.7 Cc1cc(O)cc(C)c1Cl 10.1038/s41467-023-40064-9
CHEMBL398440 154046 108 None -15 4 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 156 0 1 1 2.7 Cc1cc(O)cc(C)c1Cl 10.1038/s41467-023-40064-9
4756 16649 50 None -14 16 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 213 2 2 5 2.7 Nc1ccc(/N=N/c2ccccc2)c(N)n1 10.1038/s41467-023-40064-9
CHEMBL1201022 16649 50 None -14 16 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 213 2 2 5 2.7 Nc1ccc(/N=N/c2ccccc2)c(N)n1 10.1038/s41467-023-40064-9
CHEMBL1242 16649 50 None -14 16 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 213 2 2 5 2.7 Nc1ccc(/N=N/c2ccccc2)c(N)n1 10.1038/s41467-023-40064-9
9324 9238 60 None -5 6 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 404 2 0 4 4.8 CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
CHEMBL110691 9238 60 None -5 6 Human 4.6 pAC50 = 4.6 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 404 2 0 4 4.8 CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
108143 94581 107 None 1 2 Human 4.5 pAC50 = 4.5 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 351 3 2 2 5.0 CC1(C)CCC(C)(C)c2cc(NC(=O)c3ccc(C(=O)O)cc3)ccc21 10.1038/s41467-023-40064-9
CHEMBL25202 94581 107 None 1 2 Human 4.5 pAC50 = 4.5 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 351 3 2 2 5.0 CC1(C)CCC(C)(C)c2cc(NC(=O)c3ccc(C(=O)O)cc3)ccc21 10.1038/s41467-023-40064-9
1599 2341 50 None -15488 21 Human 4.5 pAC50 = 4.5 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
3955 2341 50 None -15488 21 Human 4.5 pAC50 = 4.5 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
7215 2341 50 None -15488 21 Human 4.5 pAC50 = 4.5 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL841 2341 50 None -15488 21 Human 4.5 pAC50 = 4.5 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
DB00836 2341 50 None -15488 21 Human 4.5 pAC50 = 4.5 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
6237 86804 46 None -3 8 Human 4.5 pAC50 = 4.5 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 518 3 1 3 5.1 CCc1oc2ccccc2c1C(=O)c1cc(I)c(O)c(I)c1 10.1038/s41467-023-40064-9
CHEMBL232201 86804 46 None -3 8 Human 4.5 pAC50 = 4.5 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 518 3 1 3 5.1 CCc1oc2ccccc2c1C(=O)c1cc(I)c(O)c(I)c1 10.1038/s41467-023-40064-9
24765256 173297 23 None -2 4 Human 4.5 pAC50 = 4.5 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 757 6 3 9 3.9 CC[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@H](C(C)(C)C)NC(=O)OCC(C)(C)CCCCc1cccc3c1CN(C3)C(=O)O2)C(=O)NS(=O)(=O)C1CC1 10.1038/s41467-023-40064-9
CHEMBL4525964 173297 23 None -2 4 Human 4.5 pAC50 = 4.5 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 757 6 3 9 3.9 CC[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H]2CN1C(=O)[C@H](C(C)(C)C)NC(=O)OCC(C)(C)CCCCc1cccc3c1CN(C3)C(=O)O2)C(=O)NS(=O)(=O)C1CC1 10.1038/s41467-023-40064-9
4229 3735 57 None - 1 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 452 12 2 5 4.7 CC(OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/C(COc1ccccc1)(F)F)O)C 10.1038/s41467-023-40064-9
7451 3735 57 None - 1 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 452 12 2 5 4.7 CC(OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/C(COc1ccccc1)(F)F)O)C 10.1038/s41467-023-40064-9
9868491 3735 57 None - 1 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 452 12 2 5 4.7 CC(OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/C(COc1ccccc1)(F)F)O)C 10.1038/s41467-023-40064-9
CHEMBL1963683 3735 57 None - 1 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 452 12 2 5 4.7 CC(OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/C(COc1ccccc1)(F)F)O)C 10.1038/s41467-023-40064-9
DB08819 3735 57 None - 1 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 452 12 2 5 4.7 CC(OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/C(COc1ccccc1)(F)F)O)C 10.1038/s41467-023-40064-9
2028 2979 80 None -15135 14 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 4 3.3 CCN(CC#CCOC(=O)C(c1ccccc1)(C1CCCCC1)O)CC 10.1038/s41467-023-40064-9
359 2979 80 None -15135 14 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 4 3.3 CCN(CC#CCOC(=O)C(c1ccccc1)(C1CCCCC1)O)CC 10.1038/s41467-023-40064-9
4634 2979 80 None -15135 14 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 4 3.3 CCN(CC#CCOC(=O)C(c1ccccc1)(C1CCCCC1)O)CC 10.1038/s41467-023-40064-9
CHEMBL1231 2979 80 None -15135 14 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 4 3.3 CCN(CC#CCOC(=O)C(c1ccccc1)(C1CCCCC1)O)CC 10.1038/s41467-023-40064-9
DB01062 2979 80 None -15135 14 Human 4.5 pAC50 = 4.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 7 1 4 3.3 CCN(CC#CCOC(=O)C(c1ccccc1)(C1CCCCC1)O)CC 10.1038/s41467-023-40064-9
24821094 67094 93 None 1 8 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 440 5 1 7 4.2 C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1 10.1038/s41467-023-40064-9
CHEMBL1873475 67094 93 None 1 8 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 440 5 1 7 4.2 C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1 10.1038/s41467-023-40064-9
2683 102888 25 None -338 24 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 10.1038/s41467-023-40064-9
CHEMBL305906 102888 25 None -338 24 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 10.1038/s41467-023-40064-9
CHEMBL334255 102888 25 None -338 24 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 304 15 0 0 6.5 CCCCCCCCCCCCCCCC[n+]1ccccc1 10.1038/s41467-023-40064-9
242 470 124 None -758 33 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
34 470 124 None -758 33 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
60795 470 124 None -758 33 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
CHEMBL1112 470 124 None -758 33 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
DB01238 470 124 None -758 33 Human 5.5 pAC50 = 5.5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 447 7 1 4 4.9 O=C1CCc2c(N1)cc(cc2)OCCCCN1CCN(CC1)c1cccc(c1Cl)Cl 10.1038/s41467-023-40064-9
187 255 39 None -7 8 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 146 3 0 2 0.3 CC(=O)OCC[N+](C)(C)C 10.1038/s41467-023-40064-9
294 255 39 None -7 8 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 146 3 0 2 0.3 CC(=O)OCC[N+](C)(C)C 10.1038/s41467-023-40064-9
65 255 39 None -7 8 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 146 3 0 2 0.3 CC(=O)OCC[N+](C)(C)C 10.1038/s41467-023-40064-9
8593 255 39 None -7 8 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 146 3 0 2 0.3 CC(=O)OCC[N+](C)(C)C 10.1038/s41467-023-40064-9
CHEMBL667 255 39 None -7 8 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 146 3 0 2 0.3 CC(=O)OCC[N+](C)(C)C 10.1038/s41467-023-40064-9
DB03128 255 39 None -7 8 Human 6.5 pAC50 = 6.5 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 146 3 0 2 0.3 CC(=O)OCC[N+](C)(C)C 10.1038/s41467-023-40064-9
1570 57299 97 None -2 3 Human 5.4 pAC50 = 5.4 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 127 0 1 3 1.5 On1ccccc1=S 10.1038/s41467-023-40064-9
CHEMBL1650619 57299 97 None -2 3 Human 5.4 pAC50 = 5.4 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 127 0 1 3 1.5 On1ccccc1=S 10.1038/s41467-023-40064-9
5440 28724 37 None -1288 16 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 399 6 0 5 5.0 CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
CHEMBL1378 28724 37 None -1288 16 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 399 6 0 5 5.0 CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2 10.1038/s41467-023-40064-9
123879 3287 82 None 1 6 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1038/s41467-023-40064-9
1910 3287 82 None 1 6 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1038/s41467-023-40064-9
1911 3287 82 None 1 6 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1038/s41467-023-40064-9
2354 3287 82 None 1 6 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1038/s41467-023-40064-9
CHEMBL361812 3287 82 None 1 6 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1038/s41467-023-40064-9
DB13036 3287 82 None 1 6 Human 7.4 pAC50 = 7.4 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1038/s41467-023-40064-9
54758501 139067 58 None -1445 11 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 486 7 2 8 5.1 C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3ccsc23)c1 10.1038/s41467-023-40064-9
CHEMBL3786343 139067 58 None -1445 11 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 486 7 2 8 5.1 C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3ccsc23)c1 10.1038/s41467-023-40064-9
443869 78141 45 None -3 10 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 491 7 1 8 3.8 COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@H]2CCN(Cc3ccccc3)C2)[C@H]1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
CHEMBL2103761 78141 45 None -3 10 Human 5.4 pAC50 = 5.4 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 491 7 1 8 3.8 COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@H]2CCN(Cc3ccccc3)C2)[C@H]1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
392622 56312 95 None -7 20 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 720 17 4 9 5.9 CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1 10.1038/s41467-023-40064-9
CHEMBL163 56312 95 None -7 20 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 720 17 4 9 5.9 CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1 10.1038/s41467-023-40064-9
1909 2822 64 None -11 11 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 479 9 1 8 3.7 COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C 10.1038/s41467-023-40064-9
2559 2822 64 None -11 11 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 479 9 1 8 3.7 COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C 10.1038/s41467-023-40064-9
4474 2822 64 None -11 11 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 479 9 1 8 3.7 COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C 10.1038/s41467-023-40064-9
CHEMBL1484 2822 64 None -11 11 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 479 9 1 8 3.7 COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C 10.1038/s41467-023-40064-9
CHEMBL3302409 2822 64 None -11 11 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 479 9 1 8 3.7 COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C 10.1038/s41467-023-40064-9
DB00622 2822 64 None -11 11 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 479 9 1 8 3.7 COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C 10.1038/s41467-023-40064-9
3356 2280 73 None -165 2 Human 8.2 pAC50 = 8.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1038/s41467-023-40064-9
4326 2280 73 None -165 2 Human 8.2 pAC50 = 8.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1038/s41467-023-40064-9
9867642 2280 73 None -165 2 Human 8.2 pAC50 = 8.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1038/s41467-023-40064-9
CHEMBL426559 2280 73 None -165 2 Human 8.2 pAC50 = 8.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1038/s41467-023-40064-9
DB11629 2280 73 None -165 2 Human 8.2 pAC50 = 8.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1038/s41467-023-40064-9
54454 5258 88 None -3 14 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 418 6 1 5 4.6 CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21 10.1038/s41467-023-40064-9
CHEMBL1064 5258 88 None -3 14 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 418 6 1 5 4.6 CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21 10.1038/s41467-023-40064-9
25102847 78221 93 None -8 10 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 501 8 2 6 5.5 COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC 10.1038/s41467-023-40064-9
CHEMBL2105717 78221 93 None -8 10 Human 5.3 pAC50 = 5.3 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 501 8 2 6 5.5 COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC 10.1038/s41467-023-40064-9
2162 41514 100 None -5 22 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl 10.1038/s41467-023-40064-9
CHEMBL1491 41514 100 None -5 22 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl 10.1038/s41467-023-40064-9
448537 160250 89 None -35 31 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL411 160250 89 None -35 31 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 10.1038/s41467-023-40064-9
82146 4530 113 None -2 8 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 348 3 1 1 6.1 C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C 10.1038/s41467-023-40064-9
CHEMBL1023 4530 113 None -2 8 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 348 3 1 1 6.1 C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C 10.1038/s41467-023-40064-9
3397 205488 112 None -1 7 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 3 1 3 3.2 CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1 10.1038/s41467-023-40064-9
CHEMBL806 205488 112 None -1 7 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 276 3 1 3 3.2 CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1 10.1038/s41467-023-40064-9
24826799 10798 104 None -19 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 532 4 1 6 4.5 Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12 10.1038/s41467-023-40064-9
CHEMBL1171837 10798 104 None -19 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 532 4 1 6 4.5 Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12 10.1038/s41467-023-40064-9
92727 204552 77 None -1 6 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 628 15 4 5 4.3 Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O 10.1038/s41467-023-40064-9
CHEMBL729 204552 77 None -1 6 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 628 15 4 5 4.3 Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O 10.1038/s41467-023-40064-9
11167602 70460 116 None -4 6 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 482 5 3 4 5.7 CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1 10.1038/s41467-023-40064-9
CHEMBL1946170 70460 116 None -4 6 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 482 5 3 4 5.7 CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1 10.1038/s41467-023-40064-9
1765 3817 98 None -100 8 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1038/s41467-023-40064-9
4184 3817 98 None -100 8 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1038/s41467-023-40064-9
9871419 3817 98 None -100 8 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1038/s41467-023-40064-9
CHEMBL398435 3817 98 None -100 8 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1038/s41467-023-40064-9
DB08816 3817 98 None -100 8 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 522 10 4 11 2.0 CCCSc1nc(N[C@@H]2C[C@H]2c2ccc(c(c2)F)F)c2c(n1)n(nn2)[C@@H]1C[C@@H]([C@H]([C@H]1O)O)OCCO 10.1038/s41467-023-40064-9
2600 3779 74 None -190 32 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
2608 3779 74 None -190 32 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
5405 3779 74 None -190 32 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
CHEMBL17157 3779 74 None -190 32 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
DB00342 3779 74 None -190 32 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O 10.1038/s41467-023-40064-9
9822750 78409 65 None -1 8 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)[C@@H]1c1ccccc1Cl 10.1038/s41467-023-40064-9
CHEMBL2111097 78409 65 None -1 8 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 408 8 2 7 2.3 CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)[C@@H]1c1ccccc1Cl 10.1038/s41467-023-40064-9
5353853 17986 47 None -38 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
9556529 17986 47 None -38 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1262 17986 47 None -38 20 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 427 6 0 4 6.1 Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
6719 32668 39 None -4 4 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 340 4 0 3 4.1 O=C1c2ccccc2C(=O)C1C(=O)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1413199 32668 39 None -4 4 Human 5.2 pAC50 = 5.2 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 340 4 0 3 4.1 O=C1c2ccccc2C(=O)C1C(=O)C(c1ccccc1)c1ccccc1 10.1038/s41467-023-40064-9
89683805 154433 67 None -2344 6 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 473 6 3 8 4.3 CC(C)(O)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1 10.1038/s41467-023-40064-9
CHEMBL3989908 154433 67 None -2344 6 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 473 6 3 8 4.3 CC(C)(O)CNc1nc(Nc2ccnc(C(F)(F)F)c2)nc(-c2cccc(C(F)(F)F)n2)n1 10.1038/s41467-023-40064-9
477468 175398 36 None 1 4 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 1269 18 16 23 -3.9 CCCCCOc1ccc(-c2cc(-c3ccc(C(=O)N[C@H]4C[C@@H](O)[C@@H](O)NC(=O)[C@@H]5[C@@H](O)[C@@H](C)CN5C(=O)[C@H]([C@H](O)CC(N)=O)NC(=O)[C@H]([C@H](O)[C@@H](O)c5ccc(O)c(OS(=O)(=O)O)c5)NC(=O)[C@@H]5C[C@@H](O)CN5C(=O)[C@H]([C@@H](C)O)NC4=O)cc3)no2)cc1 10.1038/s41467-023-40064-9
CHEMBL457547 175398 36 None 1 4 Human 5.2 pAC50 = 5.2 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 1269 18 16 23 -3.9 CCCCCOc1ccc(-c2cc(-c3ccc(C(=O)N[C@H]4C[C@@H](O)[C@@H](O)NC(=O)[C@@H]5[C@@H](O)[C@@H](C)CN5C(=O)[C@H]([C@H](O)CC(N)=O)NC(=O)[C@H]([C@H](O)[C@@H](O)c5ccc(O)c(OS(=O)(=O)O)c5)NC(=O)[C@@H]5C[C@@H](O)CN5C(=O)[C@H]([C@@H](C)O)NC4=O)cc3)no2)cc1 10.1038/s41467-023-40064-9
216237 3843 89 None -660 7 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 10.1038/s41467-023-40064-9
2226 3843 89 None -660 7 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 10.1038/s41467-023-40064-9
4110 3843 89 None -660 7 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 10.1038/s41467-023-40064-9
CHEMBL344159 3843 89 None -660 7 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 448 3 2 3 5.7 Clc1ccc2c(c1)C(O)CCCN2C(=O)c1ccc(cc1C)NC(=O)c1ccccc1C 10.1038/s41467-023-40064-9
115368 3056 47 None -2454 9 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 6 0 6 3.4 O=C1N(CCCCN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1CCCC2 10.1038/s41467-023-40064-9
2112 3056 47 None -2454 9 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 6 0 6 3.4 O=C1N(CCCCN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1CCCC2 10.1038/s41467-023-40064-9
7556 3056 47 None -2454 9 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 6 0 6 3.4 O=C1N(CCCCN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1CCCC2 10.1038/s41467-023-40064-9
CHEMBL1472975 3056 47 None -2454 9 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 6 0 6 3.4 O=C1N(CCCCN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1CCCC2 10.1038/s41467-023-40064-9
DB08922 3056 47 None -2454 9 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 426 6 0 6 3.4 O=C1N(CCCCN2CCN(CC2)c2nsc3c2cccc3)C(=O)[C@@H]2[C@H]1CCCC2 10.1038/s41467-023-40064-9
34040 28085 72 None -2511 11 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 483 4 0 6 3.9 CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13 10.1038/s41467-023-40064-9
CHEMBL1372950 28085 72 None -2511 11 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 483 4 0 6 3.9 CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13 10.1038/s41467-023-40064-9
150311 9812 102 None -1 7 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 409 6 2 3 4.9 O=C1[C@H](CC[C@H](O)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1 10.1038/s41467-023-40064-9
CHEMBL1138 9812 102 None -1 7 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 409 6 2 3 4.9 O=C1[C@H](CC[C@H](O)c2ccc(F)cc2)[C@@H](c2ccc(O)cc2)N1c1ccc(F)cc1 10.1038/s41467-023-40064-9
3839 3757 84 None -794 2 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 411 4 1 6 3.4 Cc1nc(C)c2c(n1)N(Cc1ccc(cc1)c1ccccc1c1nn[nH]n1)C(=O)CC2 10.1038/s41467-023-40064-9
60919 3757 84 None -794 2 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 411 4 1 6 3.4 Cc1nc(C)c2c(n1)N(Cc1ccc(cc1)c1ccccc1c1nn[nH]n1)C(=O)CC2 10.1038/s41467-023-40064-9
6898 3757 84 None -794 2 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 411 4 1 6 3.4 Cc1nc(C)c2c(n1)N(Cc1ccc(cc1)c1ccccc1c1nn[nH]n1)C(=O)CC2 10.1038/s41467-023-40064-9
CHEMBL432162 3757 84 None -794 2 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 411 4 1 6 3.4 Cc1nc(C)c2c(n1)N(Cc1ccc(cc1)c1ccccc1c1nn[nH]n1)C(=O)CC2 10.1038/s41467-023-40064-9
DB01349 3757 84 None -794 2 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 411 4 1 6 3.4 Cc1nc(C)c2c(n1)N(Cc1ccc(cc1)c1ccccc1c1nn[nH]n1)C(=O)CC2 10.1038/s41467-023-40064-9
151537 162664 49 None 1 4 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 543 5 6 12 0.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
41867 162664 49 None 1 4 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 543 5 6 12 0.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
CHEMBL417 162664 49 None 1 4 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 543 5 6 12 0.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
1726 2497 13 None -104 8 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 160 3 0 2 0.6 CC(C[N+](C)(C)C)OC(=O)C 10.1038/s41467-023-40064-9
1993 2497 13 None -104 8 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 160 3 0 2 0.6 CC(C[N+](C)(C)C)OC(=O)C 10.1038/s41467-023-40064-9
7438 2497 13 None -104 8 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 160 3 0 2 0.6 CC(C[N+](C)(C)C)OC(=O)C 10.1038/s41467-023-40064-9
CHEMBL978 2497 13 None -104 8 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 160 3 0 2 0.6 CC(C[N+](C)(C)C)OC(=O)C 10.1038/s41467-023-40064-9
DB06709 2497 13 None -104 8 Human 6.1 pAC50 = 6.1 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 160 3 0 2 0.6 CC(C[N+](C)(C)C)OC(=O)C 10.1038/s41467-023-40064-9
9853053 120519 74 None -5 9 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 693 10 2 3 8.4 O=C(NC1CCN(CCCCC2(C(=O)NCC(F)(F)F)c3ccccc3-c3ccccc32)CC1)c1ccccc1-c1ccc(C(F)(F)F)cc1 10.1038/s41467-023-40064-9
CHEMBL354541 120519 74 None -5 9 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 693 10 2 3 8.4 O=C(NC1CCN(CCCCC2(C(=O)NCC(F)(F)F)c3ccccc3-c3ccccc32)CC1)c1ccccc1-c1ccc(C(F)(F)F)cc1 10.1038/s41467-023-40064-9
CHEMBL4743867 214033 14 None -4466 15 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL None None None OCCN1CCN(CCC=C2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1 10.1038/s41467-023-40064-9
25151352 140606 67 None -24 11 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 417 5 2 4 5.2 FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1 10.1038/s41467-023-40064-9
CHEMBL3813873 140606 67 None -24 11 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 417 5 2 4 5.2 FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1 10.1038/s41467-023-40064-9
11976 920 59 None -2884 16 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 315 3 0 2 5.2 CN(C)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)Cl 10.1038/s41467-023-40064-9
667467 920 59 None -2884 16 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 315 3 0 2 5.2 CN(C)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)Cl 10.1038/s41467-023-40064-9
CHEMBL908 920 59 None -2884 16 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 315 3 0 2 5.2 CN(C)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)Cl 10.1038/s41467-023-40064-9
DB01239 920 59 None -2884 16 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 315 3 0 2 5.2 CN(C)CC/C=C\1/c2ccccc2Sc2c1cc(cc2)Cl 10.1038/s41467-023-40064-9
6324616 168824 25 None -1 3 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 697 2 6 12 4.8 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(cc(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
CHEMBL437765 168824 25 None -1 3 Human 5.1 pAC50 = 5.1 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 697 2 6 12 4.8 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(cc(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
43082 60283 37 None -22 10 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 6 0 2 5.5 CC(OCCN1CCCCCC1)(c1ccccc1)c1ccc(Cl)cc1 10.1038/s41467-023-40064-9
CHEMBL1742452 60283 37 None -22 10 Human 5.1 pAC50 = 5.1 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 357 6 0 2 5.5 CC(OCCN1CCCCCC1)(c1ccccc1)c1ccc(Cl)cc1 10.1038/s41467-023-40064-9
9429 202133 58 None -977 18 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 446 6 0 6 3.2 CN1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1 10.1038/s41467-023-40064-9
CHEMBL609109 202133 58 None -977 18 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 446 6 0 6 3.2 CN1CCN(CCCN2c3ccccc3Sc3ccc(S(=O)(=O)N(C)C)cc32)CC1 10.1038/s41467-023-40064-9
5584 203211 44 None -537 9 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 294 4 0 2 4.1 CC(CN(C)C)CN1c2ccccc2CCc2ccccc21 10.1038/s41467-023-40064-9
CHEMBL644 203211 44 None -537 9 Human 5.0 pAC50 = 5.0 Functional
Agonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopyAgonist activity at human TBXA2R in an in vitro cell-based assay (CRO assay) measured by fluorescence spectroscopy
ChEMBL 294 4 0 2 4.1 CC(CN(C)C)CN1c2ccccc2CCc2ccccc21 10.1038/s41467-023-40064-9
4829 199956 108 None -1 3 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 356 7 1 5 3.2 CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1 10.1038/s41467-023-40064-9
CHEMBL595 199956 108 None -1 3 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 356 7 1 5 3.2 CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1 10.1038/s41467-023-40064-9
5832 14460 54 None -11 5 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 1 0 3 4.1 C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
CHEMBL1201146 14460 54 None -11 5 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 340 1 0 3 4.1 C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
3474 38101 57 None -3 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 372 6 3 6 3.1 O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12 10.1038/s41467-023-40064-9
CHEMBL146095 38101 57 None -3 8 Human 5.0 pAC50 = 5.0 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 372 6 3 6 3.1 O=C(OCC(O)CO)c1ccccc1Nc1ccnc2cc(Cl)ccc12 10.1038/s41467-023-40064-9
108143 94581 107 None 1 2 Human 5.0 pAC50 = 5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 351 3 2 2 5.0 CC1(C)CCC(C)(C)c2cc(NC(=O)c3ccc(C(=O)O)cc3)ccc21 10.1038/s41467-023-40064-9
CHEMBL25202 94581 107 None 1 2 Human 5.0 pAC50 = 5 Functional
Antagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopyAntagonist activity at human TBXA2R in an in vitro cell-based assay measured by fluorescence spectroscopy
ChEMBL 351 3 2 2 5.0 CC1(C)CCC(C)(C)c2cc(NC(=O)c3ccc(C(=O)O)cc3)ccc21 10.1038/s41467-023-40064-9
56839344 152051 0 None 10 8 Human 9.5 pEC50 = 9.5 Functional
Cell Based Assay: Ca2+ signaling studies were performed using a FLIPR TETRA system (Molecular Devices, Sunnyvale, Calif., USA) in the 384-format. This is a high-throughput instrument for cell-based assays to monitor Ca2+ signaling associated with GPCRs and ion channels. Cells were seeded at a density of 5×104 cells/well in BioCoat poly-D-lysine coated, black wall, clear bottom 384-well plates (BD Biosciences, Franklin lakes, NJ, USA) and allowed to attach overnight in an incubator at 37° C. The cells were then washed twice with HBSS-HEPES buffer (Hanks' balanced salt solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using an ELx405 Select CW Microplate Washer (BioTek, Winooski, Vt., USA). After 60 min of dye-loading in the dark using the Ca2+-sensitive dye Fluo-4AM (Invitrogen, Carlsbad, Calif., USA), at a final concentration of 2×10^−6M, the plates were washed 4 times with HBSS-HEPES buffer to remove excess dye and leaving 50 μl of buffer in each well. The plates were then placed in the FLIPR TETRA instrument and allowed to equilibrate at 37° C. AGN-211377 was added in a 25 μl volume to each well to give final concentrations of 0.1 μM, 0.3 μM, 1 μM, 3 μM, 10 μM, and 30 μM; or 0.067 μM, 0.1 μM, 0.2 μM, 0.3 μM, 0.67 μM, and 1 μM for cells over-expressing TP receptors. After 4.5 minutes, a 7-point serial dilution of the standard agonist for the corresponding receptor, in a 25 μl volume was injected at the final concentrations from 10^−11M to 10^−5M in 10-fold serial dilution increments for cells expressing human recombinant DP1, EP1, EP2, EP3, EP4, FP, and IP receptors. The dose range for the standard agonist for human recombinant TP receptors was from 10^−12M to 10^−6M. HBSS-HEPES buffer was used as the negative control for the standard agonists. Cells were excited with LED (light emitting diode) excitation at 470-495 nm and emission was measured through an emission filter at 515-575 nm. Assay plates were read for 3.5 minutes using the FLIPRTETRA.Cell Based Assay: Ca2+ signaling studies were performed using a FLIPR TETRA system (Molecular Devices, Sunnyvale, Calif., USA) in the 384-format. This is a high-throughput instrument for cell-based assays to monitor Ca2+ signaling associated with GPCRs and ion channels. Cells were seeded at a density of 5×104 cells/well in BioCoat poly-D-lysine coated, black wall, clear bottom 384-well plates (BD Biosciences, Franklin lakes, NJ, USA) and allowed to attach overnight in an incubator at 37° C. The cells were then washed twice with HBSS-HEPES buffer (Hanks' balanced salt solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using an ELx405 Select CW Microplate Washer (BioTek, Winooski, Vt., USA). After 60 min of dye-loading in the dark using the Ca2+-sensitive dye Fluo-4AM (Invitrogen, Carlsbad, Calif., USA), at a final concentration of 2×10^−6M, the plates were washed 4 times with HBSS-HEPES buffer to remove excess dye and leaving 50 μl of buffer in each well. The plates were then placed in the FLIPR TETRA instrument and allowed to equilibrate at 37° C. AGN-211377 was added in a 25 μl volume to each well to give final concentrations of 0.1 μM, 0.3 μM, 1 μM, 3 μM, 10 μM, and 30 μM; or 0.067 μM, 0.1 μM, 0.2 μM, 0.3 μM, 0.67 μM, and 1 μM for cells over-expressing TP receptors. After 4.5 minutes, a 7-point serial dilution of the standard agonist for the corresponding receptor, in a 25 μl volume was injected at the final concentrations from 10^−11M to 10^−5M in 10-fold serial dilution increments for cells expressing human recombinant DP1, EP1, EP2, EP3, EP4, FP, and IP receptors. The dose range for the standard agonist for human recombinant TP receptors was from 10^−12M to 10^−6M. HBSS-HEPES buffer was used as the negative control for the standard agonists. Cells were excited with LED (light emitting diode) excitation at 470-495 nm and emission was measured through an emission filter at 515-575 nm. Assay plates were read for 3.5 minutes using the FLIPRTETRA.
ChEMBL 656 13 2 9 5.1 O=C(CCc1cc2c(cc1CN1CCC[C@H]1c1nc(C(=O)NCCCCC3CCCCC3)co1)OCO2)NS(=O)(=O)C(F)(F)F nan
CHEMBL3967284 152051 0 None 10 8 Human 9.5 pEC50 = 9.5 Functional
Cell Based Assay: Ca2+ signaling studies were performed using a FLIPR TETRA system (Molecular Devices, Sunnyvale, Calif., USA) in the 384-format. This is a high-throughput instrument for cell-based assays to monitor Ca2+ signaling associated with GPCRs and ion channels. Cells were seeded at a density of 5×104 cells/well in BioCoat poly-D-lysine coated, black wall, clear bottom 384-well plates (BD Biosciences, Franklin lakes, NJ, USA) and allowed to attach overnight in an incubator at 37° C. The cells were then washed twice with HBSS-HEPES buffer (Hanks' balanced salt solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using an ELx405 Select CW Microplate Washer (BioTek, Winooski, Vt., USA). After 60 min of dye-loading in the dark using the Ca2+-sensitive dye Fluo-4AM (Invitrogen, Carlsbad, Calif., USA), at a final concentration of 2×10^−6M, the plates were washed 4 times with HBSS-HEPES buffer to remove excess dye and leaving 50 μl of buffer in each well. The plates were then placed in the FLIPR TETRA instrument and allowed to equilibrate at 37° C. AGN-211377 was added in a 25 μl volume to each well to give final concentrations of 0.1 μM, 0.3 μM, 1 μM, 3 μM, 10 μM, and 30 μM; or 0.067 μM, 0.1 μM, 0.2 μM, 0.3 μM, 0.67 μM, and 1 μM for cells over-expressing TP receptors. After 4.5 minutes, a 7-point serial dilution of the standard agonist for the corresponding receptor, in a 25 μl volume was injected at the final concentrations from 10^−11M to 10^−5M in 10-fold serial dilution increments for cells expressing human recombinant DP1, EP1, EP2, EP3, EP4, FP, and IP receptors. The dose range for the standard agonist for human recombinant TP receptors was from 10^−12M to 10^−6M. HBSS-HEPES buffer was used as the negative control for the standard agonists. Cells were excited with LED (light emitting diode) excitation at 470-495 nm and emission was measured through an emission filter at 515-575 nm. Assay plates were read for 3.5 minutes using the FLIPRTETRA.Cell Based Assay: Ca2+ signaling studies were performed using a FLIPR TETRA system (Molecular Devices, Sunnyvale, Calif., USA) in the 384-format. This is a high-throughput instrument for cell-based assays to monitor Ca2+ signaling associated with GPCRs and ion channels. Cells were seeded at a density of 5×104 cells/well in BioCoat poly-D-lysine coated, black wall, clear bottom 384-well plates (BD Biosciences, Franklin lakes, NJ, USA) and allowed to attach overnight in an incubator at 37° C. The cells were then washed twice with HBSS-HEPES buffer (Hanks' balanced salt solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using an ELx405 Select CW Microplate Washer (BioTek, Winooski, Vt., USA). After 60 min of dye-loading in the dark using the Ca2+-sensitive dye Fluo-4AM (Invitrogen, Carlsbad, Calif., USA), at a final concentration of 2×10^−6M, the plates were washed 4 times with HBSS-HEPES buffer to remove excess dye and leaving 50 μl of buffer in each well. The plates were then placed in the FLIPR TETRA instrument and allowed to equilibrate at 37° C. AGN-211377 was added in a 25 μl volume to each well to give final concentrations of 0.1 μM, 0.3 μM, 1 μM, 3 μM, 10 μM, and 30 μM; or 0.067 μM, 0.1 μM, 0.2 μM, 0.3 μM, 0.67 μM, and 1 μM for cells over-expressing TP receptors. After 4.5 minutes, a 7-point serial dilution of the standard agonist for the corresponding receptor, in a 25 μl volume was injected at the final concentrations from 10^−11M to 10^−5M in 10-fold serial dilution increments for cells expressing human recombinant DP1, EP1, EP2, EP3, EP4, FP, and IP receptors. The dose range for the standard agonist for human recombinant TP receptors was from 10^−12M to 10^−6M. HBSS-HEPES buffer was used as the negative control for the standard agonists. Cells were excited with LED (light emitting diode) excitation at 470-495 nm and emission was measured through an emission filter at 515-575 nm. Assay plates were read for 3.5 minutes using the FLIPRTETRA.
ChEMBL 656 13 2 9 5.1 O=C(CCc1cc2c(cc1CN1CCC[C@H]1c1nc(C(=O)NCCCCC3CCCCC3)co1)OCO2)NS(=O)(=O)C(F)(F)F nan
118517359 144396 0 None -213 4 Human 7.0 pEC50 = 7 Functional
FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.
ChEMBL 456 8 2 3 4.8 O=C(O)c1ccc(CC[C@H]2C(=O)CC[C@@H]2/C=C/C(O)Cc2cccc(Br)c2)cc1 nan
CHEMBL3906016 144396 0 None -213 4 Human 7.0 pEC50 = 7 Functional
FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.
ChEMBL 456 8 2 3 4.8 O=C(O)c1ccc(CC[C@H]2C(=O)CC[C@@H]2/C=C/C(O)Cc2cccc(Br)c2)cc1 nan
118517359 144396 0 None -213 4 Human 7.0 pEC50 = 7.0 Functional
FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.
ChEMBL 456 8 2 3 4.8 O=C(O)c1ccc(CC[C@H]2C(=O)CC[C@@H]2/C=C/C(O)Cc2cccc(Br)c2)cc1 nan
CHEMBL3906016 144396 0 None -213 4 Human 7.0 pEC50 = 7.0 Functional
FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.
ChEMBL 456 8 2 3 4.8 O=C(O)c1ccc(CC[C@H]2C(=O)CC[C@@H]2/C=C/C(O)Cc2cccc(Br)c2)cc1 nan
11955193 143584 0 None -10 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assayAgonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay
ChEMBL 378 7 2 2 5.3 CC(C)(C)c1ccc([C@H]2[C@H](O)C[C@@H](Cl)[C@@H]2C/C=C\CCCC(=O)O)cc1 nan
CHEMBL3899346 143584 0 None -10 3 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assayAgonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay
ChEMBL 378 7 2 2 5.3 CC(C)(C)c1ccc([C@H]2[C@H](O)C[C@@H](Cl)[C@@H]2C/C=C\CCCC(=O)O)cc1 nan
1884 3083 52 None -331 9 Human 5.9 pEC50 = 5.9 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=95%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=95%)
ChEMBL 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O 10.1016/s0960-894x(00)00273-0
5280363 3083 52 None -331 9 Human 5.9 pEC50 = 5.9 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=95%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=95%)
ChEMBL 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O 10.1016/s0960-894x(00)00273-0
912 3083 52 None -331 9 Human 5.9 pEC50 = 5.9 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=95%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=95%)
ChEMBL 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O 10.1016/s0960-894x(00)00273-0
CHEMBL815 3083 52 None -331 9 Human 5.9 pEC50 = 5.9 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=95%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=95%)
ChEMBL 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O 10.1016/s0960-894x(00)00273-0
DB12789 3083 52 None -331 9 Human 5.9 pEC50 = 5.9 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=95%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=95%)
ChEMBL 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O 10.1016/s0960-894x(00)00273-0
11955293 149841 0 None 1 2 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assayAgonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay
ChEMBL 394 8 2 4 4.3 COC(=O)CCCCCC[C@@H]1[C@@H](c2ccc3c(c2)CCC3O)[C@H](O)C[C@H]1Cl nan
CHEMBL3948932 149841 0 None 1 2 Human 4.8 pEC50 = 4.8 Functional
Agonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assayAgonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay
ChEMBL 394 8 2 4 4.3 COC(=O)CCCCCC[C@@H]1[C@@H](c2ccc3c(c2)CCC3O)[C@H](O)C[C@H]1Cl nan
11955358 153082 0 None 1 3 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assayAgonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay
ChEMBL 364 8 2 2 4.7 O=C(O)CCCCCC[C@@H]1[C@@H](c2ccc3c(c2)CCC3)[C@H](O)C[C@H]1Cl nan
CHEMBL3976116 153082 0 None 1 3 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assayAgonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay
ChEMBL 364 8 2 2 4.7 O=C(O)CCCCCC[C@@H]1[C@@H](c2ccc3c(c2)CCC3)[C@H](O)C[C@H]1Cl nan
9825293 100055 9 None -83 2 Human 5.7 pEC50 = 5.7 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=50%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=50%)
ChEMBL 456 11 4 4 4.1 O=C(O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)CCc1cccc(C(F)(F)F)c1 10.1016/s0960-894x(00)00273-0
CHEMBL287080 100055 9 None -83 2 Human 5.7 pEC50 = 5.7 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=50%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=50%)
ChEMBL 456 11 4 4 4.1 O=C(O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)CCc1cccc(C(F)(F)F)c1 10.1016/s0960-894x(00)00273-0
118517361 153370 0 None -123 3 Human 6.7 pEC50 = 6.7 Functional
FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.
ChEMBL 446 8 2 3 5.1 O=C(O)c1ccc(CC[C@H]2C(=O)CC[C@@H]2/C=C/C(O)Cc2cccc(C(F)(F)F)c2)cc1 nan
CHEMBL3978590 153370 0 None -123 3 Human 6.7 pEC50 = 6.7 Functional
FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.
ChEMBL 446 8 2 3 5.1 O=C(O)c1ccc(CC[C@H]2C(=O)CC[C@@H]2/C=C/C(O)Cc2cccc(C(F)(F)F)c2)cc1 nan
6441607 155079 28 None 1 4 Human 7.6 pEC50 = 7.6 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=95%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=95%)
ChEMBL 382 12 4 4 3.7 CCCCC(C)(C)[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O 10.1016/s0960-894x(00)00273-0
CHEMBL40183 155079 28 None 1 4 Human 7.6 pEC50 = 7.6 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=95%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=95%)
ChEMBL 382 12 4 4 3.7 CCCCC(C)(C)[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O 10.1016/s0960-894x(00)00273-0
1894 957 41 None -891 5 Human 5.6 pEC50 = 5.6 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=100%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=100%)
ChEMBL 424 11 4 5 3.2 OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)Cl)O)O 10.1016/s0960-894x(00)00273-0
5311053 957 41 None -891 5 Human 5.6 pEC50 = 5.6 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=100%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=100%)
ChEMBL 424 11 4 5 3.2 OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)Cl)O)O 10.1016/s0960-894x(00)00273-0
CHEMBL37853 957 41 None -891 5 Human 5.6 pEC50 = 5.6 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=100%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=100%)
ChEMBL 424 11 4 5 3.2 OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)Cl)O)O 10.1016/s0960-894x(00)00273-0
DB11507 957 41 None -891 5 Human 5.6 pEC50 = 5.6 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=100%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=100%)
ChEMBL 424 11 4 5 3.2 OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)Cl)O)O 10.1016/s0960-894x(00)00273-0
118517490 153155 0 None -977 4 Human 5.6 pEC50 = 5.6 Functional
FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.
ChEMBL 414 8 2 3 4.4 O=C(O)c1ccc(CC[C@H]2C(=O)CC[C@@H]2/C=C/C(O)Cc2ccc(F)c(F)c2)cc1 nan
CHEMBL3976710 153155 0 None -977 4 Human 5.6 pEC50 = 5.6 Functional
FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.
ChEMBL 414 8 2 3 4.4 O=C(O)c1ccc(CC[C@H]2C(=O)CC[C@@H]2/C=C/C(O)Cc2ccc(F)c(F)c2)cc1 nan
11955294 144768 0 None -1 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assayAgonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay
ChEMBL 380 8 3 3 4.2 O=C(O)CCCCCC[C@@H]1[C@@H](c2ccc3c(c2)CCC3O)[C@H](O)C[C@H]1Cl nan
CHEMBL3909111 144768 0 None -1 2 Human 5.5 pEC50 = 5.5 Functional
Agonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assayAgonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay
ChEMBL 380 8 3 3 4.2 O=C(O)CCCCCC[C@@H]1[C@@H](c2ccc3c(c2)CCC3O)[C@H](O)C[C@H]1Cl nan
5311239 130618 31 None -30 3 Human 4.5 pEC50 = 4.5 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=100%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=100%)
ChEMBL 358 14 4 4 3.5 CCCCC[C@H](O)CC[C@H]1[C@H](O)C[C@H](O)[C@@H]1CCCCCCC(=O)O 10.1016/s0960-894x(00)00273-0
CHEMBL36817 130618 31 None -30 3 Human 4.5 pEC50 = 4.5 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=100%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=100%)
ChEMBL 358 14 4 4 3.5 CCCCC[C@H](O)CC[C@H]1[C@H](O)C[C@H](O)[C@@H]1CCCCCCC(=O)O 10.1016/s0960-894x(00)00273-0
11955384 147538 0 None -41 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assayAgonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay
ChEMBL 360 8 2 3 4.4 CC(C)(C)c1ccc([C@H]2[C@H](O)CC(=O)[C@@H]2CCCCCCC(=O)O)cc1 nan
CHEMBL3930718 147538 0 None -41 3 Human 5.4 pEC50 = 5.4 Functional
Agonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assayAgonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay
ChEMBL 360 8 2 3 4.4 CC(C)(C)c1ccc([C@H]2[C@H](O)CC(=O)[C@@H]2CCCCCCC(=O)O)cc1 nan
118517360 143975 0 None -2398 3 Human 5.3 pEC50 = 5.3 Functional
FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.
ChEMBL 412 8 2 3 4.7 O=C(O)c1ccc(CC[C@H]2C(=O)CC[C@@H]2/C=C/C(O)Cc2cccc(Cl)c2)cc1 nan
CHEMBL3902700 143975 0 None -2398 3 Human 5.3 pEC50 = 5.3 Functional
FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.
ChEMBL 412 8 2 3 4.7 O=C(O)c1ccc(CC[C@H]2C(=O)CC[C@@H]2/C=C/C(O)Cc2cccc(Cl)c2)cc1 nan
11955357 148628 0 None 26 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assayAgonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay
ChEMBL 378 8 1 3 4.8 COC(=O)CCCCCC[C@@H]1[C@@H](c2ccc3c(c2)CCC3)[C@H](O)C[C@H]1Cl nan
CHEMBL3939358 148628 0 None 26 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assayAgonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay
ChEMBL 378 8 1 3 4.8 COC(=O)CCCCCC[C@@H]1[C@@H](c2ccc3c(c2)CCC3)[C@H](O)C[C@H]1Cl nan
118517485 142750 0 None -2041 4 Human 5.3 pEC50 = 5.3 Functional
FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.
ChEMBL 396 8 2 3 4.2 O=C(O)c1ccc(CC[C@H]2C(=O)CC[C@@H]2/C=C/C(O)Cc2ccc(F)cc2)cc1 nan
CHEMBL3892492 142750 0 None -2041 4 Human 5.3 pEC50 = 5.3 Functional
FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.
ChEMBL 396 8 2 3 4.2 O=C(O)c1ccc(CC[C@H]2C(=O)CC[C@@H]2/C=C/C(O)Cc2ccc(F)cc2)cc1 nan
92135977 152896 0 None -36307 4 Human 5.1 pEC50 = 5.1 Functional
FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.
ChEMBL 396 8 2 3 4.2 O=C(O)c1ccc(CC[C@H]2C(=O)CC[C@@H]2/C=C/C(O)Cc2cccc(F)c2)cc1 nan
CHEMBL3974652 152896 0 None -36307 4 Human 5.1 pEC50 = 5.1 Functional
FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.FLIPR Assay: Calciium Signal Studies of the Flipr. Cells were seeded at a density of 5×104 cells per well in Biocoati® Poly-D-lysine-coated black-wall, clear-bottom 96-well plates (Becton-Dickinson) and allowed to attach overnight in an incubator at 37° C. Cells were then washed two times with HBSS-HEPES buffer (Hanks Balanced Salt Solution without bicarbonate and phenol red, 20 mM HEPES, pH 7.4) using a Denley Cellwash plate washer (Labsystems). After 45 minutes of dye-loading in the dark, using the calcium-sensitive dye Fluo-4 AM at a final concentration of 2 μM, plates were washed four times with HBSS-HEPES buffer to remove excess dye leaving 100 μl in each well. Plates were re-equilibrated to 37° C. for a few minutes. Cells were excited with an Argon laser at 488 nm, and emission was measured through a 510-570 nm bandwidth emission filter (FLIPR, Molecular Devices, Sunnyvale, Calif.). Drug solution was added in a 50 μl volume to each well to give the desired final concentration.
ChEMBL 396 8 2 3 4.2 O=C(O)c1ccc(CC[C@H]2C(=O)CC[C@@H]2/C=C/C(O)Cc2cccc(F)c2)cc1 nan
1955 16 1 None -3235 5 Human 5.1 pEC50 = 5.1 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=90%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=90%)
ChEMBL 428 13 4 5 3.6 O[C@@H](COc1cccc(c1)Cl)CC[C@H]1[C@H](O)C[C@@H]([C@@H]1CCCCCCC(=O)O)O 10.1016/s0960-894x(00)00273-0
5311240 16 1 None -3235 5 Human 5.1 pEC50 = 5.1 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=90%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=90%)
ChEMBL 428 13 4 5 3.6 O[C@@H](COc1cccc(c1)Cl)CC[C@H]1[C@H](O)C[C@@H]([C@@H]1CCCCCCC(=O)O)O 10.1016/s0960-894x(00)00273-0
CHEMBL36041 16 1 None -3235 5 Human 5.1 pEC50 = 5.1 Functional
Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=90%)Functional activity in RAT-1cells, transiently-transfected with human TP-receptor (% of control ligand, [3H]-U-46,619=90%)
ChEMBL 428 13 4 5 3.6 O[C@@H](COc1cccc(c1)Cl)CC[C@H]1[C@H](O)C[C@@H]([C@@H]1CCCCCCC(=O)O)O 10.1016/s0960-894x(00)00273-0
58681361 144681 0 None 19 3 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assayAgonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay
ChEMBL 318 8 2 3 3.5 Cc1ccc([C@H]2[C@H](O)CC(=O)[C@@H]2CCCCCCC(=O)O)cc1 nan
CHEMBL3908432 144681 0 None 19 3 Human 7.0 pEC50 = 7.0 Functional
Agonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assayAgonist activity at human recombinant TP receptor expressed in HEK293 cells assessed as effect on calcium accumulation by Fluo-4 AM dye based FLIPR assay
ChEMBL 318 8 2 3 3.5 Cc1ccc([C@H]2[C@H](O)CC(=O)[C@@H]2CCCCCCC(=O)O)cc1 nan
117630978 115870 0 None - 1 Human 10.8 pIC50 = 10.8 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 535 6 2 4 5.9 Cc1cccc(C)c1C1=C(O)CC(Cc2cccc3c2CCC(NS(=O)(=O)c2ccc(Cl)cc2)C3)C1=O 10.1021/ml5002085
CHEMBL3354618 115870 0 None - 1 Human 10.8 pIC50 = 10.8 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 535 6 2 4 5.9 Cc1cccc(C)c1C1=C(O)CC(Cc2cccc3c2CCC(NS(=O)(=O)c2ccc(Cl)cc2)C3)C1=O 10.1021/ml5002085
117631354 115868 0 None - 1 Human 10.3 pIC50 = 10.3 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 537 7 2 5 5.3 COc1ccc(C2=C(O)CC(Cc3cccc4c3CCC(NS(=O)(=O)c3ccc(Cl)cc3)C4)C2=O)cc1 10.1021/ml5002085
CHEMBL3354616 115868 0 None - 1 Human 10.3 pIC50 = 10.3 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 537 7 2 5 5.3 COc1ccc(C2=C(O)CC(Cc3cccc4c3CCC(NS(=O)(=O)c3ccc(Cl)cc3)C4)C2=O)cc1 10.1021/ml5002085
131116 14743 3 None - 1 Rat 9.1 pIC50 = 9.1 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 495 9 2 4 5.1 CC(C)c1ccc2c(CCCCNS(=O)(=O)c3ccc(Cl)cc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL1206329 14743 3 None - 1 Rat 9.1 pIC50 = 9.1 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 495 9 2 4 5.1 CC(C)c1ccc2c(CCCCNS(=O)(=O)c3ccc(Cl)cc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL262655 14743 3 None - 1 Rat 9.1 pIC50 = 9.1 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 495 9 2 4 5.1 CC(C)c1ccc2c(CCCCNS(=O)(=O)c3ccc(Cl)cc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
118714499 114506 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 379 5 2 3 2.8 O=C(O)Cc1cccc2c1CCC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1021/ml5002085
CHEMBL3335473 114506 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 379 5 2 3 2.8 O=C(O)Cc1cccc2c1CCC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1021/ml5002085
15745527 202947 0 None - 1 Human 7.0 pIC50 = 7 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 385 7 4 4 3.4 O=C(O)CCC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccccc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL62937 202947 0 None - 1 Human 7.0 pIC50 = 7 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 385 7 4 4 3.4 O=C(O)CCC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccccc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
10764618 83252 0 None - 1 Human 6.0 pIC50 = 6 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 420 10 3 5 3.2 CN(C)CC/N=C(/NC#N)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL21874 83252 0 None - 1 Human 6.0 pIC50 = 6 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 420 10 3 5 3.2 CN(C)CC/N=C(/NC#N)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
44387221 130090 0 None - 1 Human 6.0 pIC50 = 6 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 326 11 1 3 4.5 CCCCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL367721 130090 0 None - 1 Human 6.0 pIC50 = 6 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 326 11 1 3 4.5 CCCCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
44385988 129019 0 None - 1 Human 5.0 pIC50 = 5 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 370 13 2 4 4.3 CCCCC(O)CSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL366990 129019 0 None - 1 Human 5.0 pIC50 = 5 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 370 13 2 4 4.3 CCCCC(O)CSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
44353269 20049 0 None - 1 Human 5.0 pIC50 = 5 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(\c1cccc(C(F)(F)F)c1)c1cccnn1 10.1021/jm960341g
CHEMBL130365 20049 0 None - 1 Human 5.0 pIC50 = 5 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(\c1cccc(C(F)(F)F)c1)c1cccnn1 10.1021/jm960341g
18921506 14662 0 None - 1 Human 4.0 pIC50 = 4 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 407 8 2 3 3.9 O=C(O)c1ccc2c(c1)CC(CCCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205657 14662 0 None - 1 Human 4.0 pIC50 = 4 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 407 8 2 3 3.9 O=C(O)c1ccc2c(c1)CC(CCCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL130045 14662 0 None - 1 Human 4.0 pIC50 = 4 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 407 8 2 3 3.9 O=C(O)c1ccc2c(c1)CC(CCCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
16757078 92612 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 485 9 2 6 4.3 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Br)cc1 10.1021/jm070427h
CHEMBL243553 92612 0 None - 1 Human 6.0 pIC50 = 6 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 485 9 2 6 4.3 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Br)cc1 10.1021/jm070427h
71740443 91348 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 372 5 3 5 3.0 Cc1ccccc1Nc1ccc(C#N)cc1S(=O)(=O)NC(=O)NC(C)C 10.1016/j.ejmech.2013.04.033
CHEMBL2402428 91348 0 None - 1 Human 5.0 pIC50 = 5 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 372 5 3 5 3.0 Cc1ccccc1Nc1ccc(C#N)cc1S(=O)(=O)NC(=O)NC(C)C 10.1016/j.ejmech.2013.04.033
15290037 14808 0 None -79 2 Human 6.0 pIC50 = 6.0 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 345 6 2 3 2.0 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccccc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1207044 14808 0 None -79 2 Human 6.0 pIC50 = 6.0 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 345 6 2 3 2.0 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccccc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL341221 14808 0 None -79 2 Human 6.0 pIC50 = 6.0 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 345 6 2 3 2.0 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccccc1)C2 10.1016/s0960-894x(99)00014-1
71740563 91356 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 400 8 3 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccc(C)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402436 91356 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 400 8 3 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccc(C)cc1 10.1016/j.ejmech.2013.04.033
71740562 91355 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 386 4 3 5 3.4 Cc1ccc(Nc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402435 91355 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 386 4 3 5 3.4 Cc1ccc(Nc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1016/j.ejmech.2013.04.033
71456310 79711 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 489 11 1 4 6.0 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)C[S@+]([O-])[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80103-7
CHEMBL2115518 79711 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 489 11 1 4 6.0 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)C[S@+]([O-])[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80103-7
71740181 91343 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 387 4 2 5 3.4 Cc1cccc(Oc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)(C)C)c1 10.1016/j.ejmech.2013.04.033
CHEMBL2402423 91343 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 387 4 2 5 3.4 Cc1cccc(Oc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)(C)C)c1 10.1016/j.ejmech.2013.04.033
16757178 93319 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 441 5 2 6 4.1 Cc1cc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)ccc1Cl 10.1021/jm070427h
CHEMBL245262 93319 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 441 5 2 6 4.1 Cc1cc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)ccc1Cl 10.1021/jm070427h
16757487 93247 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 451 8 2 7 4.0 CCCOc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm070427h
CHEMBL244819 93247 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 451 8 2 7 4.0 CCCOc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm070427h
6449876 99193 22 None - 1 Human 8.0 pIC50 = 8.0 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 405 7 3 4 4.4 CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL281398 99193 22 None - 1 Human 8.0 pIC50 = 8.0 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 405 7 3 4 4.4 CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
117631017 115865 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 445 5 2 4 4.1 CC1=C(O)CC(Cc2cccc3c2CCC(NS(=O)(=O)c2ccc(Cl)cc2)C3)C1=O 10.1021/ml5002085
CHEMBL3354613 115865 0 None - 1 Human 8.0 pIC50 = 8.0 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 445 5 2 4 4.1 CC1=C(O)CC(Cc2cccc3c2CCC(NS(=O)(=O)c2ccc(Cl)cc2)C3)C1=O 10.1021/ml5002085
10601327 80069 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 496 9 3 4 5.9 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(N/C(=N\C2CCCC2)NC(=O)c2ccccc2)c1 10.1021/jm9707941
CHEMBL21303 80069 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 496 9 3 4 5.9 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(N/C(=N\C2CCCC2)NC(=O)c2ccccc2)c1 10.1021/jm9707941
16757488 93285 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 437 7 2 7 3.6 CCOc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm070427h
CHEMBL245037 93285 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 437 7 2 7 3.6 CCOc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm070427h
15018454 99439 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 369 9 2 3 3.3 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccccc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL282931 99439 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 369 9 2 3 3.3 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccccc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
44386321 60451 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 366 12 1 3 5.5 CCC/C=C(\C)CSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL175285 60451 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 366 12 1 3 5.5 CCC/C=C(\C)CSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
10762387 19878 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 381 9 1 5 3.9 O=C(O)CCCCCO/N=C(\c1cccc(C(F)(F)F)c1)c1ccncn1 10.1021/jm960341g
CHEMBL130236 19878 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 381 9 1 5 3.9 O=C(O)CCCCCO/N=C(\c1cccc(C(F)(F)F)c1)c1ccncn1 10.1021/jm960341g
10067523 19480 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(\c1cccc(C(F)(F)F)c1)c1cnccn1 10.1021/jm960341g
CHEMBL129867 19480 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(\c1cccc(C(F)(F)F)c1)c1cnccn1 10.1021/jm960341g
16757178 93319 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 441 5 2 6 4.1 Cc1cc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)ccc1Cl 10.1021/jm070427h
CHEMBL245262 93319 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 441 5 2 6 4.1 Cc1cc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)ccc1Cl 10.1021/jm070427h
118711723 114014 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Inhibition of human TP receptor expressed in QBI-HEK 293A cells assessed as IP3 metabolite level after 1 hr by HTRF assayInhibition of human TP receptor expressed in QBI-HEK 293A cells assessed as IP3 metabolite level after 1 hr by HTRF assay
ChEMBL 391 6 2 4 3.4 O=C1CC(c2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C=C1O 10.1016/j.bmcl.2014.07.047
CHEMBL3326603 114014 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Inhibition of human TP receptor expressed in QBI-HEK 293A cells assessed as IP3 metabolite level after 1 hr by HTRF assayInhibition of human TP receptor expressed in QBI-HEK 293A cells assessed as IP3 metabolite level after 1 hr by HTRF assay
ChEMBL 391 6 2 4 3.4 O=C1CC(c2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C=C1O 10.1016/j.bmcl.2014.07.047
1976 3973 18 None - 1 Human 7.9 pIC50 = 7.9 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 477 11 2 4 5.7 OC(=O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)C[C@@H]([C@@H]1N1CCCCC1)O 10.1016/S0960-894X(01)80103-7
6918030 3973 18 None - 1 Human 7.9 pIC50 = 7.9 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 477 11 2 4 5.7 OC(=O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)C[C@@H]([C@@H]1N1CCCCC1)O 10.1016/S0960-894X(01)80103-7
CHEMBL65030 3973 18 None - 1 Human 7.9 pIC50 = 7.9 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 477 11 2 4 5.7 OC(=O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)C[C@@H]([C@@H]1N1CCCCC1)O 10.1016/S0960-894X(01)80103-7
15290037 14808 0 None 79 2 Rat 7.9 pIC50 = 7.9 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 345 6 2 3 2.0 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccccc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1207044 14808 0 None 79 2 Rat 7.9 pIC50 = 7.9 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 345 6 2 3 2.0 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccccc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL341221 14808 0 None 79 2 Rat 7.9 pIC50 = 7.9 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 345 6 2 3 2.0 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccccc1)C2 10.1016/s0960-894x(99)00014-1
16757078 92612 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 485 9 2 6 4.3 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Br)cc1 10.1021/jm070427h
CHEMBL243553 92612 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 485 9 2 6 4.3 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Br)cc1 10.1021/jm070427h
10619606 99053 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 377 7 2 4 3.4 CN(C)/C(=N/c1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1)NC#N 10.1021/jm9707941
CHEMBL280380 99053 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 377 7 2 4 3.4 CN(C)/C(=N/c1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1)NC#N 10.1021/jm9707941
44353310 14665 0 None 14 2 Rat 5.9 pIC50 = 5.9 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 351 6 2 3 2.3 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)C1CCCCC1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205662 14665 0 None 14 2 Rat 5.9 pIC50 = 5.9 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 351 6 2 3 2.3 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)C1CCCCC1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL130460 14665 0 None 14 2 Rat 5.9 pIC50 = 5.9 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 351 6 2 3 2.3 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)C1CCCCC1)C2 10.1016/s0960-894x(99)00014-1
44304350 202866 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 369 7 3 3 4.4 O=C(O)CCC/C=C1/C[C@@H]2[C@@H](/C=N/NC(=O)Nc3ccccc3)CC[C@@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL62590 202866 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 369 7 3 3 4.4 O=C(O)CCC/C=C1/C[C@@H]2[C@@H](/C=N/NC(=O)Nc3ccccc3)CC[C@@H]2C1 10.1016/S0960-894X(01)80876-3
44291639 183900 0 None - 1 Rat 4.9 pIC50 = 4.9 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 411 8 2 3 5.0 CC(C)c1ccc2c(CCCS(=O)(=O)Nc3ccccc3)cc(C(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL48117 183900 0 None - 1 Rat 4.9 pIC50 = 4.9 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 411 8 2 3 5.0 CC(C)c1ccc2c(CCCS(=O)(=O)Nc3ccccc3)cc(C(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
54757964 65452 0 None - 1 Mouse 5.9 pIC50 = 5.9 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 419 8 2 4 4.0 O=C1CCC(O)=C1CCc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm200980u
CHEMBL1829804 65452 0 None - 1 Mouse 5.9 pIC50 = 5.9 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 419 8 2 4 4.0 O=C1CCC(O)=C1CCc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm200980u
11656254 77777 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 498 9 3 6 4.6 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(Br)c(C)c1 10.1021/jm060108a
CHEMBL209134 77777 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 498 9 3 6 4.6 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(Br)c(C)c1 10.1021/jm060108a
5362391 99096 25 None - 1 Human 5.9 pIC50 = 5.9 Functional
In vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human platelets
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1016/S0960-894X(01)80104-9
CHEMBL280728 99096 25 None - 1 Human 5.9 pIC50 = 5.9 Functional
In vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human platelets
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1016/S0960-894X(01)80104-9
11676121 78322 4 None - 1 Human 7.9 pIC50 = 7.9 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(C)cc1 10.1021/jm060108a
CHEMBL210964 78322 4 None - 1 Human 7.9 pIC50 = 7.9 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(C)cc1 10.1021/jm060108a
44304384 102628 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 419 7 4 4 4.0 O=C(O)CCC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3cccc(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL304254 102628 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 419 7 4 4 4.0 O=C(O)CCC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3cccc(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
10503252 163192 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 440 9 3 5 4.2 N#CN/C(=N/Cc1cccnc1)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL418188 163192 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 440 9 3 5 4.2 N#CN/C(=N/Cc1cccnc1)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
44273591 76726 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 353 8 2 3 3.0 O=C(O)CC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00199-4
CHEMBL20659 76726 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 353 8 2 3 3.0 O=C(O)CC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00199-4
10762411 81886 1 None - 1 Human 5.9 pIC50 = 5.9 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 381 7 3 3 4.7 CC(C)(C)NC(=O)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL21647 81886 1 None - 1 Human 5.9 pIC50 = 5.9 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 381 7 3 3 4.7 CC(C)(C)NC(=O)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
10717572 98697 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 431 8 3 4 4.9 N#CN/C(=N/C1CCCCC1)Nc1ccc(/C(=C\CCCC(=O)O)c2cccnc2)cc1 10.1021/jm9707941
CHEMBL277619 98697 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 431 8 3 4 4.9 N#CN/C(=N/C1CCCCC1)Nc1ccc(/C(=C\CCCC(=O)O)c2cccnc2)cc1 10.1021/jm9707941
44385934 131454 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 352 12 1 3 5.1 CCC/C=C/CSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL369153 131454 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 352 12 1 3 5.1 CCC/C=C/CSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
44387118 60814 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 346 9 1 3 4.8 O=C(O)CCC/C=C\CC1C2CCC(O2)C1CSc1ccccc1 10.1021/jm00125a009
CHEMBL176190 60814 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 346 9 1 3 4.8 O=C(O)CCC/C=C\CC1C2CCC(O2)C1CSc1ccccc1 10.1021/jm00125a009
10542153 20611 1 None - 1 Human 4.9 pIC50 = 4.9 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(/c1ccccc1)c1ccnnc1 10.1021/jm960341g
CHEMBL130823 20611 1 None - 1 Human 4.9 pIC50 = 4.9 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(/c1ccccc1)c1ccnnc1 10.1021/jm960341g
54669848 65454 0 None -42 2 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 419 7 2 4 3.8 CC1=C(O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)CC1=O 10.1021/jm200980u
CHEMBL1829806 65454 0 None -42 2 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 419 7 2 4 3.8 CC1=C(O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)CC1=O 10.1021/jm200980u
9907162 14745 0 None -50 2 Human 5.9 pIC50 = 5.9 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 365 5 2 3 2.7 O=C(O)c1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1206352 14745 0 None -50 2 Human 5.9 pIC50 = 5.9 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 365 5 2 3 2.7 O=C(O)c1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL264516 14745 0 None -50 2 Human 5.9 pIC50 = 5.9 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 365 5 2 3 2.7 O=C(O)c1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
71740182 91344 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 401 8 2 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1cccc(C)c1 10.1016/j.ejmech.2013.04.033
CHEMBL2402424 91344 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 401 8 2 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1cccc(C)c1 10.1016/j.ejmech.2013.04.033
10320462 14801 0 None -34 2 Human 5.9 pIC50 = 5.9 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 407 8 2 3 3.4 O=C(O)CCCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1207010 14801 0 None -34 2 Human 5.9 pIC50 = 5.9 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 407 8 2 3 3.4 O=C(O)CCCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL334501 14801 0 None -34 2 Human 5.9 pIC50 = 5.9 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 407 8 2 3 3.4 O=C(O)CCCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
71740183 91345 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 373 5 2 5 3.1 Cc1ccc(Oc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)C)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402425 91345 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 373 5 2 5 3.1 Cc1ccc(Oc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)C)cc1 10.1016/j.ejmech.2013.04.033
16757177 144745 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 451 11 2 7 4.0 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(OCC)cc1 10.1021/jm070427h
CHEMBL390897 144745 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 451 11 2 7 4.0 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(OCC)cc1 10.1021/jm070427h
11502680 98240 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
CHEMBL274415 98240 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
18921488 14670 0 None 10 2 Rat 7.8 pIC50 = 7.8 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 393 7 2 3 3.1 O=C(O)CCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205669 14670 0 None 10 2 Rat 7.8 pIC50 = 7.8 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 393 7 2 3 3.1 O=C(O)CCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL131894 14670 0 None 10 2 Rat 7.8 pIC50 = 7.8 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 393 7 2 3 3.1 O=C(O)CCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
44304262 102102 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 387 7 4 5 2.2 O=C(O)COC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccccc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL302235 102102 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 387 7 4 5 2.2 O=C(O)COC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccccc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
11269563 141610 0 None -676 2 Human 5.9 pIC50 = 5.9 Functional
Activity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregationActivity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregation
ChEMBL 399 5 1 3 5.2 CC(=O)c1cc(F)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1021/jm0603668
CHEMBL385126 141610 0 None -676 2 Human 5.9 pIC50 = 5.9 Functional
Activity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregationActivity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregation
ChEMBL 399 5 1 3 5.2 CC(=O)c1cc(F)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1021/jm0603668
44353308 14807 0 None 54 2 Rat 5.9 pIC50 = 5.9 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 339 9 2 3 2.1 CCCCCS(=O)(=O)NCC1Cc2ccc(CC(=O)O)cc2C1 10.1016/s0960-894x(99)00014-1
CHEMBL1207038 14807 0 None 54 2 Rat 5.9 pIC50 = 5.9 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 339 9 2 3 2.1 CCCCCS(=O)(=O)NCC1Cc2ccc(CC(=O)O)cc2C1 10.1016/s0960-894x(99)00014-1
CHEMBL340073 14807 0 None 54 2 Rat 5.9 pIC50 = 5.9 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 339 9 2 3 2.1 CCCCCS(=O)(=O)NCC1Cc2ccc(CC(=O)O)cc2C1 10.1016/s0960-894x(99)00014-1
71450832 78501 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(\c1cccc(C(F)(F)F)c1)c1ccncn1 10.1021/jm960341g
CHEMBL2111862 78501 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(\c1cccc(C(F)(F)F)c1)c1ccncn1 10.1021/jm960341g
44291597 14621 0 None - 1 Rat 5.9 pIC50 = 5.9 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 475 10 2 4 5.3 CC(C)c1ccc2c(CCCCCS(=O)(=O)Nc3ccccc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL1205051 14621 0 None - 1 Rat 5.9 pIC50 = 5.9 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 475 10 2 4 5.3 CC(C)c1ccc2c(CCCCCS(=O)(=O)Nc3ccccc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL47605 14621 0 None - 1 Rat 5.9 pIC50 = 5.9 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 475 10 2 4 5.3 CC(C)c1ccc2c(CCCCCS(=O)(=O)Nc3ccccc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
44353303 14666 0 None 2 2 Rat 6.9 pIC50 = 6.9 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 381 6 2 4 2.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)O2 10.1016/s0960-894x(99)00014-1
CHEMBL1205664 14666 0 None 2 2 Rat 6.9 pIC50 = 6.9 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 381 6 2 4 2.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)O2 10.1016/s0960-894x(99)00014-1
CHEMBL131036 14666 0 None 2 2 Rat 6.9 pIC50 = 6.9 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 381 6 2 4 2.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)O2 10.1016/s0960-894x(99)00014-1
71740057 91340 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 387 4 2 5 3.4 Cc1ccccc1Oc1ccc(C#N)cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1016/j.ejmech.2013.04.033
CHEMBL2402420 91340 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 387 4 2 5 3.4 Cc1ccccc1Oc1ccc(C#N)cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1016/j.ejmech.2013.04.033
18921526 14674 0 None -46 2 Human 5.8 pIC50 = 5.8 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 393 7 2 3 3.1 O=C(O)Cc1ccc2c(c1)CC(CCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205680 14674 0 None -46 2 Human 5.8 pIC50 = 5.8 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 393 7 2 3 3.1 O=C(O)Cc1ccc2c(c1)CC(CCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL132659 14674 0 None -46 2 Human 5.8 pIC50 = 5.8 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 393 7 2 3 3.1 O=C(O)Cc1ccc2c(c1)CC(CCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
44353169 19476 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(/c1cncnc1)c1cccc(C(F)(F)F)c1 10.1021/jm960341g
CHEMBL129843 19476 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(/c1cncnc1)c1cccc(C(F)(F)F)c1 10.1021/jm960341g
23276771 21353 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(/c1cccc(C(F)(F)F)c1)c1cnccn1 10.1021/jm960341g
CHEMBL131415 21353 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(/c1cccc(C(F)(F)F)c1)c1cnccn1 10.1021/jm960341g
44292126 14625 0 None - 1 Rat 5.8 pIC50 = 5.8 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 461 9 2 4 4.9 CC(C)c1ccc2c(CCCCS(=O)(=O)Nc3ccccc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL1205057 14625 0 None - 1 Rat 5.8 pIC50 = 5.8 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 461 9 2 4 4.9 CC(C)c1ccc2c(CCCCS(=O)(=O)Nc3ccccc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL48013 14625 0 None - 1 Rat 5.8 pIC50 = 5.8 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 461 9 2 4 4.9 CC(C)c1ccc2c(CCCCS(=O)(=O)Nc3ccccc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
44291705 101403 0 None - 1 Rat 5.8 pIC50 = 5.8 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 439 10 2 3 5.8 CC(C)c1ccc2c(CCCCCS(=O)(=O)Nc3ccccc3)cc(C(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL297275 101403 0 None - 1 Rat 5.8 pIC50 = 5.8 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 439 10 2 3 5.8 CC(C)c1ccc2c(CCCCCS(=O)(=O)Nc3ccccc3)cc(C(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
51550 205750 14 None - 1 Rat 5.8 pIC50 = 5.8 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 335 8 2 4 1.7 O=C(O)COc1ccc(CCNS(=O)(=O)c2ccccc2)cc1 10.1016/S0960-894X(00)80043-8
CHEMBL8273 205750 14 None - 1 Rat 5.8 pIC50 = 5.8 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 335 8 2 4 1.7 O=C(O)COc1ccc(CCNS(=O)(=O)c2ccccc2)cc1 10.1016/S0960-894X(00)80043-8
10780482 20917 1 None - 1 Human 4.8 pIC50 = 4.8 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(/c1ccccc1)c1ncccn1 10.1021/jm960341g
CHEMBL131078 20917 1 None - 1 Human 4.8 pIC50 = 4.8 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(/c1ccccc1)c1ncccn1 10.1021/jm960341g
16756980 93281 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 471 5 2 6 3.9 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1Br 10.1021/jm070427h
CHEMBL245032 93281 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 471 5 2 6 3.9 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1Br 10.1021/jm070427h
54757965 65280 0 None -9 2 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 353 8 2 3 2.8 O=S(=O)(NCCc1cccc(CCCO)c1)c1ccc(Cl)cc1 10.1021/jm200980u
CHEMBL1828642 65280 0 None -9 2 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 353 8 2 3 2.8 O=S(=O)(NCCc1cccc(CCCO)c1)c1ccc(Cl)cc1 10.1021/jm200980u
16757174 93245 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 423 6 2 7 3.2 COc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm070427h
CHEMBL244817 93245 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 423 6 2 7 3.2 COc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm070427h
16756978 92292 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 407 8 2 6 3.5 CCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(C)c1 10.1021/jm070427h
CHEMBL242694 92292 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 407 8 2 6 3.5 CCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(C)c1 10.1021/jm070427h
71740559 91352 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 386 4 3 5 3.4 Cc1cccc(Nc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)(C)C)c1 10.1016/j.ejmech.2013.04.033
CHEMBL2402432 91352 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 386 4 3 5 3.4 Cc1cccc(Nc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)(C)C)c1 10.1016/j.ejmech.2013.04.033
10761205 83418 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 363 7 3 4 3.2 C/N=C(/NC#N)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL21960 83418 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 363 7 3 4 3.2 C/N=C(/NC#N)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
6073 3785 49 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 407 6 2 3 3.5 OC(=O)CCc1c(C)ccc2c1CC[C@H](C2)NS(=O)(=O)c1ccc(cc1)Cl 10.1021/ml5002085
9938840 3785 49 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 407 6 2 3 3.5 OC(=O)CCc1c(C)ccc2c1CC[C@H](C2)NS(=O)(=O)c1ccc(cc1)Cl 10.1021/ml5002085
CHEMBL2107786 3785 49 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 407 6 2 3 3.5 OC(=O)CCc1c(C)ccc2c1CC[C@H](C2)NS(=O)(=O)c1ccc(cc1)Cl 10.1021/ml5002085
18921488 14670 0 None -10 2 Human 6.8 pIC50 = 6.8 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 393 7 2 3 3.1 O=C(O)CCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205669 14670 0 None -10 2 Human 6.8 pIC50 = 6.8 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 393 7 2 3 3.1 O=C(O)CCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL131894 14670 0 None -10 2 Human 6.8 pIC50 = 6.8 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 393 7 2 3 3.1 O=C(O)CCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
44304642 102241 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 421 7 4 5 2.9 O=C(O)COC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3cccc(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL303114 102241 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 421 7 4 5 2.9 O=C(O)COC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3cccc(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
44273499 98735 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 391 8 2 3 3.2 O=C(O)CC/C=C/C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(F)cc2F)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL277940 98735 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 391 8 2 3 3.2 O=C(O)CC/C=C/C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(F)cc2F)CC[C@H]1F 10.1016/0960-894X(95)00199-4
54757965 65280 0 None 9 2 Mouse 5.8 pIC50 = 5.8 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 353 8 2 3 2.8 O=S(=O)(NCCc1cccc(CCCO)c1)c1ccc(Cl)cc1 10.1021/jm200980u
CHEMBL1828642 65280 0 None 9 2 Mouse 5.8 pIC50 = 5.8 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 353 8 2 3 2.8 O=S(=O)(NCCc1cccc(CCCO)c1)c1ccc(Cl)cc1 10.1021/jm200980u
11676145 78166 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1C 10.1021/jm070427h
CHEMBL210415 78166 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1C 10.1021/jm070427h
16757380 92611 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 471 5 2 6 3.9 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Br)cc1 10.1021/jm070427h
CHEMBL243552 92611 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 471 5 2 6 3.9 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Br)cc1 10.1021/jm070427h
71740180 91342 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 373 5 2 5 3.1 Cc1cccc(Oc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)C)c1 10.1016/j.ejmech.2013.04.033
CHEMBL2402422 91342 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 373 5 2 5 3.1 Cc1cccc(Oc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)C)c1 10.1016/j.ejmech.2013.04.033
16757377 150073 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 407 5 2 6 3.5 Cc1cccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)c1 10.1021/jm070427h
CHEMBL395079 150073 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 407 5 2 6 3.5 Cc1cccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)c1 10.1021/jm070427h
9930263 99228 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 389 8 3 4 3.8 N#CN/C(=N/C1CC1)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL281621 99228 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 389 8 3 4 3.8 N#CN/C(=N/C1CC1)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
15745526 78421 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 385 7 4 4 3.4 O=C(O)CCC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccccc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL2111524 78421 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 385 7 4 4 3.4 O=C(O)CCC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccccc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
44304279 102276 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 414 8 3 5 4.3 O=C(O)CCC/C=C1/C[C@@H]2[C@@H](/C=N/NC(=O)Nc3ccc([N+](=O)[O-])cc3)CC[C@@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL303284 102276 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 414 8 3 5 4.3 O=C(O)CCC/C=C1/C[C@@H]2[C@@H](/C=N/NC(=O)Nc3ccc([N+](=O)[O-])cc3)CC[C@@H]2C1 10.1016/S0960-894X(01)80876-3
44304265 203292 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 439 6 4 4 4.3 O=C(O)CC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc(Cl)c(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL64723 203292 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 439 6 4 4 4.3 O=C(O)CC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc(Cl)c(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
44273542 98669 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 381 10 2 3 3.6 O=C(O)CCC/C=C\CC1=CCC[C@@H]1CNS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00199-4
CHEMBL277405 98669 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 381 10 2 3 3.6 O=C(O)CCC/C=C\CC1=CCC[C@@H]1CNS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00199-4
44273435 99464 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 423 8 2 3 4.2 O=C(O)CC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(Cl)c(Cl)c2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL283101 99464 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 423 8 2 3 4.2 O=C(O)CC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(Cl)c(Cl)c2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
44273742 169206 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 373 10 2 4 2.4 O=C(O)COCCCC[C@@H]1[C@@H](NS(=O)(=O)c2ccccc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL440772 169206 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 373 10 2 4 2.4 O=C(O)COCCCC[C@@H]1[C@@H](NS(=O)(=O)c2ccccc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
10786712 83204 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 392 8 3 3 4.4 N/C(=N/C1CCCC1)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL21851 83204 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 392 8 3 3 4.4 N/C(=N/C1CCCC1)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
5362391 99096 25 None - 1 Human 5.8 pIC50 = 5.8 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1021/jm9707941
CHEMBL280728 99096 25 None - 1 Human 5.8 pIC50 = 5.8 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1021/jm9707941
11545850 70236 0 None -446 2 Human 5.8 pIC50 = 5.8 Functional
Inhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptorInhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptor
ChEMBL 402 5 2 4 2.7 O=C(O)Cn1c2c(c3ccccc31)C[C@H](NS(=O)(=O)c1ccc(F)cc1)CC2 10.1021/jm049036i
CHEMBL194085 70236 0 None -446 2 Human 5.8 pIC50 = 5.8 Functional
Inhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptorInhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptor
ChEMBL 402 5 2 4 2.7 O=C(O)Cn1c2c(c3ccccc31)C[C@H](NS(=O)(=O)c1ccc(F)cc1)CC2 10.1021/jm049036i
5362391 99096 25 None - 1 Human 5.8 pIC50 = 5.8 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1021/jm960341g
CHEMBL280728 99096 25 None - 1 Human 5.8 pIC50 = 5.8 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1021/jm960341g
44291864 181632 0 None - 1 Rat 5.8 pIC50 = 5.8 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 473 10 2 3 6.4 CC(C)c1ccc2c(CCCCCS(=O)(=O)Nc3ccc(Cl)cc3)cc(C(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL47743 181632 0 None - 1 Rat 5.8 pIC50 = 5.8 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 473 10 2 3 6.4 CC(C)c1ccc2c(CCCCCS(=O)(=O)Nc3ccc(Cl)cc3)cc(C(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL1829808 65456 0 None -18 2 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 433 8 2 4 4.2 CCC1=C(O)CC(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1=O 10.1021/jm200980u
71740179 91341 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 401 8 2 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccccc1C 10.1016/j.ejmech.2013.04.033
CHEMBL2402421 91341 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 401 8 2 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccccc1C 10.1016/j.ejmech.2013.04.033
44353310 14665 0 None -14 2 Human 4.8 pIC50 = 4.8 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 351 6 2 3 2.3 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)C1CCCCC1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205662 14665 0 None -14 2 Human 4.8 pIC50 = 4.8 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 351 6 2 3 2.3 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)C1CCCCC1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL130460 14665 0 None -14 2 Human 4.8 pIC50 = 4.8 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 351 6 2 3 2.3 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)C1CCCCC1)C2 10.1016/s0960-894x(99)00014-1
54757768 65455 0 None - 1 Mouse 5.8 pIC50 = 5.8 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 475 10 1 4 4.9 CC1=C(OCC(C)C)CC(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1=O 10.1021/jm200980u
CHEMBL1829807 65455 0 None - 1 Mouse 5.8 pIC50 = 5.8 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 475 10 1 4 4.9 CC1=C(OCC(C)C)CC(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1=O 10.1021/jm200980u
CHEMBL1829810 65458 0 None 11 2 Mouse 7.8 pIC50 = 7.8 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 447 8 2 4 4.5 CC(C)C1=C(O)CC(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1=O 10.1021/jm200980u
10524500 85505 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 391 8 3 4 4.0 CC(C)/N=C(/NC#N)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL22721 85505 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 391 8 3 4 4.0 CC(C)/N=C(/NC#N)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
44305675 202974 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 505 11 1 5 5.6 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)CS(=O)(=O)[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80103-7
CHEMBL63056 202974 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 505 11 1 5 5.6 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)CS(=O)(=O)[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80103-7
131717 203389 6 None - 1 Human 7.8 pIC50 = 7.8 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 452 14 2 4 4.7 O=C(O)CCC(CCCCNS(=O)(=O)c1ccc(Cl)cc1)CCCc1cccnc1 10.1016/S0960-894X(01)80103-7
CHEMBL65414 203389 6 None - 1 Human 7.8 pIC50 = 7.8 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 452 14 2 4 4.7 O=C(O)CCC(CCCCNS(=O)(=O)c1ccc(Cl)cc1)CCCc1cccnc1 10.1016/S0960-894X(01)80103-7
131717 203389 6 None - 1 Human 7.8 pIC50 = 7.8 Functional
In vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human platelets
ChEMBL 452 14 2 4 4.7 O=C(O)CCC(CCCCNS(=O)(=O)c1ccc(Cl)cc1)CCCc1cccnc1 10.1016/S0960-894X(01)80104-9
CHEMBL65414 203389 6 None - 1 Human 7.8 pIC50 = 7.8 Functional
In vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human platelets
ChEMBL 452 14 2 4 4.7 O=C(O)CCC(CCCCNS(=O)(=O)c1ccc(Cl)cc1)CCCc1cccnc1 10.1016/S0960-894X(01)80104-9
44304271 100721 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 421 7 4 5 2.9 O=C(O)COC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3cccc(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL292601 100721 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 421 7 4 5 2.9 O=C(O)COC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3cccc(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
44304264 102215 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 455 7 4 5 3.5 O=C(O)COC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc(Cl)c(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL302917 102215 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 455 7 4 5 3.5 O=C(O)COC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc(Cl)c(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
44304297 203167 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 437 7 3 3 5.7 O=C(O)CCC/C=C1\C[C@@H]2[C@@H](/C=N/NC(=O)Nc3ccc(Cl)c(Cl)c3)CC[C@@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL64229 203167 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 437 7 3 3 5.7 O=C(O)CCC/C=C1\C[C@@H]2[C@@H](/C=N/NC(=O)Nc3ccc(Cl)c(Cl)c3)CC[C@@H]2C1 10.1016/S0960-894X(01)80876-3
44273351 73361 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 391 10 2 4 2.5 O=C(O)COCCCC[C@@H]1[C@@H](NS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL20133 73361 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 391 10 2 4 2.5 O=C(O)COCCCC[C@@H]1[C@@H](NS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
44273521 73945 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 414 10 2 5 3.2 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccccc2[N+](=O)[O-])CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL20212 73945 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 414 10 2 5 3.2 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccccc2[N+](=O)[O-])CC[C@H]1F 10.1016/0960-894X(95)00199-4
44273448 74754 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 349 8 2 3 3.2 Cc1ccc(S(=O)(=O)N[C@H]2CCC=C2C/C=C\CCC(=O)O)cc1 10.1016/0960-894X(95)00199-4
CHEMBL20308 74754 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 349 8 2 3 3.2 Cc1ccc(S(=O)(=O)N[C@H]2CCC=C2C/C=C\CCC(=O)O)cc1 10.1016/0960-894X(95)00199-4
44273415 75361 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 387 10 2 4 2.7 Cc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](F)[C@@H]2CCCCOCC(=O)O)cc1 10.1016/0960-894X(95)00199-4
CHEMBL20376 75361 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 387 10 2 4 2.7 Cc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](F)[C@@H]2CCCCOCC(=O)O)cc1 10.1016/0960-894X(95)00199-4
44273414 98729 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 389 10 2 4 2.6 O=C(O)COCCCCC1=CCC[C@@H]1NS(=O)(=O)c1ccc(F)cc1F 10.1016/0960-894X(95)00199-4
CHEMBL277879 98729 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 389 10 2 4 2.6 O=C(O)COCCCCC1=CCC[C@@H]1NS(=O)(=O)c1ccc(F)cc1F 10.1016/0960-894X(95)00199-4
44273570 99120 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 403 9 2 3 3.8 O=C(O)CC/C=C\C[C@@H]1[C@@H](CNS(=O)(=O)c2ccc(Cl)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL280934 99120 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 403 9 2 3 3.8 O=C(O)CC/C=C\C[C@@H]1[C@@H](CNS(=O)(=O)c2ccc(Cl)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
44273449 99188 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 409 10 2 4 2.6 O=C(O)COCCCC[C@@H]1[C@@H](NS(=O)(=O)c2ccc(F)cc2F)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL281383 99188 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 409 10 2 4 2.6 O=C(O)COCCCC[C@@H]1[C@@H](NS(=O)(=O)c2ccc(F)cc2F)CC[C@H]1F 10.1016/0960-894X(95)00199-4
23276768 116760 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(\c1ccnnc1)c1cccc(C(F)(F)F)c1 10.1021/jm960341g
CHEMBL337607 116760 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(\c1ccnnc1)c1cccc(C(F)(F)F)c1 10.1021/jm960341g
11676145 78166 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1C 10.1021/jm070427h
CHEMBL210415 78166 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1C 10.1021/jm070427h
6436053 98711 13 None - 1 Human 7.7 pIC50 = 7.7 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 484 11 2 4 4.9 O=C(O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm9707941
CHEMBL277689 98711 13 None - 1 Human 7.7 pIC50 = 7.7 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 484 11 2 4 4.9 O=C(O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm9707941
44304290 102688 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 432 8 4 7 2.1 O=C(O)COC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc([N+](=O)[O-])cc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL304652 102688 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 432 8 4 7 2.1 O=C(O)COC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc([N+](=O)[O-])cc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
22882094 102757 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 439 6 4 4 4.3 O=C(O)CC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc(Cl)c(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL305114 102757 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 439 6 4 4 4.3 O=C(O)CC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc(Cl)c(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
10546960 203355 0 None -6 2 Human 6.7 pIC50 = 6.7 Functional
Inhibition of human TP receptor expressed in QBI-HEK 293A cells assessed as IP3 metabolite level after 1 hr by HTRF assayInhibition of human TP receptor expressed in QBI-HEK 293A cells assessed as IP3 metabolite level after 1 hr by HTRF assay
ChEMBL 367 8 2 3 2.9 O=C(O)CCc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1016/j.bmcl.2014.07.047
CHEMBL65121 203355 0 None -6 2 Human 6.7 pIC50 = 6.7 Functional
Inhibition of human TP receptor expressed in QBI-HEK 293A cells assessed as IP3 metabolite level after 1 hr by HTRF assayInhibition of human TP receptor expressed in QBI-HEK 293A cells assessed as IP3 metabolite level after 1 hr by HTRF assay
ChEMBL 367 8 2 3 2.9 O=C(O)CCc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1016/j.bmcl.2014.07.047
44273404 74189 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 398 11 2 6 2.2 O=C(O)COCCCCC1=CCC[C@@H]1NS(=O)(=O)c1ccccc1[N+](=O)[O-] 10.1016/0960-894X(95)00199-4
CHEMBL20231 74189 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 398 11 2 6 2.2 O=C(O)COCCCCC1=CCC[C@@H]1NS(=O)(=O)c1ccccc1[N+](=O)[O-] 10.1016/0960-894X(95)00199-4
44273523 74445 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 369 8 2 3 3.5 O=C(O)CC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccc(Cl)cc1 10.1016/0960-894X(95)00199-4
CHEMBL20274 74445 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 369 8 2 3 3.5 O=C(O)CC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccc(Cl)cc1 10.1016/0960-894X(95)00199-4
44273474 75957 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 399 9 2 3 4.4 O=C(O)CCC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccc2ccccc2c1 10.1016/0960-894X(95)00199-4
CHEMBL20524 75957 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 399 9 2 3 4.4 O=C(O)CCC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccc2ccccc2c1 10.1016/0960-894X(95)00199-4
44273402 75959 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 387 9 2 3 3.3 O=C(O)CC/C=C\C[C@@H]1[C@@H](CNS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL20525 75959 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 387 9 2 3 3.3 O=C(O)CC/C=C\C[C@@H]1[C@@H](CNS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
44273387 76344 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 421 10 2 4 3.6 O=C(O)COCCCCC1=CCC[C@@H]1NS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/0960-894X(95)00199-4
CHEMBL20590 76344 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 421 10 2 4 3.6 O=C(O)COCCCCC1=CCC[C@@H]1NS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/0960-894X(95)00199-4
44273502 79938 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 369 8 2 3 3.2 Cc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](F)[C@@H]2C/C=C\CCC(=O)O)cc1 10.1016/0960-894X(95)00199-4
CHEMBL21255 79938 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 369 8 2 3 3.2 Cc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](F)[C@@H]2C/C=C\CCC(=O)O)cc1 10.1016/0960-894X(95)00199-4
44273588 99055 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 383 9 2 3 3.4 Cc1ccc(S(=O)(=O)NC[C@H]2CC[C@@H](F)[C@@H]2C/C=C\CCC(=O)O)cc1 10.1016/0960-894X(95)00199-4
CHEMBL280403 99055 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 383 9 2 3 3.4 Cc1ccc(S(=O)(=O)NC[C@H]2CC[C@@H](F)[C@@H]2C/C=C\CCC(=O)O)cc1 10.1016/0960-894X(95)00199-4
44273780 99189 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 367 10 2 4 2.6 Cc1ccc(S(=O)(=O)N[C@H]2CCC=C2CCCCOCC(=O)O)cc1 10.1016/0960-894X(95)00199-4
CHEMBL281385 99189 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 367 10 2 4 2.6 Cc1ccc(S(=O)(=O)N[C@H]2CCC=C2CCCCOCC(=O)O)cc1 10.1016/0960-894X(95)00199-4
44273522 166946 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 403 8 2 3 4.2 O=C(O)CC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/0960-894X(95)00199-4
CHEMBL428707 166946 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 403 8 2 3 4.2 O=C(O)CC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/0960-894X(95)00199-4
44353290 14678 0 None - 1 Rat 5.7 pIC50 = 5.7 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 346 6 2 4 1.4 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1cccnc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205689 14678 0 None - 1 Rat 5.7 pIC50 = 5.7 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 346 6 2 4 1.4 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1cccnc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL134128 14678 0 None - 1 Rat 5.7 pIC50 = 5.7 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 346 6 2 4 1.4 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1cccnc1)C2 10.1016/s0960-894x(99)00014-1
44385988 129019 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 370 13 2 4 4.3 CCCCC(O)CSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL366990 129019 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 370 13 2 4 4.3 CCCCC(O)CSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
44292084 174169 0 None - 1 Rat 4.7 pIC50 = 4.7 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 473 8 2 4 5.1 CC(C)c1ccc2c(CCCC(=O)NS(=O)(=O)c3ccc(Cl)cc3)cc(C(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL45471 174169 0 None - 1 Rat 4.7 pIC50 = 4.7 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 473 8 2 4 5.1 CC(C)c1ccc2c(CCCC(=O)NS(=O)(=O)c3ccc(Cl)cc3)cc(C(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
16756978 92292 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 407 8 2 6 3.5 CCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(C)c1 10.1021/jm070427h
CHEMBL242694 92292 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 407 8 2 6 3.5 CCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(C)c1 10.1021/jm070427h
16757488 93285 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 437 7 2 7 3.6 CCOc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm070427h
CHEMBL245037 93285 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 437 7 2 7 3.6 CCOc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm070427h
16757174 93245 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 423 6 2 7 3.2 COc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm070427h
CHEMBL244817 93245 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 423 6 2 7 3.2 COc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm070427h
11488860 19291 0 None -7762 2 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at TP receptor in human platelet assessed as thromboxane A2- induced platelet aggregationAntagonist activity at TP receptor in human platelet assessed as thromboxane A2- induced platelet aggregation
ChEMBL 497 5 1 4 5.7 C[C@@H](c1ccc(C(F)(F)F)cc1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
CHEMBL1290413 19291 0 None -7762 2 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at TP receptor in human platelet assessed as thromboxane A2- induced platelet aggregationAntagonist activity at TP receptor in human platelet assessed as thromboxane A2- induced platelet aggregation
ChEMBL 497 5 1 4 5.7 C[C@@H](c1ccc(C(F)(F)F)cc1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
16755884 93318 22 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 423 6 2 7 3.2 COc1cccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)c1 10.1021/jm070427h
CHEMBL245261 93318 22 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 423 6 2 7 3.2 COc1cccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)c1 10.1021/jm070427h
CHEMBL1829810 65458 0 None -11 2 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 447 8 2 4 4.5 CC(C)C1=C(O)CC(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1=O 10.1021/jm200980u
44293931 101936 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonistic activity against Thromboxane A2 receptor in guinea pig trachea in the presence of 9,11-azo-PGH2Antagonistic activity against Thromboxane A2 receptor in guinea pig trachea in the presence of 9,11-azo-PGH2
ChEMBL 384 10 2 3 4.7 C[C@@H](c1ccccc1)[C@H](O)/C=C/C1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00168a032
CHEMBL301098 101936 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonistic activity against Thromboxane A2 receptor in guinea pig trachea in the presence of 9,11-azo-PGH2Antagonistic activity against Thromboxane A2 receptor in guinea pig trachea in the presence of 9,11-azo-PGH2
ChEMBL 384 10 2 3 4.7 C[C@@H](c1ccccc1)[C@H](O)/C=C/C1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00168a032
163920 14675 12 None 165 2 Rat 8.7 pIC50 = 8.7 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 365 5 2 3 2.4 O=C(O)Cc1ccc2c(c1)CC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205685 14675 12 None 165 2 Rat 8.7 pIC50 = 8.7 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 365 5 2 3 2.4 O=C(O)Cc1ccc2c(c1)CC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL133420 14675 12 None 165 2 Rat 8.7 pIC50 = 8.7 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 365 5 2 3 2.4 O=C(O)Cc1ccc2c(c1)CC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
15291968 100890 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Inhibition of human TP receptor expressed in QBI-HEK 293A cells assessed as IP3 metabolite level after 1 hr by HTRF assayInhibition of human TP receptor expressed in QBI-HEK 293A cells assessed as IP3 metabolite level after 1 hr by HTRF assay
ChEMBL 393 6 2 3 3.2 O=C(O)CCc1cccc2c1CCC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/j.bmcl.2014.07.047
CHEMBL29374 100890 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Inhibition of human TP receptor expressed in QBI-HEK 293A cells assessed as IP3 metabolite level after 1 hr by HTRF assayInhibition of human TP receptor expressed in QBI-HEK 293A cells assessed as IP3 metabolite level after 1 hr by HTRF assay
ChEMBL 393 6 2 3 3.2 O=C(O)CCc1cccc2c1CCC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/j.bmcl.2014.07.047
22882109 100734 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 453 7 4 4 4.7 O=C(O)CCC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc(Cl)c(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL292712 100734 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 453 7 4 4 4.7 O=C(O)CCC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc(Cl)c(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
22882097 167992 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 416 7 4 6 2.9 O=C(O)CC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc([N+](=O)[O-])cc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL431956 167992 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 416 7 4 6 2.9 O=C(O)CC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc([N+](=O)[O-])cc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
44304362 200867 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 432 8 4 7 2.1 O=C(O)COC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc([N+](=O)[O-])cc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL60128 200867 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 432 8 4 7 2.1 O=C(O)COC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc([N+](=O)[O-])cc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
44304641 202890 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 453 7 4 4 4.7 O=C(O)CCC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc(Cl)c(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL62702 202890 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 453 7 4 4 4.7 O=C(O)CCC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc(Cl)c(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
44273434 74444 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 419 9 2 3 4.4 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc3ccccc3c2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL20273 74444 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 419 9 2 3 4.4 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc3ccccc3c2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
44273540 79813 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 385 11 2 4 2.7 O=C(O)COCCCCC1=CCC[C@@H]1CNS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00199-4
CHEMBL21204 79813 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 385 11 2 4 2.7 O=C(O)COCCCCC1=CCC[C@@H]1CNS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00199-4
44273792 99359 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 405 9 2 3 3.6 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(F)cc2F)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL282458 99359 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 405 9 2 3 3.6 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(F)cc2F)CC[C@H]1F 10.1016/0960-894X(95)00199-4
44273574 77005 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 355 8 2 3 2.9 O=C(O)CC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccccc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL20711 77005 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 355 8 2 3 2.9 O=C(O)CC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccccc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
44273796 77872 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 353 10 2 4 2.3 O=C(O)COCCCCC1=CCC[C@@H]1NS(=O)(=O)c1ccccc1 10.1016/0960-894X(95)00199-4
CHEMBL20933 77872 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 353 10 2 4 2.3 O=C(O)COCCCCC1=CCC[C@@H]1NS(=O)(=O)c1ccccc1 10.1016/0960-894X(95)00199-4
44273805 78324 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 401 10 2 3 3.7 O=C(O)CCC/C=C\C[C@@H]1[C@@H](CNS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL21097 78324 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 401 10 2 3 3.7 O=C(O)CCC/C=C\C[C@@H]1[C@@H](CNS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
44273778 99389 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 371 10 2 4 2.5 O=C(O)COCCCCC1=CCC[C@@H]1NS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00199-4
CHEMBL282652 99389 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 371 10 2 4 2.5 O=C(O)COCCCCC1=CCC[C@@H]1NS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00199-4
44273464 99608 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 400 9 2 4 3.8 O=C(O)CCC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1cccc2cccnc12 10.1016/0960-894X(95)00199-4
CHEMBL284019 99608 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 400 9 2 4 3.8 O=C(O)CCC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1cccc2cccnc12 10.1016/0960-894X(95)00199-4
122197353 133465 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 420 9 2 4 3.8 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2cccc3cccnc23)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL3706741 133465 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 420 9 2 4 3.8 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2cccc3cccnc23)CC[C@H]1F 10.1016/0960-894X(95)00199-4
44273541 99261 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 371 8 2 3 3.1 O=C(O)CC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccc(F)cc1F 10.1016/0960-894X(95)00199-4
CHEMBL281825 99261 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 371 8 2 3 3.1 O=C(O)CC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccc(F)cc1F 10.1016/0960-894X(95)00199-4
44386190 60419 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 390 12 1 4 4.8 O=C(O)CCC/C=C\CC1C2CCC(O2)C1CSCCOc1ccccc1 10.1021/jm00125a009
CHEMBL175076 60419 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 390 12 1 4 4.8 O=C(O)CCC/C=C\CC1C2CCC(O2)C1CSCCOc1ccccc1 10.1021/jm00125a009
44386035 128671 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 366 10 1 3 5.3 O=C(O)CCC/C=C\CC1C2CCC(O2)C1CSCC1CCCCC1 10.1021/jm00125a009
CHEMBL366812 128671 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 366 10 1 3 5.3 O=C(O)CCC/C=C\CC1C2CCC(O2)C1CSCC1CCCCC1 10.1021/jm00125a009
10637871 21818 1 None - 1 Human 4.7 pIC50 = 4.7 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(\c1ccccc1)c1cncnc1 10.1021/jm960341g
CHEMBL131949 21818 1 None - 1 Human 4.7 pIC50 = 4.7 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(\c1ccccc1)c1cncnc1 10.1021/jm960341g
16757080 144180 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 441 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(Cl)c1 10.1021/jm070427h
CHEMBL390414 144180 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 441 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(Cl)c1 10.1021/jm070427h
16757381 143923 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 427 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1Cl 10.1021/jm070427h
CHEMBL390216 143923 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 427 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1Cl 10.1021/jm070427h
16757376 153487 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 393 6 2 6 3.1 Cc1cccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)C)c1 10.1021/jm070427h
CHEMBL397964 153487 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 393 6 2 6 3.1 Cc1cccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)C)c1 10.1021/jm070427h
71740563 91356 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 400 8 3 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccc(C)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402436 91356 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 400 8 3 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccc(C)cc1 10.1016/j.ejmech.2013.04.033
16757268 92287 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 431 5 2 7 3.2 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)N/C(=N\C#N)NC(C)(C)C)cc1 10.1021/jm070427h
CHEMBL242687 92287 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 431 5 2 7 3.2 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)N/C(=N\C#N)NC(C)(C)C)cc1 10.1021/jm070427h
44273497 98763 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 389 8 2 3 3.5 O=C(O)CC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(Cl)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL278100 98763 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 389 8 2 3 3.5 O=C(O)CC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(Cl)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
10500543 83200 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 389 8 3 4 3.8 N#CN/C(=N/C1CC1)Nc1ccc(/C(=C\CCCC(=O)O)c2cccnc2)cc1 10.1021/jm9707941
CHEMBL21849 83200 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 389 8 3 4 3.8 N#CN/C(=N/C1CC1)Nc1ccc(/C(=C\CCCC(=O)O)c2cccnc2)cc1 10.1021/jm9707941
10833696 168523 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 381 9 1 5 3.9 O=C(O)CCCCCO/N=C(\c1ccnnc1)c1cccc(C(F)(F)F)c1 10.1021/jm960341g
CHEMBL435412 168523 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 381 9 1 5 3.9 O=C(O)CCCCCO/N=C(\c1ccnnc1)c1cccc(C(F)(F)F)c1 10.1021/jm960341g
16757083 142598 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 519 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(I)cc1 10.1021/jm070427h
CHEMBL389135 142598 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 519 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(I)cc1 10.1021/jm070427h
54757771 65461 0 None -8 2 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 515 12 1 4 5.7 CC(C)COC1=C(CC2CC2)C(=O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1 10.1021/jm200980u
CHEMBL1829813 65461 0 None -8 2 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 515 12 1 4 5.7 CC(C)COC1=C(CC2CC2)C(=O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1 10.1021/jm200980u
16757486 93211 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 533 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(I)cc1 10.1021/jm070427h
CHEMBL244608 93211 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 533 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(I)cc1 10.1021/jm070427h
44305343 100682 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 473 11 1 4 6.9 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)CS[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80103-7
CHEMBL292331 100682 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 473 11 1 4 6.9 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)CS[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80103-7
10409713 14669 0 None 42 2 Rat 7.7 pIC50 = 7.7 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 395 6 2 3 3.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc3ccccc3c1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205668 14669 0 None 42 2 Rat 7.7 pIC50 = 7.7 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 395 6 2 3 3.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc3ccccc3c1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL131497 14669 0 None 42 2 Rat 7.7 pIC50 = 7.7 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 395 6 2 3 3.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc3ccccc3c1)C2 10.1016/s0960-894x(99)00014-1
44291635 14785 0 None - 1 Rat 6.7 pIC50 = 6.7 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 495 9 2 4 5.6 CC(C)c1ccc2c(CCCCS(=O)(=O)Nc3ccc(Cl)cc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL1206702 14785 0 None - 1 Rat 6.7 pIC50 = 6.7 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 495 9 2 4 5.6 CC(C)c1ccc2c(CCCCS(=O)(=O)Nc3ccc(Cl)cc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL298462 14785 0 None - 1 Rat 6.7 pIC50 = 6.7 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 495 9 2 4 5.6 CC(C)c1ccc2c(CCCCS(=O)(=O)Nc3ccc(Cl)cc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
71740559 91352 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 386 4 3 5 3.4 Cc1cccc(Nc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)(C)C)c1 10.1016/j.ejmech.2013.04.033
CHEMBL2402432 91352 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 386 4 3 5 3.4 Cc1cccc(Nc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)(C)C)c1 10.1016/j.ejmech.2013.04.033
44273462 74408 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 335 8 2 3 2.9 O=C(O)CC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccccc1 10.1016/0960-894X(95)00199-4
CHEMBL20257 74408 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 335 8 2 3 2.9 O=C(O)CC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccccc1 10.1016/0960-894X(95)00199-4
11633163 138836 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(C)c1 10.1021/jm070427h
CHEMBL378137 138836 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(C)c1 10.1021/jm070427h
71740179 91341 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 401 8 2 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccccc1C 10.1016/j.ejmech.2013.04.033
CHEMBL2402421 91341 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 401 8 2 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccccc1C 10.1016/j.ejmech.2013.04.033
44305452 203361 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 473 11 1 4 6.9 O=C(O)CCC/C=C\C[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)CS[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80103-7
CHEMBL65161 203361 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 473 11 1 4 6.9 O=C(O)CCC/C=C\C[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)CS[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80103-7
44304473 202900 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 369 7 3 3 4.4 O=C(O)CCC/C=C1\C[C@@H]2[C@@H](/C=N/NC(=O)Nc3ccccc3)CC[C@@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL62739 202900 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 369 7 3 3 4.4 O=C(O)CCC/C=C1\C[C@@H]2[C@@H](/C=N/NC(=O)Nc3ccccc3)CC[C@@H]2C1 10.1016/S0960-894X(01)80876-3
44273506 78220 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 349 9 2 3 3.3 O=C(O)CCC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccccc1 10.1016/0960-894X(95)00199-4
CHEMBL21057 78220 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 349 9 2 3 3.3 O=C(O)CCC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccccc1 10.1016/0960-894X(95)00199-4
16756977 92290 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 407 5 2 6 3.5 Cc1ccccc1Oc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm070427h
CHEMBL242692 92290 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 407 5 2 6 3.5 Cc1ccccc1Oc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm070427h
71740560 91353 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 400 8 3 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1cccc(C)c1 10.1016/j.ejmech.2013.04.033
CHEMBL2402433 91353 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 400 8 3 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1cccc(C)c1 10.1016/j.ejmech.2013.04.033
71740180 91342 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 373 5 2 5 3.1 Cc1cccc(Oc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)C)c1 10.1016/j.ejmech.2013.04.033
CHEMBL2402422 91342 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 373 5 2 5 3.1 Cc1cccc(Oc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)C)c1 10.1016/j.ejmech.2013.04.033
16757080 144180 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 441 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(Cl)c1 10.1021/jm070427h
CHEMBL390414 144180 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 441 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(Cl)c1 10.1021/jm070427h
44305478 100744 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 505 11 1 5 5.6 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)S(=O)(=O)C[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80103-7
CHEMBL292740 100744 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 505 11 1 5 5.6 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)S(=O)(=O)C[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80103-7
5312142 78233 11 None - 1 Human 6.6 pIC50 = 6.6 Functional
Inhibition of U46619-induced platelet aggregationInhibition of U46619-induced platelet aggregation
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
CHEMBL210602 78233 11 None - 1 Human 6.6 pIC50 = 6.6 Functional
Inhibition of U46619-induced platelet aggregationInhibition of U46619-induced platelet aggregation
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
15018463 169380 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 389 10 2 3 3.6 O=C(O)CCCCCC[C@@H]1[C@@H](NS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL442143 169380 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 389 10 2 3 3.6 O=C(O)CCCCCC[C@@H]1[C@@H](NS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
10661867 20577 1 None - 1 Human 4.6 pIC50 = 4.6 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(/c1ccccc1)c1cnccn1 10.1021/jm960341g
CHEMBL130790 20577 1 None - 1 Human 4.6 pIC50 = 4.6 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(/c1ccccc1)c1cnccn1 10.1021/jm960341g
16757381 143923 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 427 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1Cl 10.1021/jm070427h
CHEMBL390216 143923 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 427 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1Cl 10.1021/jm070427h
13720717 77851 0 None 1 3 Human 5.6 pIC50 = 5.6 Functional
Inhibitory activity against U-46,619-induced responses in human platelet aggregation (Thromboxane A2 alpha receptor)Inhibitory activity against U-46,619-induced responses in human platelet aggregation (Thromboxane A2 alpha receptor)
ChEMBL 363 5 3 6 2.7 COc1cc(C[C@H]2NCCc3cc(O)c(O)c(F)c32)cc(OC)c1OC 10.1021/jm00081a007
CHEMBL2092996 77851 0 None 1 3 Human 5.6 pIC50 = 5.6 Functional
Inhibitory activity against U-46,619-induced responses in human platelet aggregation (Thromboxane A2 alpha receptor)Inhibitory activity against U-46,619-induced responses in human platelet aggregation (Thromboxane A2 alpha receptor)
ChEMBL 363 5 3 6 2.7 COc1cc(C[C@H]2NCCc3cc(O)c(O)c(F)c32)cc(OC)c1OC 10.1021/jm00081a007
54669847 65453 0 None -4 2 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 405 7 2 4 3.4 O=C1C=C(O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1 10.1021/jm200980u
CHEMBL1829805 65453 0 None -4 2 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 405 7 2 4 3.4 O=C1C=C(O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1 10.1021/jm200980u
44273489 74145 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 363 9 2 3 3.6 Cc1ccc(S(=O)(=O)N[C@H]2CCC=C2C/C=C\CCCC(=O)O)cc1 10.1016/0960-894X(95)00199-4
CHEMBL20228 74145 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 363 9 2 3 3.6 Cc1ccc(S(=O)(=O)N[C@H]2CCC=C2C/C=C\CCCC(=O)O)cc1 10.1016/0960-894X(95)00199-4
23276770 118489 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(/c1cccc(C(F)(F)F)c1)c1ccncn1 10.1021/jm960341g
CHEMBL341426 118489 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(/c1cccc(C(F)(F)F)c1)c1ccncn1 10.1021/jm960341g
44386678 168347 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 386 13 1 4 4.0 CCCCCCS(=O)(=O)CC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL434362 168347 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 386 13 1 4 4.0 CCCCCCS(=O)(=O)CC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
10852668 19570 1 None - 1 Human 4.6 pIC50 = 4.6 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 313 9 1 5 2.9 O=C(O)CCCCCO/N=C(/c1ccccc1)c1ccncn1 10.1021/jm960341g
CHEMBL129995 19570 1 None - 1 Human 4.6 pIC50 = 4.6 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 313 9 1 5 2.9 O=C(O)CCCCCO/N=C(/c1ccccc1)c1ccncn1 10.1021/jm960341g
10827996 116185 1 None - 1 Human 4.6 pIC50 = 4.6 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(/c1ccccc1)c1ccncn1 10.1021/jm960341g
CHEMBL335841 116185 1 None - 1 Human 4.6 pIC50 = 4.6 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(/c1ccccc1)c1ccncn1 10.1021/jm960341g
54757771 65461 0 None 8 2 Mouse 5.6 pIC50 = 5.6 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 515 12 1 4 5.7 CC(C)COC1=C(CC2CC2)C(=O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1 10.1021/jm200980u
CHEMBL1829813 65461 0 None 8 2 Mouse 5.6 pIC50 = 5.6 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 515 12 1 4 5.7 CC(C)COC1=C(CC2CC2)C(=O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1 10.1021/jm200980u
11633163 138836 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(C)c1 10.1021/jm070427h
CHEMBL378137 138836 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(C)c1 10.1021/jm070427h
16756980 93281 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 471 5 2 6 3.9 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1Br 10.1021/jm070427h
CHEMBL245032 93281 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 471 5 2 6 3.9 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1Br 10.1021/jm070427h
54757770 65459 0 None 20 2 Mouse 6.6 pIC50 = 6.6 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 503 11 1 4 5.6 CC(C)COC1=C(C(C)C)C(=O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1 10.1021/jm200980u
CHEMBL1829811 65459 0 None 20 2 Mouse 6.6 pIC50 = 6.6 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 503 11 1 4 5.6 CC(C)COC1=C(C(C)C)C(=O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1 10.1021/jm200980u
9907162 14745 0 None 50 2 Rat 7.6 pIC50 = 7.6 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 365 5 2 3 2.7 O=C(O)c1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1206352 14745 0 None 50 2 Rat 7.6 pIC50 = 7.6 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 365 5 2 3 2.7 O=C(O)c1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL264516 14745 0 None 50 2 Rat 7.6 pIC50 = 7.6 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 365 5 2 3 2.7 O=C(O)c1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
44305522 202971 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
In vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human platelets
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)OC[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80104-9
CHEMBL63040 202971 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
In vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human platelets
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)OC[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80104-9
15018450 72963 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 383 9 2 3 3.6 Cc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](F)[C@@H]2C/C=C\CCCC(=O)O)cc1 10.1016/0960-894X(95)00199-4
CHEMBL20065 72963 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 383 9 2 3 3.6 Cc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](F)[C@@H]2C/C=C\CCCC(=O)O)cc1 10.1016/0960-894X(95)00199-4
10669025 205056 1 None - 1 Human 5.6 pIC50 = 5.6 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 405 7 3 4 4.4 CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=C/CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL7718 205056 1 None - 1 Human 5.6 pIC50 = 5.6 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 405 7 3 4 4.4 CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=C/CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
44291875 101479 0 None - 1 Rat 5.6 pIC50 = 5.6 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 459 9 2 3 6.0 CC(C)c1ccc2c(CCCCS(=O)(=O)Nc3ccc(Cl)cc3)cc(C(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL297808 101479 0 None - 1 Rat 5.6 pIC50 = 5.6 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 459 9 2 3 6.0 CC(C)c1ccc2c(CCCCS(=O)(=O)Nc3ccc(Cl)cc3)cc(C(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
44304706 203288 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 371 6 4 4 3.0 O=C(O)CC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccccc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL64707 203288 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 371 6 4 4 3.0 O=C(O)CC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccccc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
16757376 153487 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 393 6 2 6 3.1 Cc1cccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)C)c1 10.1021/jm070427h
CHEMBL397964 153487 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 393 6 2 6 3.1 Cc1cccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)C)c1 10.1021/jm070427h
16757175 93246 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 437 10 2 7 3.6 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(OC)cc1 10.1021/jm070427h
CHEMBL244818 93246 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 437 10 2 7 3.6 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(OC)cc1 10.1021/jm070427h
10546960 203355 0 None 6 2 Mouse 7.6 pIC50 = 7.6 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 367 8 2 3 2.9 O=C(O)CCc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm200980u
CHEMBL65121 203355 0 None 6 2 Mouse 7.6 pIC50 = 7.6 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 367 8 2 3 2.9 O=C(O)CCc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm200980u
10550018 162260 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 419 10 3 4 4.7 CC(C)CC/N=C(/NC#N)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL416374 162260 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 419 10 3 4 4.7 CC(C)CC/N=C(/NC#N)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
16757176 93284 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 465 12 2 7 4.4 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(OCCC)cc1 10.1021/jm070427h
CHEMBL245036 93284 0 None - 1 Human 4.6 pIC50 = 4.6 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 465 12 2 7 4.4 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(OCCC)cc1 10.1021/jm070427h
71740444 91349 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 386 4 3 5 3.4 Cc1ccccc1Nc1ccc(C#N)cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1016/j.ejmech.2013.04.033
CHEMBL2402429 91349 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 386 4 3 5 3.4 Cc1ccccc1Nc1ccc(C#N)cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1016/j.ejmech.2013.04.033
117630015 115869 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 591 9 1 4 7.0 Cc1cccc(C)c1C1=C(OCC(C)C)CC(Cc2cccc3c2CCC(NS(=O)(=O)c2ccc(Cl)cc2)C3)C1=O 10.1021/ml5002085
CHEMBL3354617 115869 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 591 9 1 4 7.0 Cc1cccc(C)c1C1=C(OCC(C)C)CC(Cc2cccc3c2CCC(NS(=O)(=O)c2ccc(Cl)cc2)C3)C1=O 10.1021/ml5002085
11676121 78322 4 None - 1 Human 6.6 pIC50 = 6.6 Functional
Inhibition of U46619-induced platelet aggregationInhibition of U46619-induced platelet aggregation
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(C)cc1 10.1021/jm060108a
CHEMBL210964 78322 4 None - 1 Human 6.6 pIC50 = 6.6 Functional
Inhibition of U46619-induced platelet aggregationInhibition of U46619-induced platelet aggregation
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(C)cc1 10.1021/jm060108a
44305522 202971 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
In vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human platelets
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)OC[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80104-9
CHEMBL63040 202971 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
In vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human platelets
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)OC[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80104-9
65772 60403 8 None -54 11 Human 6.6 pIC50 = 6.6 Functional
Inhibitory activity against U-46,619-induced responses in human platelet aggregation (Thromboxane A2 alpha receptor)Inhibitory activity against U-46,619-induced responses in human platelet aggregation (Thromboxane A2 alpha receptor)
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm00081a007
CHEMBL174984 60403 8 None -54 11 Human 6.6 pIC50 = 6.6 Functional
Inhibitory activity against U-46,619-induced responses in human platelet aggregation (Thromboxane A2 alpha receptor)Inhibitory activity against U-46,619-induced responses in human platelet aggregation (Thromboxane A2 alpha receptor)
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm00081a007
15290043 14802 0 None -33 2 Human 5.6 pIC50 = 5.6 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 351 6 2 4 2.1 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1cccs1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1207012 14802 0 None -33 2 Human 5.6 pIC50 = 5.6 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 351 6 2 4 2.1 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1cccs1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL335043 14802 0 None -33 2 Human 5.6 pIC50 = 5.6 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 351 6 2 4 2.1 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1cccs1)C2 10.1016/s0960-894x(99)00014-1
18921481 14664 0 None -81 2 Human 5.5 pIC50 = 5.5 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 421 9 2 3 3.8 O=C(O)CCCCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205661 14664 0 None -81 2 Human 5.5 pIC50 = 5.5 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 421 9 2 3 3.8 O=C(O)CCCCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL130377 14664 0 None -81 2 Human 5.5 pIC50 = 5.5 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 421 9 2 3 3.8 O=C(O)CCCCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
117630458 115871 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 521 7 2 4 5.4 O=C1C(Cc2ccccc2)=C(O)CC1Cc1cccc2c1CCC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1021/ml5002085
CHEMBL3354619 115871 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 521 7 2 4 5.4 O=C1C(Cc2ccccc2)=C(O)CC1Cc1cccc2c1CCC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1021/ml5002085
10385168 116580 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 381 9 1 5 3.9 O=C(O)CCCCCO/N=C(/c1ccnnc1)c1cccc(C(F)(F)F)c1 10.1021/jm960341g
CHEMBL336548 116580 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 381 9 1 5 3.9 O=C(O)CCCCCO/N=C(/c1ccnnc1)c1cccc(C(F)(F)F)c1 10.1021/jm960341g
11633215 140155 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 423 5 2 6 3.8 Cc1ccc(Sc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
CHEMBL380274 140155 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 423 5 2 6 3.8 Cc1ccc(Sc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
15290042 14873 0 None 162 2 Rat 6.5 pIC50 = 6.5 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 395 6 2 3 3.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1cccc3ccccc13)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1207638 14873 0 None 162 2 Rat 6.5 pIC50 = 6.5 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 395 6 2 3 3.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1cccc3ccccc13)C2 10.1016/s0960-894x(99)00014-1
CHEMBL422441 14873 0 None 162 2 Rat 6.5 pIC50 = 6.5 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 395 6 2 3 3.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1cccc3ccccc13)C2 10.1016/s0960-894x(99)00014-1
71740560 91353 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 400 8 3 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1cccc(C)c1 10.1016/j.ejmech.2013.04.033
CHEMBL2402433 91353 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 400 8 3 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1cccc(C)c1 10.1016/j.ejmech.2013.04.033
10646254 81139 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 429 9 3 6 4.8 CC(C)(C)NC(Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1)=C(C#N)C#N 10.1021/jm9707941
CHEMBL21570 81139 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 429 9 3 6 4.8 CC(C)(C)NC(Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1)=C(C#N)C#N 10.1021/jm9707941
219052 14804 2 None 120 2 Rat 8.5 pIC50 = 8.5 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 379 6 2 3 2.7 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1207021 14804 2 None 120 2 Rat 8.5 pIC50 = 8.5 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 379 6 2 3 2.7 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL336846 14804 2 None 120 2 Rat 8.5 pIC50 = 8.5 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 379 6 2 3 2.7 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
54669848 65454 0 None 42 2 Mouse 8.5 pIC50 = 8.5 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 419 7 2 4 3.8 CC1=C(O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)CC1=O 10.1021/jm200980u
CHEMBL1829806 65454 0 None 42 2 Mouse 8.5 pIC50 = 8.5 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 419 7 2 4 3.8 CC1=C(O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)CC1=O 10.1021/jm200980u
117630548 115866 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 507 6 2 4 5.3 O=C1C(c2ccccc2)=C(O)CC1Cc1cccc2c1CCC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1021/ml5002085
CHEMBL3354614 115866 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 507 6 2 4 5.3 O=C1C(c2ccccc2)=C(O)CC1Cc1cccc2c1CCC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1021/ml5002085
10669649 81705 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 417 8 3 4 4.5 N#CN/C(=N/C1CCCC1)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL21639 81705 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 417 8 3 4 4.5 N#CN/C(=N/C1CCCC1)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
11661725 77859 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 420 5 3 6 3.7 Cc1cccc(C)c1Nc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm060108a
CHEMBL209306 77859 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 420 5 3 6 3.7 Cc1cccc(C)c1Nc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm060108a
10503638 164809 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 448 10 4 6 3.8 CC(C)C/N=C(\Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1)Nc1nn[nH]n1 10.1021/jm9707941
CHEMBL421854 164809 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 448 10 4 6 3.8 CC(C)C/N=C(\Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1)Nc1nn[nH]n1 10.1021/jm9707941
11567679 77748 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Inhibition of U46619-induced platelet aggregationInhibition of U46619-induced platelet aggregation
ChEMBL 407 5 2 6 3.5 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
CHEMBL209035 77748 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Inhibition of U46619-induced platelet aggregationInhibition of U46619-induced platelet aggregation
ChEMBL 407 5 2 6 3.5 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
10494367 19505 1 None - 1 Human 5.5 pIC50 = 5.5 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(\c1ccccc1)c1ncccn1 10.1021/jm960341g
CHEMBL129935 19505 1 None - 1 Human 5.5 pIC50 = 5.5 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(\c1ccccc1)c1ncccn1 10.1021/jm960341g
10518244 21928 1 None - 1 Human 4.5 pIC50 = 4.5 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(\c1ccccc1)c1ccncn1 10.1021/jm960341g
CHEMBL132043 21928 1 None - 1 Human 4.5 pIC50 = 4.5 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(\c1ccccc1)c1ccncn1 10.1021/jm960341g
16757486 93211 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 533 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(I)cc1 10.1021/jm070427h
CHEMBL244608 93211 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 533 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(I)cc1 10.1021/jm070427h
71740183 91345 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 373 5 2 5 3.1 Cc1ccc(Oc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)C)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402425 91345 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 373 5 2 5 3.1 Cc1ccc(Oc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)C)cc1 10.1016/j.ejmech.2013.04.033
16757081 92865 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 427 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Cl)cc1 10.1021/jm070427h
CHEMBL243983 92865 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 427 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Cl)cc1 10.1021/jm070427h
16757079 92845 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 441 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1Cl 10.1021/jm070427h
CHEMBL243773 92845 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 441 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1Cl 10.1021/jm070427h
18921526 14674 0 None 46 2 Rat 7.5 pIC50 = 7.5 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 393 7 2 3 3.1 O=C(O)Cc1ccc2c(c1)CC(CCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205680 14674 0 None 46 2 Rat 7.5 pIC50 = 7.5 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 393 7 2 3 3.1 O=C(O)Cc1ccc2c(c1)CC(CCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL132659 14674 0 None 46 2 Rat 7.5 pIC50 = 7.5 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 393 7 2 3 3.1 O=C(O)Cc1ccc2c(c1)CC(CCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
44457587 83495 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 436 9 3 6 3.7 CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=N\OCCCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL22023 83495 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 436 9 3 6 3.7 CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=N\OCCCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
16756981 152602 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 485 9 2 6 4.3 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1Br 10.1021/jm070427h
CHEMBL397198 152602 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 485 9 2 6 4.3 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1Br 10.1021/jm070427h
5312142 78233 11 None - 1 Human 6.5 pIC50 = 6.5 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
CHEMBL210602 78233 11 None - 1 Human 6.5 pIC50 = 6.5 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
5312142 78233 11 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm070427h
CHEMBL210602 78233 11 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm070427h
71740557 91350 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 400 8 3 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccccc1C 10.1016/j.ejmech.2013.04.033
CHEMBL2402430 91350 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 400 8 3 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccccc1C 10.1016/j.ejmech.2013.04.033
10717914 169108 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 439 9 3 4 4.8 N#CN/C(=N/Cc1ccccc1)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL440096 169108 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 439 9 3 4 4.8 N#CN/C(=N/Cc1ccccc1)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
44353303 14666 0 None -2 2 Human 6.5 pIC50 = 6.5 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 381 6 2 4 2.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)O2 10.1016/s0960-894x(99)00014-1
CHEMBL1205664 14666 0 None -2 2 Human 6.5 pIC50 = 6.5 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 381 6 2 4 2.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)O2 10.1016/s0960-894x(99)00014-1
CHEMBL131036 14666 0 None -2 2 Human 6.5 pIC50 = 6.5 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 381 6 2 4 2.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)O2 10.1016/s0960-894x(99)00014-1
10526115 80515 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 419 8 3 4 4.8 CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=C\CCCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL21478 80515 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 419 8 3 4 4.8 CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=C\CCCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
10766313 98699 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 458 8 3 5 3.9 CC(C)(C)/N=C(\Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1)NS(C)(=O)=O 10.1021/jm9707941
CHEMBL277620 98699 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 458 8 3 5 3.9 CC(C)(C)/N=C(\Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1)NS(C)(=O)=O 10.1021/jm9707941
10637870 20524 1 None - 1 Human 4.5 pIC50 = 4.5 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(\c1ccccc1)c1ccnnc1 10.1021/jm960341g
CHEMBL130755 20524 1 None - 1 Human 4.5 pIC50 = 4.5 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(\c1ccccc1)c1ccnnc1 10.1021/jm960341g
10545734 166947 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 349 7 3 4 2.8 N#CN/C(N)=N\c1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL428709 166947 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 349 7 3 4 2.8 N#CN/C(N)=N\c1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
18921481 14664 0 None 81 2 Rat 7.5 pIC50 = 7.5 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 421 9 2 3 3.8 O=C(O)CCCCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205661 14664 0 None 81 2 Rat 7.5 pIC50 = 7.5 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 421 9 2 3 3.8 O=C(O)CCCCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL130377 14664 0 None 81 2 Rat 7.5 pIC50 = 7.5 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 421 9 2 3 3.8 O=C(O)CCCCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
44385759 60458 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 354 13 1 3 5.4 CCCCCCCSC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL175325 60458 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 354 13 1 3 5.4 CCCCCCCSC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
163920 14675 12 None -165 2 Human 6.4 pIC50 = 6.4 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 365 5 2 3 2.4 O=C(O)Cc1ccc2c(c1)CC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205685 14675 12 None -165 2 Human 6.4 pIC50 = 6.4 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 365 5 2 3 2.4 O=C(O)Cc1ccc2c(c1)CC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL133420 14675 12 None -165 2 Human 6.4 pIC50 = 6.4 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 365 5 2 3 2.4 O=C(O)Cc1ccc2c(c1)CC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
219052 14804 2 None -120 2 Human 6.4 pIC50 = 6.4 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 379 6 2 3 2.7 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1207021 14804 2 None -120 2 Human 6.4 pIC50 = 6.4 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 379 6 2 3 2.7 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL336846 14804 2 None -120 2 Human 6.4 pIC50 = 6.4 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 379 6 2 3 2.7 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
10384315 165146 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(\c1cncnc1)c1cccc(C(F)(F)F)c1 10.1021/jm960341g
CHEMBL422793 165146 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(\c1cncnc1)c1cccc(C(F)(F)F)c1 10.1021/jm960341g
71740057 91340 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 387 4 2 5 3.4 Cc1ccccc1Oc1ccc(C#N)cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1016/j.ejmech.2013.04.033
CHEMBL2402420 91340 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 387 4 2 5 3.4 Cc1ccccc1Oc1ccc(C#N)cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1016/j.ejmech.2013.04.033
1986 1312 50 None 7 2 Rat 7.4 pIC50 = 7.4 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 353 7 2 3 2.5 OC(=O)Cc1ccc(cc1)CCNS(=O)(=O)c1ccc(cc1)Cl 10.1016/s0960-894x(99)00014-1
54343 1312 50 None 7 2 Rat 7.4 pIC50 = 7.4 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 353 7 2 3 2.5 OC(=O)Cc1ccc(cc1)CCNS(=O)(=O)c1ccc(cc1)Cl 10.1016/s0960-894x(99)00014-1
CHEMBL71685 1312 50 None 7 2 Rat 7.4 pIC50 = 7.4 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 353 7 2 3 2.5 OC(=O)Cc1ccc(cc1)CCNS(=O)(=O)c1ccc(cc1)Cl 10.1016/s0960-894x(99)00014-1
44387046 62135 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 354 13 1 3 5.3 CCCCCSCCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL177760 62135 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 354 13 1 3 5.3 CCCCCSCCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
16757179 93320 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 455 9 2 6 4.5 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Cl)c(C)c1 10.1021/jm070427h
CHEMBL245263 93320 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 455 9 2 6 4.5 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Cl)c(C)c1 10.1021/jm070427h
16756977 92290 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 407 5 2 6 3.5 Cc1ccccc1Oc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm070427h
CHEMBL242692 92290 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 407 5 2 6 3.5 Cc1ccccc1Oc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm070427h
54758054 65450 0 None -4 2 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 420 8 3 6 1.8 O=c1c(O)c(NCc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)c1=O 10.1021/jm200980u
CHEMBL1829802 65450 0 None -4 2 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 420 8 3 6 1.8 O=c1c(O)c(NCc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)c1=O 10.1021/jm200980u
10620837 99181 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 397 7 3 3 5.3 CC(C)(C)/N=C(/S)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL281338 99181 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 397 7 3 3 5.3 CC(C)(C)/N=C(/S)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
11647396 77782 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 418 5 2 6 3.5 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)N2CCCCC2)cc1 10.1021/jm060108a
CHEMBL209168 77782 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 418 5 2 6 3.5 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)N2CCCCC2)cc1 10.1021/jm060108a
10320462 14801 0 None 34 2 Rat 7.4 pIC50 = 7.4 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 407 8 2 3 3.4 O=C(O)CCCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1207010 14801 0 None 34 2 Rat 7.4 pIC50 = 7.4 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 407 8 2 3 3.4 O=C(O)CCCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL334501 14801 0 None 34 2 Rat 7.4 pIC50 = 7.4 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 407 8 2 3 3.4 O=C(O)CCCc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
44386034 60388 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 368 13 1 3 5.7 CCCCCC(C)SCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL174856 60388 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 368 13 1 3 5.7 CCCCCC(C)SCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
118719206 115464 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 354 13 1 3 5.3 CCCCCCSC[C@H]1C2CCC(O2)[C@H]1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL3350918 115464 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 354 13 1 3 5.3 CCCCCCSC[C@H]1C2CCC(O2)[C@H]1C/C=C\CCCC(=O)O 10.1021/jm00125a009
56659855 65318 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at thromboxane receptor in human blood assessed as inhibition of U-46619-induced effectAntagonist activity at thromboxane receptor in human blood assessed as inhibition of U-46619-induced effect
ChEMBL 353 7 2 8 -0.1 NC(=O)c1c(CSCC(=O)Oc2ccccc2C(=O)O)no[n+]1[O-] 10.1016/j.bmc.2011.08.018
CHEMBL1829095 65318 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at thromboxane receptor in human blood assessed as inhibition of U-46619-induced effectAntagonist activity at thromboxane receptor in human blood assessed as inhibition of U-46619-induced effect
ChEMBL 353 7 2 8 -0.1 NC(=O)c1c(CSCC(=O)Oc2ccccc2C(=O)O)no[n+]1[O-] 10.1016/j.bmc.2011.08.018
44386134 62354 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 284 8 1 3 3.3 CSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL177907 62354 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 284 8 1 3 3.3 CSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
54757769 65457 0 None -8 2 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 489 11 1 4 5.3 CCC1=C(OCC(C)C)CC(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1=O 10.1021/jm200980u
CHEMBL1829809 65457 0 None -8 2 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 489 11 1 4 5.3 CCC1=C(OCC(C)C)CC(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1=O 10.1021/jm200980u
16757079 92845 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 441 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1Cl 10.1021/jm070427h
CHEMBL243773 92845 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 441 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1Cl 10.1021/jm070427h
71740308 91358 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 391 4 2 5 3.3 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402438 91358 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 391 4 2 5 3.3 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
10095268 86156 0 None -7 3 Human 7.4 pIC50 = 7.4 Functional
Inhibition of human recombinant TP receptor expressed in CHO cells by calcium mobilisation assayInhibition of human recombinant TP receptor expressed in CHO cells by calcium mobilisation assay
ChEMBL 449 6 1 3 6.8 Cc1ccc(-n2c(C)ccc2-c2cc(Cl)ccc2OCc2ccc(F)cc2)cc1C(=O)O 10.1016/j.bmcl.2006.11.059
CHEMBL231184 86156 0 None -7 3 Human 7.4 pIC50 = 7.4 Functional
Inhibition of human recombinant TP receptor expressed in CHO cells by calcium mobilisation assayInhibition of human recombinant TP receptor expressed in CHO cells by calcium mobilisation assay
ChEMBL 449 6 1 3 6.8 Cc1ccc(-n2c(C)ccc2-c2cc(Cl)ccc2OCc2ccc(F)cc2)cc1C(=O)O 10.1016/j.bmcl.2006.11.059
56680341 65319 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at thromboxane receptor in human blood assessed as inhibition of U-46619-induced effectAntagonist activity at thromboxane receptor in human blood assessed as inhibition of U-46619-induced effect
ChEMBL 337 7 2 8 0.7 NC(=O)c1nonc1CSCC(=O)Oc1ccccc1C(=O)O 10.1016/j.bmc.2011.08.018
CHEMBL1829096 65319 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
Antagonist activity at thromboxane receptor in human blood assessed as inhibition of U-46619-induced effectAntagonist activity at thromboxane receptor in human blood assessed as inhibition of U-46619-induced effect
ChEMBL 337 7 2 8 0.7 NC(=O)c1nonc1CSCC(=O)Oc1ccccc1C(=O)O 10.1016/j.bmc.2011.08.018
16757377 150073 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 407 5 2 6 3.5 Cc1cccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)c1 10.1021/jm070427h
CHEMBL395079 150073 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 407 5 2 6 3.5 Cc1cccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)c1 10.1021/jm070427h
13720716 63053 0 None -165 3 Human 4.4 pIC50 = 4.4 Functional
Inhibitory activity against U-46,619-induced responses in human platelet aggregation (Thromboxane A2 alpha receptor)Inhibitory activity against U-46,619-induced responses in human platelet aggregation (Thromboxane A2 alpha receptor)
ChEMBL 363 5 3 6 2.7 COc1cc(C[C@@H]2NCCc3cc(O)c(O)c(F)c32)cc(OC)c1OC 10.1021/jm00081a007
CHEMBL1788251 63053 0 None -165 3 Human 4.4 pIC50 = 4.4 Functional
Inhibitory activity against U-46,619-induced responses in human platelet aggregation (Thromboxane A2 alpha receptor)Inhibitory activity against U-46,619-induced responses in human platelet aggregation (Thromboxane A2 alpha receptor)
ChEMBL 363 5 3 6 2.7 COc1cc(C[C@@H]2NCCc3cc(O)c(O)c(F)c32)cc(OC)c1OC 10.1021/jm00081a007
16757081 92865 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 427 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Cl)cc1 10.1021/jm070427h
CHEMBL243983 92865 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 427 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Cl)cc1 10.1021/jm070427h
16757083 142598 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 519 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(I)cc1 10.1021/jm070427h
CHEMBL389135 142598 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 519 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(I)cc1 10.1021/jm070427h
44138108 184285 0 None -7413 2 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at TP1 in human platelet-rich plasma assessed as inhibition of U44619-induced platelet aggregationAntagonist activity at TP1 in human platelet-rich plasma assessed as inhibition of U44619-induced platelet aggregation
ChEMBL 434 5 1 4 6.6 CC(C)c1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CC[C@@H]1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL483991 184285 0 None -7413 2 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at TP1 in human platelet-rich plasma assessed as inhibition of U44619-induced platelet aggregationAntagonist activity at TP1 in human platelet-rich plasma assessed as inhibition of U44619-induced platelet aggregation
ChEMBL 434 5 1 4 6.6 CC(C)c1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CC[C@@H]1CC(=O)O 10.1016/j.bmcl.2009.03.010
56680464 65460 0 None -7 2 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 461 9 2 4 3.8 O=C1C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)CC(O)C1CC1CC1 10.1021/jm200980u
CHEMBL1829812 65460 0 None -7 2 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 461 9 2 4 3.8 O=C1C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)CC(O)C1CC1CC1 10.1021/jm200980u
71740561 91354 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 372 5 3 5 3.0 Cc1ccc(Nc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)C)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402434 91354 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 372 5 3 5 3.0 Cc1ccc(Nc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)C)cc1 10.1016/j.ejmech.2013.04.033
16756982 93316 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 485 9 2 6 4.3 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(Br)c1 10.1021/jm070427h
CHEMBL245254 93316 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 485 9 2 6 4.3 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(Br)c1 10.1021/jm070427h
16757375 92187 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 407 8 2 6 3.5 CCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1C 10.1021/jm070427h
CHEMBL242479 92187 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 407 8 2 6 3.5 CCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1C 10.1021/jm070427h
44387050 61305 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 368 14 1 3 5.7 CCCCCCCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL176714 61305 0 None - 1 Human 4.4 pIC50 = 4.4 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 368 14 1 3 5.7 CCCCCCCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
71740561 91354 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 372 5 3 5 3.0 Cc1ccc(Nc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)C)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402434 91354 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 372 5 3 5 3.0 Cc1ccc(Nc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)C)cc1 10.1016/j.ejmech.2013.04.033
16757378 93280 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 393 7 2 6 3.1 CCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm070427h
CHEMBL245031 93280 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 393 7 2 6 3.1 CCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm070427h
16756981 152602 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 485 9 2 6 4.3 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1Br 10.1021/jm070427h
CHEMBL397198 152602 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 485 9 2 6 4.3 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1Br 10.1021/jm070427h
11656254 77777 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 498 9 3 6 4.6 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(Br)c(C)c1 10.1021/jm060108a
CHEMBL209134 77777 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 498 9 3 6 4.6 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(Br)c(C)c1 10.1021/jm060108a
11294166 77045 0 None -10232 2 Human 4.4 pIC50 = 4.4 Functional
Activity at TP receptor assessed as inhibition of U46619-induced platelet aggregation in platelet rich plasmaActivity at TP receptor assessed as inhibition of U46619-induced platelet aggregation in platelet rich plasma
ChEMBL 461 6 2 5 4.3 CC(O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1016/j.bmcl.2006.02.062
CHEMBL207203 77045 0 None -10232 2 Human 4.4 pIC50 = 4.4 Functional
Activity at TP receptor assessed as inhibition of U46619-induced platelet aggregation in platelet rich plasmaActivity at TP receptor assessed as inhibition of U46619-induced platelet aggregation in platelet rich plasma
ChEMBL 461 6 2 5 4.3 CC(O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1016/j.bmcl.2006.02.062
11294166 77045 0 None -10232 2 Human 4.4 pIC50 = 4.4 Functional
Activity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregationActivity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregation
ChEMBL 461 6 2 5 4.3 CC(O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1021/jm0603668
CHEMBL207203 77045 0 None -10232 2 Human 4.4 pIC50 = 4.4 Functional
Activity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregationActivity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregation
ChEMBL 461 6 2 5 4.3 CC(O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1021/jm0603668
71740308 91358 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 391 4 2 5 3.3 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402438 91358 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 391 4 2 5 3.3 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
44457567 80268 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 450 11 3 6 5.2 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(N/C(=C/[N+](=O)[O-])NC2CCCCC2)c1 10.1021/jm9707941
CHEMBL21392 80268 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 450 11 3 6 5.2 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(N/C(=C/[N+](=O)[O-])NC2CCCCC2)c1 10.1021/jm9707941
44273488 99471 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 367 9 2 3 3.4 O=C(O)CCC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00199-4
CHEMBL283128 99471 0 None - 1 Human 5.4 pIC50 = 5.4 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 367 9 2 3 3.4 O=C(O)CCC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00199-4
16757175 93246 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 437 10 2 7 3.6 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(OC)cc1 10.1021/jm070427h
CHEMBL244818 93246 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 437 10 2 7 3.6 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(OC)cc1 10.1021/jm070427h
16757378 93280 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 393 7 2 6 3.1 CCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm070427h
CHEMBL245031 93280 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 393 7 2 6 3.1 CCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm070427h
11568384 77796 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 440 7 3 6 3.8 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NCc2ccccc2)cc1 10.1021/jm060108a
CHEMBL209245 77796 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 440 7 3 6 3.8 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NCc2ccccc2)cc1 10.1021/jm060108a
11510008 77282 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1cccc(C)c1 10.1021/jm060108a
CHEMBL208115 77282 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1cccc(C)c1 10.1021/jm060108a
16757485 93181 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 533 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(I)c1 10.1021/jm070427h
CHEMBL244401 93181 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 533 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(I)c1 10.1021/jm070427h
44305343 100682 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 473 11 1 4 6.9 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)CS[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80103-7
CHEMBL292331 100682 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 473 11 1 4 6.9 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)CS[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80103-7
44305326 202926 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 473 11 1 4 6.9 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)SC[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80103-7
CHEMBL62834 202926 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 473 11 1 4 6.9 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)SC[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80103-7
11604299 139582 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 426 10 3 6 3.9 CCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1021/jm060108a
CHEMBL379736 139582 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 426 10 3 6 3.9 CCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1021/jm060108a
1986 1312 50 None -7 2 Human 6.3 pIC50 = 6.3 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 353 7 2 3 2.5 OC(=O)Cc1ccc(cc1)CCNS(=O)(=O)c1ccc(cc1)Cl 10.1016/s0960-894x(99)00014-1
54343 1312 50 None -7 2 Human 6.3 pIC50 = 6.3 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 353 7 2 3 2.5 OC(=O)Cc1ccc(cc1)CCNS(=O)(=O)c1ccc(cc1)Cl 10.1016/s0960-894x(99)00014-1
CHEMBL71685 1312 50 None -7 2 Human 6.3 pIC50 = 6.3 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 353 7 2 3 2.5 OC(=O)Cc1ccc(cc1)CCNS(=O)(=O)c1ccc(cc1)Cl 10.1016/s0960-894x(99)00014-1
9802748 135923 0 None -229 2 Human 5.3 pIC50 = 5.3 Functional
Inhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptorInhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptor
ChEMBL 430 6 1 4 3.4 CN([C@@H]1CCc2c(c3ccccc3n2CCC(=O)O)C1)S(=O)(=O)c1ccc(F)cc1 10.1021/jm049036i
CHEMBL373118 135923 0 None -229 2 Human 5.3 pIC50 = 5.3 Functional
Inhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptorInhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptor
ChEMBL 430 6 1 4 3.4 CN([C@@H]1CCc2c(c3ccccc3n2CCC(=O)O)C1)S(=O)(=O)c1ccc(F)cc1 10.1021/jm049036i
54757769 65457 0 None 8 2 Mouse 6.3 pIC50 = 6.3 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 489 11 1 4 5.3 CCC1=C(OCC(C)C)CC(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1=O 10.1021/jm200980u
CHEMBL1829809 65457 0 None 8 2 Mouse 6.3 pIC50 = 6.3 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 489 11 1 4 5.3 CCC1=C(OCC(C)C)CC(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1=O 10.1021/jm200980u
71740668 91337 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 390 4 3 5 3.2 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402417 91337 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 390 4 3 5 3.2 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
10526677 99429 1 None - 1 Human 7.3 pIC50 = 7.3 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 431 8 3 4 4.9 N#CN/C(=N/C1CCCCC1)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL282884 99429 1 None - 1 Human 7.3 pIC50 = 7.3 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 431 8 3 4 4.9 N#CN/C(=N/C1CCCCC1)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
11568248 138655 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 434 9 3 6 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1c(C)cccc1C 10.1021/jm060108a
CHEMBL377679 138655 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 434 9 3 6 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1c(C)cccc1C 10.1021/jm060108a
16757082 93051 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 519 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(I)c1 10.1021/jm070427h
CHEMBL244190 93051 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 519 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(I)c1 10.1021/jm070427h
44273463 161837 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 389 10 2 3 3.5 O=C(O)CCCCC[C@@H]1[C@@H](CNS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL414609 161837 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 389 10 2 3 3.5 O=C(O)CCCCC[C@@H]1[C@@H](CNS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
10756561 20275 1 None - 1 Human 4.3 pIC50 = 4.3 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(\c1ccccc1)c1cnccn1 10.1021/jm960341g
CHEMBL130564 20275 1 None - 1 Human 4.3 pIC50 = 4.3 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(\c1ccccc1)c1cnccn1 10.1021/jm960341g
71740444 91349 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 386 4 3 5 3.4 Cc1ccccc1Nc1ccc(C#N)cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1016/j.ejmech.2013.04.033
CHEMBL2402429 91349 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 386 4 3 5 3.4 Cc1ccccc1Nc1ccc(C#N)cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1016/j.ejmech.2013.04.033
15290042 14873 0 None -162 2 Human 4.3 pIC50 = 4.3 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 395 6 2 3 3.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1cccc3ccccc13)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1207638 14873 0 None -162 2 Human 4.3 pIC50 = 4.3 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 395 6 2 3 3.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1cccc3ccccc13)C2 10.1016/s0960-894x(99)00014-1
CHEMBL422441 14873 0 None -162 2 Human 4.3 pIC50 = 4.3 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 395 6 2 3 3.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1cccc3ccccc13)C2 10.1016/s0960-894x(99)00014-1
16757176 93284 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 465 12 2 7 4.4 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(OCCC)cc1 10.1021/jm070427h
CHEMBL245036 93284 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 465 12 2 7 4.4 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(OCCC)cc1 10.1021/jm070427h
71740668 91337 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 390 4 3 5 3.2 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402417 91337 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 390 4 3 5 3.2 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
56680464 65460 0 None 7 2 Mouse 8.2 pIC50 = 8.2 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 461 9 2 4 3.8 O=C1C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)CC(O)C1CC1CC1 10.1021/jm200980u
CHEMBL1829812 65460 0 None 7 2 Mouse 8.2 pIC50 = 8.2 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 461 9 2 4 3.8 O=C1C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)CC(O)C1CC1CC1 10.1021/jm200980u
22882112 203341 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 430 8 4 6 3.3 O=C(O)CCC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc([N+](=O)[O-])cc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL64977 203341 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 430 8 4 6 3.3 O=C(O)CCC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc([N+](=O)[O-])cc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
11676121 78322 4 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(C)cc1 10.1021/jm060108a
CHEMBL210964 78322 4 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(C)cc1 10.1021/jm060108a
44385825 59688 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 388 12 1 3 5.3 O=C(O)CCC/C=C\CC1C2CCC(O2)C1CSCCCc1ccccc1 10.1021/jm00125a009
CHEMBL172265 59688 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 388 12 1 3 5.3 O=C(O)CCC/C=C\CC1C2CCC(O2)C1CSCCCc1ccccc1 10.1021/jm00125a009
10686658 18863 1 None - 1 Human 5.3 pIC50 = 5.3 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 313 9 1 5 2.9 O=C(O)CCCCCO/N=C(\c1ccccc1)c1ccncn1 10.1021/jm960341g
CHEMBL128188 18863 1 None - 1 Human 5.3 pIC50 = 5.3 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 313 9 1 5 2.9 O=C(O)CCCCCO/N=C(\c1ccccc1)c1ccncn1 10.1021/jm960341g
16756877 92186 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 393 6 2 6 3.1 Cc1ccccc1Oc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)C 10.1021/jm070427h
CHEMBL242478 92186 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 393 6 2 6 3.1 Cc1ccccc1Oc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)C 10.1021/jm070427h
5311234 115139 25 None -257 4 Human 6.3 pIC50 = 6.3 Functional
Functional activity in RAT-1 cells, transiently transfected with human prostaglandin TP receptorFunctional activity in RAT-1 cells, transiently transfected with human prostaglandin TP receptor
ChEMBL 390 11 4 5 2.5 O=C(O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)COc1ccccc1 10.1021/jm010264b
CHEMBL334398 115139 25 None -257 4 Human 6.3 pIC50 = 6.3 Functional
Functional activity in RAT-1 cells, transiently transfected with human prostaglandin TP receptorFunctional activity in RAT-1 cells, transiently transfected with human prostaglandin TP receptor
ChEMBL 390 11 4 5 2.5 O=C(O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)COc1ccccc1 10.1021/jm010264b
70684971 77854 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 436 9 3 6 3.7 CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=N/OCCCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL2093006 77854 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 436 9 3 6 3.7 CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=N/OCCCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
44305522 202971 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
In vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human platelets
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)OC[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80104-9
CHEMBL63040 202971 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
In vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human platelets
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)OC[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80104-9
18921515 14663 0 None 141 2 Rat 6.3 pIC50 = 6.3 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 407 8 2 3 3.4 O=C(O)Cc1ccc2c(c1)CC(CCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205659 14663 0 None 141 2 Rat 6.3 pIC50 = 6.3 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 407 8 2 3 3.4 O=C(O)Cc1ccc2c(c1)CC(CCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL130170 14663 0 None 141 2 Rat 6.3 pIC50 = 6.3 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 407 8 2 3 3.4 O=C(O)Cc1ccc2c(c1)CC(CCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
16755885 144752 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 437 6 2 7 3.5 COc1cc(C)ccc1Oc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm070427h
CHEMBL390899 144752 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 437 6 2 7 3.5 COc1cc(C)ccc1Oc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm070427h
54669847 65453 0 None 4 2 Mouse 7.3 pIC50 = 7.3 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 405 7 2 4 3.4 O=C1C=C(O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1 10.1021/jm200980u
CHEMBL1829805 65453 0 None 4 2 Mouse 7.3 pIC50 = 7.3 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 405 7 2 4 3.4 O=C1C=C(O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1 10.1021/jm200980u
11531590 77893 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 407 8 2 6 3.5 CCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
CHEMBL209406 77893 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 407 8 2 6 3.5 CCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
44304533 100611 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 416 7 4 6 2.9 O=C(O)CC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc([N+](=O)[O-])cc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL291865 100611 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 416 7 4 6 2.9 O=C(O)CC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc([N+](=O)[O-])cc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
44304296 203030 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 405 6 4 4 3.6 O=C(O)CC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3cccc(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL63382 203030 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 405 6 4 4 3.6 O=C(O)CC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3cccc(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
23276769 20364 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(/c1cccc(C(F)(F)F)c1)c1ncccn1 10.1021/jm960341g
CHEMBL130623 20364 0 None - 1 Human 4.3 pIC50 = 4.3 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(/c1cccc(C(F)(F)F)c1)c1ncccn1 10.1021/jm960341g
10546960 203355 0 None -6 2 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 367 8 2 3 2.9 O=C(O)CCc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/ml5002085
CHEMBL65121 203355 0 None -6 2 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 367 8 2 3 2.9 O=C(O)CCc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/ml5002085
16757380 92611 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 471 5 2 6 3.9 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Br)cc1 10.1021/jm070427h
CHEMBL243552 92611 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 471 5 2 6 3.9 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Br)cc1 10.1021/jm070427h
11704760 77611 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 435 10 2 6 4.3 CCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
CHEMBL208818 77611 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 435 10 2 6 4.3 CCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
71740311 91367 2 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 407 4 2 5 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Cl)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402576 91367 2 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 407 4 2 5 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Cl)cc1 10.1016/j.ejmech.2013.04.033
16755885 144752 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 437 6 2 7 3.5 COc1cc(C)ccc1Oc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm070427h
CHEMBL390899 144752 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 437 6 2 7 3.5 COc1cc(C)ccc1Oc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm070427h
5312142 78233 11 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm070427h
CHEMBL210602 78233 11 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm070427h
5312142 78233 11 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
CHEMBL210602 78233 11 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
54757770 65459 0 None -20 2 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 503 11 1 4 5.6 CC(C)COC1=C(C(C)C)C(=O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1 10.1021/jm200980u
CHEMBL1829811 65459 0 None -20 2 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 503 11 1 4 5.6 CC(C)COC1=C(C(C)C)C(=O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1 10.1021/jm200980u
71740438 91331 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 451 4 2 5 3.9 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Br)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402411 91331 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 451 4 2 5 3.9 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Br)cc1 10.1016/j.ejmech.2013.04.033
11662021 139553 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 434 9 3 6 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1cc(C)cc(C)c1 10.1021/jm060108a
CHEMBL379659 139553 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 434 9 3 6 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1cc(C)cc(C)c1 10.1021/jm060108a
71138349 114013 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of human TP receptor expressed in QBI-HEK 293A cells assessed as IP3 metabolite level after 1 hr by HTRF assayInhibition of human TP receptor expressed in QBI-HEK 293A cells assessed as IP3 metabolite level after 1 hr by HTRF assay
ChEMBL 405 7 2 4 3.6 O=C1CCC(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)=C1O 10.1016/j.bmcl.2014.07.047
CHEMBL3326602 114013 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of human TP receptor expressed in QBI-HEK 293A cells assessed as IP3 metabolite level after 1 hr by HTRF assayInhibition of human TP receptor expressed in QBI-HEK 293A cells assessed as IP3 metabolite level after 1 hr by HTRF assay
ChEMBL 405 7 2 4 3.6 O=C1CCC(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)=C1O 10.1016/j.bmcl.2014.07.047
15018459 99264 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 387 9 2 3 3.4 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL281849 99264 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 387 9 2 3 3.4 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
44386125 60371 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 298 9 1 3 3.7 CCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL174662 60371 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 298 9 1 3 3.7 CCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
44292032 14784 0 None - 1 Rat 4.3 pIC50 = 4.3 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 509 8 2 5 4.6 CC(C)c1ccc2c(CCCC(=O)NS(=O)(=O)c3ccc(Cl)cc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL1206700 14784 0 None - 1 Rat 4.3 pIC50 = 4.3 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 509 8 2 5 4.6 CC(C)c1ccc2c(CCCC(=O)NS(=O)(=O)c3ccc(Cl)cc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL297989 14784 0 None - 1 Rat 4.3 pIC50 = 4.3 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 509 8 2 5 4.6 CC(C)c1ccc2c(CCCC(=O)NS(=O)(=O)c3ccc(Cl)cc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
10697301 83402 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 520 9 3 5 5.3 CC(C)(C)/N=C(\Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1)NS(=O)(=O)c1ccccc1 10.1021/jm9707941
CHEMBL21954 83402 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 520 9 3 5 5.3 CC(C)(C)/N=C(\Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1)NS(=O)(=O)c1ccccc1 10.1021/jm9707941
11633215 140155 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 423 5 2 6 3.8 Cc1ccc(Sc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
CHEMBL380274 140155 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 423 5 2 6 3.8 Cc1ccc(Sc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
11502680 98240 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
CHEMBL274415 98240 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
11697902 78351 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 440 11 3 6 4.3 CCCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1021/jm060108a
CHEMBL211008 78351 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 440 11 3 6 4.3 CCCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1021/jm060108a
44273436 98644 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 418 11 2 6 2.3 O=C(O)COCCCC[C@@H]1[C@@H](NS(=O)(=O)c2ccccc2[N+](=O)[O-])CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL277241 98644 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 418 11 2 6 2.3 O=C(O)COCCCC[C@@H]1[C@@H](NS(=O)(=O)c2ccccc2[N+](=O)[O-])CC[C@H]1F 10.1016/0960-894X(95)00199-4
44386325 131846 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 374 11 1 3 5.0 O=C(O)CCC/C=C\CC1C2CCC(O2)C1CSCCc1ccccc1 10.1021/jm00125a009
CHEMBL369458 131846 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 374 11 1 3 5.0 O=C(O)CCC/C=C\CC1C2CCC(O2)C1CSCCc1ccccc1 10.1021/jm00125a009
71740441 91334 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 499 4 2 5 3.7 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(I)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402414 91334 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 499 4 2 5 3.7 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(I)cc1 10.1016/j.ejmech.2013.04.033
71740441 91334 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 499 4 2 5 3.7 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(I)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402414 91334 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 499 4 2 5 3.7 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(I)cc1 10.1016/j.ejmech.2013.04.033
11531590 77893 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 407 8 2 6 3.5 CCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
CHEMBL209406 77893 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 407 8 2 6 3.5 CCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
11661725 77859 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 420 5 3 6 3.7 Cc1cccc(C)c1Nc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm060108a
CHEMBL209306 77859 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 420 5 3 6 3.7 Cc1cccc(C)c1Nc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm060108a
44273498 162384 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 400 9 2 5 2.8 O=C(O)CC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccccc2[N+](=O)[O-])CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL416551 162384 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 400 9 2 5 2.8 O=C(O)CC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccccc2[N+](=O)[O-])CC[C@H]1F 10.1016/0960-894X(95)00199-4
71740311 91367 2 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 407 4 2 5 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Cl)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402576 91367 2 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 407 4 2 5 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Cl)cc1 10.1016/j.ejmech.2013.04.033
16757179 93320 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 455 9 2 6 4.5 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Cl)c(C)c1 10.1021/jm070427h
CHEMBL245263 93320 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 455 9 2 6 4.5 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Cl)c(C)c1 10.1021/jm070427h
44305481 202929 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 489 11 1 4 6.0 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)[S+]([O-])C[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80103-7
CHEMBL62852 202929 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 489 11 1 4 6.0 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)[S+]([O-])C[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80103-7
11567679 77748 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 407 5 2 6 3.5 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
CHEMBL209035 77748 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 407 5 2 6 3.5 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
70685025 77968 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 352 12 1 3 5.1 CCC/C=C\CSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL2096755 77968 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 352 12 1 3 5.1 CCC/C=C\CSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
16757268 92287 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 431 5 2 7 3.2 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)N/C(=N\C#N)NC(C)(C)C)cc1 10.1021/jm070427h
CHEMBL242687 92287 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 431 5 2 7 3.2 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)N/C(=N\C#N)NC(C)(C)C)cc1 10.1021/jm070427h
11567679 77748 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 407 5 2 6 3.5 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
CHEMBL209035 77748 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 407 5 2 6 3.5 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
11704760 77611 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 435 10 2 6 4.3 CCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
CHEMBL208818 77611 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 435 10 2 6 4.3 CCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
44304557 202886 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 414 8 3 5 4.3 O=C(O)CCC/C=C1\C[C@@H]2[C@@H](/C=N/NC(=O)Nc3ccc([N+](=O)[O-])cc3)CC[C@@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL62671 202886 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 414 8 3 5 4.3 O=C(O)CCC/C=C1\C[C@@H]2[C@@H](/C=N/NC(=O)Nc3ccc([N+](=O)[O-])cc3)CC[C@@H]2C1 10.1016/S0960-894X(01)80876-3
16756982 93316 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 485 9 2 6 4.3 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(Br)c1 10.1021/jm070427h
CHEMBL245254 93316 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 485 9 2 6 4.3 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(Br)c1 10.1021/jm070427h
71740438 91331 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 451 4 2 5 3.9 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Br)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402411 91331 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 451 4 2 5 3.9 CC(C)(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Br)cc1 10.1016/j.ejmech.2013.04.033
71138563 114508 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 481 8 2 4 5.0 O=C1C(c2ccccc2)=C(O)CC1Cc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/ml5002085
CHEMBL3335482 114508 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 481 8 2 4 5.0 O=C1C(c2ccccc2)=C(O)CC1Cc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/ml5002085
16757379 93315 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 471 5 2 6 3.9 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(Br)c1 10.1021/jm070427h
CHEMBL245253 93315 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 471 5 2 6 3.9 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(Br)c1 10.1021/jm070427h
15290041 14671 0 None - 1 Rat 5.2 pIC50 = 5.2 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 359 7 2 3 2.1 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)Cc1ccccc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205676 14671 0 None - 1 Rat 5.2 pIC50 = 5.2 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 359 7 2 3 2.1 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)Cc1ccccc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL132573 14671 0 None - 1 Rat 5.2 pIC50 = 5.2 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 359 7 2 3 2.1 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)Cc1ccccc1)C2 10.1016/s0960-894x(99)00014-1
117631097 115867 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 525 6 2 4 5.4 O=C1C(c2ccc(F)cc2)=C(O)CC1Cc1cccc2c1CCC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1021/ml5002085
CHEMBL3354615 115867 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 525 6 2 4 5.4 O=C1C(c2ccc(F)cc2)=C(O)CC1Cc1cccc2c1CCC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1021/ml5002085
44304559 100585 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 455 7 4 5 3.5 O=C(O)COC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc(Cl)c(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL291651 100585 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 455 7 4 5 3.5 O=C(O)COC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc(Cl)c(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
44304263 203059 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 430 8 4 6 3.3 O=C(O)CCC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc([N+](=O)[O-])cc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL63602 203059 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 430 8 4 6 3.3 O=C(O)CCC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccc([N+](=O)[O-])cc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
22882110 203204 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 419 7 4 4 4.0 O=C(O)CCC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3cccc(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL64349 203204 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 419 7 4 4 4.0 O=C(O)CCC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3cccc(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
11510008 77282 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1cccc(C)c1 10.1021/jm060108a
CHEMBL208115 77282 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1cccc(C)c1 10.1021/jm060108a
22882095 101022 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 405 6 4 4 3.6 O=C(O)CC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3cccc(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL294516 101022 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 405 6 4 4 3.6 O=C(O)CC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3cccc(Cl)c3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
22882098 203250 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 371 6 4 4 3.0 O=C(O)CC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccccc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL64561 203250 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 371 6 4 4 3.0 O=C(O)CC/C=C1/C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccccc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
44273539 79810 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 367 9 2 3 3.3 O=C(O)CC/C=C\CC1=CCC[C@@H]1CNS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00199-4
CHEMBL21203 79810 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 367 9 2 3 3.3 O=C(O)CC/C=C\CC1=CCC[C@@H]1CNS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00199-4
44273524 99331 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 380 9 2 5 2.8 O=C(O)CC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccccc1[N+](=O)[O-] 10.1016/0960-894X(95)00199-4
CHEMBL282225 99331 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 380 9 2 5 2.8 O=C(O)CC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccccc1[N+](=O)[O-] 10.1016/0960-894X(95)00199-4
11683470 77363 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 433 6 2 6 4.0 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC2CCCCC2)cc1 10.1021/jm060108a
CHEMBL208543 77363 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 433 6 2 6 4.0 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC2CCCCC2)cc1 10.1021/jm060108a
44304222 200318 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 387 7 4 5 2.2 O=C(O)COC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccccc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL59745 200318 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 387 7 4 5 2.2 O=C(O)COC/C=C1\C[C@H]2C[C@@H](O)[C@H](/C=N/NC(=O)Nc3ccccc3)[C@H]2C1 10.1016/S0960-894X(01)80876-3
44273260 98678 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 403 11 2 3 3.9 O=C(O)CCCCCC[C@@H]1[C@@H](CNS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL277460 98678 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 403 11 2 3 3.9 O=C(O)CCCCCC[C@@H]1[C@@H](CNS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
10451585 22313 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(/c1ccnnc1)c1cccc(C(F)(F)F)c1 10.1021/jm960341g
CHEMBL132385 22313 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(/c1ccnnc1)c1cccc(C(F)(F)F)c1 10.1021/jm960341g
10546960 203355 0 None -6 2 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 367 8 2 3 2.9 O=C(O)CCc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm200980u
CHEMBL65121 203355 0 None -6 2 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 367 8 2 3 2.9 O=C(O)CCc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm200980u
10764758 84895 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 423 9 4 4 3.9 CC(C)C/N=C(/NC(N)=O)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL22363 84895 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 423 9 4 4 3.9 CC(C)C/N=C(/NC(N)=O)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
71740056 91339 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 373 5 2 5 3.1 Cc1ccccc1Oc1ccc(C#N)cc1S(=O)(=O)NC(=O)NC(C)C 10.1016/j.ejmech.2013.04.033
CHEMBL2402419 91339 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 373 5 2 5 3.1 Cc1ccccc1Oc1ccc(C#N)cc1S(=O)(=O)NC(=O)NC(C)C 10.1016/j.ejmech.2013.04.033
5312142 78233 11 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL210602 78233 11 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1016/j.ejmech.2013.04.033
44273538 98701 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 369 10 2 3 3.6 O=C(O)CCCCCCC1=CCC[C@@H]1NS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00199-4
CHEMBL277629 98701 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 369 10 2 3 3.6 O=C(O)CCCCCCC1=CCC[C@@H]1NS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00199-4
71740185 91347 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 401 8 2 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(C)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402427 91347 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 401 8 2 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(C)cc1 10.1016/j.ejmech.2013.04.033
44273447 76195 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 437 9 2 3 4.6 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(Cl)c(Cl)c2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL20583 76195 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 437 9 2 3 4.6 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(Cl)c(Cl)c2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
44385450 130298 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 370 13 1 3 4.3 CCCCCC[S+]([O-])CC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL368006 130298 0 None - 1 Human 4.2 pIC50 = 4.2 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 370 13 1 3 4.3 CCCCCC[S+]([O-])CC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
54758053 65449 0 None -8 2 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 391 8 2 5 2.2 O=S(=O)(NCCc1cccc(CCc2nn[nH]n2)c1)c1ccc(Cl)cc1 10.1021/jm200980u
CHEMBL1829801 65449 0 None -8 2 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence methodAntagonist activity at human prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence method
ChEMBL 391 8 2 5 2.2 O=S(=O)(NCCc1cccc(CCc2nn[nH]n2)c1)c1ccc(Cl)cc1 10.1021/jm200980u
11568384 77796 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 440 7 3 6 3.8 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NCc2ccccc2)cc1 10.1021/jm060108a
CHEMBL209245 77796 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 440 7 3 6 3.8 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NCc2ccccc2)cc1 10.1021/jm060108a
11647396 77782 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 418 5 2 6 3.5 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)N2CCCCC2)cc1 10.1021/jm060108a
CHEMBL209168 77782 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 418 5 2 6 3.5 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)N2CCCCC2)cc1 10.1021/jm060108a
71740669 91338 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 404 8 3 5 3.6 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402418 91338 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 404 8 3 5 3.6 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
44273475 74593 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 405 11 2 4 2.7 O=C(O)COCCCC[C@@H]1[C@@H](CNS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL20298 74593 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 405 11 2 4 2.7 O=C(O)COCCCC[C@@H]1[C@@H](CNS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
44273402 75959 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 387 9 2 3 3.3 O=C(O)CC/C=C\C[C@@H]1[C@@H](CNS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL20525 75959 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 387 9 2 3 3.3 O=C(O)CC/C=C\C[C@@H]1[C@@H](CNS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
44273412 77260 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 387 9 2 3 3.3 O=C(O)CC/C=C\C[C@H]1[C@@H](F)CC[C@@H]1CNS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00199-4
CHEMBL20797 77260 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 387 9 2 3 3.3 O=C(O)CC/C=C\C[C@H]1[C@@H](F)CC[C@@H]1CNS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00199-4
44304226 200507 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 403 7 3 3 5.1 O=C(O)CCC/C=C1/C[C@@H]2[C@@H](/C=N/NC(=O)Nc3cccc(Cl)c3)CC[C@@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL59875 200507 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 403 7 3 3 5.1 O=C(O)CCC/C=C1/C[C@@H]2[C@@H](/C=N/NC(=O)Nc3cccc(Cl)c3)CC[C@@H]2C1 10.1016/S0960-894X(01)80876-3
44292083 14617 0 None - 1 Rat 4.2 pIC50 = 4.2 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 475 8 2 5 4.0 CC(C)c1ccc2c(CCCC(=O)NS(=O)(=O)c3ccccc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL1205041 14617 0 None - 1 Rat 4.2 pIC50 = 4.2 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 475 8 2 5 4.0 CC(C)c1ccc2c(CCCC(=O)NS(=O)(=O)c3ccccc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL45623 14617 0 None - 1 Rat 4.2 pIC50 = 4.2 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 475 8 2 5 4.0 CC(C)c1ccc2c(CCCC(=O)NS(=O)(=O)c3ccccc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
18921514 14803 0 None 117 2 Rat 7.2 pIC50 = 7.2 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 379 6 2 3 3.1 O=C(O)c1ccc2c(c1)CC(CCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1207018 14803 0 None 117 2 Rat 7.2 pIC50 = 7.2 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 379 6 2 3 3.1 O=C(O)c1ccc2c(c1)CC(CCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL336352 14803 0 None 117 2 Rat 7.2 pIC50 = 7.2 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 379 6 2 3 3.1 O=C(O)c1ccc2c(c1)CC(CCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
18921516 14806 0 None -77 2 Human 5.2 pIC50 = 5.2 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 393 7 2 3 3.5 O=C(O)c1ccc2c(c1)CC(CCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1207036 14806 0 None -77 2 Human 5.2 pIC50 = 5.2 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 393 7 2 3 3.5 O=C(O)c1ccc2c(c1)CC(CCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL339994 14806 0 None -77 2 Human 5.2 pIC50 = 5.2 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 393 7 2 3 3.5 O=C(O)c1ccc2c(c1)CC(CCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
11502680 98240 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Inhibition of U46619-induced platelet aggregationInhibition of U46619-induced platelet aggregation
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
CHEMBL274415 98240 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Inhibition of U46619-induced platelet aggregationInhibition of U46619-induced platelet aggregation
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
16757375 92187 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 407 8 2 6 3.5 CCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1C 10.1021/jm070427h
CHEMBL242479 92187 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 407 8 2 6 3.5 CCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccccc1C 10.1021/jm070427h
71740669 91338 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 404 8 3 5 3.6 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402418 91338 0 None - 1 Human 5.2 pIC50 = 5.2 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 404 8 3 5 3.6 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
71740182 91344 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 401 8 2 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1cccc(C)c1 10.1016/j.ejmech.2013.04.033
CHEMBL2402424 91344 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 401 8 2 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1cccc(C)c1 10.1016/j.ejmech.2013.04.033
71740184 91346 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 387 4 2 5 3.4 Cc1ccc(Oc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402426 91346 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 387 4 2 5 3.4 Cc1ccc(Oc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1016/j.ejmech.2013.04.033
44273483 74850 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 394 10 2 5 3.2 O=C(O)CCC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccccc1[N+](=O)[O-] 10.1016/0960-894X(95)00199-4
CHEMBL20316 74850 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 394 10 2 5 3.2 O=C(O)CCC/C=C\CC1=CCC[C@@H]1NS(=O)(=O)c1ccccc1[N+](=O)[O-] 10.1016/0960-894X(95)00199-4
16757379 93315 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 471 5 2 6 3.9 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(Br)c1 10.1021/jm070427h
CHEMBL245253 93315 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 471 5 2 6 3.9 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(Br)c1 10.1021/jm070427h
71740181 91343 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 387 4 2 5 3.4 Cc1cccc(Oc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)(C)C)c1 10.1016/j.ejmech.2013.04.033
CHEMBL2402423 91343 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 387 4 2 5 3.4 Cc1cccc(Oc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)(C)C)c1 10.1016/j.ejmech.2013.04.033
16757483 143927 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 427 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(Cl)c1 10.1021/jm070427h
CHEMBL390217 143927 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 427 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(Cl)c1 10.1021/jm070427h
10669026 80672 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 405 9 3 4 4.3 CC(C)C/N=C(/NC#N)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL21513 80672 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 405 9 3 4 4.3 CC(C)C/N=C(/NC#N)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
10024143 74639 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 403 9 2 3 3.9 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(Cl)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL20300 74639 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 403 9 2 3 3.9 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(Cl)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
11683470 77363 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 433 6 2 6 4.0 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC2CCCCC2)cc1 10.1021/jm060108a
CHEMBL208543 77363 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 433 6 2 6 4.0 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC2CCCCC2)cc1 10.1021/jm060108a
5312142 78233 11 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL210602 78233 11 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1016/j.ejmech.2013.04.033
44385826 60385 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 352 12 1 3 5.1 CC/C=C/CCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL174835 60385 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 352 12 1 3 5.1 CC/C=C/CCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
44386126 98623 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 372 13 1 4 5.2 CCCCSCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL277056 98623 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 372 13 1 4 5.2 CCCCSCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
44387119 129481 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 330 10 1 4 4.0 CSCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL367261 129481 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
In vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasmaIn vitro inhibition of arachidonic acid induced platelet aggregation in human platelet-rich plasma
ChEMBL 330 10 1 4 4.0 CSCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
10543197 21257 1 None - 1 Human 5.2 pIC50 = 5.2 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 313 9 1 5 2.9 O=C(O)CCCCCO/N=C(\c1ccccc1)c1ccnnc1 10.1021/jm960341g
CHEMBL131334 21257 1 None - 1 Human 5.2 pIC50 = 5.2 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 313 9 1 5 2.9 O=C(O)CCCCCO/N=C(\c1ccccc1)c1ccnnc1 10.1021/jm960341g
10518243 20927 1 None - 1 Human 4.2 pIC50 = 4.2 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(/c1ccccc1)c1cccnn1 10.1021/jm960341g
CHEMBL131088 20927 1 None - 1 Human 4.2 pIC50 = 4.2 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(/c1ccccc1)c1cccnn1 10.1021/jm960341g
10756559 116658 1 None - 1 Human 5.1 pIC50 = 5.1 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(/c1ccccc1)c1cncnc1 10.1021/jm960341g
CHEMBL337048 116658 1 None - 1 Human 5.1 pIC50 = 5.1 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 299 8 1 5 2.5 O=C(O)CCCCO/N=C(/c1ccccc1)c1cncnc1 10.1021/jm960341g
44387045 166210 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 369 12 2 4 3.2 CCCNC(=O)CSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL426586 166210 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 369 12 2 4 3.2 CCCNC(=O)CSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
18921515 14663 0 None -141 2 Human 4.1 pIC50 = 4.1 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 407 8 2 3 3.4 O=C(O)Cc1ccc2c(c1)CC(CCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205659 14663 0 None -141 2 Human 4.1 pIC50 = 4.1 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 407 8 2 3 3.4 O=C(O)Cc1ccc2c(c1)CC(CCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL130170 14663 0 None -141 2 Human 4.1 pIC50 = 4.1 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 407 8 2 3 3.4 O=C(O)Cc1ccc2c(c1)CC(CCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
71740443 91348 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 372 5 3 5 3.0 Cc1ccccc1Nc1ccc(C#N)cc1S(=O)(=O)NC(=O)NC(C)C 10.1016/j.ejmech.2013.04.033
CHEMBL2402428 91348 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 372 5 3 5 3.0 Cc1ccccc1Nc1ccc(C#N)cc1S(=O)(=O)NC(=O)NC(C)C 10.1016/j.ejmech.2013.04.033
16757483 143927 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 427 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(Cl)c1 10.1021/jm070427h
CHEMBL390217 143927 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 427 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(Cl)c1 10.1021/jm070427h
16757177 144745 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 451 11 2 7 4.0 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(OCC)cc1 10.1021/jm070427h
CHEMBL390897 144745 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 451 11 2 7 4.0 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(OCC)cc1 10.1021/jm070427h
71740184 91346 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 387 4 2 5 3.4 Cc1ccc(Oc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402426 91346 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 387 4 2 5 3.4 Cc1ccc(Oc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1016/j.ejmech.2013.04.033
44273500 76622 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 373 8 2 3 3.0 O=C(O)CC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
CHEMBL20635 76622 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)Compound was evaluated for the inhibition of platelet aggregation, assessed turbidimetrically in citreated human platelet rich plasma (PRP)
ChEMBL 373 8 2 3 3.0 O=C(O)CC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(F)cc2)CC[C@H]1F 10.1016/0960-894X(95)00199-4
11662021 139553 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 434 9 3 6 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1cc(C)cc(C)c1 10.1021/jm060108a
CHEMBL379659 139553 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Activity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPbeta (long isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 434 9 3 6 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1cc(C)cc(C)c1 10.1021/jm060108a
10670440 80506 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 433 9 3 4 5.2 CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=C\CCCCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL21476 80506 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 433 9 3 4 5.2 CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=C\CCCCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
71451008 79717 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 489 11 1 4 6.0 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)C[S@@+]([O-])[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80103-7
CHEMBL2115559 79717 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 489 11 1 4 6.0 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)C[S@@+]([O-])[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80103-7
3356 2280 73 None -165 2 Human 6.1 pIC50 = 6.1 Functional
Activity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregationActivity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregation
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1021/jm0603668
4326 2280 73 None -165 2 Human 6.1 pIC50 = 6.1 Functional
Activity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregationActivity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregation
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1021/jm0603668
9867642 2280 73 None -165 2 Human 6.1 pIC50 = 6.1 Functional
Activity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregationActivity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregation
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1021/jm0603668
CHEMBL426559 2280 73 None -165 2 Human 6.1 pIC50 = 6.1 Functional
Activity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregationActivity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregation
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1021/jm0603668
DB11629 2280 73 None -165 2 Human 6.1 pIC50 = 6.1 Functional
Activity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregationActivity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregation
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1021/jm0603668
10591274 116098 1 None - 1 Human 5.1 pIC50 = 5.1 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 313 9 1 5 2.9 O=C(O)CCCCCO/N=C(/c1ccccc1)c1ccnnc1 10.1021/jm960341g
CHEMBL335717 116098 1 None - 1 Human 5.1 pIC50 = 5.1 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 313 9 1 5 2.9 O=C(O)CCCCCO/N=C(/c1ccccc1)c1ccnnc1 10.1021/jm960341g
18921514 14803 0 None -117 2 Human 5.1 pIC50 = 5.1 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 379 6 2 3 3.1 O=C(O)c1ccc2c(c1)CC(CCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1207018 14803 0 None -117 2 Human 5.1 pIC50 = 5.1 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 379 6 2 3 3.1 O=C(O)c1ccc2c(c1)CC(CCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL336352 14803 0 None -117 2 Human 5.1 pIC50 = 5.1 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 379 6 2 3 3.1 O=C(O)c1ccc2c(c1)CC(CCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
44353308 14807 0 None -54 2 Human 4.1 pIC50 = 4.1 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 339 9 2 3 2.1 CCCCCS(=O)(=O)NCC1Cc2ccc(CC(=O)O)cc2C1 10.1016/s0960-894x(99)00014-1
CHEMBL1207038 14807 0 None -54 2 Human 4.1 pIC50 = 4.1 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 339 9 2 3 2.1 CCCCCS(=O)(=O)NCC1Cc2ccc(CC(=O)O)cc2C1 10.1016/s0960-894x(99)00014-1
CHEMBL340073 14807 0 None -54 2 Human 4.1 pIC50 = 4.1 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 339 9 2 3 2.1 CCCCCS(=O)(=O)NCC1Cc2ccc(CC(=O)O)cc2C1 10.1016/s0960-894x(99)00014-1
71740667 91336 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 376 5 3 5 2.8 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402416 91336 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 376 5 3 5 2.8 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
71740557 91350 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 400 8 3 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccccc1C 10.1016/j.ejmech.2013.04.033
CHEMBL2402430 91350 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 400 8 3 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccccc1C 10.1016/j.ejmech.2013.04.033
44305550 203417 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
In vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human platelets
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CO[C@H]1c1cccnc1 10.1016/S0960-894X(01)80104-9
CHEMBL65622 203417 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
In vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human platelets
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CO[C@H]1c1cccnc1 10.1016/S0960-894X(01)80104-9
54758053 65449 0 None 8 2 Mouse 8.1 pIC50 = 8.1 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 391 8 2 5 2.2 O=S(=O)(NCCc1cccc(CCc2nn[nH]n2)c1)c1ccc(Cl)cc1 10.1021/jm200980u
CHEMBL1829801 65449 0 None 8 2 Mouse 8.1 pIC50 = 8.1 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 391 8 2 5 2.2 O=S(=O)(NCCc1cccc(CCc2nn[nH]n2)c1)c1ccc(Cl)cc1 10.1021/jm200980u
123879 3287 82 None 1 6 Human 8.1 pIC50 = 8.1 Functional
Inhibition of beta-arrestin translocation at human Thromboxane A2 receptor in BRET assayInhibition of beta-arrestin translocation at human Thromboxane A2 receptor in BRET assay
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
1910 3287 82 None 1 6 Human 8.1 pIC50 = 8.1 Functional
Inhibition of beta-arrestin translocation at human Thromboxane A2 receptor in BRET assayInhibition of beta-arrestin translocation at human Thromboxane A2 receptor in BRET assay
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
1911 3287 82 None 1 6 Human 8.1 pIC50 = 8.1 Functional
Inhibition of beta-arrestin translocation at human Thromboxane A2 receptor in BRET assayInhibition of beta-arrestin translocation at human Thromboxane A2 receptor in BRET assay
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
2354 3287 82 None 1 6 Human 8.1 pIC50 = 8.1 Functional
Inhibition of beta-arrestin translocation at human Thromboxane A2 receptor in BRET assayInhibition of beta-arrestin translocation at human Thromboxane A2 receptor in BRET assay
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
CHEMBL361812 3287 82 None 1 6 Human 8.1 pIC50 = 8.1 Functional
Inhibition of beta-arrestin translocation at human Thromboxane A2 receptor in BRET assayInhibition of beta-arrestin translocation at human Thromboxane A2 receptor in BRET assay
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
DB13036 3287 82 None 1 6 Human 8.1 pIC50 = 8.1 Functional
Inhibition of beta-arrestin translocation at human Thromboxane A2 receptor in BRET assayInhibition of beta-arrestin translocation at human Thromboxane A2 receptor in BRET assay
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
11597294 166176 4 None -33 2 Human 7.1 pIC50 = 7.1 Functional
Activity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregationActivity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregation
ChEMBL 435 4 1 2 5.7 O=C(O)C[C@H]1CCc2c1n(Cc1ccc(Cl)cc1)c1c(Br)cc(F)cc21 10.1021/jm0603668
CHEMBL426387 166176 4 None -33 2 Human 7.1 pIC50 = 7.1 Functional
Activity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregationActivity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregation
ChEMBL 435 4 1 2 5.7 O=C(O)C[C@H]1CCc2c1n(Cc1ccc(Cl)cc1)c1c(Br)cc(F)cc21 10.1021/jm0603668
11568248 138655 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 434 9 3 6 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1c(C)cccc1C 10.1021/jm060108a
CHEMBL377679 138655 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 434 9 3 6 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1c(C)cccc1C 10.1021/jm060108a
11633215 140155 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Inhibition of U46619-induced platelet aggregationInhibition of U46619-induced platelet aggregation
ChEMBL 423 5 2 6 3.8 Cc1ccc(Sc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
CHEMBL380274 140155 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Inhibition of U46619-induced platelet aggregationInhibition of U46619-induced platelet aggregation
ChEMBL 423 5 2 6 3.8 Cc1ccc(Sc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
44305343 100682 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 473 11 1 4 6.9 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)CS[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80103-7
CHEMBL292331 100682 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
In vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist activity was determined by inhibition of U-46619 induced aggregation of washed human platelets
ChEMBL 473 11 1 4 6.9 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)CS[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80103-7
10548488 78278 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 391 6 3 4 4.0 CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=C\CCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL21072 78278 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 391 6 3 4 4.0 CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=C\CCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
11604299 139582 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 426 10 3 6 3.9 CCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1021/jm060108a
CHEMBL379736 139582 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 426 10 3 6 3.9 CCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1021/jm060108a
71740667 91336 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 376 5 3 5 2.8 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402416 91336 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 376 5 3 5 2.8 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Nc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
44305824 100998 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
In vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human platelets
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)CO[C@H]1c1cccnc1 10.1016/S0960-894X(01)80104-9
CHEMBL294353 100998 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
In vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human platelets
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)CO[C@H]1c1cccnc1 10.1016/S0960-894X(01)80104-9
10552843 83205 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 483 8 3 4 5.6 N#CN/C(=N/C12CC3CC(CC(C3)C1)C2)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
CHEMBL21852 83205 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 483 8 3 4 5.6 N#CN/C(=N/C12CC3CC(CC(C3)C1)C2)Nc1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1021/jm9707941
10741449 78902 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 433 9 3 6 4.3 CC(C)(C)Nc1c(Nc2cccc(/C(=C\CCCC(=O)O)c3cccnc3)c2)c(=O)c1=O 10.1021/jm9707941
CHEMBL2112933 78902 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.In vitro activity on thromboxane A2 receptor antagonism in gel filtered human platelets.
ChEMBL 433 9 3 6 4.3 CC(C)(C)Nc1c(Nc2cccc(/C(=C\CCCC(=O)O)c3cccnc3)c2)c(=O)c1=O 10.1021/jm9707941
118718127 115276 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 354 13 1 3 5.3 CCCCCCSC[C@H]1C2CC[C@@H](O2)[C@H]1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL3349042 115276 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 354 13 1 3 5.3 CCCCCCSC[C@H]1C2CC[C@@H](O2)[C@H]1C/C=C\CCCC(=O)O 10.1021/jm00125a009
11408533 141327 0 None -2089 2 Human 5.1 pIC50 = 5.1 Functional
Activity at TP receptor assessed as inhibition of U46619-induced platelet aggregation in platelet rich plasmaActivity at TP receptor assessed as inhibition of U46619-induced platelet aggregation in platelet rich plasma
ChEMBL 459 6 1 5 4.5 CC(=O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1016/j.bmcl.2006.02.062
CHEMBL383484 141327 0 None -2089 2 Human 5.1 pIC50 = 5.1 Functional
Activity at TP receptor assessed as inhibition of U46619-induced platelet aggregation in platelet rich plasmaActivity at TP receptor assessed as inhibition of U46619-induced platelet aggregation in platelet rich plasma
ChEMBL 459 6 1 5 4.5 CC(=O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1016/j.bmcl.2006.02.062
11408533 141327 0 None -2089 2 Human 5.1 pIC50 = 5.1 Functional
Activity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregationActivity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregation
ChEMBL 459 6 1 5 4.5 CC(=O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1021/jm0603668
CHEMBL383484 141327 0 None -2089 2 Human 5.1 pIC50 = 5.1 Functional
Activity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregationActivity at human TP receptor in platelet rich plasma assessed as inhibition U44619-induced platelet aggregation
ChEMBL 459 6 1 5 4.5 CC(=O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1021/jm0603668
16756979 92316 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 393 6 2 6 3.1 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)C)cc1 10.1021/jm070427h
CHEMBL242904 92316 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 393 6 2 6 3.1 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)C)cc1 10.1021/jm070427h
71740310 91366 2 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 393 5 2 5 3.4 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Cl)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402575 91366 2 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 393 5 2 5 3.4 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Cl)cc1 10.1016/j.ejmech.2013.04.033
15290043 14802 0 None 33 2 Rat 7.1 pIC50 = 7.1 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 351 6 2 4 2.1 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1cccs1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1207012 14802 0 None 33 2 Rat 7.1 pIC50 = 7.1 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 351 6 2 4 2.1 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1cccs1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL335043 14802 0 None 33 2 Rat 7.1 pIC50 = 7.1 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 351 6 2 4 2.1 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1cccs1)C2 10.1016/s0960-894x(99)00014-1
18921516 14806 0 None 77 2 Rat 7.1 pIC50 = 7.1 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 393 7 2 3 3.5 O=C(O)c1ccc2c(c1)CC(CCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1207036 14806 0 None 77 2 Rat 7.1 pIC50 = 7.1 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 393 7 2 3 3.5 O=C(O)c1ccc2c(c1)CC(CCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL339994 14806 0 None 77 2 Rat 7.1 pIC50 = 7.1 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 393 7 2 3 3.5 O=C(O)c1ccc2c(c1)CC(CCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
71740562 91355 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 386 4 3 5 3.4 Cc1ccc(Nc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402435 91355 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 386 4 3 5 3.4 Cc1ccc(Nc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1016/j.ejmech.2013.04.033
71740439 91332 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 465 8 2 5 4.3 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Br)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402412 91332 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 465 8 2 5 4.3 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Br)cc1 10.1016/j.ejmech.2013.04.033
44291594 14618 0 None - 1 Rat 6.1 pIC50 = 6.1 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 509 10 2 4 6.0 CC(C)c1ccc2c(CCCCCS(=O)(=O)Nc3ccc(Cl)cc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL1205044 14618 0 None - 1 Rat 6.1 pIC50 = 6.1 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 509 10 2 4 6.0 CC(C)c1ccc2c(CCCCCS(=O)(=O)Nc3ccc(Cl)cc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL46338 14618 0 None - 1 Rat 6.1 pIC50 = 6.1 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 509 10 2 4 6.0 CC(C)c1ccc2c(CCCCCS(=O)(=O)Nc3ccc(Cl)cc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
44291637 14878 0 None - 1 Rat 6.1 pIC50 = 6.1 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 481 8 2 4 5.2 CC(C)c1ccc2c(CCCS(=O)(=O)Nc3ccc(Cl)cc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL1207689 14878 0 None - 1 Rat 6.1 pIC50 = 6.1 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 481 8 2 4 5.2 CC(C)c1ccc2c(CCCS(=O)(=O)Nc3ccc(Cl)cc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL430569 14878 0 None - 1 Rat 6.1 pIC50 = 6.1 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 481 8 2 4 5.2 CC(C)c1ccc2c(CCCS(=O)(=O)Nc3ccc(Cl)cc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
44386253 60430 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 386 11 1 3 5.4 O=C(O)CCC/C=C\CC1C2CCC(O2)C1CSC/C=C/c1ccccc1 10.1021/jm00125a009
CHEMBL175178 60430 0 None - 1 Human 4.1 pIC50 = 4.1 Functional
In vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasmaIn vitro evaluation for arachidonic acid induced platelet aggregation of human platelet-rich plasma
ChEMBL 386 11 1 3 5.4 O=C(O)CCC/C=C\CC1C2CCC(O2)C1CSC/C=C/c1ccccc1 10.1021/jm00125a009
71740312 91368 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 421 8 2 5 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Cl)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402577 91368 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 421 8 2 5 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Cl)cc1 10.1016/j.ejmech.2013.04.033
71740056 91339 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 373 5 2 5 3.1 Cc1ccccc1Oc1ccc(C#N)cc1S(=O)(=O)NC(=O)NC(C)C 10.1016/j.ejmech.2013.04.033
CHEMBL2402419 91339 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 373 5 2 5 3.1 Cc1ccccc1Oc1ccc(C#N)cc1S(=O)(=O)NC(=O)NC(C)C 10.1016/j.ejmech.2013.04.033
44291863 14620 0 None - 1 Rat 5.1 pIC50 = 5.1 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 447 8 2 4 4.5 CC(C)c1ccc2c(CCCS(=O)(=O)Nc3ccccc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL1205050 14620 0 None - 1 Rat 5.1 pIC50 = 5.1 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 447 8 2 4 4.5 CC(C)c1ccc2c(CCCS(=O)(=O)Nc3ccccc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL47510 14620 0 None - 1 Rat 5.1 pIC50 = 5.1 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 447 8 2 4 4.5 CC(C)c1ccc2c(CCCS(=O)(=O)Nc3ccccc3)cc(S(=O)(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
44291496 168756 0 None - 1 Rat 5.1 pIC50 = 5.1 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 425 9 2 3 5.4 CC(C)c1ccc2c(CCCCS(=O)(=O)Nc3ccccc3)cc(C(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL43726 168756 0 None - 1 Rat 5.1 pIC50 = 5.1 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 425 9 2 3 5.4 CC(C)c1ccc2c(CCCCS(=O)(=O)Nc3ccccc3)cc(C(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
16757484 93049 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 441 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Cl)cc1 10.1021/jm070427h
CHEMBL244188 93049 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 441 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Cl)cc1 10.1021/jm070427h
71740312 91368 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 421 8 2 5 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Cl)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402577 91368 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 421 8 2 5 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Cl)cc1 10.1016/j.ejmech.2013.04.033
16757487 93247 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 451 8 2 7 4.0 CCCOc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm070427h
CHEMBL244819 93247 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 451 8 2 7 4.0 CCCOc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm070427h
16756877 92186 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 393 6 2 6 3.1 Cc1ccccc1Oc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)C 10.1021/jm070427h
CHEMBL242478 92186 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 393 6 2 6 3.1 Cc1ccccc1Oc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)C 10.1021/jm070427h
16756979 92316 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 393 6 2 6 3.1 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)C)cc1 10.1021/jm070427h
CHEMBL242904 92316 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform alpha expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 393 6 2 6 3.1 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)C)cc1 10.1021/jm070427h
44305538 102136 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
In vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human platelets
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)CO[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80104-9
CHEMBL302457 102136 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
In vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human plateletsIn vitro thromboxane receptor antagonist against U-46619 induced aggregation of washed human platelets
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)CO[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80104-9
10686657 20016 1 None - 1 Human 5.1 pIC50 = 5.1 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 313 9 1 5 2.9 O=C(O)CCCCCO/N=C(/c1ccccc1)c1cncnc1 10.1021/jm960341g
CHEMBL130341 20016 1 None - 1 Human 5.1 pIC50 = 5.1 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 313 9 1 5 2.9 O=C(O)CCCCCO/N=C(/c1ccccc1)c1cncnc1 10.1021/jm960341g
16757485 93181 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 533 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(I)c1 10.1021/jm070427h
CHEMBL244401 93181 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 533 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(I)c1 10.1021/jm070427h
118714500 114507 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 346 3 1 2 5.3 Cc1cccc(C)c1C1=C(O)CC(Cc2cccc3c2CCCC3)C1=O 10.1021/ml5002085
CHEMBL3335481 114507 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 346 3 1 2 5.3 Cc1cccc(C)c1C1=C(O)CC(Cc2cccc3c2CCCC3)C1=O 10.1021/ml5002085
71138378 114509 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 487 8 2 4 5.4 O=C1C(C2CCCCC2)=C(O)CC1Cc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/ml5002085
CHEMBL3335483 114509 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assayAntagonist activity against human thromboxane A2 receptor alpha expressed in QBI-HEK293A cells assessed as reduction in I-BOP-induced inositol monophosphate production incubated for 15 to 60 mins before I-BOP addition by HTRF assay
ChEMBL 487 8 2 4 5.4 O=C1C(C2CCCCC2)=C(O)CC1Cc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/ml5002085
CHEMBL1829808 65456 0 None 18 2 Mouse 8.0 pIC50 = 8.0 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 433 8 2 4 4.2 CCC1=C(O)CC(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1=O 10.1021/jm200980u
123879 3287 82 None 1 6 Human 8.0 pIC50 = 8.0 Functional
Inhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptorInhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
1910 3287 82 None 1 6 Human 8.0 pIC50 = 8.0 Functional
Inhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptorInhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
1911 3287 82 None 1 6 Human 8.0 pIC50 = 8.0 Functional
Inhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptorInhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
2354 3287 82 None 1 6 Human 8.0 pIC50 = 8.0 Functional
Inhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptorInhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
CHEMBL361812 3287 82 None 1 6 Human 8.0 pIC50 = 8.0 Functional
Inhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptorInhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
DB13036 3287 82 None 1 6 Human 8.0 pIC50 = 8.0 Functional
Inhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptorInhibition of U-46,619-induced inositol phosphate accumulation at human Thromboxane A2 receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
11661725 77859 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Inhibition of U46619-induced platelet aggregationInhibition of U46619-induced platelet aggregation
ChEMBL 420 5 3 6 3.7 Cc1cccc(C)c1Nc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm060108a
CHEMBL209306 77859 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Inhibition of U46619-induced platelet aggregationInhibition of U46619-induced platelet aggregation
ChEMBL 420 5 3 6 3.7 Cc1cccc(C)c1Nc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm060108a
71740185 91347 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 401 8 2 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(C)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402427 91347 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 401 8 2 5 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(C)cc1 10.1016/j.ejmech.2013.04.033
11647396 77782 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Inhibition of U46619-induced platelet aggregationInhibition of U46619-induced platelet aggregation
ChEMBL 418 5 2 6 3.5 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)N2CCCCC2)cc1 10.1021/jm060108a
CHEMBL209168 77782 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Inhibition of U46619-induced platelet aggregationInhibition of U46619-induced platelet aggregation
ChEMBL 418 5 2 6 3.5 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)N2CCCCC2)cc1 10.1021/jm060108a
44304640 202829 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 437 7 3 3 5.7 O=C(O)CCC/C=C1/C[C@@H]2[C@@H](/C=N/NC(=O)Nc3ccc(Cl)c(Cl)c3)CC[C@@H]2C1 10.1016/S0960-894X(01)80876-3
CHEMBL62410 202829 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619Ability to inhibit blood platelet aggregation of human platelet-rich plasma induced by TP-receptor agonist U 46619
ChEMBL 437 7 3 3 5.7 O=C(O)CCC/C=C1/C[C@@H]2[C@@H](/C=N/NC(=O)Nc3ccc(Cl)c(Cl)c3)CC[C@@H]2C1 10.1016/S0960-894X(01)80876-3
54758054 65450 0 None 4 2 Mouse 7.0 pIC50 = 7.0 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 420 8 3 6 1.8 O=c1c(O)c(NCc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)c1=O 10.1021/jm200980u
CHEMBL1829802 65450 0 None 4 2 Mouse 7.0 pIC50 = 7.0 Functional
Antagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assayAntagonist activity at mouse prostanoid TP receptor expressed in QBI-HEK 293A cells assessed as inhibition of 1-BOP-induced increase in inositol monophosphate after 1 hr by time-resolved fluorescence assay
ChEMBL 420 8 3 6 1.8 O=c1c(O)c(NCc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)c1=O 10.1021/jm200980u
44291693 181547 0 None - 1 Rat 5.0 pIC50 = 5.0 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 445 8 2 3 5.6 CC(C)c1ccc2c(CCCS(=O)(=O)Nc3ccc(Cl)cc3)cc(C(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
CHEMBL47658 181547 0 None - 1 Rat 5.0 pIC50 = 5.0 Functional
Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)Tested for antagonistic activity on isolated rat thoracic aorta (thromboxane A2 receptor) precontracted by U-46619 (3 x 10 e-8 M)
ChEMBL 445 8 2 3 5.6 CC(C)c1ccc2c(CCCS(=O)(=O)Nc3ccc(Cl)cc3)cc(C(=O)O)c-2cc1 10.1016/S0960-894X(00)80043-8
71740558 91351 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 372 5 3 5 3.0 Cc1cccc(Nc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)C)c1 10.1016/j.ejmech.2013.04.033
CHEMBL2402431 91351 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 372 5 3 5 3.0 Cc1cccc(Nc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)C)c1 10.1016/j.ejmech.2013.04.033
71740313 91330 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 437 5 2 5 3.5 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Br)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402410 91330 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 437 5 2 5 3.5 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Br)cc1 10.1016/j.ejmech.2013.04.033
11697902 78351 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 440 11 3 6 4.3 CCCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1021/jm060108a
CHEMBL211008 78351 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Activity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilizationActivity at TPalpha (short isoform) receptor expressed in HEK293 cells assessed as ability to antagonize U46619-mediated calcium ion mobilization
ChEMBL 440 11 3 6 4.3 CCCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1021/jm060108a
71740307 91357 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 377 5 2 5 2.9 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402437 91357 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 377 5 2 5 2.9 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
71740309 91359 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 405 8 2 5 3.7 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402439 91359 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 405 8 2 5 3.7 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
71740310 91366 2 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 393 5 2 5 3.4 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Cl)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402575 91366 2 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 393 5 2 5 3.4 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Cl)cc1 10.1016/j.ejmech.2013.04.033
71740313 91330 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 437 5 2 5 3.5 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Br)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402410 91330 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 437 5 2 5 3.5 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Br)cc1 10.1016/j.ejmech.2013.04.033
71740440 91333 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 485 5 2 5 3.4 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(I)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402413 91333 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 485 5 2 5 3.4 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(I)cc1 10.1016/j.ejmech.2013.04.033
71740442 91335 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 513 8 2 5 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(I)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402415 91335 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 513 8 2 5 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(I)cc1 10.1016/j.ejmech.2013.04.033
16757082 93051 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 519 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(I)c1 10.1021/jm070427h
CHEMBL244190 93051 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 519 5 2 6 3.8 CC(C)(C)NC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1cccc(I)c1 10.1021/jm070427h
10409713 14669 0 None -42 2 Human 6.0 pIC50 = 6.0 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 395 6 2 3 3.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc3ccccc3c1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205668 14669 0 None -42 2 Human 6.0 pIC50 = 6.0 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 395 6 2 3 3.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc3ccccc3c1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL131497 14669 0 None -42 2 Human 6.0 pIC50 = 6.0 Functional
In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)In vitro thromboxane A2 antagonistic activity on aggregation of rabbit platelets induced by U-46,619 (4 uM)
ChEMBL 395 6 2 3 3.2 O=C(O)Cc1ccc2c(c1)CC(CNS(=O)(=O)c1ccc3ccccc3c1)C2 10.1016/s0960-894x(99)00014-1
71740558 91351 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 372 5 3 5 3.0 Cc1cccc(Nc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)C)c1 10.1016/j.ejmech.2013.04.033
CHEMBL2402431 91351 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 372 5 3 5 3.0 Cc1cccc(Nc2ccc(C#N)cc2S(=O)(=O)NC(=O)NC(C)C)c1 10.1016/j.ejmech.2013.04.033
71740440 91333 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 485 5 2 5 3.4 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(I)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402413 91333 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 485 5 2 5 3.4 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(I)cc1 10.1016/j.ejmech.2013.04.033
71740442 91335 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 513 8 2 5 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(I)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402415 91335 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 513 8 2 5 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(I)cc1 10.1016/j.ejmech.2013.04.033
71740309 91359 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 405 8 2 5 3.7 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402439 91359 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 405 8 2 5 3.7 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
71740439 91332 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 465 8 2 5 4.3 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Br)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402412 91332 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay
ChEMBL 465 8 2 5 4.3 CCCCCNC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(Br)cc1 10.1016/j.ejmech.2013.04.033
71740307 91357 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 377 5 2 5 2.9 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
CHEMBL2402437 91357 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assayAntagonist activity at human thromboxane A2 receptor alpha over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization by fluorescence assay
ChEMBL 377 5 2 5 2.9 CC(C)NC(=O)NS(=O)(=O)c1cc(C#N)ccc1Oc1ccc(F)cc1 10.1016/j.ejmech.2013.04.033
18921519 14668 0 None - 1 Rat 6.0 pIC50 = 6.0 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 421 9 2 3 3.8 O=C(O)Cc1ccc2c(c1)CC(CCCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL1205667 14668 0 None - 1 Rat 6.0 pIC50 = 6.0 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 421 9 2 3 3.8 O=C(O)Cc1ccc2c(c1)CC(CCCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
CHEMBL131336 14668 0 None - 1 Rat 6.0 pIC50 = 6.0 Functional
In vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aortaIn vitro thromboxane A2 antagonistic activity on U-46619 (0.1 uM) induced contraction of rat aorta
ChEMBL 421 9 2 3 3.8 O=C(O)Cc1ccc2c(c1)CC(CCCCNS(=O)(=O)c1ccc(Cl)cc1)C2 10.1016/s0960-894x(99)00014-1
16757484 93049 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 441 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Cl)cc1 10.1021/jm070427h
CHEMBL244188 93049 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 441 9 2 6 4.2 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(Cl)cc1 10.1021/jm070427h
16755884 93318 22 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 423 6 2 7 3.2 COc1cccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)c1 10.1021/jm070427h
CHEMBL245261 93318 22 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilizationAntagonist activity at human thromboxane A2 receptor isoform beta expressed in HEK293 cells assessed as inhibition of U46619-induced calcium mobilization
ChEMBL 423 6 2 7 3.2 COc1cccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)c1 10.1021/jm070427h
44353162 20564 0 None - 1 Human 4.0 pIC50 = 4 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(\c1cccc(C(F)(F)F)c1)c1ncccn1 10.1021/jm960341g
CHEMBL130785 20564 0 None - 1 Human 4.0 pIC50 = 4 Functional
TXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human plateletsTXA2 receptor antagonism, measured by the displacement of [3H]SQ29,548 from the PGH-2/TXA-2 receptor on human platelets
ChEMBL 367 8 1 5 3.5 O=C(O)CCCCO/N=C(\c1cccc(C(F)(F)F)c1)c1ncccn1 10.1021/jm960341g
44305299 203396 0 None - 0 Rat 10.8 pKd = 10.8 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 457 10 2 3 4.5 O=C(O)CCc1cc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc(Cc2ccccc2)c1 10.1016/s0960-894x(98)00242-x
CHEMBL65478 203396 0 None - 0 Rat 10.8 pKd = 10.8 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 457 10 2 3 4.5 O=C(O)CCc1cc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc(Cc2ccccc2)c1 10.1016/s0960-894x(98)00242-x
9891134 202884 3 None - 0 Rat 10.6 pKd = 10.6 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 475 10 2 3 4.6 O=C(O)CCc1cc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc(Cc2ccc(F)cc2)c1 10.1016/s0960-894x(98)00242-x
CHEMBL62666 202884 3 None - 0 Rat 10.6 pKd = 10.6 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 475 10 2 3 4.6 O=C(O)CCc1cc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc(Cc2ccc(F)cc2)c1 10.1016/s0960-894x(98)00242-x
19962365 203498 0 None - 0 Rat 10.6 pKd = 10.6 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 501 11 2 5 4.1 COc1ccc(C(=O)c2cc(CCNS(=O)(=O)c3ccc(Cl)cc3)cc(CCC(=O)O)c2)cc1 10.1016/s0960-894x(98)00242-x
CHEMBL66194 203498 0 None - 0 Rat 10.6 pKd = 10.6 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 501 11 2 5 4.1 COc1ccc(C(=O)c2cc(CCNS(=O)(=O)c3ccc(Cl)cc3)cc(CCC(=O)O)c2)cc1 10.1016/s0960-894x(98)00242-x
19962395 203443 0 None - 0 Rat 10.4 pKd = 10.4 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 496 10 2 5 4.0 N#Cc1ccc(C(=O)c2cc(CCNS(=O)(=O)c3ccc(Cl)cc3)cc(CCC(=O)O)c2)cc1 10.1016/s0960-894x(98)00242-x
CHEMBL65780 203443 0 None - 0 Rat 10.4 pKd = 10.4 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 496 10 2 5 4.0 N#Cc1ccc(C(=O)c2cc(CCNS(=O)(=O)c3ccc(Cl)cc3)cc(CCC(=O)O)c2)cc1 10.1016/s0960-894x(98)00242-x
44305435 203362 0 None - 0 Rat 10.2 pKd = 10.2 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 487 11 2 4 4.5 COc1ccccc1Cc1cc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc(CCC(=O)O)c1 10.1016/s0960-894x(98)00242-x
CHEMBL65167 203362 0 None - 0 Rat 10.2 pKd = 10.2 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 487 11 2 4 4.5 COc1ccccc1Cc1cc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc(CCC(=O)O)c1 10.1016/s0960-894x(98)00242-x
44305171 203410 0 None - 0 Rat 10.2 pKd = 10.2 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 535 11 2 5 3.9 CS(=O)(=O)c1ccc(Cc2cc(CCNS(=O)(=O)c3ccc(Cl)cc3)cc(CCC(=O)O)c2)cc1 10.1016/s0960-894x(98)00242-x
CHEMBL65571 203410 0 None - 0 Rat 10.2 pKd = 10.2 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 535 11 2 5 3.9 CS(=O)(=O)c1ccc(Cc2cc(CCNS(=O)(=O)c3ccc(Cl)cc3)cc(CCC(=O)O)c2)cc1 10.1016/s0960-894x(98)00242-x
44332831 4570 0 None - 0 Rat 10.1 pKd = 10.1 Functional
Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 495 10 2 5 4.1 Cc1c(Cc2ccncc2)c2cc(CCC(=O)O)ccc2n1CCNS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00529-4
CHEMBL102533 4570 0 None - 0 Rat 10.1 pKd = 10.1 Functional
Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 495 10 2 5 4.1 Cc1c(Cc2ccncc2)c2cc(CCC(=O)O)ccc2n1CCNS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00529-4
44305385 102239 0 None - 0 Rat 10.1 pKd = 10.1 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 475 10 2 3 4.6 O=C(O)CCc1cc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc(Cc2cccc(F)c2)c1 10.1016/s0960-894x(98)00242-x
CHEMBL303097 102239 0 None - 0 Rat 10.1 pKd = 10.1 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 475 10 2 3 4.6 O=C(O)CCc1cc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc(Cc2cccc(F)c2)c1 10.1016/s0960-894x(98)00242-x
19962368 203363 0 None - 0 Rat 10.0 pKd = 10 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 489 10 2 4 4.2 O=C(O)CCc1cc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc(C(=O)c2ccc(F)cc2)c1 10.1016/s0960-894x(98)00242-x
CHEMBL65175 203363 0 None - 0 Rat 10.0 pKd = 10 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 489 10 2 4 4.2 O=C(O)CCc1cc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc(C(=O)c2ccc(F)cc2)c1 10.1016/s0960-894x(98)00242-x
18926588 168817 0 None - 0 Rat 9.8 pKd = 9.8 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 482 9 2 5 4.7 COc1ccc(S(=O)(=O)Nc2ccc3c(c2)c(Cc2ccc(F)cc2)cn3CCC(=O)O)cc1 10.1016/0960-894X(96)00299-5
CHEMBL43770 168817 0 None - 0 Rat 9.8 pKd = 9.8 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 482 9 2 5 4.7 COc1ccc(S(=O)(=O)Nc2ccc3c(c2)c(Cc2ccc(F)cc2)cn3CCC(=O)O)cc1 10.1016/0960-894X(96)00299-5
19962351 203442 0 None - 0 Rat 9.7 pKd = 9.7 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 491 10 3 4 4.1 O=C(O)CCc1cc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc(C(O)c2ccc(F)cc2)c1 10.1016/s0960-894x(98)00242-x
CHEMBL65779 203442 0 None - 0 Rat 9.7 pKd = 9.7 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 491 10 3 4 4.1 O=C(O)CCc1cc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc(C(O)c2ccc(F)cc2)c1 10.1016/s0960-894x(98)00242-x
18926534 168820 0 None - 0 Rat 9.6 pKd = 9.6 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 486 8 2 4 5.3 O=C(O)CCn1cc(Cc2ccc(F)cc2)c2cc(NS(=O)(=O)c3ccc(Cl)cc3)ccc21 10.1016/0960-894X(96)00299-5
CHEMBL43772 168820 0 None - 0 Rat 9.6 pKd = 9.6 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 486 8 2 4 5.3 O=C(O)CCn1cc(Cc2ccc(F)cc2)c2cc(NS(=O)(=O)c3ccc(Cl)cc3)ccc21 10.1016/0960-894X(96)00299-5
18926517 179361 0 None - 0 Rat 9.6 pKd = 9.6 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 466 8 2 4 5.0 Cc1ccc(S(=O)(=O)Nc2ccc3c(c2)c(Cc2ccc(F)cc2)cn3CCC(=O)O)cc1 10.1016/0960-894X(96)00299-5
CHEMBL47372 179361 0 None - 0 Rat 9.6 pKd = 9.6 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 466 8 2 4 5.0 Cc1ccc(S(=O)(=O)Nc2ccc3c(c2)c(Cc2ccc(F)cc2)cn3CCC(=O)O)cc1 10.1016/0960-894X(96)00299-5
10367276 96623 0 None - 0 Human 9.5 pKd = 9.5 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 466 8 2 5 4.2 O=C(O)CC/C=C\C[C@@H]1CN(S(=O)(=O)c2cccc3cnccc23)C[C@@H]1c1ccccc1O 10.1016/0960-894X(96)00021-2
CHEMBL263442 96623 0 None - 0 Human 9.5 pKd = 9.5 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 466 8 2 5 4.2 O=C(O)CC/C=C\C[C@@H]1CN(S(=O)(=O)c2cccc3cnccc23)C[C@@H]1c1ccccc1O 10.1016/0960-894X(96)00021-2
19962400 203340 0 None - 0 Rat 9.5 pKd = 9.5 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 549 11 2 6 3.5 CS(=O)(=O)c1ccc(C(=O)c2cc(CCNS(=O)(=O)c3ccc(Cl)cc3)cc(CCC(=O)O)c2)cc1 10.1016/s0960-894x(98)00242-x
CHEMBL64971 203340 0 None - 0 Rat 9.5 pKd = 9.5 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 549 11 2 6 3.5 CS(=O)(=O)c1ccc(C(=O)c2cc(CCNS(=O)(=O)c3ccc(Cl)cc3)cc(CCC(=O)O)c2)cc1 10.1016/s0960-894x(98)00242-x
6604763 101816 15 None - 0 Human 9.4 pKd = 9.4 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 402 7 2 4 5.3 O=C(O)CC/C=C\C[C@@H]1CO[C@H](c2ccccc2Cl)O[C@@H]1c1ccccc1O 10.1016/0960-894X(96)00021-2
CHEMBL30024 101816 15 None - 0 Human 9.4 pKd = 9.4 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 402 7 2 4 5.3 O=C(O)CC/C=C\C[C@@H]1CO[C@H](c2ccccc2Cl)O[C@@H]1c1ccccc1O 10.1016/0960-894X(96)00021-2
44294109 187716 0 None - 0 Rat 9.4 pKd = 9.4 Functional
Antagonistic activity against Thromboxane A2 receptor in rat aorta in the presence of 11,9-epoxymethano-PGH2Antagonistic activity against Thromboxane A2 receptor in rat aorta in the presence of 11,9-epoxymethano-PGH2
ChEMBL 387 10 4 4 3.3 O=C(O)CCC/C=C\C[C@H]1C2CCC(O2)[C@H]1CNNC(=O)Nc1ccccc1 10.1021/jm00168a032
CHEMBL49535 187716 0 None - 0 Rat 9.4 pKd = 9.4 Functional
Antagonistic activity against Thromboxane A2 receptor in rat aorta in the presence of 11,9-epoxymethano-PGH2Antagonistic activity against Thromboxane A2 receptor in rat aorta in the presence of 11,9-epoxymethano-PGH2
ChEMBL 387 10 4 4 3.3 O=C(O)CCC/C=C\C[C@H]1C2CCC(O2)[C@H]1CNNC(=O)Nc1ccccc1 10.1021/jm00168a032
10321942 202981 0 None - 0 Rat 9.4 pKd = 9.4 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 458 10 2 4 3.9 O=C(O)CCc1cc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc(Cc2cccnc2)c1 10.1016/s0960-894x(98)00242-x
CHEMBL63090 202981 0 None - 0 Rat 9.4 pKd = 9.4 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 458 10 2 4 3.9 O=C(O)CCc1cc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc(Cc2cccnc2)c1 10.1016/s0960-894x(98)00242-x
18926553 183912 0 None - 0 Rat 9.3 pKd = 9.3 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 470 8 2 4 4.8 O=C(O)CCn1cc(Cc2ccc(F)cc2)c2cc(NS(=O)(=O)c3ccc(F)cc3)ccc21 10.1016/0960-894X(96)00299-5
CHEMBL48128 183912 0 None - 0 Rat 9.3 pKd = 9.3 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 470 8 2 4 4.8 O=C(O)CCn1cc(Cc2ccc(F)cc2)c2cc(NS(=O)(=O)c3ccc(F)cc3)ccc21 10.1016/0960-894X(96)00299-5
44294109 187716 0 None - 0 Human 9.2 pKd = 9.2 Functional
Antagonistic activity against Thromboxane A2 receptor in guinea pig trachea in the presence of 11,9-epoxymethano-PGH2Antagonistic activity against Thromboxane A2 receptor in guinea pig trachea in the presence of 11,9-epoxymethano-PGH2
ChEMBL 387 10 4 4 3.3 O=C(O)CCC/C=C\C[C@H]1C2CCC(O2)[C@H]1CNNC(=O)Nc1ccccc1 10.1021/jm00168a032
CHEMBL49535 187716 0 None - 0 Human 9.2 pKd = 9.2 Functional
Antagonistic activity against Thromboxane A2 receptor in guinea pig trachea in the presence of 11,9-epoxymethano-PGH2Antagonistic activity against Thromboxane A2 receptor in guinea pig trachea in the presence of 11,9-epoxymethano-PGH2
ChEMBL 387 10 4 4 3.3 O=C(O)CCC/C=C\C[C@H]1C2CCC(O2)[C@H]1CNNC(=O)Nc1ccccc1 10.1021/jm00168a032
44374902 54809 0 None - 0 Rat 9.2 pKd = 9.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 579 11 2 6 3.5 O=C(O)CCO/N=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL161253 54809 0 None - 0 Rat 9.2 pKd = 9.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 579 11 2 6 3.5 O=C(O)CCO/N=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
9830229 56207 0 None - 0 Rat 9.2 pKd = 9.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 604 11 2 4 5.6 CC(C)(CNS(=O)(=O)c1ccc(I)cc1)c1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL162641 56207 0 None - 0 Rat 9.2 pKd = 9.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 604 11 2 4 5.6 CC(C)(CNS(=O)(=O)c1ccc(I)cc1)c1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1016/S0960-894X(01)81051-9
18926545 171647 0 None - 0 Rat 9.2 pKd = 9.2 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 452 8 2 4 4.6 O=C(O)CCn1cc(Cc2ccc(F)cc2)c2cc(NS(=O)(=O)c3ccccc3)ccc21 10.1016/0960-894X(96)00299-5
CHEMBL44660 171647 0 None - 0 Rat 9.2 pKd = 9.2 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 452 8 2 4 4.6 O=C(O)CCn1cc(Cc2ccc(F)cc2)c2cc(NS(=O)(=O)c3ccccc3)ccc21 10.1016/0960-894X(96)00299-5
10323516 108561 1 None - 0 Rat 9.2 pKd = 9.2 Functional
Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 495 10 2 5 4.1 Cc1c(Cc2cccnc2)c2cc(CCC(=O)O)ccc2n1CCNS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00529-4
CHEMBL320235 108561 1 None - 0 Rat 9.2 pKd = 9.2 Functional
Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 495 10 2 5 4.1 Cc1c(Cc2cccnc2)c2cc(CCC(=O)O)ccc2n1CCNS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00529-4
44344654 10521 0 None - 0 Human 9.0 pKd = 9 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 449 8 2 4 4.3 O=C(O)CC/C=C\C[C@@H]1CN(S(=O)(=O)c2ccc(Cl)cc2)C[C@@H]1c1ccccc1O 10.1016/0960-894X(96)00021-2
CHEMBL116852 10521 0 None - 0 Human 9.0 pKd = 9 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 449 8 2 4 4.3 O=C(O)CC/C=C\C[C@@H]1CN(S(=O)(=O)c2ccc(Cl)cc2)C[C@@H]1c1ccccc1O 10.1016/0960-894X(96)00021-2
15684002 119862 0 None - 0 Rat 9.0 pKd = 9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 576 11 2 4 4.9 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL348790 119862 0 None - 0 Rat 9.0 pKd = 9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 576 11 2 4 4.9 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
15024087 120210 0 None - 0 Human 9.0 pKd = 9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 506 12 1 5 6.0 CCc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL352040 120210 0 None - 0 Human 9.0 pKd = 9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 506 12 1 5 6.0 CCc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
131717 203389 6 None - 1 Human 8.9 pKd = 8.9 Functional
In vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous veinIn vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous vein
ChEMBL 452 14 2 4 4.7 O=C(O)CCC(CCCCNS(=O)(=O)c1ccc(Cl)cc1)CCCc1cccnc1 10.1016/S0960-894X(01)80104-9
CHEMBL65414 203389 6 None - 1 Human 8.9 pKd = 8.9 Functional
In vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous veinIn vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous vein
ChEMBL 452 14 2 4 4.7 O=C(O)CCC(CCCCNS(=O)(=O)c1ccc(Cl)cc1)CCCc1cccnc1 10.1016/S0960-894X(01)80104-9
10321666 181205 0 None - 0 Rat 8.9 pKd = 8.9 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 453 8 2 5 4.0 O=C(O)CCn1cc(Cc2cccnc2)c2cc(NS(=O)(=O)c3ccc(F)cc3)ccc21 10.1016/0960-894X(96)00299-5
CHEMBL47612 181205 0 None - 0 Rat 8.9 pKd = 8.9 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 453 8 2 5 4.0 O=C(O)CCn1cc(Cc2cccnc2)c2cc(NS(=O)(=O)c3ccc(F)cc3)ccc21 10.1016/0960-894X(96)00299-5
44344840 10242 0 None - 0 Human 8.8 pKd = 8.8 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 465 8 2 4 4.8 O=C(O)CC/C=C\C[C@@H]1CN(S(=O)(=O)c2cccc3ccccc23)C[C@@H]1c1ccccc1O 10.1016/0960-894X(96)00021-2
CHEMBL116088 10242 0 None - 0 Human 8.8 pKd = 8.8 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 465 8 2 4 4.8 O=C(O)CC/C=C\C[C@@H]1CN(S(=O)(=O)c2cccc3ccccc23)C[C@@H]1c1ccccc1O 10.1016/0960-894X(96)00021-2
10005561 168128 1 None - 0 Rat 8.8 pKd = 8.8 Functional
Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 484 10 2 6 3.3 Cc1c(Cn2ccnc2)c2cc(CCC(=O)O)ccc2n1CCNS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00529-4
CHEMBL432958 168128 1 None - 0 Rat 8.8 pKd = 8.8 Functional
Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 484 10 2 6 3.3 Cc1c(Cn2ccnc2)c2cc(CCC(=O)O)ccc2n1CCNS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00529-4
44374886 53099 0 None - 0 Rat 8.8 pKd = 8.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 565 10 2 6 3.1 O=C(O)CO/N=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL159775 53099 0 None - 0 Rat 8.8 pKd = 8.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 565 10 2 6 3.1 O=C(O)CO/N=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
44374517 54643 0 None - 0 Human 8.8 pKd = 8.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3CO)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL161108 54643 0 None - 0 Human 8.8 pKd = 8.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3CO)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
10546960 203355 0 None - 2 Rat 8.7 pKd = 8.7 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 367 8 2 3 2.9 O=C(O)CCc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1016/s0960-894x(98)00242-x
CHEMBL65121 203355 0 None - 2 Rat 8.7 pKd = 8.7 Functional
In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619In vitro Thromboxane A2 (TXA2) receptor antagonism was tested by its ability to inhibit the contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 367 8 2 3 2.9 O=C(O)CCc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1016/s0960-894x(98)00242-x
44374837 53330 0 None - 0 Rat 8.7 pKd = 8.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 607 11 2 6 4.2 CC(C)(CNS(=O)(=O)c1ccc(I)cc1)c1cccc(/C(=N\OCCC(=O)O)c2cccnc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL159979 53330 0 None - 0 Rat 8.7 pKd = 8.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 607 11 2 6 4.2 CC(C)(CNS(=O)(=O)c1ccc(I)cc1)c1cccc(/C(=N\OCCC(=O)O)c2cccnc2)c1 10.1016/S0960-894X(01)81051-9
44374461 54805 0 None - 0 Human 8.7 pKd = 8.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 521 13 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3CCO)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL161252 54805 0 None - 0 Human 8.7 pKd = 8.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 521 13 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3CCO)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
44293931 101936 0 None - 1 Human 8.0 pKd = 8 Functional
Antagonistic activity against Thromboxane A2 receptor in guinea pig trachea in the presence of 11,9-epoxymethano-PGH2Antagonistic activity against Thromboxane A2 receptor in guinea pig trachea in the presence of 11,9-epoxymethano-PGH2
ChEMBL 384 10 2 3 4.7 C[C@@H](c1ccccc1)[C@H](O)/C=C/C1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00168a032
CHEMBL301098 101936 0 None - 1 Human 8.0 pKd = 8 Functional
Antagonistic activity against Thromboxane A2 receptor in guinea pig trachea in the presence of 11,9-epoxymethano-PGH2Antagonistic activity against Thromboxane A2 receptor in guinea pig trachea in the presence of 11,9-epoxymethano-PGH2
ChEMBL 384 10 2 3 4.7 C[C@@H](c1ccccc1)[C@H](O)/C=C/C1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00168a032
44293931 101936 0 None - 1 Rat 8.0 pKd = 8 Functional
Antagonistic activity against Thromboxane A2 receptor in rat aorta in the presence of 11,9-epoxymethano-PGH2Antagonistic activity against Thromboxane A2 receptor in rat aorta in the presence of 11,9-epoxymethano-PGH2
ChEMBL 384 10 2 3 4.7 C[C@@H](c1ccccc1)[C@H](O)/C=C/C1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00168a032
CHEMBL301098 101936 0 None - 1 Rat 8.0 pKd = 8 Functional
Antagonistic activity against Thromboxane A2 receptor in rat aorta in the presence of 11,9-epoxymethano-PGH2Antagonistic activity against Thromboxane A2 receptor in rat aorta in the presence of 11,9-epoxymethano-PGH2
ChEMBL 384 10 2 3 4.7 C[C@@H](c1ccccc1)[C@H](O)/C=C/C1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00168a032
44374917 54936 0 None - 0 Rat 8.0 pKd = 8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 590 12 2 4 5.3 O=C(O)CCCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL161422 54936 0 None - 0 Rat 8.0 pKd = 8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 590 12 2 4 5.3 O=C(O)CCCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
15024089 51892 0 None - 0 Rat 8.0 pKd = 8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 534 14 1 5 6.8 CCCCc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL158576 51892 0 None - 0 Rat 8.0 pKd = 8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 534 14 1 5 6.8 CCCCc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
15024087 120210 0 None - 0 Rat 8.0 pKd = 8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 506 12 1 5 6.0 CCc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL352040 120210 0 None - 0 Rat 8.0 pKd = 8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 506 12 1 5 6.0 CCc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
13560651 54940 0 None - 0 Human 8.0 pKd = 8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL161427 54940 0 None - 0 Human 8.0 pKd = 8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
44374532 120070 0 None - 0 Human 8.0 pKd = 8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 570 13 2 6 5.5 CS(=O)(=O)Nc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL350642 120070 0 None - 0 Human 8.0 pKd = 8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 570 13 2 6 5.5 CS(=O)(=O)Nc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
15024095 56226 0 None - 0 Human 8.0 pKd = 8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 478 11 1 5 5.5 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2ccncc2)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL162691 56226 0 None - 0 Human 8.0 pKd = 8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 478 11 1 5 5.5 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2ccncc2)cc1 10.1016/S0960-894X(01)81050-7
44305522 202971 0 None - 1 Human 8.0 pKd = 8.0 Functional
In vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous veinIn vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous vein
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)OC[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80104-9
CHEMBL63040 202971 0 None - 1 Human 8.0 pKd = 8.0 Functional
In vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous veinIn vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous vein
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)OC[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80104-9
19104271 172675 0 None - 0 Rat 7.0 pKd = 7 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 353 7 2 3 3.5 O=C(O)CCCc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)cc1 10.1016/0960-894X(96)00299-5
CHEMBL44998 172675 0 None - 0 Rat 7.0 pKd = 7 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 353 7 2 3 3.5 O=C(O)CCCc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)cc1 10.1016/0960-894X(96)00299-5
44374902 54809 0 None - 0 Human 7.0 pKd = 7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 579 11 2 6 3.5 O=C(O)CCO/N=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL161253 54809 0 None - 0 Human 7.0 pKd = 7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 579 11 2 6 3.5 O=C(O)CCO/N=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
44374454 119908 0 None - 0 Human 7.0 pKd = 7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL349223 119908 0 None - 0 Human 7.0 pKd = 7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
15684009 56568 0 None - 0 Human 6.0 pKd = 6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 495 12 2 6 4.2 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccccc2[N+](=O)[O-])c1 10.1016/S0960-894X(01)81051-9
CHEMBL164109 56568 0 None - 0 Human 6.0 pKd = 6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 495 12 2 6 4.2 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccccc2[N+](=O)[O-])c1 10.1016/S0960-894X(01)81051-9
44375168 164869 0 None - 0 Human 6.0 pKd = 6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 464 12 2 4 4.7 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCCNS(=O)(=O)c2ccccc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL422017 164869 0 None - 0 Human 6.0 pKd = 6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 464 12 2 4 4.7 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCCNS(=O)(=O)c2ccccc2)c1 10.1016/S0960-894X(01)81051-9
44374454 119908 0 None - 0 Rat 6.0 pKd = 6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL349223 119908 0 None - 0 Rat 6.0 pKd = 6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
44387031 60492 0 None - 0 Human 6.0 pKd = 6 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 496 8 1 4 6.3 O=C(O)CC1CCCc2c1n(Cc1cccc(OCCCC#Cc3cccnc3)c1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
CHEMBL175538 60492 0 None - 0 Human 6.0 pKd = 6 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 496 8 1 4 6.3 O=C(O)CC1CCCc2c1n(Cc1cccc(OCCCC#Cc3cccnc3)c1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
44326663 108598 0 None - 0 Human 5.0 pKd = 5 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 851 21 3 10 9.3 N#Cc1ccc([C@H]2OC[C@@H](C/C=C\CCC(=O)NCCCCCCNC(=O)CC/C=C\C[C@@H]3CO[C@H](c4ccc(C#N)cc4)O[C@@H]3c3ccccc3O)[C@@H](c3cccnc3)O2)cc1 10.1016/0960-894X(96)00004-2
CHEMBL320461 108598 0 None - 0 Human 5.0 pKd = 5 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 851 21 3 10 9.3 N#Cc1ccc([C@H]2OC[C@@H](C/C=C\CCC(=O)NCCCCCCNC(=O)CC/C=C\C[C@@H]3CO[C@H](c4ccc(C#N)cc4)O[C@@H]3c3ccccc3O)[C@@H](c3cccnc3)O2)cc1 10.1016/0960-894X(96)00004-2
10010816 108633 0 None - 0 Human 5.0 pKd = 5 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 854 16 1 11 10.8 N#Cc1ccc([C@H]2OC[C@@H](C/C=C\CCC(=O)Oc3ccccc3OC(=O)CC/C=C\C[C@@H]3CO[C@H](c4ccccc4Cl)O[C@@H]3c3ccccc3O)[C@@H](c3cccnc3)O2)cc1 10.1016/0960-894X(96)00004-2
CHEMBL320682 108633 0 None - 0 Human 5.0 pKd = 5 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 854 16 1 11 10.8 N#Cc1ccc([C@H]2OC[C@@H](C/C=C\CCC(=O)Oc3ccccc3OC(=O)CC/C=C\C[C@@H]3CO[C@H](c4ccccc4Cl)O[C@@H]3c3ccccc3O)[C@@H](c3cccnc3)O2)cc1 10.1016/0960-894X(96)00004-2
44326662 111544 0 None - 0 Human 5.0 pKd = 5 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 853 21 1 12 10.1 N#Cc1ccc([C@H]2OC[C@@H](C/C=C\CCC(=O)OCCCCCCOC(=O)CC/C=C\C[C@@H]3CO[C@H](c4ccc(C#N)cc4)O[C@@H]3c3ccccc3O)[C@@H](c3cccnc3)O2)cc1 10.1016/0960-894X(96)00004-2
CHEMBL327992 111544 0 None - 0 Human 5.0 pKd = 5 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 853 21 1 12 10.1 N#Cc1ccc([C@H]2OC[C@@H](C/C=C\CCC(=O)OCCCCCCOC(=O)CC/C=C\C[C@@H]3CO[C@H](c4ccc(C#N)cc4)O[C@@H]3c3ccccc3O)[C@@H](c3cccnc3)O2)cc1 10.1016/0960-894X(96)00004-2
44326473 207486 0 None - 0 Human 5.0 pKd = 5 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 795 17 3 10 7.7 N#Cc1ccc([C@H]2OC[C@@H](C/C=C\CCC(=O)NCCNC(=O)CC/C=C\C[C@@H]3CO[C@H](c4ccc(C#N)cc4)O[C@@H]3c3ccccc3O)[C@@H](c3cccnc3)O2)cc1 10.1016/0960-894X(96)00004-2
CHEMBL94375 207486 0 None - 0 Human 5.0 pKd = 5 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 795 17 3 10 7.7 N#Cc1ccc([C@H]2OC[C@@H](C/C=C\CCC(=O)NCCNC(=O)CC/C=C\C[C@@H]3CO[C@H](c4ccc(C#N)cc4)O[C@@H]3c3ccccc3O)[C@@H](c3cccnc3)O2)cc1 10.1016/0960-894X(96)00004-2
10259965 207487 0 None - 0 Human 5.0 pKd = 5 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 845 16 1 12 10.0 N#Cc1ccc([C@H]2OC[C@@H](C/C=C\CCC(=O)Oc3ccccc3OC(=O)CC/C=C\C[C@@H]3CO[C@H](c4ccc(C#N)cc4)O[C@@H]3c3ccccc3O)[C@@H](c3cccnc3)O2)cc1 10.1016/0960-894X(96)00004-2
CHEMBL94381 207487 0 None - 0 Human 5.0 pKd = 5 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 845 16 1 12 10.0 N#Cc1ccc([C@H]2OC[C@@H](C/C=C\CCC(=O)Oc3ccccc3OC(=O)CC/C=C\C[C@@H]3CO[C@H](c4ccc(C#N)cc4)O[C@@H]3c3ccccc3O)[C@@H](c3cccnc3)O2)cc1 10.1016/0960-894X(96)00004-2
44326472 207539 0 None - 0 Human 5.0 pKd = 5 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 845 16 1 12 10.0 N#Cc1ccc([C@H]2OC[C@@H](C/C=C\CCC(=O)Oc3ccc(OC(=O)CC/C=C\C[C@@H]4CO[C@H](c5ccc(C#N)cc5)O[C@@H]4c4ccccc4O)cc3)[C@@H](c3cccnc3)O2)cc1 10.1016/0960-894X(96)00004-2
CHEMBL94692 207539 0 None - 0 Human 5.0 pKd = 5 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 845 16 1 12 10.0 N#Cc1ccc([C@H]2OC[C@@H](C/C=C\CCC(=O)Oc3ccc(OC(=O)CC/C=C\C[C@@H]4CO[C@H](c5ccc(C#N)cc5)O[C@@H]4c4ccccc4O)cc3)[C@@H](c3cccnc3)O2)cc1 10.1016/0960-894X(96)00004-2
10601707 44109 0 None - 0 Human 7.0 pKd = 7.0 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 507 11 2 5 6.1 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)N[C@@H]3C[C@H]3c3ccccc3)co2)cc1)c1cccnc1 10.1021/jm980173n
CHEMBL151519 44109 0 None - 0 Human 7.0 pKd = 7.0 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 507 11 2 5 6.1 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)N[C@@H]3C[C@H]3c3ccccc3)co2)cc1)c1cccnc1 10.1021/jm980173n
10768214 42862 0 None - 0 Human 7.0 pKd = 7.0 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 517 13 2 6 5.9 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCOC3CCCCC3)co2)cc1)c1cccnc1 10.1021/jm980173n
CHEMBL150289 42862 0 None - 0 Human 7.0 pKd = 7.0 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 517 13 2 6 5.9 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCOC3CCCCC3)co2)cc1)c1cccnc1 10.1021/jm980173n
10840154 43784 0 None - 0 Human 6.9 pKd = 6.9 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 539 14 2 6 6.2 COc1ccc(CCCNC(=O)c2coc(-c3ccc(/C(=C\CCCCC(=O)O)c4cccnc4)cc3)n2)cc1 10.1021/jm980173n
CHEMBL151091 43784 0 None - 0 Human 6.9 pKd = 6.9 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 539 14 2 6 6.2 COc1ccc(CCCNC(=O)c2coc(-c3ccc(/C(=C\CCCCC(=O)O)c4cccnc4)cc3)n2)cc1 10.1021/jm980173n
44344874 163359 0 None - 0 Human 7.9 pKd = 7.9 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 449 8 2 4 4.3 O=C(O)CC/C=C\C[C@@H]1CN(S(=O)(=O)c2ccc(Cl)cc2)C[C@H]1c1ccccc1O 10.1016/0960-894X(96)00021-2
CHEMBL419224 163359 0 None - 0 Human 7.9 pKd = 7.9 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 449 8 2 4 4.3 O=C(O)CC/C=C\C[C@@H]1CN(S(=O)(=O)c2ccc(Cl)cc2)C[C@H]1c1ccccc1O 10.1016/0960-894X(96)00021-2
44374860 56489 0 None - 0 Rat 7.9 pKd = 7.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 593 12 2 6 3.8 O=C(O)CCCO/N=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL163276 56489 0 None - 0 Rat 7.9 pKd = 7.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 593 12 2 6 3.8 O=C(O)CCCO/N=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
44374518 52592 0 None - 0 Rat 7.9 pKd = 7.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3cccc(CO)c3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL159275 52592 0 None - 0 Rat 7.9 pKd = 7.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3cccc(CO)c3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
15024091 53112 0 None - 0 Rat 7.9 pKd = 7.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 508 12 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cnccc2CO)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL159787 53112 0 None - 0 Rat 7.9 pKd = 7.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 508 12 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cnccc2CO)cc1 10.1016/S0960-894X(01)81050-7
44374517 54643 0 None - 0 Rat 7.9 pKd = 7.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3CO)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL161108 54643 0 None - 0 Rat 7.9 pKd = 7.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3CO)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
44374723 55178 0 None - 0 Rat 7.9 pKd = 7.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 584 14 2 6 5.1 CNS(=O)(=O)Cc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL161746 55178 0 None - 0 Rat 7.9 pKd = 7.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 584 14 2 6 5.1 CNS(=O)(=O)Cc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
44374699 52591 0 None - 0 Human 7.9 pKd = 7.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 477 11 1 4 6.1 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL159272 52591 0 None - 0 Human 7.9 pKd = 7.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 477 11 1 4 6.1 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
44374525 120137 0 None - 0 Human 7.9 pKd = 7.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 570 13 2 6 5.5 CS(=O)(=O)Nc1cccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)c1 10.1016/S0960-894X(01)81049-0
CHEMBL351252 120137 0 None - 0 Human 7.9 pKd = 7.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 570 13 2 6 5.5 CS(=O)(=O)Nc1cccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)c1 10.1016/S0960-894X(01)81049-0
15024085 168266 0 None - 0 Human 7.9 pKd = 7.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 478 11 1 5 5.5 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cccnc2)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL433884 168266 0 None - 0 Human 7.9 pKd = 7.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 478 11 1 5 5.5 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cccnc2)cc1 10.1016/S0960-894X(01)81050-7
10626384 121191 1 None - 0 Human 6.9 pKd = 6.9 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 545 14 2 6 6.5 COC1CCC(CCCNC(=O)c2coc(-c3ccc(/C(=C\CCCCC(=O)O)c4cccnc4)cc3)n2)CC1 10.1021/jm980173n
CHEMBL357723 121191 1 None - 0 Human 6.9 pKd = 6.9 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 545 14 2 6 6.5 COC1CCC(CCCNC(=O)c2coc(-c3ccc(/C(=C\CCCCC(=O)O)c4cccnc4)cc3)n2)CC1 10.1021/jm980173n
44375168 164869 0 None - 0 Rat 6.9 pKd = 6.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 464 12 2 4 4.7 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCCNS(=O)(=O)c2ccccc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL422017 164869 0 None - 0 Rat 6.9 pKd = 6.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 464 12 2 4 4.7 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCCNS(=O)(=O)c2ccccc2)c1 10.1016/S0960-894X(01)81051-9
44374600 53442 0 None - 0 Rat 6.9 pKd = 6.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 548 13 2 5 5.7 CC(=O)NCc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL160091 53442 0 None - 0 Rat 6.9 pKd = 6.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 548 13 2 5 5.7 CC(=O)NCc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
5362391 99096 25 None - 1 Rat 5.9 pKd = 5.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1016/S0960-894X(01)81051-9
CHEMBL280728 99096 25 None - 1 Rat 5.9 pKd = 5.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1016/S0960-894X(01)81051-9
5362391 99096 25 None - 1 Rat 5.9 pKd = 5.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1016/S0960-894X(01)81050-7
CHEMBL280728 99096 25 None - 1 Rat 5.9 pKd = 5.9 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1016/S0960-894X(01)81050-7
10091054 207906 0 None - 0 Human 5.9 pKd = 5.9 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 378 7 1 5 4.2 N#Cc1ccc([C@H]2OC[C@@H](C/C=C\CCC(=O)O)[C@@H](c3cccnc3)O2)cc1 10.1016/0960-894X(96)00004-2
CHEMBL96727 207906 0 None - 0 Human 5.9 pKd = 5.9 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 378 7 1 5 4.2 N#Cc1ccc([C@H]2OC[C@@H](C/C=C\CCC(=O)O)[C@@H](c3cccnc3)O2)cc1 10.1016/0960-894X(96)00004-2
15462462 198262 0 None - 0 Human 6.9 pKd = 6.9 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 481 11 2 5 5.7 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCc3ccccc3)co2)cc1)c1cccnc1 10.1021/jm980173n
CHEMBL57576 198262 0 None - 0 Human 6.9 pKd = 6.9 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 481 11 2 5 5.7 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCc3ccccc3)co2)cc1)c1cccnc1 10.1021/jm980173n
44333075 4593 0 None - 0 Rat 6.9 pKd = 6.9 Functional
Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 484 10 2 6 3.3 Cc1c(Cn2ccnc2)n(CCNS(=O)(=O)c2ccc(F)cc2)c2ccc(CCC(=O)O)cc12 10.1016/0960-894X(95)00529-4
CHEMBL102692 4593 0 None - 0 Rat 6.9 pKd = 6.9 Functional
Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 484 10 2 6 3.3 Cc1c(Cn2ccnc2)n(CCNS(=O)(=O)c2ccc(F)cc2)c2ccc(CCC(=O)O)cc12 10.1016/0960-894X(95)00529-4
10790792 121293 0 None - 0 Human 5.9 pKd = 5.9 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 477 14 2 6 5.0 CCOCCCNC(=O)c1coc(-c2ccc(/C(=C\CCCCC(=O)O)c3cccnc3)cc2)n1 10.1021/jm980173n
CHEMBL358012 121293 0 None - 0 Human 5.9 pKd = 5.9 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 477 14 2 6 5.0 CCOCCCNC(=O)c1coc(-c2ccc(/C(=C\CCCCC(=O)O)c3cccnc3)cc2)n1 10.1021/jm980173n
6439002 119518 5 None - 0 Rat 6.8 pKd = 6.8 Functional
Ability to inhibit U-46,619-induced contraction of isolated strips of rat aorta, which is the measure of thromboxane receptor antagonismAbility to inhibit U-46,619-induced contraction of isolated strips of rat aorta, which is the measure of thromboxane receptor antagonism
ChEMBL 318 7 1 3 4.3 CC1(C)OC[C@@H](C/C=C\CCCC(=O)O)[C@@H](c2ccccc2)O1 10.1021/jm00384a012
CHEMBL345614 119518 5 None - 0 Rat 6.8 pKd = 6.8 Functional
Ability to inhibit U-46,619-induced contraction of isolated strips of rat aorta, which is the measure of thromboxane receptor antagonismAbility to inhibit U-46,619-induced contraction of isolated strips of rat aorta, which is the measure of thromboxane receptor antagonism
ChEMBL 318 7 1 3 4.3 CC1(C)OC[C@@H](C/C=C\CCCC(=O)O)[C@@H](c2ccccc2)O1 10.1021/jm00384a012
44374895 52726 0 None - 0 Rat 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 450 11 2 4 4.3 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccccc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL159447 52726 0 None - 0 Rat 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 450 11 2 4 4.3 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccccc2)c1 10.1016/S0960-894X(01)81051-9
44374564 52889 0 None - 0 Rat 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 520 12 2 5 5.2 NC(=O)c1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL159581 52889 0 None - 0 Rat 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 520 12 2 5 5.2 NC(=O)c1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
44374480 54910 0 None - 0 Rat 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 584 14 2 6 5.1 CNS(=O)(=O)Cc1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL161360 54910 0 None - 0 Rat 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 584 14 2 6 5.1 CNS(=O)(=O)Cc1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1 10.1016/S0960-894X(01)81049-0
15024096 55624 0 None - 0 Rat 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 508 12 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2ccncc2CO)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL162133 55624 0 None - 0 Rat 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 508 12 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2ccncc2CO)cc1 10.1016/S0960-894X(01)81050-7
44374440 56148 0 None - 0 Rat 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@@H]1C(OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL162589 56148 0 None - 0 Rat 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@@H]1C(OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
15024098 120028 0 None - 0 Rat 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 506 12 1 5 6.0 CCc1cnccc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL350292 120028 0 None - 0 Rat 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 506 12 1 5 6.0 CCc1cnccc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
44374564 52889 0 None - 0 Human 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 520 12 2 5 5.2 NC(=O)c1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL159581 52889 0 None - 0 Human 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 520 12 2 5 5.2 NC(=O)c1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
44374693 120027 0 None - 0 Human 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 493 11 2 5 5.8 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3O)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL350286 120027 0 None - 0 Human 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 493 11 2 5 5.8 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3O)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
44374439 120059 0 None - 0 Human 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL350579 120059 0 None - 0 Human 7.8 pKd = 7.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
44301194 100563 0 None - 0 Human 6.8 pKd = 6.8 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 461 13 2 5 5.7 CCCCCNC(=O)c1coc(-c2ccc(/C(=C\CCCCC(=O)O)c3cccnc3)cc2)n1 10.1021/jm980173n
CHEMBL291539 100563 0 None - 0 Human 6.8 pKd = 6.8 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 461 13 2 5 5.7 CCCCCNC(=O)c1coc(-c2ccc(/C(=C\CCCCC(=O)O)c3cccnc3)cc2)n1 10.1021/jm980173n
11800240 44410 0 None - 0 Human 6.8 pKd = 6.8 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 525 14 2 6 5.8 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCOCc3ccccc3)co2)cc1)c1cccnc1 10.1021/jm980173n
CHEMBL151860 44410 0 None - 0 Human 6.8 pKd = 6.8 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 525 14 2 6 5.8 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCOCc3ccccc3)co2)cc1)c1cccnc1 10.1021/jm980173n
44374482 119880 0 None - 0 Rat 6.8 pKd = 6.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 534 13 2 5 5.1 NC(=O)Cc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL348980 119880 0 None - 0 Rat 6.8 pKd = 6.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 534 13 2 5 5.1 NC(=O)Cc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
44385671 166340 0 None - 0 Human 6.8 pKd = 6.8 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 496 8 1 4 6.3 O=C(O)CC1CCCc2c1n(Cc1ccc(OCCCC#Cc3cccnc3)cc1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
CHEMBL427300 166340 0 None - 0 Human 6.8 pKd = 6.8 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 496 8 1 4 6.3 O=C(O)CC1CCCc2c1n(Cc1ccc(OCCCC#Cc3cccnc3)cc1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
44344856 14200 0 None - 0 Human 5.8 pKd = 5.8 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 366 8 2 4 3.8 O=C(O)CC/C=C\C[C@@H]1CN(Cc2cccnc2)C[C@@H]1c1ccccc1O 10.1016/0960-894X(96)00021-2
CHEMBL119887 14200 0 None - 0 Human 5.8 pKd = 5.8 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 366 8 2 4 3.8 O=C(O)CC/C=C\C[C@@H]1CN(Cc2cccnc2)C[C@@H]1c1ccccc1O 10.1016/0960-894X(96)00021-2
44374860 56489 0 None - 0 Human 5.8 pKd = 5.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 593 12 2 6 3.8 O=C(O)CCCO/N=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL163276 56489 0 None - 0 Human 5.8 pKd = 5.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 593 12 2 6 3.8 O=C(O)CCCO/N=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
5284442 97175 30 None - 0 Human 4.8 pKd = 4.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 281 7 1 2 4.2 O=C(O)CCCC/C=C(\c1ccccc1)c1cccnc1 10.1016/S0960-894X(01)81051-9
CHEMBL26820 97175 30 None - 0 Human 4.8 pKd = 4.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 281 7 1 2 4.2 O=C(O)CCCC/C=C(\c1ccccc1)c1cccnc1 10.1016/S0960-894X(01)81051-9
5284442 97175 30 None - 0 Human 4.8 pKd = 4.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 281 7 1 2 4.2 O=C(O)CCCC/C=C(\c1ccccc1)c1cccnc1 10.1016/S0960-894X(01)81050-7
CHEMBL26820 97175 30 None - 0 Human 4.8 pKd = 4.8 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 281 7 1 2 4.2 O=C(O)CCCC/C=C(\c1ccccc1)c1cccnc1 10.1016/S0960-894X(01)81050-7
44366545 168361 0 None - 0 Human 6.8 pKd = 6.8 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 565 11 2 7 5.6 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)co2)cc1)c1cccnc1 10.1021/jm980173n
CHEMBL434449 168361 0 None - 0 Human 6.8 pKd = 6.8 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 565 11 2 7 5.6 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NS(=O)(=O)c3ccc(Cl)cc3)co2)cc1)c1cccnc1 10.1021/jm980173n
10554249 119700 0 None - 0 Human 6.8 pKd = 6.8 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 531 14 2 6 6.3 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCOC3CCCCC3)co2)cc1)c1cccnc1 10.1021/jm980173n
CHEMBL347343 119700 0 None - 0 Human 6.8 pKd = 6.8 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 531 14 2 6 6.3 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCOC3CCCCC3)co2)cc1)c1cccnc1 10.1021/jm980173n
44344859 110626 0 None - 0 Human 7.7 pKd = 7.7 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 387 11 2 3 4.7 CCCCCCC(=O)N1C[C@@H](C/C=C\CCC(=O)O)[C@@H](c2ccccc2O)C1 10.1016/0960-894X(96)00021-2
CHEMBL325703 110626 0 None - 0 Human 7.7 pKd = 7.7 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 387 11 2 3 4.7 CCCCCCC(=O)N1C[C@@H](C/C=C\CCC(=O)O)[C@@H](c2ccccc2O)C1 10.1016/0960-894X(96)00021-2
15024097 53189 0 None - 0 Rat 7.7 pKd = 7.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 492 11 1 5 5.8 Cc1cnccc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL159860 53189 0 None - 0 Rat 7.7 pKd = 7.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 492 11 1 5 5.8 Cc1cnccc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
44374514 53269 0 None - 0 Rat 7.7 pKd = 7.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 520 12 2 5 5.2 NC(=O)c1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL159927 53269 0 None - 0 Rat 7.7 pKd = 7.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 520 12 2 5 5.2 NC(=O)c1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1 10.1016/S0960-894X(01)81049-0
44374473 54789 0 None - 0 Rat 7.7 pKd = 7.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccc(CO)cc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL161240 54789 0 None - 0 Rat 7.7 pKd = 7.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccc(CO)cc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
44374693 120027 0 None - 0 Rat 7.7 pKd = 7.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 493 11 2 5 5.8 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3O)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL350286 120027 0 None - 0 Rat 7.7 pKd = 7.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 493 11 2 5 5.8 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3O)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
44374724 120215 0 None - 0 Rat 7.7 pKd = 7.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 548 13 2 5 5.7 CC(=O)NCc1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL352076 120215 0 None - 0 Rat 7.7 pKd = 7.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 548 13 2 5 5.7 CC(=O)NCc1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1 10.1016/S0960-894X(01)81049-0
44374481 164792 0 None - 0 Rat 7.7 pKd = 7.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 534 13 2 5 5.1 NC(=O)Cc1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL421831 164792 0 None - 0 Rat 7.7 pKd = 7.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 534 13 2 5 5.1 NC(=O)Cc1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1 10.1016/S0960-894X(01)81049-0
44344858 10776 0 None - 0 Human 6.7 pKd = 6.7 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 345 7 2 3 3.4 CC(C)C(=O)N1C[C@@H](C/C=C\CCC(=O)O)[C@@H](c2ccccc2O)C1 10.1016/0960-894X(96)00021-2
CHEMBL117163 10776 0 None - 0 Human 6.7 pKd = 6.7 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 345 7 2 3 3.4 CC(C)C(=O)N1C[C@@H](C/C=C\CCC(=O)O)[C@@H](c2ccccc2O)C1 10.1016/0960-894X(96)00021-2
44272000 98803 0 None - 0 Human 6.7 pKd = 6.7 Functional
Antagonistic potency against Thromboxane A2 receptor expressed as inhibition of U 46619-induced platelet aggregation in human platelet rich plasma.Antagonistic potency against Thromboxane A2 receptor expressed as inhibition of U 46619-induced platelet aggregation in human platelet rich plasma.
ChEMBL 543 15 1 8 6.4 CCCCCCn1cncc1[C@H]1O[C@@H](C(C)(C)Oc2ccc(C)cc2[N+](=O)[O-])OC[C@H]1C/C=C\CCC(=O)O 10.1016/S0960-894X(00)80210-3
CHEMBL278458 98803 0 None - 0 Human 6.7 pKd = 6.7 Functional
Antagonistic potency against Thromboxane A2 receptor expressed as inhibition of U 46619-induced platelet aggregation in human platelet rich plasma.Antagonistic potency against Thromboxane A2 receptor expressed as inhibition of U 46619-induced platelet aggregation in human platelet rich plasma.
ChEMBL 543 15 1 8 6.4 CCCCCCn1cncc1[C@H]1O[C@@H](C(C)(C)Oc2ccc(C)cc2[N+](=O)[O-])OC[C@H]1C/C=C\CCC(=O)O 10.1016/S0960-894X(00)80210-3
44374850 52776 0 None - 0 Rat 6.7 pKd = 6.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 607 13 2 6 4.2 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL159481 52776 0 None - 0 Rat 6.7 pKd = 6.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 607 13 2 6 4.2 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
15684009 56568 0 None - 0 Rat 6.7 pKd = 6.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 495 12 2 6 4.2 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccccc2[N+](=O)[O-])c1 10.1016/S0960-894X(01)81051-9
CHEMBL164109 56568 0 None - 0 Rat 6.7 pKd = 6.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 495 12 2 6 4.2 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccccc2[N+](=O)[O-])c1 10.1016/S0960-894X(01)81051-9
44374886 53099 0 None - 0 Human 6.7 pKd = 6.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 565 10 2 6 3.1 O=C(O)CO/N=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL159775 53099 0 None - 0 Human 6.7 pKd = 6.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 565 10 2 6 3.1 O=C(O)CO/N=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
9830229 56207 0 None - 0 Human 6.7 pKd = 6.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 604 11 2 4 5.6 CC(C)(CNS(=O)(=O)c1ccc(I)cc1)c1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL162641 56207 0 None - 0 Human 6.7 pKd = 6.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 604 11 2 4 5.6 CC(C)(CNS(=O)(=O)c1ccc(I)cc1)c1cccc(/C(=C\CCCC(=O)O)c2cccnc2)c1 10.1016/S0960-894X(01)81051-9
44385499 59669 0 None - 0 Human 6.7 pKd = 6.7 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 510 9 1 4 6.7 O=C(O)CC1CCCc2c1n(Cc1ccc(OCCCCC#Cc3cccnc3)cc1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
CHEMBL172198 59669 0 None - 0 Human 6.7 pKd = 6.7 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 510 9 1 4 6.7 O=C(O)CC1CCCc2c1n(Cc1ccc(OCCCCC#Cc3cccnc3)cc1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
44374850 52776 0 None - 0 Human 5.7 pKd = 5.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 607 13 2 6 4.2 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL159481 52776 0 None - 0 Human 5.7 pKd = 5.7 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 607 13 2 6 4.2 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
44333081 172883 0 None - 0 Rat 8.6 pKd = 8.6 Functional
Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 418 8 2 4 3.4 Cc1c(C)n(CCNS(=O)(=O)c2ccc(F)cc2)c2ccc(CCC(=O)O)cc12 10.1016/0960-894X(95)00529-4
CHEMBL451553 172883 0 None - 0 Rat 8.6 pKd = 8.6 Functional
Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 418 8 2 4 3.4 Cc1c(C)n(CCNS(=O)(=O)c2ccc(F)cc2)c2ccc(CCC(=O)O)cc12 10.1016/0960-894X(95)00529-4
44374724 120215 0 None - 0 Human 8.6 pKd = 8.6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 548 13 2 5 5.7 CC(=O)NCc1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL352076 120215 0 None - 0 Human 8.6 pKd = 8.6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 548 13 2 5 5.7 CC(=O)NCc1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1 10.1016/S0960-894X(01)81049-0
15024088 52819 0 None - 0 Human 8.6 pKd = 8.6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 520 13 1 5 6.4 CCCc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL159517 52819 0 None - 0 Human 8.6 pKd = 8.6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 520 13 1 5 6.4 CCCc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
15024086 119946 0 None - 0 Human 8.6 pKd = 8.6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 492 11 1 5 5.8 Cc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL349625 119946 0 None - 0 Human 8.6 pKd = 8.6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 492 11 1 5 5.8 Cc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
18926528 181196 0 None - 0 Rat 8.6 pKd = 8.6 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 378 6 2 4 3.6 O=C(O)CCn1ccc2cc(NS(=O)(=O)c3ccc(Cl)cc3)ccc21 10.1016/0960-894X(96)00299-5
CHEMBL47611 181196 0 None - 0 Rat 8.6 pKd = 8.6 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 378 6 2 4 3.6 O=C(O)CCn1ccc2cc(NS(=O)(=O)c3ccc(Cl)cc3)ccc21 10.1016/0960-894X(96)00299-5
44305522 202971 0 None - 1 Human 7.7 pKd = 7.7 Functional
In vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous veinIn vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous vein
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)OC[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80104-9
CHEMBL63040 202971 0 None - 1 Human 7.7 pKd = 7.7 Functional
In vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous veinIn vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous vein
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)OC[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80104-9
44374845 120178 0 None - 0 Rat 7.6 pKd = 7.6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 468 11 2 4 4.4 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(F)cc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL351657 120178 0 None - 0 Rat 7.6 pKd = 7.6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 468 11 2 4 4.4 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(F)cc2)c1 10.1016/S0960-894X(01)81051-9
15024092 52240 0 None - 0 Rat 7.6 pKd = 7.6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 508 12 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cncc(CO)c2)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL158875 52240 0 None - 0 Rat 7.6 pKd = 7.6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 508 12 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cncc(CO)c2)cc1 10.1016/S0960-894X(01)81050-7
44374699 52591 0 None - 0 Rat 7.6 pKd = 7.6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 477 11 1 4 6.1 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL159272 52591 0 None - 0 Rat 7.6 pKd = 7.6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 477 11 1 4 6.1 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
44374600 53442 0 None - 0 Human 7.6 pKd = 7.6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 548 13 2 5 5.7 CC(=O)NCc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL160091 53442 0 None - 0 Human 7.6 pKd = 7.6 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 548 13 2 5 5.7 CC(=O)NCc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
44344788 113969 0 None - 0 Human 6.6 pKd = 6.6 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 365 8 2 3 4.4 O=C(O)CC/C=C\C[C@@H]1CN(Cc2ccccc2)C[C@@H]1c1ccccc1O 10.1016/0960-894X(96)00021-2
CHEMBL332609 113969 0 None - 0 Human 6.6 pKd = 6.6 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 365 8 2 3 4.4 O=C(O)CC/C=C\C[C@@H]1CN(Cc2ccccc2)C[C@@H]1c1ccccc1O 10.1016/0960-894X(96)00021-2
44386636 60533 0 None - 0 Human 5.6 pKd = 5.6 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 510 9 1 4 6.7 O=C(O)CC1CCCc2c1n(Cc1cccc(OCCCCC#Cc3cccnc3)c1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
CHEMBL175801 60533 0 None - 0 Human 5.6 pKd = 5.6 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 510 9 1 4 6.7 O=C(O)CC1CCCc2c1n(Cc1cccc(OCCCCC#Cc3cccnc3)c1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
6439002 119518 5 None - 0 Human 6.6 pKd = 6.6 Functional
Ability to inhibit U-46,619-induced contraction of isolated strips of guinea pig tracheal chain, which is the measure of thromboxane receptor antagonismAbility to inhibit U-46,619-induced contraction of isolated strips of guinea pig tracheal chain, which is the measure of thromboxane receptor antagonism
ChEMBL 318 7 1 3 4.3 CC1(C)OC[C@@H](C/C=C\CCCC(=O)O)[C@@H](c2ccccc2)O1 10.1021/jm00384a012
CHEMBL345614 119518 5 None - 0 Human 6.6 pKd = 6.6 Functional
Ability to inhibit U-46,619-induced contraction of isolated strips of guinea pig tracheal chain, which is the measure of thromboxane receptor antagonismAbility to inhibit U-46,619-induced contraction of isolated strips of guinea pig tracheal chain, which is the measure of thromboxane receptor antagonism
ChEMBL 318 7 1 3 4.3 CC1(C)OC[C@@H](C/C=C\CCCC(=O)O)[C@@H](c2ccccc2)O1 10.1021/jm00384a012
44366527 39635 0 None - 0 Human 7.6 pKd = 7.6 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 531 15 3 4 6.3 C=C(NC(=O)c1ccc(/C(=C\CCCCC(=O)O)c2cccnc2)cc1)C(=O)NCCCCC1CCCCC1 10.1021/jm980173n
CHEMBL147444 39635 0 None - 0 Human 7.6 pKd = 7.6 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 531 15 3 4 6.3 C=C(NC(=O)c1ccc(/C(=C\CCCCC(=O)O)c2cccnc2)cc1)C(=O)NCCCCC1CCCCC1 10.1021/jm980173n
15024094 54959 0 None - 0 Rat 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 522 13 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cnccc2CCO)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL161532 54959 0 None - 0 Rat 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 522 13 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cnccc2CCO)cc1 10.1016/S0960-894X(01)81050-7
15024093 55963 0 None - 0 Rat 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 508 12 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cccnc2CO)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL162409 55963 0 None - 0 Rat 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 508 12 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cccnc2CO)cc1 10.1016/S0960-894X(01)81050-7
15024090 119548 0 None - 0 Rat 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 534 11 1 5 6.8 CC(C)(C)c1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL345876 119548 0 None - 0 Rat 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 534 11 1 5 6.8 CC(C)(C)c1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
44374514 53269 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 520 12 2 5 5.2 NC(=O)c1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL159927 53269 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 520 12 2 5 5.2 NC(=O)c1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1 10.1016/S0960-894X(01)81049-0
44374473 54789 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccc(CO)cc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL161240 54789 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccc(CO)cc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
44374480 54910 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 584 14 2 6 5.1 CNS(=O)(=O)Cc1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL161360 54910 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 584 14 2 6 5.1 CNS(=O)(=O)Cc1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1 10.1016/S0960-894X(01)81049-0
44374487 120080 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3CO)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL350805 120080 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3CO)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
15024091 53112 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 508 12 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cnccc2CO)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL159787 53112 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 508 12 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cnccc2CO)cc1 10.1016/S0960-894X(01)81050-7
15024094 54959 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 522 13 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cnccc2CCO)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL161532 54959 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 522 13 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cnccc2CCO)cc1 10.1016/S0960-894X(01)81050-7
15024096 55624 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 508 12 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2ccncc2CO)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL162133 55624 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 508 12 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2ccncc2CO)cc1 10.1016/S0960-894X(01)81050-7
15024093 55963 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 508 12 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cccnc2CO)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL162409 55963 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 508 12 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cccnc2CO)cc1 10.1016/S0960-894X(01)81050-7
15024090 119548 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 534 11 1 5 6.8 CC(C)(C)c1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL345876 119548 0 None - 0 Human 8.5 pKd = 8.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 534 11 1 5 6.8 CC(C)(C)c1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
6604763 101816 15 None - 0 Human 8.5 pKd = 8.5 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 402 7 2 4 5.3 O=C(O)CC/C=C\C[C@@H]1CO[C@H](c2ccccc2Cl)O[C@@H]1c1ccccc1O 10.1016/0960-894X(96)00004-2
CHEMBL30024 101816 15 None - 0 Human 8.5 pKd = 8.5 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 402 7 2 4 5.3 O=C(O)CC/C=C\C[C@@H]1CO[C@H](c2ccccc2Cl)O[C@@H]1c1ccccc1O 10.1016/0960-894X(96)00004-2
18926578 168813 0 None - 0 Rat 8.4 pKd = 8.4 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 362 6 2 4 3.1 O=C(O)CCn1ccc2cc(NS(=O)(=O)c3ccc(F)cc3)ccc21 10.1016/0960-894X(96)00299-5
CHEMBL43768 168813 0 None - 0 Rat 8.4 pKd = 8.4 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 362 6 2 4 3.1 O=C(O)CCn1ccc2cc(NS(=O)(=O)c3ccc(F)cc3)ccc21 10.1016/0960-894X(96)00299-5
44272014 98828 0 None - 0 Human 8.4 pKd = 8.4 Functional
Antagonistic potency against Thromboxane A2 receptor expressed as inhibition of U 46619-induced platelet aggregation in human platelet rich plasma.Antagonistic potency against Thromboxane A2 receptor expressed as inhibition of U 46619-induced platelet aggregation in human platelet rich plasma.
ChEMBL 473 10 1 8 4.3 Cc1ccc(OC(C)(C)[C@H]2OC[C@@H](C/C=C\CCC(=O)O)[C@@H](c3cncn3C)O2)c([N+](=O)[O-])c1 10.1016/S0960-894X(00)80210-3
CHEMBL278714 98828 0 None - 0 Human 8.4 pKd = 8.4 Functional
Antagonistic potency against Thromboxane A2 receptor expressed as inhibition of U 46619-induced platelet aggregation in human platelet rich plasma.Antagonistic potency against Thromboxane A2 receptor expressed as inhibition of U 46619-induced platelet aggregation in human platelet rich plasma.
ChEMBL 473 10 1 8 4.3 Cc1ccc(OC(C)(C)[C@H]2OC[C@@H](C/C=C\CCC(=O)O)[C@@H](c3cncn3C)O2)c([N+](=O)[O-])c1 10.1016/S0960-894X(00)80210-3
6439492 98977 14 None - 0 Human 8.4 pKd = 8.4 Functional
Antagonistic potency against Thromboxane A2 receptor expressed as inhibition of U 46619-induced platelet aggregation in human platelet rich plasma.Antagonistic potency against Thromboxane A2 receptor expressed as inhibition of U 46619-induced platelet aggregation in human platelet rich plasma.
ChEMBL 470 10 1 7 5.0 Cc1ccc(OC(C)(C)[C@H]2OC[C@@H](C/C=C\CCC(=O)O)[C@@H](c3cccnc3)O2)c([N+](=O)[O-])c1 10.1016/S0960-894X(00)80210-3
CHEMBL279847 98977 14 None - 0 Human 8.4 pKd = 8.4 Functional
Antagonistic potency against Thromboxane A2 receptor expressed as inhibition of U 46619-induced platelet aggregation in human platelet rich plasma.Antagonistic potency against Thromboxane A2 receptor expressed as inhibition of U 46619-induced platelet aggregation in human platelet rich plasma.
ChEMBL 470 10 1 7 5.0 Cc1ccc(OC(C)(C)[C@H]2OC[C@@H](C/C=C\CCC(=O)O)[C@@H](c3cccnc3)O2)c([N+](=O)[O-])c1 10.1016/S0960-894X(00)80210-3
44374857 56276 0 None - 0 Rat 8.4 pKd = 8.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 495 12 2 6 4.2 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc([N+](=O)[O-])cc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL162879 56276 0 None - 0 Rat 8.4 pKd = 8.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 495 12 2 6 4.2 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc([N+](=O)[O-])cc2)c1 10.1016/S0960-894X(01)81051-9
44374532 120070 0 None - 0 Rat 8.4 pKd = 8.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 570 13 2 6 5.5 CS(=O)(=O)Nc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL350642 120070 0 None - 0 Rat 8.4 pKd = 8.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 570 13 2 6 5.5 CS(=O)(=O)Nc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
44374711 120044 0 None - 0 Human 8.4 pKd = 8.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccc(CO)cc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL350418 120044 0 None - 0 Human 8.4 pKd = 8.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccc(CO)cc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
44374481 164792 0 None - 0 Human 8.4 pKd = 8.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 534 13 2 5 5.1 NC(=O)Cc1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL421831 164792 0 None - 0 Human 8.4 pKd = 8.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 534 13 2 5 5.1 NC(=O)Cc1ccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)cc1 10.1016/S0960-894X(01)81049-0
15024089 51892 0 None - 0 Human 8.4 pKd = 8.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 534 14 1 5 6.8 CCCCc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL158576 51892 0 None - 0 Human 8.4 pKd = 8.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 534 14 1 5 6.8 CCCCc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
44375026 119750 0 None - 0 Rat 7.5 pKd = 7.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 436 10 2 4 3.9 O=C(O)CC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccccc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL347812 119750 0 None - 0 Rat 7.5 pKd = 7.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 436 10 2 4 3.9 O=C(O)CC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccccc2)c1 10.1016/S0960-894X(01)81051-9
15024088 52819 0 None - 0 Rat 7.5 pKd = 7.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 520 13 1 5 6.4 CCCc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL159517 52819 0 None - 0 Rat 7.5 pKd = 7.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 520 13 1 5 6.4 CCCc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
44374461 54805 0 None - 0 Rat 7.5 pKd = 7.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 521 13 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3CCO)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL161252 54805 0 None - 0 Rat 7.5 pKd = 7.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 521 13 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3CCO)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
13560651 54940 0 None - 0 Rat 7.5 pKd = 7.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL161427 54940 0 None - 0 Rat 7.5 pKd = 7.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
15024086 119946 0 None - 0 Rat 7.5 pKd = 7.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 492 11 1 5 5.8 Cc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL349625 119946 0 None - 0 Rat 7.5 pKd = 7.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 492 11 1 5 5.8 Cc1ccncc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
15684007 53281 0 None - 0 Human 6.5 pKd = 6.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 518 11 2 4 5.6 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(Cl)c(Cl)c2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL159936 53281 0 None - 0 Human 6.5 pKd = 6.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 518 11 2 4 5.6 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(Cl)c(Cl)c2)c1 10.1016/S0960-894X(01)81051-9
44374837 53330 0 None - 0 Human 6.5 pKd = 6.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 607 11 2 6 4.2 CC(C)(CNS(=O)(=O)c1ccc(I)cc1)c1cccc(/C(=N\OCCC(=O)O)c2cccnc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL159979 53330 0 None - 0 Human 6.5 pKd = 6.5 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 607 11 2 6 4.2 CC(C)(CNS(=O)(=O)c1ccc(I)cc1)c1cccc(/C(=N\OCCC(=O)O)c2cccnc2)c1 10.1016/S0960-894X(01)81051-9
44385778 60306 0 None - 0 Human 5.5 pKd = 5.5 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 500 11 1 4 6.9 O=C(O)CC1CCCc2c1n(Cc1cccc(OCCCCCc3cccnc3)c1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
CHEMBL174388 60306 0 None - 0 Human 5.5 pKd = 5.5 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 500 11 1 4 6.9 O=C(O)CC1CCCc2c1n(Cc1cccc(OCCCCCc3cccnc3)c1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
44386372 129396 0 None - 0 Human 5.5 pKd = 5.5 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 338 4 1 3 4.1 O=C(O)CC1CCCc2c1n(Cc1cccnc1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
CHEMBL367109 129396 0 None - 0 Human 5.5 pKd = 5.5 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 338 4 1 3 4.1 O=C(O)CC1CCCc2c1n(Cc1cccnc1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
18926585 172737 0 None - 0 Rat 5.4 pKd = 5.4 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 456 8 2 6 3.6 Cc1c(Cn2ccnc2)c2cc(NS(=O)(=O)c3ccc(F)cc3)ccc2n1CCC(=O)O 10.1016/0960-894X(96)00299-5
CHEMBL45075 172737 0 None - 0 Rat 5.4 pKd = 5.4 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 456 8 2 6 3.6 Cc1c(Cn2ccnc2)c2cc(NS(=O)(=O)c3ccc(F)cc3)ccc2n1CCC(=O)O 10.1016/0960-894X(96)00299-5
44374561 120005 0 None - 0 Rat 7.4 pKd = 7.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 477 11 1 4 6.1 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL350111 120005 0 None - 0 Rat 7.4 pKd = 7.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 477 11 1 4 6.1 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
15024085 168266 0 None - 0 Rat 7.4 pKd = 7.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 478 11 1 5 5.5 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cccnc2)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL433884 168266 0 None - 0 Rat 7.4 pKd = 7.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 478 11 1 5 5.5 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cccnc2)cc1 10.1016/S0960-894X(01)81050-7
44374440 56148 0 None - 0 Human 7.4 pKd = 7.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@@H]1C(OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL162589 56148 0 None - 0 Human 7.4 pKd = 7.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@@H]1C(OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
5362391 99096 25 None - 1 Human 5.4 pKd = 5.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1016/S0960-894X(01)81051-9
CHEMBL280728 99096 25 None - 1 Human 5.4 pKd = 5.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1016/S0960-894X(01)81051-9
5362391 99096 25 None - 1 Human 5.4 pKd = 5.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1016/S0960-894X(01)81050-7
CHEMBL280728 99096 25 None - 1 Human 5.4 pKd = 5.4 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1016/S0960-894X(01)81050-7
44385951 62111 0 None - 0 Human 5.4 pKd = 5.4 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 484 10 1 3 7.1 O=C(O)CC1CCCc2c1n(Cc1cccc(CCCCCc3cccnc3)c1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
CHEMBL177596 62111 0 None - 0 Human 5.4 pKd = 5.4 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 484 10 1 3 7.1 O=C(O)CC1CCCc2c1n(Cc1cccc(CCCCCc3cccnc3)c1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
10554248 119628 0 None - 0 Human 7.4 pKd = 7.4 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 531 14 2 6 6.1 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCOCC3CCCCC3)co2)cc1)c1cccnc1 10.1021/jm980173n
CHEMBL346644 119628 0 None - 0 Human 7.4 pKd = 7.4 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 531 14 2 6 6.1 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCOCC3CCCCC3)co2)cc1)c1cccnc1 10.1021/jm980173n
5362391 99096 25 None - 1 Human 6.4 pKd = 6.4 Functional
In vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous veinIn vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous vein
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1016/S0960-894X(01)80104-9
CHEMBL280728 99096 25 None - 1 Human 6.4 pKd = 6.4 Functional
In vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous veinIn vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous vein
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1016/S0960-894X(01)80104-9
10602360 39543 0 None - 0 Human 6.3 pKd = 6.3 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 533 14 2 7 5.1 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCOCC3CCCCO3)co2)cc1)c1cccnc1 10.1021/jm980173n
CHEMBL147308 39543 0 None - 0 Human 6.3 pKd = 6.3 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 533 14 2 7 5.1 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCOCC3CCCCO3)co2)cc1)c1cccnc1 10.1021/jm980173n
9869582 98636 0 None - 0 Human 8.3 pKd = 8.3 Functional
Antagonistic potency against Thromboxane A2 receptor expressed as inhibition of U 46619-induced platelet aggregation in human platelet rich plasma.Antagonistic potency against Thromboxane A2 receptor expressed as inhibition of U 46619-induced platelet aggregation in human platelet rich plasma.
ChEMBL 476 10 1 8 5.1 Cc1ccc(OC(C)(C)[C@H]2OC[C@@H](C/C=C\CCC(=O)O)[C@@H](c3cncs3)O2)c([N+](=O)[O-])c1 10.1016/S0960-894X(00)80210-3
CHEMBL277167 98636 0 None - 0 Human 8.3 pKd = 8.3 Functional
Antagonistic potency against Thromboxane A2 receptor expressed as inhibition of U 46619-induced platelet aggregation in human platelet rich plasma.Antagonistic potency against Thromboxane A2 receptor expressed as inhibition of U 46619-induced platelet aggregation in human platelet rich plasma.
ChEMBL 476 10 1 8 5.1 Cc1ccc(OC(C)(C)[C@H]2OC[C@@H](C/C=C\CCC(=O)O)[C@@H](c3cncs3)O2)c([N+](=O)[O-])c1 10.1016/S0960-894X(00)80210-3
44374516 119905 0 None - 0 Human 8.3 pKd = 8.3 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3cccc(CO)c3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL349187 119905 0 None - 0 Human 8.3 pKd = 8.3 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3cccc(CO)c3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
44374561 120005 0 None - 0 Human 8.3 pKd = 8.3 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 477 11 1 4 6.1 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL350111 120005 0 None - 0 Human 8.3 pKd = 8.3 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 477 11 1 4 6.1 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
44326541 169139 0 None - 0 Human 8.3 pKd = 8.3 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 393 7 2 5 4.5 N#Cc1ccc([C@H]2OC[C@@H](C/C=C\CCC(=O)O)[C@@H](c3ccccc3O)O2)cc1 10.1016/0960-894X(96)00004-2
CHEMBL440321 169139 0 None - 0 Human 8.3 pKd = 8.3 Functional
Thromboxane (TXA2) receptor antagonist activity using human plateletThromboxane (TXA2) receptor antagonist activity using human platelet
ChEMBL 393 7 2 5 4.5 N#Cc1ccc([C@H]2OC[C@@H](C/C=C\CCC(=O)O)[C@@H](c3ccccc3O)O2)cc1 10.1016/0960-894X(96)00004-2
13560651 54940 0 None - 0 Rat 7.3 pKd = 7.3 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL161427 54940 0 None - 0 Rat 7.3 pKd = 7.3 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
44374711 120044 0 None - 0 Rat 7.3 pKd = 7.3 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccc(CO)cc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL350418 120044 0 None - 0 Rat 7.3 pKd = 7.3 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccc(CO)cc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
44374525 120137 0 None - 0 Rat 7.3 pKd = 7.3 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 570 13 2 6 5.5 CS(=O)(=O)Nc1cccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)c1 10.1016/S0960-894X(01)81049-0
CHEMBL351252 120137 0 None - 0 Rat 7.3 pKd = 7.3 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 570 13 2 6 5.5 CS(=O)(=O)Nc1cccc(-c2ccc(COC3CC[C@H](N4CCCCCC4)[C@H]3OC/C=C\CCC(=O)O)cc2)c1 10.1016/S0960-894X(01)81049-0
6439002 119518 5 None - 0 Human 6.3 pKd = 6.3 Functional
Ability to inhibit U-46,619-induced contraction of isolated strips of rabbit thoracic aorta, which is the measure of thromboxane receptor antagonismAbility to inhibit U-46,619-induced contraction of isolated strips of rabbit thoracic aorta, which is the measure of thromboxane receptor antagonism
ChEMBL 318 7 1 3 4.3 CC1(C)OC[C@@H](C/C=C\CCCC(=O)O)[C@@H](c2ccccc2)O1 10.1021/jm00384a012
CHEMBL345614 119518 5 None - 0 Human 6.3 pKd = 6.3 Functional
Ability to inhibit U-46,619-induced contraction of isolated strips of rabbit thoracic aorta, which is the measure of thromboxane receptor antagonismAbility to inhibit U-46,619-induced contraction of isolated strips of rabbit thoracic aorta, which is the measure of thromboxane receptor antagonism
ChEMBL 318 7 1 3 4.3 CC1(C)OC[C@@H](C/C=C\CCCC(=O)O)[C@@H](c2ccccc2)O1 10.1021/jm00384a012
44374666 119957 0 None - 0 Human 6.3 pKd = 6.3 Functional
Ability to inhibit U-46,619-induced contraction of isolated strips of rabbit thoracic aorta, which is the measure of thromboxane receptor antagonismAbility to inhibit U-46,619-induced contraction of isolated strips of rabbit thoracic aorta, which is the measure of thromboxane receptor antagonism
ChEMBL 290 7 1 3 3.5 O=C(O)CCC/C=C\C[C@@H]1COCO[C@@H]1c1ccccc1 10.1021/jm00384a012
CHEMBL349706 119957 0 None - 0 Human 6.3 pKd = 6.3 Functional
Ability to inhibit U-46,619-induced contraction of isolated strips of rabbit thoracic aorta, which is the measure of thromboxane receptor antagonismAbility to inhibit U-46,619-induced contraction of isolated strips of rabbit thoracic aorta, which is the measure of thromboxane receptor antagonism
ChEMBL 290 7 1 3 3.5 O=C(O)CCC/C=C\C[C@@H]1COCO[C@@H]1c1ccccc1 10.1021/jm00384a012
44386373 165985 0 None - 0 Human 6.3 pKd = 6.3 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 486 10 1 4 6.5 O=C(O)CC1CCCc2c1n(Cc1cccc(OCCCCc3cccnc3)c1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
CHEMBL425325 165985 0 None - 0 Human 6.3 pKd = 6.3 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 486 10 1 4 6.5 O=C(O)CC1CCCc2c1n(Cc1cccc(OCCCCc3cccnc3)c1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
10768772 42826 0 None - 0 Human 7.3 pKd = 7.3 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 539 15 2 6 6.4 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCCOc3ccccc3)co2)cc1)c1cccnc1 10.1021/jm980173n
CHEMBL150252 42826 0 None - 0 Human 7.3 pKd = 7.3 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 539 15 2 6 6.4 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCCOc3ccccc3)co2)cc1)c1cccnc1 10.1021/jm980173n
10530889 42767 0 None - 0 Human 7.2 pKd = 7.2 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 559 15 2 6 6.9 CC(OCCCNC(=O)c1coc(-c2ccc(/C(=C\CCCCC(=O)O)c3cccnc3)cc2)n1)C1CCCCC1 10.1021/jm980173n
CHEMBL150206 42767 0 None - 0 Human 7.2 pKd = 7.2 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 559 15 2 6 6.9 CC(OCCCNC(=O)c1coc(-c2ccc(/C(=C\CCCCC(=O)O)c3cccnc3)cc2)n1)C1CCCCC1 10.1021/jm980173n
44344807 13899 0 None - 0 Human 8.2 pKd = 8.2 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 479 9 2 4 5.2 O=C(O)CCC/C=C\C[C@@H]1CN(S(=O)(=O)c2cccc3ccccc23)C[C@@H]1c1ccccc1O 10.1016/0960-894X(96)00021-2
CHEMBL119624 13899 0 None - 0 Human 8.2 pKd = 8.2 Functional
Antagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig tracheaAntagonistic activity against TP-receptor by inhibition of U 46619-induced contraction of isolated guinea pig trachea
ChEMBL 479 9 2 4 5.2 O=C(O)CCC/C=C\C[C@@H]1CN(S(=O)(=O)c2cccc3ccccc23)C[C@@H]1c1ccccc1O 10.1016/0960-894X(96)00021-2
18926535 101161 0 None - 0 Rat 8.2 pKd = 8.2 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 442 8 2 6 3.3 O=C(O)CCn1cc(Cn2ccnc2)c2cc(NS(=O)(=O)c3ccc(F)cc3)ccc21 10.1016/0960-894X(96)00299-5
CHEMBL295512 101161 0 None - 0 Rat 8.2 pKd = 8.2 Functional
Compound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umolCompound was tested for TXA2 receptor antagonism by measuring its ability to inhibit contraction of rat aorta induced by the stable TXA2 agonist U-46,619 at 1 umol
ChEMBL 442 8 2 6 3.3 O=C(O)CCn1cc(Cn2ccnc2)c2cc(NS(=O)(=O)c3ccc(F)cc3)ccc21 10.1016/0960-894X(96)00299-5
44374487 120080 0 None - 0 Rat 8.2 pKd = 8.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3CO)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL350805 120080 0 None - 0 Rat 8.2 pKd = 8.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3CO)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
44374546 120167 0 None - 0 Rat 8.2 pKd = 8.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 493 11 2 5 5.8 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccc(O)cc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL351563 120167 0 None - 0 Rat 8.2 pKd = 8.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 493 11 2 5 5.8 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccc(O)cc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
14371756 78377 0 None - 0 Human 8.2 pKd = 8.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2ccccc2CO)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL2110359 78377 0 None - 0 Human 8.2 pKd = 8.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2ccccc2CO)cc1 10.1016/S0960-894X(01)81049-0
44374579 119490 0 None - 0 Human 8.2 pKd = 8.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 570 13 2 6 5.5 CS(=O)(=O)Nc1ccccc1-c1ccc(CO[C@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL345396 119490 0 None - 0 Human 8.2 pKd = 8.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 570 13 2 6 5.5 CS(=O)(=O)Nc1ccccc1-c1ccc(CO[C@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
44374546 120167 0 None - 0 Human 8.2 pKd = 8.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 493 11 2 5 5.8 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccc(O)cc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL351563 120167 0 None - 0 Human 8.2 pKd = 8.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 493 11 2 5 5.8 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccc(O)cc3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
15024092 52240 0 None - 0 Human 8.2 pKd = 8.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 508 12 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cncc(CO)c2)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL158875 52240 0 None - 0 Human 8.2 pKd = 8.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 508 12 2 6 5.0 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2cncc(CO)c2)cc1 10.1016/S0960-894X(01)81050-7
15024097 53189 0 None - 0 Human 8.2 pKd = 8.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 492 11 1 5 5.8 Cc1cnccc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL159860 53189 0 None - 0 Human 8.2 pKd = 8.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 492 11 1 5 5.8 Cc1cnccc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
15024098 120028 0 None - 0 Human 8.2 pKd = 8.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 506 12 1 5 6.0 CCc1cnccc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL350292 120028 0 None - 0 Human 8.2 pKd = 8.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood.
ChEMBL 506 12 1 5 6.0 CCc1cnccc1-c1ccc(CO[C@@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81050-7
44332843 4724 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Compound was tested in vitro for thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619Compound was tested in vitro for thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 294 5 2 2 3.5 Cc1[nH]c2ccc(CCC(=O)O)cc2c1Cc1ccncc1 10.1016/0960-894X(95)00529-4
CHEMBL103580 4724 0 None - 0 Rat 7.2 pKd = 7.2 Functional
Compound was tested in vitro for thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619Compound was tested in vitro for thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 294 5 2 2 3.5 Cc1[nH]c2ccc(CCC(=O)O)cc2c1Cc1ccncc1 10.1016/0960-894X(95)00529-4
10601707 44109 0 None - 0 Human 7.2 pKd = 7.2 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 507 11 2 5 6.1 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)N[C@@H]3C[C@H]3c3ccccc3)co2)cc1)c1cccnc1 10.1021/jm980173n
CHEMBL151519 44109 0 None - 0 Human 7.2 pKd = 7.2 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 507 11 2 5 6.1 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)N[C@@H]3C[C@H]3c3ccccc3)co2)cc1)c1cccnc1 10.1021/jm980173n
15684007 53281 0 None - 0 Rat 7.2 pKd = 7.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 518 11 2 4 5.6 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(Cl)c(Cl)c2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL159936 53281 0 None - 0 Rat 7.2 pKd = 7.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 518 11 2 4 5.6 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(Cl)c(Cl)c2)c1 10.1016/S0960-894X(01)81051-9
44374550 53140 0 None - 0 Rat 7.2 pKd = 7.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 535 12 3 5 5.6 NC(=O)Nc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL159814 53140 0 None - 0 Rat 7.2 pKd = 7.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 535 12 3 5 5.6 NC(=O)Nc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
44374579 119490 0 None - 0 Rat 7.2 pKd = 7.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 570 13 2 6 5.5 CS(=O)(=O)Nc1ccccc1-c1ccc(CO[C@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL345396 119490 0 None - 0 Rat 7.2 pKd = 7.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 570 13 2 6 5.5 CS(=O)(=O)Nc1ccccc1-c1ccc(CO[C@H]2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
44374439 120059 0 None - 0 Rat 7.2 pKd = 7.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL350579 120059 0 None - 0 Rat 7.2 pKd = 7.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
44374439 120059 0 None - 0 Human 7.2 pKd = 7.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL350579 120059 0 None - 0 Human 7.2 pKd = 7.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
44374857 56276 0 None - 0 Human 6.2 pKd = 6.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 495 12 2 6 4.2 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc([N+](=O)[O-])cc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL162879 56276 0 None - 0 Human 6.2 pKd = 6.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 495 12 2 6 4.2 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc([N+](=O)[O-])cc2)c1 10.1016/S0960-894X(01)81051-9
15684002 119862 0 None - 0 Human 6.2 pKd = 6.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 576 11 2 4 4.9 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL348790 119862 0 None - 0 Human 6.2 pKd = 6.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 576 11 2 4 4.9 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
44386425 123823 0 None - 0 Human 6.2 pKd = 6.2 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 498 10 1 4 7.0 O=C(O)CC1CCCc2c1n(Cc1cccc(OCCC/C=C\c3cccnc3)c1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
CHEMBL362418 123823 0 None - 0 Human 6.2 pKd = 6.2 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 498 10 1 4 7.0 O=C(O)CC1CCCc2c1n(Cc1cccc(OCCC/C=C\c3cccnc3)c1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
5284442 97175 30 None - 0 Rat 5.2 pKd = 5.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 281 7 1 2 4.2 O=C(O)CCCC/C=C(\c1ccccc1)c1cccnc1 10.1016/S0960-894X(01)81051-9
CHEMBL26820 97175 30 None - 0 Rat 5.2 pKd = 5.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced contraction of rat isolated thoracic aortic strip
ChEMBL 281 7 1 2 4.2 O=C(O)CCCC/C=C(\c1ccccc1)c1cccnc1 10.1016/S0960-894X(01)81051-9
5284442 97175 30 None - 0 Rat 5.2 pKd = 5.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 281 7 1 2 4.2 O=C(O)CCCC/C=C(\c1ccccc1)c1cccnc1 10.1016/S0960-894X(01)81050-7
CHEMBL26820 97175 30 None - 0 Rat 5.2 pKd = 5.2 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 281 7 1 2 4.2 O=C(O)CCCC/C=C(\c1ccccc1)c1cccnc1 10.1016/S0960-894X(01)81050-7
10769084 43022 0 None - 0 Human 7.2 pKd = 7.2 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 553 16 2 6 6.8 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCCCOc3ccccc3)co2)cc1)c1cccnc1 10.1021/jm980173n
CHEMBL150436 43022 0 None - 0 Human 7.2 pKd = 7.2 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 553 16 2 6 6.8 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCCCOc3ccccc3)co2)cc1)c1cccnc1 10.1021/jm980173n
10696954 43217 0 None - 0 Human 5.2 pKd = 5.2 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 507 16 2 7 4.6 COCCOCCCNC(=O)c1coc(-c2ccc(/C(=C\CCCCC(=O)O)c3cccnc3)cc2)n1 10.1021/jm980173n
CHEMBL150598 43217 0 None - 0 Human 5.2 pKd = 5.2 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 507 16 2 7 4.6 COCCOCCCNC(=O)c1coc(-c2ccc(/C(=C\CCCCC(=O)O)c3cccnc3)cc2)n1 10.1021/jm980173n
44332844 4770 0 None - 0 Rat 8.1 pKd = 8.1 Functional
Compound was tested in vitro for thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619Compound was tested in vitro for thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 481 10 2 5 3.8 O=C(O)CCc1ccc2c(c1)c(Cc1ccncc1)cn2CCNS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00529-4
CHEMBL103924 4770 0 None - 0 Rat 8.1 pKd = 8.1 Functional
Compound was tested in vitro for thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619Compound was tested in vitro for thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 481 10 2 5 3.8 O=C(O)CCc1ccc2c(c1)c(Cc1ccncc1)cn2CCNS(=O)(=O)c1ccc(F)cc1 10.1016/0960-894X(95)00529-4
44374518 52592 0 None - 0 Human 8.1 pKd = 8.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3cccc(CO)c3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL159275 52592 0 None - 0 Human 8.1 pKd = 8.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3cccc(CO)c3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
44374550 53140 0 None - 0 Human 8.1 pKd = 8.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 535 12 3 5 5.6 NC(=O)Nc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL159814 53140 0 None - 0 Human 8.1 pKd = 8.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 535 12 3 5 5.6 NC(=O)Nc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
13560651 54940 0 None - 0 Human 8.1 pKd = 8.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL161427 54940 0 None - 0 Human 8.1 pKd = 8.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
44374723 55178 0 None - 0 Human 8.1 pKd = 8.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 584 14 2 6 5.1 CNS(=O)(=O)Cc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL161746 55178 0 None - 0 Human 8.1 pKd = 8.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 584 14 2 6 5.1 CNS(=O)(=O)Cc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
44374482 119880 0 None - 0 Human 8.1 pKd = 8.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 534 13 2 5 5.1 NC(=O)Cc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
CHEMBL348980 119880 0 None - 0 Human 8.1 pKd = 8.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced platelet aggregation in human whole blood
ChEMBL 534 13 2 5 5.1 NC(=O)Cc1ccccc1-c1ccc(COC2CC[C@H](N3CCCCCC3)[C@H]2OC/C=C\CCC(=O)O)cc1 10.1016/S0960-894X(01)81049-0
44305522 202971 0 None - 1 Human 7.2 pKd = 7.2 Functional
In vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous veinIn vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous vein
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)OC[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80104-9
CHEMBL63040 202971 0 None - 1 Human 7.2 pKd = 7.2 Functional
In vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous veinIn vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous vein
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@@H]1[C@@H](c2cccnc2)OC[C@@H]1OCc1ccc(-c2ccccc2)cc1 10.1016/S0960-894X(01)80104-9
44305538 102136 0 None - 1 Human 7.1 pKd = 7.1 Functional
In vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous veinIn vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous vein
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)CO[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80104-9
CHEMBL302457 102136 0 None - 1 Human 7.1 pKd = 7.1 Functional
In vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous veinIn vitro Thromboxane receptor antagonist against U-46619 induced contraction of dog saphenous vein
ChEMBL 457 11 1 4 6.2 O=C(O)CC/C=C\CC[C@H]1[C@H](OCc2ccc(-c3ccccc3)cc2)CO[C@@H]1c1cccnc1 10.1016/S0960-894X(01)80104-9
10505899 43773 0 None - 0 Human 7.1 pKd = 7.1 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 511 13 2 6 5.6 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCOc3ccccc3)co2)cc1)c1cccnc1 10.1021/jm980173n
CHEMBL151083 43773 0 None - 0 Human 7.1 pKd = 7.1 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 511 13 2 6 5.6 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCOc3ccccc3)co2)cc1)c1cccnc1 10.1021/jm980173n
15024095 56226 0 None - 0 Rat 7.1 pKd = 7.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 478 11 1 5 5.5 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2ccncc2)cc1 10.1016/S0960-894X(01)81050-7
CHEMBL162691 56226 0 None - 0 Rat 7.1 pKd = 7.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 478 11 1 5 5.5 O=C(O)CC/C=C\CO[C@@H]1[C@@H](N2CCCCCC2)CC[C@H]1OCc1ccc(-c2ccncc2)cc1 10.1016/S0960-894X(01)81050-7
44374516 119905 0 None - 0 Rat 7.1 pKd = 7.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3cccc(CO)c3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL349187 119905 0 None - 0 Rat 7.1 pKd = 7.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 507 12 2 5 5.6 O=C(O)CC/C=C\CO[C@H]1[C@@H](OCc2ccc(-c3cccc(CO)c3)cc2)CC[C@@H]1N1CCCCCC1 10.1016/S0960-894X(01)81049-0
10406932 99016 1 None - 0 Human 7.1 pKd = 7.1 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 371 4 1 2 5.4 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
CHEMBL280107 99016 1 None - 0 Human 7.1 pKd = 7.1 Functional
Tested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasmaTested for thromboxane antagonist potency (pA2) against U 44619 induced platelet aggregation using human platelet rich plasma
ChEMBL 371 4 1 2 5.4 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1ccc(F)cc21 10.1016/S0960-894X(00)80601-0
15462460 201844 0 None - 0 Human 6.1 pKd = 6.1 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 445 11 2 5 5.0 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCC3CC3)co2)cc1)c1cccnc1 10.1021/jm980173n
CHEMBL60710 201844 0 None - 0 Human 6.1 pKd = 6.1 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 445 11 2 5 5.0 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCC3CC3)co2)cc1)c1cccnc1 10.1021/jm980173n
44374895 52726 0 None - 0 Human 6.1 pKd = 6.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 450 11 2 4 4.3 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccccc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL159447 52726 0 None - 0 Human 6.1 pKd = 6.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 450 11 2 4 4.3 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccccc2)c1 10.1016/S0960-894X(01)81051-9
44374917 54936 0 None - 0 Human 6.1 pKd = 6.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 590 12 2 4 5.3 O=C(O)CCCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL161422 54936 0 None - 0 Human 6.1 pKd = 6.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 590 12 2 4 5.3 O=C(O)CCCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(I)cc2)c1 10.1016/S0960-894X(01)81051-9
44374845 120178 0 None - 0 Human 6.1 pKd = 6.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 468 11 2 4 4.4 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(F)cc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL351657 120178 0 None - 0 Human 6.1 pKd = 6.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 468 11 2 4 4.4 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(F)cc2)c1 10.1016/S0960-894X(01)81051-9
44374439 120059 0 None - 0 Rat 6.1 pKd = 6.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
CHEMBL350579 120059 0 None - 0 Rat 6.1 pKd = 6.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic stripIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619-induced contraction of rat isolated thoracic aortic strip
ChEMBL 463 11 1 4 5.7 O=C(O)CC/C=C\CO[C@H]1C(OCc2ccc(-c3ccccc3)cc2)CC[C@@H]1N1CCCCC1 10.1016/S0960-894X(01)81049-0
44375026 119750 0 None - 0 Human 5.1 pKd = 5.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 436 10 2 4 3.9 O=C(O)CC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccccc2)c1 10.1016/S0960-894X(01)81051-9
CHEMBL347812 119750 0 None - 0 Human 5.1 pKd = 5.1 Functional
In vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole bloodIn vitro thromboxane A2 receptor antagonism through inhibition of U-46619 induced platelet aggregation in human whole blood
ChEMBL 436 10 2 4 3.9 O=C(O)CC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccccc2)c1 10.1016/S0960-894X(01)81051-9
5362391 99096 25 None - 1 Human 5.1 pKd = 5.1 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1021/jm980173n
CHEMBL280728 99096 25 None - 1 Human 5.1 pKd = 5.1 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1021/jm980173n
51550 205750 14 None - 1 Rat 7.1 pKd = 7.1 Functional
Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 335 8 2 4 1.7 O=C(O)COc1ccc(CCNS(=O)(=O)c2ccccc2)cc1 10.1016/0960-894X(95)00529-4
CHEMBL8273 205750 14 None - 1 Rat 7.1 pKd = 7.1 Functional
Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619Compound was tested in vitro for Thromboxane A2 receptor antagonism by inhibiting contraction of rat aorta induced by the stable thromboxane agonist U-46,619
ChEMBL 335 8 2 4 1.7 O=C(O)COc1ccc(CCNS(=O)(=O)c2ccccc2)cc1 10.1016/0960-894X(95)00529-4
10720045 43172 0 None - 0 Human 7.1 pKd = 7.1 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 495 12 2 5 5.8 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCc3ccccc3)co2)cc1)c1cccnc1 10.1021/jm980173n
CHEMBL150563 43172 0 None - 0 Human 7.1 pKd = 7.1 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 495 12 2 5 5.8 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCc3ccccc3)co2)cc1)c1cccnc1 10.1021/jm980173n
5284442 97175 30 None - 0 Human 5.1 pKd = 5.1 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 281 7 1 2 4.2 O=C(O)CCCC/C=C(\c1ccccc1)c1cccnc1 10.1021/jm980173n
CHEMBL26820 97175 30 None - 0 Human 5.1 pKd = 5.1 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 281 7 1 2 4.2 O=C(O)CCCC/C=C(\c1ccccc1)c1cccnc1 10.1021/jm980173n
10768926 43294 0 None - 0 Human 7.1 pKd = 7.1 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 545 15 2 6 6.7 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCCOC3CCCCC3)co2)cc1)c1cccnc1 10.1021/jm980173n
CHEMBL150660 43294 0 None - 0 Human 7.1 pKd = 7.1 Functional
In vitro for antagonistic activity against thromboxane synthase receptorIn vitro for antagonistic activity against thromboxane synthase receptor
ChEMBL 545 15 2 6 6.7 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCCOC3CCCCC3)co2)cc1)c1cccnc1 10.1021/jm980173n
9958626 101703 0 None - 0 Human 8.0 pKd = 8 Functional
Compound was tested in vitro for antagonistic activity against thromboxane receptor. Compound was tested in vitro for antagonistic activity against thromboxane receptor.
ChEMBL 529 14 2 5 7.3 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)cc1)c1cccnc1 10.1021/jm980173n
CHEMBL299467 101703 0 None - 0 Human 8.0 pKd = 8 Functional
Compound was tested in vitro for antagonistic activity against thromboxane receptor. Compound was tested in vitro for antagonistic activity against thromboxane receptor.
ChEMBL 529 14 2 5 7.3 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)cc1)c1cccnc1 10.1021/jm980173n
52944928 19292 0 None - 0 Human 7.0 pKi = 7 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 447 5 1 4 4.8 C[C@@H](c1ccc(F)cc1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
CHEMBL1290414 19292 0 None - 0 Human 7.0 pKi = 7 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 447 5 1 4 4.8 C[C@@H](c1ccc(F)cc1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
9817405 165403 5 None - 0 Human 5.0 pKi = 5 Functional
Antagonistic activity at Thromboxane A2 receptor in human was determinedAntagonistic activity at Thromboxane A2 receptor in human was determined
ChEMBL 288 4 1 1 4.5 O=C(O)/C=C/c1ccccc1Cc1ccc2ccccc2c1 10.1016/s0960-894x(01)00056-7
CHEMBL423815 165403 5 None - 0 Human 5.0 pKi = 5 Functional
Antagonistic activity at Thromboxane A2 receptor in human was determinedAntagonistic activity at Thromboxane A2 receptor in human was determined
ChEMBL 288 4 1 1 4.5 O=C(O)/C=C/c1ccccc1Cc1ccc2ccccc2c1 10.1016/s0960-894x(01)00056-7
52949846 19309 0 None - 0 Human 7.0 pKi = 7.0 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 507 5 1 4 5.5 C[C@@H](c1ccc(Br)cc1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
CHEMBL1290523 19309 0 None - 0 Human 7.0 pKi = 7.0 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 507 5 1 4 5.5 C[C@@H](c1ccc(Br)cc1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
52943623 18980 0 None - 0 Human 7.0 pKi = 7.0 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 497 5 1 4 6.0 C[C@@H](c1ccc(Cl)c(Cl)c1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
CHEMBL1287835 18980 0 None - 0 Human 7.0 pKi = 7.0 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 497 5 1 4 6.0 C[C@@H](c1ccc(Cl)c(Cl)c1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
11386109 19331 0 None - 0 Human 6.9 pKi = 6.9 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 481 6 1 4 5.3 CS(=O)(=O)c1cc(F)cc2c3c(n([C@@H](CF)c4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CCC3 10.1016/j.bmcl.2010.10.018
CHEMBL1290639 19331 0 None - 0 Human 6.9 pKi = 6.9 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 481 6 1 4 5.3 CS(=O)(=O)c1cc(F)cc2c3c(n([C@@H](CF)c4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CCC3 10.1016/j.bmcl.2010.10.018
11294992 19351 0 None - 0 Human 6.9 pKi = 6.9 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 499 6 1 4 5.6 CS(=O)(=O)c1cc(F)cc2c3c(n([C@H](c4ccc(Cl)cc4)C(F)F)c12)[C@@H](CC(=O)O)CCC3 10.1016/j.bmcl.2010.10.018
CHEMBL1290755 19351 0 None - 0 Human 6.9 pKi = 6.9 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 499 6 1 4 5.6 CS(=O)(=O)c1cc(F)cc2c3c(n([C@H](c4ccc(Cl)cc4)C(F)F)c12)[C@@H](CC(=O)O)CCC3 10.1016/j.bmcl.2010.10.018
52945002 19330 0 None - 0 Human 5.8 pKi = 5.8 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 507 6 1 6 4.1 C[C@@H](c1ccc(S(C)(=O)=O)cc1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
CHEMBL1290638 19330 0 None - 0 Human 5.8 pKi = 5.8 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 507 6 1 6 4.1 C[C@@H](c1ccc(S(C)(=O)=O)cc1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
10095268 86156 0 None -7 3 Human 7.8 pKi = 7.8 Functional
Inhibition of human recombinant TP receptor expressed in CHO cells by calcium mobilisation assayInhibition of human recombinant TP receptor expressed in CHO cells by calcium mobilisation assay
ChEMBL 449 6 1 3 6.8 Cc1ccc(-n2c(C)ccc2-c2cc(Cl)ccc2OCc2ccc(F)cc2)cc1C(=O)O 10.1016/j.bmcl.2006.11.059
CHEMBL231184 86156 0 None -7 3 Human 7.8 pKi = 7.8 Functional
Inhibition of human recombinant TP receptor expressed in CHO cells by calcium mobilisation assayInhibition of human recombinant TP receptor expressed in CHO cells by calcium mobilisation assay
ChEMBL 449 6 1 3 6.8 Cc1ccc(-n2c(C)ccc2-c2cc(Cl)ccc2OCc2ccc(F)cc2)cc1C(=O)O 10.1016/j.bmcl.2006.11.059
44390268 64269 0 None - 0 Human 5.8 pKi = 5.8 Functional
Inhibitory activity for binding of PGD-2 in hTP binding assay using HEK293 cell membranesInhibitory activity for binding of PGD-2 in hTP binding assay using HEK293 cell membranes
ChEMBL 416 6 2 4 3.9 O=C(O)CCn1c2c(c3cc(NS(=O)(=O)c4ccc(F)cc4)ccc31)CCCC2 10.1016/j.bmcl.2004.12.055
CHEMBL180929 64269 0 None - 0 Human 5.8 pKi = 5.8 Functional
Inhibitory activity for binding of PGD-2 in hTP binding assay using HEK293 cell membranesInhibitory activity for binding of PGD-2 in hTP binding assay using HEK293 cell membranes
ChEMBL 416 6 2 4 3.9 O=C(O)CCn1c2c(c3cc(NS(=O)(=O)c4ccc(F)cc4)ccc31)CCCC2 10.1016/j.bmcl.2004.12.055
123879 3287 82 None 1 6 Human 7.8 pKi = 7.8 Functional
Inhibitory activity for binding of PGD-2 in hTP binding assay using HEK293 cell membranesInhibitory activity for binding of PGD-2 in hTP binding assay using HEK293 cell membranes
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2004.12.055
1910 3287 82 None 1 6 Human 7.8 pKi = 7.8 Functional
Inhibitory activity for binding of PGD-2 in hTP binding assay using HEK293 cell membranesInhibitory activity for binding of PGD-2 in hTP binding assay using HEK293 cell membranes
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2004.12.055
1911 3287 82 None 1 6 Human 7.8 pKi = 7.8 Functional
Inhibitory activity for binding of PGD-2 in hTP binding assay using HEK293 cell membranesInhibitory activity for binding of PGD-2 in hTP binding assay using HEK293 cell membranes
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2004.12.055
2354 3287 82 None 1 6 Human 7.8 pKi = 7.8 Functional
Inhibitory activity for binding of PGD-2 in hTP binding assay using HEK293 cell membranesInhibitory activity for binding of PGD-2 in hTP binding assay using HEK293 cell membranes
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2004.12.055
CHEMBL361812 3287 82 None 1 6 Human 7.8 pKi = 7.8 Functional
Inhibitory activity for binding of PGD-2 in hTP binding assay using HEK293 cell membranesInhibitory activity for binding of PGD-2 in hTP binding assay using HEK293 cell membranes
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2004.12.055
DB13036 3287 82 None 1 6 Human 7.8 pKi = 7.8 Functional
Inhibitory activity for binding of PGD-2 in hTP binding assay using HEK293 cell membranesInhibitory activity for binding of PGD-2 in hTP binding assay using HEK293 cell membranes
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2004.12.055
11259797 19234 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 463 5 1 4 5.3 C[C@@H](c1ccc(Cl)cc1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
CHEMBL1290079 19234 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 463 5 1 4 5.3 C[C@@H](c1ccc(Cl)cc1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
10216985 19220 0 None - 0 Human 8.6 pKi = 8.6 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 449 5 1 4 4.8 CS(=O)(=O)c1cc(F)cc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2010.10.018
CHEMBL1289984 19220 0 None - 0 Human 8.6 pKi = 8.6 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 449 5 1 4 4.8 CS(=O)(=O)c1cc(F)cc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2010.10.018
21019821 19235 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 481 5 1 4 5.5 C[C@@H](c1ccc(Cl)c(F)c1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
CHEMBL1290080 19235 0 None - 0 Human 6.7 pKi = 6.7 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 481 5 1 4 5.5 C[C@@H](c1ccc(Cl)c(F)c1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
52948543 19250 0 None - 0 Human 6.6 pKi = 6.6 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 481 5 1 4 5.5 C[C@@H](c1ccc(Cl)cc1F)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
CHEMBL1290187 19250 0 None - 0 Human 6.6 pKi = 6.6 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 481 5 1 4 5.5 C[C@@H](c1ccc(Cl)cc1F)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
52948585 19268 0 None - 0 Human 6.5 pKi = 6.5 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 463 5 1 4 5.3 C[C@@H](c1cccc(Cl)c1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
CHEMBL1290299 19268 0 None - 0 Human 6.5 pKi = 6.5 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 463 5 1 4 5.3 C[C@@H](c1cccc(Cl)c1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
24760470 14739 0 None - 1 Human 7.5 pKi = 7.5 Functional
Antagonist activity against TP receptor by FLIPR assayAntagonist activity against TP receptor by FLIPR assay
ChEMBL 334 4 1 4 4.6 CC(C)Cc1cn(-c2nc(C(=O)O)cs2)c2cc(Cl)ccc12 10.1016/j.bmcl.2008.03.018
CHEMBL1206294 14739 0 None - 1 Human 7.5 pKi = 7.5 Functional
Antagonist activity against TP receptor by FLIPR assayAntagonist activity against TP receptor by FLIPR assay
ChEMBL 334 4 1 4 4.6 CC(C)Cc1cn(-c2nc(C(=O)O)cs2)c2cc(Cl)ccc12 10.1016/j.bmcl.2008.03.018
CHEMBL257997 14739 0 None - 1 Human 7.5 pKi = 7.5 Functional
Antagonist activity against TP receptor by FLIPR assayAntagonist activity against TP receptor by FLIPR assay
ChEMBL 334 4 1 4 4.6 CC(C)Cc1cn(-c2nc(C(=O)O)cs2)c2cc(Cl)ccc12 10.1016/j.bmcl.2008.03.018
11488860 19291 0 None -7762 2 Human 6.5 pKi = 6.5 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 497 5 1 4 5.7 C[C@@H](c1ccc(C(F)(F)F)cc1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
CHEMBL1290413 19291 0 None -7762 2 Human 6.5 pKi = 6.5 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 497 5 1 4 5.7 C[C@@H](c1ccc(C(F)(F)F)cc1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
52941281 19267 0 None - 0 Human 6.4 pKi = 6.4 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 429 5 1 4 4.7 C[C@@H](c1ccccc1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
CHEMBL1290298 19267 0 None - 0 Human 6.4 pKi = 6.4 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 429 5 1 4 4.7 C[C@@H](c1ccccc1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
24760471 14844 0 None - 1 Human 6.4 pKi = 6.4 Functional
Antagonist activity against TP receptor by FLIPR assayAntagonist activity against TP receptor by FLIPR assay
ChEMBL 317 4 1 3 4.8 CC(C)Cc1cn(-c2ccc(C(=O)O)o2)c2cc(Cl)ccc12 10.1016/j.bmcl.2008.03.018
CHEMBL1207406 14844 0 None - 1 Human 6.4 pKi = 6.4 Functional
Antagonist activity against TP receptor by FLIPR assayAntagonist activity against TP receptor by FLIPR assay
ChEMBL 317 4 1 3 4.8 CC(C)Cc1cn(-c2ccc(C(=O)O)o2)c2cc(Cl)ccc12 10.1016/j.bmcl.2008.03.018
CHEMBL403407 14844 0 None - 1 Human 6.4 pKi = 6.4 Functional
Antagonist activity against TP receptor by FLIPR assayAntagonist activity against TP receptor by FLIPR assay
ChEMBL 317 4 1 3 4.8 CC(C)Cc1cn(-c2ccc(C(=O)O)o2)c2cc(Cl)ccc12 10.1016/j.bmcl.2008.03.018
9817292 57227 0 None - 0 Human 5.3 pKi = 5.3 Functional
Antagonistic activity at Thromboxane A2 receptor in human was determinedAntagonistic activity at Thromboxane A2 receptor in human was determined
ChEMBL 284 5 1 2 4.1 CSc1ccc(Cc2ccccc2/C=C/C(=O)O)cc1 10.1016/s0960-894x(01)00056-7
CHEMBL165010 57227 0 None - 0 Human 5.3 pKi = 5.3 Functional
Antagonistic activity at Thromboxane A2 receptor in human was determinedAntagonistic activity at Thromboxane A2 receptor in human was determined
ChEMBL 284 5 1 2 4.1 CSc1ccc(Cc2ccccc2/C=C/C(=O)O)cc1 10.1016/s0960-894x(01)00056-7
24760390 14733 0 None - 1 Human 7.3 pKi = 7.3 Functional
Antagonist activity against TP receptor by FLIPR assayAntagonist activity against TP receptor by FLIPR assay
ChEMBL 378 4 1 4 4.7 CC(C)Cc1cn(-c2nc(C(=O)O)cs2)c2cc(Br)ccc12 10.1016/j.bmcl.2008.03.018
CHEMBL1206284 14733 0 None - 1 Human 7.3 pKi = 7.3 Functional
Antagonist activity against TP receptor by FLIPR assayAntagonist activity against TP receptor by FLIPR assay
ChEMBL 378 4 1 4 4.7 CC(C)Cc1cn(-c2nc(C(=O)O)cs2)c2cc(Br)ccc12 10.1016/j.bmcl.2008.03.018
CHEMBL257134 14733 0 None - 1 Human 7.3 pKi = 7.3 Functional
Antagonist activity against TP receptor by FLIPR assayAntagonist activity against TP receptor by FLIPR assay
ChEMBL 378 4 1 4 4.7 CC(C)Cc1cn(-c2nc(C(=O)O)cs2)c2cc(Br)ccc12 10.1016/j.bmcl.2008.03.018
44377464 120085 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonistic activity at Thromboxane A2 receptor in human was determinedAntagonistic activity at Thromboxane A2 receptor in human was determined
ChEMBL 306 4 1 1 4.7 O=C(O)/C=C/c1ccccc1Cc1ccc(Cl)cc1Cl 10.1016/s0960-894x(01)00056-7
CHEMBL350832 120085 0 None - 0 Human 6.3 pKi = 6.3 Functional
Antagonistic activity at Thromboxane A2 receptor in human was determinedAntagonistic activity at Thromboxane A2 receptor in human was determined
ChEMBL 306 4 1 1 4.7 O=C(O)/C=C/c1ccccc1Cc1ccc(Cl)cc1Cl 10.1016/s0960-894x(01)00056-7
24760322 14722 0 None - 1 Human 7.1 pKi = 7.1 Functional
Antagonist activity against TP receptor by FLIPR assayAntagonist activity against TP receptor by FLIPR assay
ChEMBL 362 4 1 4 5.4 CC(C)(C)CCc1cn(-c2nc(C(=O)O)cs2)c2cc(Cl)ccc12 10.1016/j.bmcl.2008.03.018
CHEMBL1206265 14722 0 None - 1 Human 7.1 pKi = 7.1 Functional
Antagonist activity against TP receptor by FLIPR assayAntagonist activity against TP receptor by FLIPR assay
ChEMBL 362 4 1 4 5.4 CC(C)(C)CCc1cn(-c2nc(C(=O)O)cs2)c2cc(Cl)ccc12 10.1016/j.bmcl.2008.03.018
CHEMBL255675 14722 0 None - 1 Human 7.1 pKi = 7.1 Functional
Antagonist activity against TP receptor by FLIPR assayAntagonist activity against TP receptor by FLIPR assay
ChEMBL 362 4 1 4 5.4 CC(C)(C)CCc1cn(-c2nc(C(=O)O)cs2)c2cc(Cl)ccc12 10.1016/j.bmcl.2008.03.018
10402929 57543 0 None - 0 Human 6.1 pKi = 6.1 Functional
Antagonistic activity at Thromboxane A2 receptor in human was determinedAntagonistic activity at Thromboxane A2 receptor in human was determined
ChEMBL 306 4 1 1 4.7 O=C(O)/C=C/c1ccccc1Cc1ccc(Cl)c(Cl)c1 10.1016/s0960-894x(01)00056-7
CHEMBL166351 57543 0 None - 0 Human 6.1 pKi = 6.1 Functional
Antagonistic activity at Thromboxane A2 receptor in human was determinedAntagonistic activity at Thromboxane A2 receptor in human was determined
ChEMBL 306 4 1 1 4.7 O=C(O)/C=C/c1ccccc1Cc1ccc(Cl)c(Cl)c1 10.1016/s0960-894x(01)00056-7
52944959 19310 0 None - 0 Human 7.0 pKi = 7.0 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 454 5 1 5 4.6 C[C@@H](c1ccc(C#N)cc1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
CHEMBL1290524 19310 0 None - 0 Human 7.0 pKi = 7.0 Functional
Antagonist activity at prostanoid TP receptorAntagonist activity at prostanoid TP receptor
ChEMBL 454 5 1 5 4.6 C[C@@H](c1ccc(C#N)cc1)n1c2c(c3cc(F)cc(S(C)(=O)=O)c31)CCC[C@@H]2CC(=O)O 10.1016/j.bmcl.2010.10.018
6071 311 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 382 13 2 5 4.4 CCCCC[C@@H](CC[C@H]1[C@@H]2OC(=O)O[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 8882612
73755173 311 0 None - 1 Human 7.8 pEC50 = 7.8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 382 13 2 5 4.4 CCCCC[C@@H](CC[C@H]1[C@@H]2OC(=O)O[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 8882612
11968293 312 0 None - 1 Rat 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 366 12 2 5 4.1 CCCCC[C@@H](/C=C/[C@H]1[C@H]2OC(=O)O[C@H]([C@@H]1C/C=C\CCCCO)C2)O 8882612
3387 312 0 None - 1 Rat 8.9 pEC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 366 12 2 5 4.1 CCCCC[C@@H](/C=C/[C@H]1[C@H]2OC(=O)O[C@H]([C@@H]1C/C=C\CCCCO)C2)O 8882612
6070 3660 0 None - 1 Rat 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 350 12 2 3 4.5 CCCCC[C@@H](/C=C/[C@H]1C[C@H]2C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O2)O 4067988
73755172 3660 0 None - 1 Rat 9.1 pEC50 = 9.1 Functional
UnclassifiedUnclassified
Guide to Pharmacology 350 12 2 3 4.5 CCCCC[C@@H](/C=C/[C@H]1C[C@H]2C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O2)O 4067988
10341876 3013 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonism of TPalpha (short) isoform expressed in COS7 cells.Antagonism of TPalpha (short) isoform expressed in COS7 cells.
Guide to Pharmacology 416 17 1 3 6.8 CCCCC/C=C\CC(C(C1CC1)[C@H](/C=C\C/C=C\CCCC(=O)OC)O)C1CC1 14560042
9755 3013 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonism of TPalpha (short) isoform expressed in COS7 cells.Antagonism of TPalpha (short) isoform expressed in COS7 cells.
Guide to Pharmacology 416 17 1 3 6.8 CCCCC/C=C\CC(C(C1CC1)[C@H](/C=C\C/C=C\CCCC(=O)OC)O)C1CC1 14560042
10341876 3013 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonism of TPbeta (long) isoform expressed in COS7 cells.Antagonism of TPbeta (long) isoform expressed in COS7 cells.
Guide to Pharmacology 416 17 1 3 6.8 CCCCC/C=C\CC(C(C1CC1)[C@H](/C=C\C/C=C\CCCC(=O)OC)O)C1CC1 14560042
9755 3013 0 None - 1 Human 5.9 pIC50 = 5.9 Functional
Antagonism of TPbeta (long) isoform expressed in COS7 cells.Antagonism of TPbeta (long) isoform expressed in COS7 cells.
Guide to Pharmacology 416 17 1 3 6.8 CCCCC/C=C\CC(C(C1CC1)[C@H](/C=C\C/C=C\CCCC(=O)OC)O)C1CC1 14560042
11537 2897 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonism of U46619-mediated [Ca<sup>2+</sup>]<sup>i</sup> mobilization in HEK293 cells expressing TP&aipha;Antagonism of U46619-mediated [Ca<sup>2+</sup>]<sup>i</sup> mobilization in HEK293 cells expressing TP&aipha;
Guide to Pharmacology 515 7 2 6 5.4 N#Cc1ccc(c(c1)S(=O)(=O)NC(=O)NC(C)(C)C)Oc1cccc(c1)c1ccc(cc1)OC(F)F None
124147085 2897 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonism of U46619-mediated [Ca<sup>2+</sup>]<sup>i</sup> mobilization in HEK293 cells expressing TP&aipha;Antagonism of U46619-mediated [Ca<sup>2+</sup>]<sup>i</sup> mobilization in HEK293 cells expressing TP&aipha;
Guide to Pharmacology 515 7 2 6 5.4 N#Cc1ccc(c(c1)S(=O)(=O)NC(=O)NC(C)(C)C)Oc1cccc(c1)c1ccc(cc1)OC(F)F None
11537 2897 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonism of U46619-mediated [Ca<sup>2+</sup>]<sup>i</sup> mobilization in HEK293 cells expressing TP&beta;Antagonism of U46619-mediated [Ca<sup>2+</sup>]<sup>i</sup> mobilization in HEK293 cells expressing TP&beta;
Guide to Pharmacology 515 7 2 6 5.4 N#Cc1ccc(c(c1)S(=O)(=O)NC(=O)NC(C)(C)C)Oc1cccc(c1)c1ccc(cc1)OC(F)F None
124147085 2897 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonism of U46619-mediated [Ca<sup>2+</sup>]<sup>i</sup> mobilization in HEK293 cells expressing TP&beta;Antagonism of U46619-mediated [Ca<sup>2+</sup>]<sup>i</sup> mobilization in HEK293 cells expressing TP&beta;
Guide to Pharmacology 515 7 2 6 5.4 N#Cc1ccc(c(c1)S(=O)(=O)NC(=O)NC(C)(C)C)Oc1cccc(c1)c1ccc(cc1)OC(F)F None
6073 3785 49 None - 1 Human 6.5 pIC50 = 6.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 407 6 2 3 3.5 OC(=O)CCc1c(C)ccc2c1CC[C@H](C2)NS(=O)(=O)c1ccc(cc1)Cl 9871769
9938840 3785 49 None - 1 Human 6.5 pIC50 = 6.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 407 6 2 3 3.5 OC(=O)CCc1c(C)ccc2c1CC[C@H](C2)NS(=O)(=O)c1ccc(cc1)Cl 9871769
CHEMBL2107786 3785 49 None - 1 Human 6.5 pIC50 = 6.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology 407 6 2 3 3.5 OC(=O)CCc1c(C)ccc2c1CC[C@H](C2)NS(=O)(=O)c1ccc(cc1)Cl 9871769
1939 3688 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 366 12 2 3 5.2 CCCCC[C@H](/C=C/[C@H]1C[C@H]2C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)S2)O 8242228
5311453 3688 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology 366 12 2 3 5.2 CCCCC[C@H](/C=C/[C@H]1C[C@H]2C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)S2)O 8242228
23654676 1977 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 402 7 2 4 5.3 OC(=O)CC/C=C/C[C@@H]1CO[C@@H](O[C@@H]1c1ccccc1O)c1ccccc1Cl 8859002
6072 1977 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 402 7 2 4 5.3 OC(=O)CC/C=C/C[C@@H]1CO[C@@H](O[C@@H]1c1ccccc1O)c1ccccc1Cl 8859002




Ligands (move mouse cursor over ligand name to see structure) Receptor Assay information Chemical information
Sel. page Similar-
ity
Common
name
GPCRdb
ID
#Vendors

Reference
ligand
Fold
selectivity
# Tested
GPCRs
Species

p-value
(-log)
Activity
Type
Activity
Relation
Activity
Value
Assay
Type
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

31508 97218 38 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 278 2 0 3 4.0 Cc1ccc2c(-c3ccccc3)nc(=O)n(C(C)C)c2c1 10.1038/s41467-023-40064-9
CHEMBL268501 97218 38 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 278 2 0 3 4.0 Cc1ccc2c(-c3ccccc3)nc(=O)n(C(C)C)c2c1 10.1038/s41467-023-40064-9
91610 141353 96 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 527 7 2 6 3.5 COc1ccc2c(c1)C(=O)N(CCc1ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc1)C(=O)C2(C)C 10.1038/s41467-023-40064-9
CHEMBL383634 141353 96 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 527 7 2 6 3.5 COc1ccc2c(c1)C(=O)N(CCc1ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc1)C(=O)C2(C)C 10.1038/s41467-023-40064-9
5029 15545 92 None - 4 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 359 8 1 5 3.0 COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C 10.1038/s41467-023-40064-9
CHEMBL1219 15545 92 None - 4 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 359 8 1 5 3.0 COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C 10.1038/s41467-023-40064-9
135564886 14493 5 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
135673376 14493 5 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
137157436 14493 5 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
145948239 14493 5 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
71587099 14493 5 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
CHEMBL1201304 14493 5 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 752 14 1 6 8.7 CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 10.1038/s41467-023-40064-9
2179 167518 76 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 393 5 2 5 4.5 COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12 10.1038/s41467-023-40064-9
CHEMBL1256655 167518 76 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 393 5 2 5 4.5 COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12 10.1038/s41467-023-40064-9
CHEMBL43 167518 76 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 393 5 2 5 4.5 COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12 10.1038/s41467-023-40064-9
53232 188625 95 None - 2 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 404 6 1 5 4.2 CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21 10.1038/s41467-023-40064-9
CHEMBL503 188625 95 None - 2 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 404 6 1 5 4.2 CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21 10.1038/s41467-023-40064-9
5282219 35869 63 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 450 12 1 5 5.7 CC(C)=CCOc1ccc(/C=C/C(=O)c2ccc(OCC=C(C)C)cc2OCC(=O)O)cc1 10.1038/s41467-023-40064-9
CHEMBL1441961 35869 63 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 450 12 1 5 5.7 CC(C)=CCOc1ccc(/C=C/C(=O)c2ccc(OCC=C(C)C)cc2OCC(=O)O)cc1 10.1038/s41467-023-40064-9
4614 5391 103 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 293 5 1 3 4.0 O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1 10.1038/s41467-023-40064-9
CHEMBL1071 5391 103 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 293 5 1 3 4.0 O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1 10.1038/s41467-023-40064-9
10531 1420 21 None - 23 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
121 1420 21 None - 23 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
888 1420 21 None - 23 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
CHEMBL1732 1420 21 None - 23 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
DB00320 1420 21 None - 23 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 583 4 3 6 2.1 CN1C[C@@H](C[C@H]2[C@H]1Cc1c[nH]c3c1c2ccc3)C(=O)N[C@]1(C)O[C@@]2(N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1[C@H]2CCC1)O 10.1038/s41467-023-40064-9
5353627 84541 8 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 411 8 3 4 4.6 CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21 10.1038/s41467-023-40064-9
CHEMBL2220442 84541 8 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 411 8 3 4 4.6 CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21 10.1038/s41467-023-40064-9
11980903 14492 19 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 382 4 0 2 5.3 Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1 10.1038/s41467-023-40064-9
22526 14492 19 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 382 4 0 2 5.3 Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1 10.1038/s41467-023-40064-9
5281035 14492 19 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 382 4 0 2 5.3 Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL1201303 14492 19 None - 0 Human 4.9 pAC50 = 4.9 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 382 4 0 2 5.3 Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1 10.1038/s41467-023-40064-9
5991 203919 72 None - 4 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 296 0 2 2 3.6 C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
CHEMBL691 203919 72 None - 4 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 296 0 2 2 3.6 C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C 10.1038/s41467-023-40064-9
445643 97389 69 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 803 7 3 12 4.6 C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC 10.1038/s41467-023-40064-9
CHEMBL269732 97389 69 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 803 7 3 12 4.6 C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC 10.1038/s41467-023-40064-9
2812 4779 101 None - 34 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 10.1038/s41467-023-40064-9
CHEMBL104 4779 101 None - 34 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 344 4 0 2 5.4 Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 10.1038/s41467-023-40064-9
54454 5258 88 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 418 6 1 5 4.6 CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21 10.1038/s41467-023-40064-9
CHEMBL1064 5258 88 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 418 6 1 5 4.6 CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21 10.1038/s41467-023-40064-9
236702 45730 63 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 434 3 2 6 2.5 CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C 10.1038/s41467-023-40064-9
CHEMBL1530428 45730 63 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 434 3 2 6 2.5 CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C 10.1038/s41467-023-40064-9
2194 63083 101 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 240 2 0 4 4.2 COc1ccc(-c2cc(=S)ss2)cc1 10.1038/s41467-023-40064-9
CHEMBL178862 63083 101 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 240 2 0 4 4.2 COc1ccc(-c2cc(=S)ss2)cc1 10.1038/s41467-023-40064-9
2880 98008 49 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 310 5 0 3 4.6 C=C(c1ccccc1OCc1cccc(Cl)c1)n1ccnc1 10.1038/s41467-023-40064-9
CHEMBL27289 98008 49 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 310 5 0 3 4.6 C=C(c1ccccc1OCc1cccc(Cl)c1)n1ccnc1 10.1038/s41467-023-40064-9
216239 23795 118 None - 7 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 464 5 3 4 5.6 CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1 10.1038/s41467-023-40064-9
CHEMBL1200485 23795 118 None - 7 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 464 5 3 4 5.6 CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1 10.1038/s41467-023-40064-9
CHEMBL1336 23795 118 None - 7 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 464 5 3 4 5.6 CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1 10.1038/s41467-023-40064-9
2540 4401 111 None - 4 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 610 10 1 11 6.3 CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1 10.1038/s41467-023-40064-9
CHEMBL1014 4401 111 None - 4 Human 5.8 pAC50 = 5.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 610 10 1 11 6.3 CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1 10.1038/s41467-023-40064-9
135398735 136968 32 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
136262914 136968 32 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
CHEMBL374478 136968 32 None - 0 Human 4.8 pAC50 = 4.8 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 822 4 6 15 4.3 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
2583 3776 118 None - 1 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
592 3776 118 None - 1 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
65999 3776 118 None - 1 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
CHEMBL1017 3776 118 None - 1 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
DB00966 3776 118 None - 1 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 514 7 1 5 7.3 CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2 10.1038/s41467-023-40064-9
1605 2342 117 None - 4 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 382 1 0 3 4.9 CCOC(=O)N1CCC(=C2c3ccc(cc3CCc3c2nccc3)Cl)CC1 10.1038/s41467-023-40064-9
3957 2342 117 None - 4 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 382 1 0 3 4.9 CCOC(=O)N1CCC(=C2c3ccc(cc3CCc3c2nccc3)Cl)CC1 10.1038/s41467-023-40064-9
7216 2342 117 None - 4 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 382 1 0 3 4.9 CCOC(=O)N1CCC(=C2c3ccc(cc3CCc3c2nccc3)Cl)CC1 10.1038/s41467-023-40064-9
CHEMBL998 2342 117 None - 4 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 382 1 0 3 4.9 CCOC(=O)N1CCC(=C2c3ccc(cc3CCc3c2nccc3)Cl)CC1 10.1038/s41467-023-40064-9
DB00455 2342 117 None - 4 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 382 1 0 3 4.9 CCOC(=O)N1CCC(=C2c3ccc(cc3CCc3c2nccc3)Cl)CC1 10.1038/s41467-023-40064-9
392622 56312 95 None - 4 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 720 17 4 9 5.9 CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1 10.1038/s41467-023-40064-9
CHEMBL163 56312 95 None - 4 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 720 17 4 9 5.9 CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1 10.1038/s41467-023-40064-9
104850 3330 96 None - 5 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
4150 3330 96 None - 5 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
743 3330 96 None - 5 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
CHEMBL111 3330 96 None - 5 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
DB06155 3330 96 None - 5 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 462 4 1 4 5.9 Clc1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCCCC1 10.1038/s41467-023-40064-9
6436173 55116 45 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 785 2 5 13 6.2 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
CHEMBL1617 55116 45 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 785 2 5 13 6.2 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(nc6cc(C)ccn65)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C 10.1038/s41467-023-40064-9
448537 160250 89 None - 25 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 10.1038/s41467-023-40064-9
CHEMBL411 160250 89 None - 25 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 268 4 2 2 4.8 CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1 10.1038/s41467-023-40064-9
3784 57172 101 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 371 4 1 8 2.6 COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc2nonc12 10.1038/s41467-023-40064-9
CHEMBL1648 57172 101 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 371 4 1 8 2.6 COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc2nonc12 10.1038/s41467-023-40064-9
41781 9979 104 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 348 5 3 5 2.5 Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1 10.1038/s41467-023-40064-9
51371498 9979 104 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 348 5 3 5 2.5 Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1 10.1038/s41467-023-40064-9
CHEMBL1148 9979 104 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 348 5 3 5 2.5 Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1 10.1038/s41467-023-40064-9
5282138 173123 95 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 492 10 1 8 4.3 COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
CHEMBL452076 173123 95 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 492 10 1 8 4.3 COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC/C=C/c2ccccc2)C1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
5564 206006 118 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 288 2 1 2 5.1 Oc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl 10.1038/s41467-023-40064-9
CHEMBL849 206006 118 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 288 2 1 2 5.1 Oc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl 10.1038/s41467-023-40064-9
8730 195891 72 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 777 5 3 4 4.6 N[C@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O 10.1038/s41467-023-40064-9
90657408 195891 72 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 777 5 3 4 4.6 N[C@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O 10.1038/s41467-023-40064-9
CHEMBL559 195891 72 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 777 5 3 4 4.6 N[C@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O 10.1038/s41467-023-40064-9
16220172 73043 95 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 392 2 3 3 5.1 CC(C)(C)c1cc(C(C)(C)C)c(NC(=O)c2c[nH]c3ccccc3c2=O)cc1O 10.1038/s41467-023-40064-9
CHEMBL2010601 73043 95 None - 0 Human 4.7 pAC50 = 4.7 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 392 2 3 3 5.1 CC(C)(C)c1cc(C(C)(C)C)c(NC(=O)c2c[nH]c3ccccc3c2=O)cc1O 10.1038/s41467-023-40064-9
240 944 43 None - 24 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
2769 944 43 None - 24 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
44279790 944 43 None - 24 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
660 944 43 None - 24 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
CHEMBL1729 944 43 None - 24 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
CHEMBL560739 944 43 None - 24 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
DB00604 944 43 None - 24 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 465 9 2 6 3.4 COC1CN(CCCOc2ccc(cc2)F)CCC1NC(=O)c1cc(Cl)c(cc1OC)N 10.1038/s41467-023-40064-9
CHEMBL2135460 209276 55 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL None None None NCCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](NC(=O)CNC(=O)CNC(=O)CN)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O 10.1038/s41467-023-40064-9
1890 2759 49 None - 16 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
4449 2759 49 None - 16 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
7247 2759 49 None - 16 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
CHEMBL623 2759 49 None - 16 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
DB01149 2759 49 None - 16 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 469 10 0 7 3.6 CCc1nn(c(=O)n1CCOc1ccccc1)CCCN1CCN(CC1)c1cccc(c1)Cl 10.1038/s41467-023-40064-9
5077 3578 79 None - 4 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 496 12 1 7 3.9 O=C(NS(=O)(=O)C)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C 10.1038/s41467-023-40064-9
7552 3578 79 None - 4 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 496 12 1 7 3.9 O=C(NS(=O)(=O)C)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C 10.1038/s41467-023-40064-9
9913767 3578 79 None - 4 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 496 12 1 7 3.9 O=C(NS(=O)(=O)C)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C 10.1038/s41467-023-40064-9
CHEMBL238804 3578 79 None - 4 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 496 12 1 7 3.9 O=C(NS(=O)(=O)C)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C 10.1038/s41467-023-40064-9
DB11362 3578 79 None - 4 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 496 12 1 7 3.9 O=C(NS(=O)(=O)C)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C 10.1038/s41467-023-40064-9
134 2514 24 None - 67 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO 10.1038/s41467-023-40064-9
1775 2514 24 None - 67 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO 10.1038/s41467-023-40064-9
9681 2514 24 None - 67 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO 10.1038/s41467-023-40064-9
CHEMBL1065 2514 24 None - 67 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO 10.1038/s41467-023-40064-9
DB00247 2514 24 None - 67 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 353 4 2 4 1.9 CC[C@H](NC(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C)CO 10.1038/s41467-023-40064-9
15951529 6428 121 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 464 3 1 4 4.0 CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F 10.1038/s41467-023-40064-9
CHEMBL1082407 6428 121 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 464 3 1 4 4.0 CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F 10.1038/s41467-023-40064-9
30323 62485 57 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 527 4 5 11 1.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
CHEMBL1563 62485 57 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 527 4 5 11 1.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
CHEMBL178 62485 57 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 527 4 5 11 1.0 COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 10.1038/s41467-023-40064-9
71771 207353 92 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 353 6 2 4 3.9 O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
CHEMBL93645 207353 92 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 353 6 2 4 3.9 O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl 10.1038/s41467-023-40064-9
2449 204230 94 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 354 8 1 3 4.6 CC1=C(C)C(=O)C(C(CCCCCC(=O)O)c2ccccc2)=C(C)C1=O 10.1038/s41467-023-40064-9
CHEMBL70972 204230 94 None - 0 Human 5.6 pAC50 = 5.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 354 8 1 3 4.6 CC1=C(C)C(=O)C(C(CCCCCC(=O)O)c2ccccc2)=C(C)C1=O 10.1038/s41467-023-40064-9
1549120 196486 85 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 319 4 1 4 2.9 CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1 10.1038/s41467-023-40064-9
CHEMBL56337 196486 85 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 319 4 1 4 2.9 CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1 10.1038/s41467-023-40064-9
4495 196535 92 None - 29 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 308 5 1 5 2.8 CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1 10.1038/s41467-023-40064-9
CHEMBL56367 196535 92 None - 29 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 308 5 1 5 2.8 CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1 10.1038/s41467-023-40064-9
5852 2617 55 None - 4 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 419 11 1 5 4.9 OC(=O)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C 10.1038/s41467-023-40064-9
9931891 2617 55 None - 4 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 419 11 1 5 4.9 OC(=O)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C 10.1038/s41467-023-40064-9
CHEMBL239226 2617 55 None - 4 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 419 11 1 5 4.9 OC(=O)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C 10.1038/s41467-023-40064-9
5482 14420 80 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 386 6 0 4 5.9 Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1200438 14420 80 None - 0 Human 4.6 pAC50 = 4.6 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 386 6 0 4 5.9 Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
53276 95034 53 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 304 5 3 5 3.0 CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)nc1N 10.1038/s41467-023-40064-9
CHEMBL255044 95034 53 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 304 5 3 5 3.0 CCOC(=O)Nc1ccc(NCc2ccc(F)cc2)nc1N 10.1038/s41467-023-40064-9
71398 106439 44 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 302 5 4 4 3.6 C[C@@H](Cc1ccc(O)c(O)c1)[C@H](C)Cc1ccc(O)c(O)c1 10.1038/s41467-023-40064-9
CHEMBL313972 106439 44 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 302 5 4 4 3.6 C[C@@H](Cc1ccc(O)c(O)c1)[C@H](C)Cc1ccc(O)c(O)c1 10.1038/s41467-023-40064-9
2333 142335 97 None - 2 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 422 3 1 3 5.5 CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1 10.1038/s41467-023-40064-9
CHEMBL388590 142335 97 None - 2 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 422 3 1 3 5.5 CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1 10.1038/s41467-023-40064-9
135398745 2914 112 None -512 65 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
47 2914 112 None -512 65 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
CHEMBL715 2914 112 None -512 65 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
DB00334 2914 112 None -512 65 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C 10.1038/s41467-023-40064-9
3760 50300 37 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 414 6 0 3 6.5 Clc1ccc(C(Cn2ccnc2)OCc2c(Cl)cccc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
CHEMBL1571863 50300 37 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 414 6 0 3 6.5 Clc1ccc(C(Cn2ccnc2)OCc2c(Cl)cccc2Cl)c(Cl)c1 10.1038/s41467-023-40064-9
3401 78283 80 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 346 4 0 2 5.0 Fc1ccc(C(c2ccccc2)(c2ccccc2F)n2ccnc2)cc1 10.1038/s41467-023-40064-9
CHEMBL2107430 78283 80 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 346 4 0 2 5.0 Fc1ccc(C(c2ccccc2)(c2ccccc2F)n2ccnc2)cc1 10.1038/s41467-023-40064-9
123879 3287 82 None 3 4 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1038/s41467-023-40064-9
1910 3287 82 None 3 4 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1038/s41467-023-40064-9
1911 3287 82 None 3 4 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1038/s41467-023-40064-9
2354 3287 82 None 3 4 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1038/s41467-023-40064-9
CHEMBL361812 3287 82 None 3 4 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1038/s41467-023-40064-9
DB13036 3287 82 None 3 4 Human 7.5 pAC50 = 7.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1038/s41467-023-40064-9
3686 94667 108 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 338 12 1 5 3.5 COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O 10.1038/s41467-023-40064-9
CHEMBL252556 94667 108 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 338 12 1 5 3.5 COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O 10.1038/s41467-023-40064-9
2132 46224 91 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 376 3 3 3 3.2 Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1 10.1038/s41467-023-40064-9
CHEMBL1514634 46224 91 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 376 3 3 3 3.2 Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1 10.1038/s41467-023-40064-9
CHEMBL153479 46224 91 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 376 3 3 3 3.2 Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1 10.1038/s41467-023-40064-9
5472 205818 75 None - 3 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 10.1038/s41467-023-40064-9
CHEMBL1717 205818 75 None - 3 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 10.1038/s41467-023-40064-9
CHEMBL833 205818 75 None - 3 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 263 2 0 2 4.0 Clc1ccccc1CN1CCc2sccc2C1 10.1038/s41467-023-40064-9
3883 183535 112 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 369 5 1 4 3.5 Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1 10.1038/s41467-023-40064-9
CHEMBL480 183535 112 None - 0 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 369 5 1 4 3.5 Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1 10.1038/s41467-023-40064-9
4494 190187 87 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 385 5 1 8 2.5 COC(=O)C1=C(C#N)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
CHEMBL517427 190187 87 None - 0 Human 4.5 pAC50 = 4.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 385 5 1 8 2.5 COC(=O)C1=C(C#N)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1 10.1038/s41467-023-40064-9
1883 3082 75 None -380 24 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O 10.1038/s41467-023-40064-9
1916 3082 75 None -380 24 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O 10.1038/s41467-023-40064-9
5280360 3082 75 None -380 24 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O 10.1038/s41467-023-40064-9
913 3082 75 None -380 24 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O 10.1038/s41467-023-40064-9
CHEMBL548 3082 75 None -380 24 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O 10.1038/s41467-023-40064-9
DB00917 3082 75 None -380 24 Human 5.5 pAC50 = 5.5 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O 10.1038/s41467-023-40064-9
3356 2280 73 None -38 8 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1038/s41467-023-40064-9
4326 2280 73 None -38 8 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1038/s41467-023-40064-9
9867642 2280 73 None -38 8 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1038/s41467-023-40064-9
CHEMBL426559 2280 73 None -38 8 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1038/s41467-023-40064-9
DB11629 2280 73 None -38 8 Human 6.4 pAC50 = 6.4 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1038/s41467-023-40064-9
41684 31221 105 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 307 4 1 7 2.2 CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1 10.1038/s41467-023-40064-9
CHEMBL1401 31221 105 None - 0 Human 5.3 pAC50 = 5.3 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 307 4 1 7 2.2 CC(=O)Oc1ccccc1C(=O)Nc1ncc([N+](=O)[O-])s1 10.1038/s41467-023-40064-9
28230148 205731 97 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 320 3 2 6 0.7 CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21 10.1038/s41467-023-40064-9
3229 205731 97 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 320 3 2 6 0.7 CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21 10.1038/s41467-023-40064-9
CHEMBL826 205731 97 None - 0 Human 5.2 pAC50 = 5.2 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 320 3 2 6 0.7 CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21 10.1038/s41467-023-40064-9
135409453 3773 41 None - 2 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
226 3773 41 None - 2 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
CHEMBL76370 3773 41 None - 2 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 301 7 3 3 2.6 CCCCCN=C(N/N=C/c1c[nH]c2c1cc(OC)cc2)N 10.1038/s41467-023-40064-9
24821094 67094 93 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 440 5 1 7 4.2 C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1 10.1038/s41467-023-40064-9
CHEMBL1873475 67094 93 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 440 5 1 7 4.2 C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1 10.1038/s41467-023-40064-9
3333 40168 111 None - 1 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 383 4 1 5 4.0 CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl 10.1038/s41467-023-40064-9
CHEMBL1480 40168 111 None - 1 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 383 4 1 5 4.0 CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl 10.1038/s41467-023-40064-9
6450551 19211 106 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 386 5 2 4 4.6 CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1 10.1038/s41467-023-40064-9
CHEMBL1289926 19211 106 None - 0 Human 5.1 pAC50 = 5.1 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 386 5 2 4 4.6 CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1 10.1038/s41467-023-40064-9
5329102 194726 86 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 398 7 3 3 3.3 CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C 10.1038/s41467-023-40064-9
CHEMBL535 194726 86 None - 0 Human 5.0 pAC50 = 5.0 Binding
Binding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assayBinding affinity towards human TBXA2R in an in vitro assay with cellular components measured by scintillation proximity assay
ChEMBL 398 7 3 3 3.3 CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C 10.1038/s41467-023-40064-9
44306573 163157 0 None - 0 Rat 9.6 pEC50 = 9.6 Binding
Activity against thromboxane A2 receptor evaluated by contraction of isolated rat thoracic aortaActivity against thromboxane A2 receptor evaluated by contraction of isolated rat thoracic aorta
ChEMBL 380 12 2 5 4.2 CCCCCC(O)/C=C/[C@H]1[C@H]2C[C@H](OC(=O)O2)[C@@H]1C/C=C\CCCC(=O)O 10.1016/S0960-894X(01)80110-4
CHEMBL417967 163157 0 None - 0 Rat 9.6 pEC50 = 9.6 Binding
Activity against thromboxane A2 receptor evaluated by contraction of isolated rat thoracic aortaActivity against thromboxane A2 receptor evaluated by contraction of isolated rat thoracic aorta
ChEMBL 380 12 2 5 4.2 CCCCCC(O)/C=C/[C@H]1[C@H]2C[C@H](OC(=O)O2)[C@@H]1C/C=C\CCCC(=O)O 10.1016/S0960-894X(01)80110-4
15289204 203090 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Activity against thromboxane A2 receptor evaluated by contraction of isolated rat thoracic aortaActivity against thromboxane A2 receptor evaluated by contraction of isolated rat thoracic aorta
ChEMBL 366 12 2 5 4.1 CCCCCC(O)/C=C/[C@H]1[C@H]2C[C@H](OC(=O)O2)[C@@H]1C/C=C\CCCCO 10.1016/S0960-894X(01)80110-4
CHEMBL63892 203090 0 None - 0 Rat 9.0 pEC50 = 9 Binding
Activity against thromboxane A2 receptor evaluated by contraction of isolated rat thoracic aortaActivity against thromboxane A2 receptor evaluated by contraction of isolated rat thoracic aorta
ChEMBL 366 12 2 5 4.1 CCCCCC(O)/C=C/[C@H]1[C@H]2C[C@H](OC(=O)O2)[C@@H]1C/C=C\CCCCO 10.1016/S0960-894X(01)80110-4
44306573 163157 0 None - 0 Human 7.6 pEC50 = 7.6 Binding
Activity against thromboxane A2 receptor evaluated by aggregation of human plateletsActivity against thromboxane A2 receptor evaluated by aggregation of human platelets
ChEMBL 380 12 2 5 4.2 CCCCCC(O)/C=C/[C@H]1[C@H]2C[C@H](OC(=O)O2)[C@@H]1C/C=C\CCCC(=O)O 10.1016/S0960-894X(01)80110-4
CHEMBL417967 163157 0 None - 0 Human 7.6 pEC50 = 7.6 Binding
Activity against thromboxane A2 receptor evaluated by aggregation of human plateletsActivity against thromboxane A2 receptor evaluated by aggregation of human platelets
ChEMBL 380 12 2 5 4.2 CCCCCC(O)/C=C/[C@H]1[C@H]2C[C@H](OC(=O)O2)[C@@H]1C/C=C\CCCC(=O)O 10.1016/S0960-894X(01)80110-4
44306604 169314 0 None - 0 Human 5.5 pEC50 = 5.5 Binding
Activity against thromboxane A2 receptor evaluated by aggregation of human plateletsActivity against thromboxane A2 receptor evaluated by aggregation of human platelets
ChEMBL 379 12 2 5 3.6 CCCCCC(O)/C=C/[C@H]1[C@H]2C[C@H](OC(=O)O2)[C@@H]1C/C=C\CCCC(N)=O 10.1016/S0960-894X(01)80110-4
CHEMBL441620 169314 0 None - 0 Human 5.5 pEC50 = 5.5 Binding
Activity against thromboxane A2 receptor evaluated by aggregation of human plateletsActivity against thromboxane A2 receptor evaluated by aggregation of human platelets
ChEMBL 379 12 2 5 3.6 CCCCCC(O)/C=C/[C@H]1[C@H]2C[C@H](OC(=O)O2)[C@@H]1C/C=C\CCCC(N)=O 10.1016/S0960-894X(01)80110-4
44306912 102355 0 None - 0 Rat 6.5 pEC50 = 6.5 Binding
Activity against thromboxane A2 receptor evaluated by contraction of isolated rat thoracic aortaActivity against thromboxane A2 receptor evaluated by contraction of isolated rat thoracic aorta
ChEMBL 421 13 2 5 4.7 CCCCCC(O)/C=C/[C@H]1[C@H]2C[C@H](OC(=O)O2)[C@@H]1C/C=C\CCCC(=O)NC(C)C 10.1016/S0960-894X(01)80110-4
CHEMBL303777 102355 0 None - 0 Rat 6.5 pEC50 = 6.5 Binding
Activity against thromboxane A2 receptor evaluated by contraction of isolated rat thoracic aortaActivity against thromboxane A2 receptor evaluated by contraction of isolated rat thoracic aorta
ChEMBL 421 13 2 5 4.7 CCCCCC(O)/C=C/[C@H]1[C@H]2C[C@H](OC(=O)O2)[C@@H]1C/C=C\CCCC(=O)NC(C)C 10.1016/S0960-894X(01)80110-4
44306604 169314 0 None - 0 Rat 7.2 pEC50 = 7.2 Binding
Activity against thromboxane A2 receptor evaluated by contraction of isolated rat thoracic aortaActivity against thromboxane A2 receptor evaluated by contraction of isolated rat thoracic aorta
ChEMBL 379 12 2 5 3.6 CCCCCC(O)/C=C/[C@H]1[C@H]2C[C@H](OC(=O)O2)[C@@H]1C/C=C\CCCC(N)=O 10.1016/S0960-894X(01)80110-4
CHEMBL441620 169314 0 None - 0 Rat 7.2 pEC50 = 7.2 Binding
Activity against thromboxane A2 receptor evaluated by contraction of isolated rat thoracic aortaActivity against thromboxane A2 receptor evaluated by contraction of isolated rat thoracic aorta
ChEMBL 379 12 2 5 3.6 CCCCCC(O)/C=C/[C@H]1[C@H]2C[C@H](OC(=O)O2)[C@@H]1C/C=C\CCCC(N)=O 10.1016/S0960-894X(01)80110-4
10717385 168512 0 None - 0 Human 9.9 pIC50 = 9.9 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 427 9 2 3 4.7 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc3ccccc3c2)[C@H]2CC[C@@H]1C2 10.1021/jm970343g
CHEMBL435382 168512 0 None - 0 Human 9.9 pIC50 = 9.9 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 427 9 2 3 4.7 O=C(O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc3ccccc3c2)[C@H]2CC[C@@H]1C2 10.1021/jm970343g
11647396 77782 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 418 5 2 6 3.5 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)N2CCCCC2)cc1 10.1021/jm060108a
CHEMBL209168 77782 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 418 5 2 6 3.5 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)N2CCCCC2)cc1 10.1021/jm060108a
11661725 77859 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 420 5 3 6 3.7 Cc1cccc(C)c1Nc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm060108a
CHEMBL209306 77859 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 420 5 3 6 3.7 Cc1cccc(C)c1Nc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm060108a
11656254 77777 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 498 9 3 6 4.6 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(Br)c(C)c1 10.1021/jm060108a
CHEMBL209134 77777 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 498 9 3 6 4.6 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(Br)c(C)c1 10.1021/jm060108a
11502680 98240 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
CHEMBL274415 98240 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
11647396 77782 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 418 5 2 6 3.5 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)N2CCCCC2)cc1 10.1021/jm060108a
CHEMBL209168 77782 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 418 5 2 6 3.5 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)N2CCCCC2)cc1 10.1021/jm060108a
11531590 77893 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 407 8 2 6 3.5 CCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
CHEMBL209406 77893 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 407 8 2 6 3.5 CCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
11662021 139553 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 434 9 3 6 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1cc(C)cc(C)c1 10.1021/jm060108a
CHEMBL379659 139553 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 434 9 3 6 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1cc(C)cc(C)c1 10.1021/jm060108a
11604299 139582 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 426 10 3 6 3.9 CCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1021/jm060108a
CHEMBL379736 139582 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 426 10 3 6 3.9 CCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1021/jm060108a
11704760 77611 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 435 10 2 6 4.3 CCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
CHEMBL208818 77611 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 435 10 2 6 4.3 CCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
11531590 77893 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 407 8 2 6 3.5 CCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
CHEMBL209406 77893 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 407 8 2 6 3.5 CCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
11633215 140155 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 423 5 2 6 3.8 Cc1ccc(Sc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
CHEMBL380274 140155 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 423 5 2 6 3.8 Cc1ccc(Sc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
5312142 78233 11 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
CHEMBL210602 78233 11 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
11661725 77859 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 420 5 3 6 3.7 Cc1cccc(C)c1Nc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm060108a
CHEMBL209306 77859 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 420 5 3 6 3.7 Cc1cccc(C)c1Nc1ccc([N+](=O)[O-])cc1S(=O)(=O)NC(=O)NC(C)(C)C 10.1021/jm060108a
11683470 77363 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 433 6 2 6 4.0 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC2CCCCC2)cc1 10.1021/jm060108a
CHEMBL208543 77363 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 433 6 2 6 4.0 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC2CCCCC2)cc1 10.1021/jm060108a
11510008 77282 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1cccc(C)c1 10.1021/jm060108a
CHEMBL208115 77282 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1cccc(C)c1 10.1021/jm060108a
5312142 78233 11 None - 0 Human 9.0 pIC50 = 9.0 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
CHEMBL210602 78233 11 None - 0 Human 9.0 pIC50 = 9.0 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 406 5 3 6 3.4 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
11604299 139582 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 426 10 3 6 3.9 CCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1021/jm060108a
CHEMBL379736 139582 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 426 10 3 6 3.9 CCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1021/jm060108a
11662021 139553 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 434 9 3 6 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1cc(C)cc(C)c1 10.1021/jm060108a
CHEMBL379659 139553 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 434 9 3 6 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1cc(C)cc(C)c1 10.1021/jm060108a
9866368 204635 33 None - 0 Human 9.0 pIC50 = 9.0 Binding
In vitro inhibitory concentration of compound against thromboxane A2 receptorIn vitro inhibitory concentration of compound against thromboxane A2 receptor
ChEMBL 412 9 3 6 3.5 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1016/s0960-894x(01)00114-7
CHEMBL7353 204635 33 None - 0 Human 9.0 pIC50 = 9.0 Binding
In vitro inhibitory concentration of compound against thromboxane A2 receptorIn vitro inhibitory concentration of compound against thromboxane A2 receptor
ChEMBL 412 9 3 6 3.5 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1016/s0960-894x(01)00114-7
11568384 77796 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 440 7 3 6 3.8 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NCc2ccccc2)cc1 10.1021/jm060108a
CHEMBL209245 77796 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 440 7 3 6 3.8 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NCc2ccccc2)cc1 10.1021/jm060108a
11567679 77748 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 407 5 2 6 3.5 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
CHEMBL209035 77748 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 407 5 2 6 3.5 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
11568248 138655 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 434 9 3 6 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1c(C)cccc1C 10.1021/jm060108a
CHEMBL377679 138655 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 434 9 3 6 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1c(C)cccc1C 10.1021/jm060108a
11683470 77363 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 433 6 2 6 4.0 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC2CCCCC2)cc1 10.1021/jm060108a
CHEMBL208543 77363 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 433 6 2 6 4.0 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC2CCCCC2)cc1 10.1021/jm060108a
11568248 138655 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 434 9 3 6 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1c(C)cccc1C 10.1021/jm060108a
CHEMBL377679 138655 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 434 9 3 6 4.1 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1c(C)cccc1C 10.1021/jm060108a
11704760 77611 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 435 10 2 6 4.3 CCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
CHEMBL208818 77611 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 435 10 2 6 4.3 CCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
11633215 140155 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 423 5 2 6 3.8 Cc1ccc(Sc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
CHEMBL380274 140155 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 423 5 2 6 3.8 Cc1ccc(Sc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
11567679 77748 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 407 5 2 6 3.5 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
CHEMBL209035 77748 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 407 5 2 6 3.5 Cc1ccc(Oc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NC(C)(C)C)cc1 10.1021/jm060108a
11656254 77777 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 498 9 3 6 4.6 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(Br)c(C)c1 10.1021/jm060108a
CHEMBL209134 77777 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 498 9 3 6 4.6 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(Br)c(C)c1 10.1021/jm060108a
11568384 77796 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 440 7 3 6 3.8 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NCc2ccccc2)cc1 10.1021/jm060108a
CHEMBL209245 77796 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 440 7 3 6 3.8 Cc1ccc(Nc2ccc([N+](=O)[O-])cc2S(=O)(=O)NC(=O)NCc2ccccc2)cc1 10.1021/jm060108a
44350662 18011 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 518 9 2 4 5.5 O=C(O)c1cccc(/C=C(\c2ccc(CCNS(=O)(=O)c3ccc(Cl)cc3)cc2)c2cccnc2)c1 10.1021/jm00027a004
CHEMBL126334 18011 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 518 9 2 4 5.5 O=C(O)c1cccc(/C=C(\c2ccc(CCNS(=O)(=O)c3ccc(Cl)cc3)cc2)c2cccnc2)c1 10.1021/jm00027a004
10386455 111274 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 403 11 1 5 4.5 O=C(O)/C=C/CCCO/N=C(\c1ccccc1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
CHEMBL326521 111274 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 403 11 1 5 4.5 O=C(O)/C=C/CCCO/N=C(\c1ccccc1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
10669025 205056 1 None - 0 Human 8.0 pIC50 = 8.0 Binding
In vitro inhibitory concentration of compound against thromboxane A2 receptorIn vitro inhibitory concentration of compound against thromboxane A2 receptor
ChEMBL 405 7 3 4 4.4 CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=C/CCCC(=O)O)c2cccnc2)c1 10.1016/s0960-894x(01)00114-7
CHEMBL7718 205056 1 None - 0 Human 8.0 pIC50 = 8.0 Binding
In vitro inhibitory concentration of compound against thromboxane A2 receptorIn vitro inhibitory concentration of compound against thromboxane A2 receptor
ChEMBL 405 7 3 4 4.4 CC(C)(C)/N=C(\NC#N)Nc1cccc(/C(=C/CCCC(=O)O)c2cccnc2)c1 10.1016/s0960-894x(01)00114-7
54592351 77259 5 None - 0 Human 8.0 pIC50 = 8.0 Binding
Binding affinity towards Thromboxane A2/ Prostaglandin H2 receptor in human platelet membranes using [125I]- as the radioligand.Binding affinity towards Thromboxane A2/ Prostaglandin H2 receptor in human platelet membranes using [125I]- as the radioligand.
ChEMBL 371 4 1 2 5.4 O=C(O)C[C@@H]1CCCc2c1n(Cc1ccc(Cl)cc1)c1ccc(F)cc21 10.1021/jm00108a042
CHEMBL2079673 77259 5 None - 0 Human 8.0 pIC50 = 8.0 Binding
Binding affinity towards Thromboxane A2/ Prostaglandin H2 receptor in human platelet membranes using [125I]- as the radioligand.Binding affinity towards Thromboxane A2/ Prostaglandin H2 receptor in human platelet membranes using [125I]- as the radioligand.
ChEMBL 371 4 1 2 5.4 O=C(O)C[C@@H]1CCCc2c1n(Cc1ccc(Cl)cc1)c1ccc(F)cc21 10.1021/jm00108a042
9983481 18955 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 500 11 2 4 4.2 O=C(O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1ccc[n+]([O-])c1 10.1021/jm00027a004
CHEMBL128678 18955 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 500 11 2 4 4.2 O=C(O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1ccc[n+]([O-])c1 10.1021/jm00027a004
10002804 161944 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 430 13 2 4 4.0 CCCCS(=O)(=O)NCCc1ccc(/C(=C\CCCC(=O)O)c2cccnc2)cc1 10.1021/jm00027a004
CHEMBL415519 161944 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 430 13 2 4 4.0 CCCCS(=O)(=O)NCCc1ccc(/C(=C\CCCC(=O)O)c2cccnc2)cc1 10.1021/jm00027a004
10623568 205328 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 453 10 2 3 5.2 O=C(O)CCC/C=C\C[C@@H]1[C@H]2CC[C@H](C2)[C@H]1NS(=O)(=O)c1ccc(-c2ccccc2)cc1 10.1021/jm970343g
CHEMBL79511 205328 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 453 10 2 3 5.2 O=C(O)CCC/C=C\C[C@@H]1[C@H]2CC[C@H](C2)[C@H]1NS(=O)(=O)c1ccc(-c2ccccc2)cc1 10.1021/jm970343g
44159772 68392 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranesDisplacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranes
ChEMBL 535 9 1 4 6.8 CCN(Cc1cc(C(F)(F)F)ccc1-c1cc(CC(=O)O)ccc1OC)C(=O)OCc1ccc(Cl)cc1 10.1016/j.bmcl.2011.01.024
CHEMBL1916708 68392 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Displacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranesDisplacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranes
ChEMBL 535 9 1 4 6.8 CCN(Cc1cc(C(F)(F)F)ccc1-c1cc(CC(=O)O)ccc1OC)C(=O)OCc1ccc(Cl)cc1 10.1016/j.bmcl.2011.01.024
9865257 15584 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 391 11 1 5 4.3 O=C(O)CCCCO/N=C(/c1ccccc1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
CHEMBL122123 15584 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 391 11 1 5 4.3 O=C(O)CCCCO/N=C(/c1ccccc1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
10458951 17979 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 508 11 2 6 4.2 O=S(=O)(NCCc1ccc(/C(=C\CCCc2nnn[nH]2)c2cccnc2)cc1)c1ccc(Cl)cc1 10.1021/jm00027a004
CHEMBL126185 17979 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 508 11 2 6 4.2 O=S(=O)(NCCc1ccc(/C(=C\CCCc2nnn[nH]2)c2cccnc2)cc1)c1ccc(Cl)cc1 10.1021/jm00027a004
10028328 18513 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 484 11 2 4 4.9 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm00027a004
CHEMBL127380 18513 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 484 11 2 4 4.9 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm00027a004
11753841 118072 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 456 9 2 4 4.2 O=C(O)C/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL340504 118072 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 456 9 2 4 4.2 O=C(O)C/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
10460371 19407 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 556 14 2 5 5.1 O=C(O)CCC/C=C(\c1ccc(CCN(CCC(=O)O)S(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL129365 19407 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 556 14 2 5 5.1 O=C(O)CCC/C=C(\c1ccc(CCN(CCC(=O)O)S(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
10340286 14511 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 389 10 1 5 4.1 O=C(O)/C=C/CCO/N=C(\c1ccccc1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
CHEMBL120165 14511 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 389 10 1 5 4.1 O=C(O)/C=C/CCO/N=C(\c1ccccc1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
10047870 18069 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 422 8 2 4 3.4 Cc1ccc(S(=O)(=O)NCCc2ccc(/C(=C\C(=O)O)c3cccnc3)cc2)cc1 10.1021/jm00027a004
CHEMBL126654 18069 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 422 8 2 4 3.4 Cc1ccc(S(=O)(=O)NCCc2ccc(/C(=C\C(=O)O)c3cccnc3)cc2)cc1 10.1021/jm00027a004
10320386 116891 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 428 11 2 3 4.7 O=C(O)CCC/C=C(\c1ccc(CCNC(=O)Cc2ccccc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL338334 116891 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 428 11 2 3 4.7 O=C(O)CCC/C=C(\c1ccc(CCNC(=O)Cc2ccccc2)cc1)c1cccnc1 10.1021/jm00027a004
10767455 105810 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 492 10 3 3 5.7 O=C(O)CCC/C=C\C[C@@H]1[C@H]2CC[C@H](C2)[C@H]1NS(=O)(=O)c1ccc2cc(-c3ccccc3)[nH]c2c1 10.1021/jm970343g
CHEMBL312697 105810 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 492 10 3 3 5.7 O=C(O)CCC/C=C\C[C@@H]1[C@H]2CC[C@H](C2)[C@H]1NS(=O)(=O)c1ccc2cc(-c3ccccc3)[nH]c2c1 10.1021/jm970343g
10448061 14984 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 309 13 1 5 3.5 CCCCCC/C(Cn1ccnc1)=N/OCCCCC(=O)O 10.1021/jm00047a016
CHEMBL120904 14984 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 309 13 1 5 3.5 CCCCCC/C(Cn1ccnc1)=N/OCCCCC(=O)O 10.1021/jm00047a016
10369102 18056 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 510 9 2 4 5.3 O=C(O)CCC/C=C(/c1cccnc1)c1ccc2c(c1)CCC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1021/jm00027a004
CHEMBL126577 18056 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 510 9 2 4 5.3 O=C(O)CCC/C=C(/c1cccnc1)c1ccc2c(c1)CCC(NS(=O)(=O)c1ccc(Cl)cc1)C2 10.1021/jm00027a004
44350670 18010 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 518 9 2 4 5.5 O=C(O)c1ccc(/C=C(\c2ccc(CCNS(=O)(=O)c3ccc(Cl)cc3)cc2)c2cccnc2)cc1 10.1021/jm00027a004
CHEMBL126333 18010 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 518 9 2 4 5.5 O=C(O)c1ccc(/C=C(\c2ccc(CCNS(=O)(=O)c3ccc(Cl)cc3)cc2)c2cccnc2)cc1 10.1021/jm00027a004
18944131 87195 0 None - 1 Human 6.9 pIC50 = 6.9 Binding
In vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparationIn vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparation
ChEMBL 484 10 2 6 4.0 O=C(O)CCc1ccccc1CC1OCOC1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
CHEMBL23273 87195 0 None - 1 Human 6.9 pIC50 = 6.9 Binding
In vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparationIn vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparation
ChEMBL 484 10 2 6 4.0 O=C(O)CCc1ccccc1CC1OCOC1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
10251833 15200 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 425 12 0 6 5.4 CCOC(=O)CCCCO/N=C(\C1CCCCC1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
CHEMBL121043 15200 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 425 12 0 6 5.4 CCOC(=O)CCCCO/N=C(\C1CCCCC1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
10696132 168124 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 481 11 2 5 6.0 O=C(O)CCC/C=C\C[C@@H]1[C@H]2CC[C@H](C2)[C@H]1NS(=O)(=O)c1ccc(/N=N/c2ccccc2)cc1 10.1021/jm970343g
CHEMBL432935 168124 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 481 11 2 5 6.0 O=C(O)CCC/C=C\C[C@@H]1[C@H]2CC[C@H](C2)[C@H]1NS(=O)(=O)c1ccc(/N=N/c2ccccc2)cc1 10.1021/jm970343g
10648014 205299 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 469 11 2 4 5.4 O=C(O)CCC/C=C\C[C@@H]1[C@H]2CC[C@H](C2)[C@H]1NS(=O)(=O)c1ccc(Oc2ccccc2)cc1 10.1021/jm970343g
CHEMBL79260 205299 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 469 11 2 4 5.4 O=C(O)CCC/C=C\C[C@@H]1[C@H]2CC[C@H](C2)[C@H]1NS(=O)(=O)c1ccc(Oc2ccccc2)cc1 10.1021/jm970343g
44537923 139186 7 None - 0 Human 4.9 pIC50 = 4.9 Binding
Binding affinity to thromboxane A2 receptor (unknown origin)Binding affinity to thromboxane A2 receptor (unknown origin)
ChEMBL 457 6 2 8 1.4 O=C(NCc1cc(Cl)ccc1-n1cnnn1)[C@@H]1CC=NN1C(=O)[C@H](O)c1ccc(F)cc1 10.1039/C5MD00479A
CHEMBL3787587 139186 7 None - 0 Human 4.9 pIC50 = 4.9 Binding
Binding affinity to thromboxane A2 receptor (unknown origin)Binding affinity to thromboxane A2 receptor (unknown origin)
ChEMBL 457 6 2 8 1.4 O=C(NCc1cc(Cl)ccc1-n1cnnn1)[C@@H]1CC=NN1C(=O)[C@H](O)c1ccc(F)cc1 10.1039/C5MD00479A
123879 3287 82 None 3 4 Human 7.9 pIC50 = 7.9 Binding
Displacement of [3H]SQ-29548 from thromboxane receptor in human platelet membraneDisplacement of [3H]SQ-29548 from thromboxane receptor in human platelet membrane
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2009.06.085
1910 3287 82 None 3 4 Human 7.9 pIC50 = 7.9 Binding
Displacement of [3H]SQ-29548 from thromboxane receptor in human platelet membraneDisplacement of [3H]SQ-29548 from thromboxane receptor in human platelet membrane
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2009.06.085
1911 3287 82 None 3 4 Human 7.9 pIC50 = 7.9 Binding
Displacement of [3H]SQ-29548 from thromboxane receptor in human platelet membraneDisplacement of [3H]SQ-29548 from thromboxane receptor in human platelet membrane
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2009.06.085
2354 3287 82 None 3 4 Human 7.9 pIC50 = 7.9 Binding
Displacement of [3H]SQ-29548 from thromboxane receptor in human platelet membraneDisplacement of [3H]SQ-29548 from thromboxane receptor in human platelet membrane
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2009.06.085
CHEMBL361812 3287 82 None 3 4 Human 7.9 pIC50 = 7.9 Binding
Displacement of [3H]SQ-29548 from thromboxane receptor in human platelet membraneDisplacement of [3H]SQ-29548 from thromboxane receptor in human platelet membrane
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2009.06.085
DB13036 3287 82 None 3 4 Human 7.9 pIC50 = 7.9 Binding
Displacement of [3H]SQ-29548 from thromboxane receptor in human platelet membraneDisplacement of [3H]SQ-29548 from thromboxane receptor in human platelet membrane
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2009.06.085
10341794 14527 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 415 11 1 5 5.0 O=C(O)CCCCO/N=C(/C1CCCCC1)C(Cc1cccc(F)c1)n1ccnc1 10.1021/jm00047a016
CHEMBL120207 14527 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 415 11 1 5 5.0 O=C(O)CCCCO/N=C(/C1CCCCC1)C(Cc1cccc(F)c1)n1ccnc1 10.1021/jm00047a016
15616468 204270 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Compound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membraneCompound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membrane
ChEMBL 372 8 1 3 4.7 CC1=C(C)C(=O)C(C(CCCCCC(=O)O)c2ccc(F)cc2)=C(C)C1=O 10.1021/jm00090a009
CHEMBL71222 204270 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Compound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membraneCompound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membrane
ChEMBL 372 8 1 3 4.7 CC1=C(C)C(=O)C(C(CCCCCC(=O)O)c2ccc(F)cc2)=C(C)C1=O 10.1021/jm00090a009
10402603 15444 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 301 9 1 5 2.6 O=C(O)CCCCO/N=C(\Cn1ccnc1)c1ccccc1 10.1021/jm00047a016
CHEMBL121507 15444 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 301 9 1 5 2.6 O=C(O)CCCCO/N=C(\Cn1ccnc1)c1ccccc1 10.1021/jm00047a016
1986 1312 50 None - 1 Human 6.8 pIC50 = 6.8 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 353 7 2 3 2.5 OC(=O)Cc1ccc(cc1)CCNS(=O)(=O)c1ccc(cc1)Cl 10.1021/jm00047a016
54343 1312 50 None - 1 Human 6.8 pIC50 = 6.8 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 353 7 2 3 2.5 OC(=O)Cc1ccc(cc1)CCNS(=O)(=O)c1ccc(cc1)Cl 10.1021/jm00047a016
CHEMBL71685 1312 50 None - 1 Human 6.8 pIC50 = 6.8 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 353 7 2 3 2.5 OC(=O)Cc1ccc(cc1)CCNS(=O)(=O)c1ccc(cc1)Cl 10.1021/jm00047a016
10552450 205311 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 473 10 2 4 7.1 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3ccc(/N=N/c4ccccc4)cc3)[C@@H]1C2 10.1021/jm970343g
CHEMBL79360 205311 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 473 10 2 4 7.1 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3ccc(/N=N/c4ccccc4)cc3)[C@@H]1C2 10.1021/jm970343g
54592351 77259 5 None - 0 Human 5.8 pIC50 = 5.8 Binding
Binding affinity towards Thromboxane A2/ Prostaglandin H2 receptor in human platelet membranes using [125I]- as the radioligand.Binding affinity towards Thromboxane A2/ Prostaglandin H2 receptor in human platelet membranes using [125I]- as the radioligand.
ChEMBL 371 4 1 2 5.4 O=C(O)C[C@@H]1CCCc2c1n(Cc1ccc(Cl)cc1)c1ccc(F)cc21 10.1021/jm00108a042
CHEMBL2079673 77259 5 None - 0 Human 5.8 pIC50 = 5.8 Binding
Binding affinity towards Thromboxane A2/ Prostaglandin H2 receptor in human platelet membranes using [125I]- as the radioligand.Binding affinity towards Thromboxane A2/ Prostaglandin H2 receptor in human platelet membranes using [125I]- as the radioligand.
ChEMBL 371 4 1 2 5.4 O=C(O)C[C@@H]1CCCc2c1n(Cc1ccc(Cl)cc1)c1ccc(F)cc21 10.1021/jm00108a042
11545879 14906 3 None -125 3 Human 5.8 pIC50 = 5.8 Binding
Activity at TP receptor by FLIPR methodActivity at TP receptor by FLIPR method
ChEMBL 381 6 1 3 5.8 CC(C)COc1ccc(Cl)cc1-c1ccccc1-c1cccc(C(=O)O)n1 10.1016/j.bmcl.2008.11.032
CHEMBL1207973 14906 3 None -125 3 Human 5.8 pIC50 = 5.8 Binding
Activity at TP receptor by FLIPR methodActivity at TP receptor by FLIPR method
ChEMBL 381 6 1 3 5.8 CC(C)COc1ccc(Cl)cc1-c1ccccc1-c1cccc(C(=O)O)n1 10.1016/j.bmcl.2008.11.032
CHEMBL467510 14906 3 None -125 3 Human 5.8 pIC50 = 5.8 Binding
Activity at TP receptor by FLIPR methodActivity at TP receptor by FLIPR method
ChEMBL 381 6 1 3 5.8 CC(C)COc1ccc(Cl)cc1-c1ccccc1-c1cccc(C(=O)O)n1 10.1016/j.bmcl.2008.11.032
10431402 14542 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 405 12 1 5 4.7 O=C(O)CCCCCO/N=C(\c1ccccc1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
CHEMBL120284 14542 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 405 12 1 5 4.7 O=C(O)CCCCCO/N=C(\c1ccccc1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
10255332 19269 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 497 11 2 4 4.6 CNC(=O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL129030 19269 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 497 11 2 4 4.6 CNC(=O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
10430550 11795 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 391 11 1 5 4.3 O=C(O)CCCCO/N=C(\c1ccccc1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
CHEMBL118184 11795 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 391 11 1 5 4.3 O=C(O)CCCCO/N=C(\c1ccccc1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
10455115 14610 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 425 11 1 5 5.0 O=C(O)CCCCO/N=C(/c1ccccc1)C(Cc1ccc(Cl)cc1)n1ccnc1 10.1021/jm00047a016
CHEMBL120496 14610 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 425 11 1 5 5.0 O=C(O)CCCCO/N=C(/c1ccccc1)C(Cc1ccc(Cl)cc1)n1ccnc1 10.1021/jm00047a016
5362391 99096 25 None -1 2 Human 5.8 pIC50 = 5.8 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1021/jm00027a004
CHEMBL280728 99096 25 None -1 2 Human 5.8 pIC50 = 5.8 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1021/jm00027a004
10671942 104216 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 467 9 2 4 5.5 O=C(O)CCC/C=C\C[C@@H]1[C@H]2CC[C@H](C2)[C@H]1NS(=O)(=O)c1ccc2oc3ccccc3c2c1 10.1021/jm970343g
CHEMBL309835 104216 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 467 9 2 4 5.5 O=C(O)CCC/C=C\C[C@@H]1[C@H]2CC[C@H](C2)[C@H]1NS(=O)(=O)c1ccc2oc3ccccc3c2c1 10.1021/jm970343g
10074652 18230 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 498 12 2 4 5.3 O=C(O)CCCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL127017 18230 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 498 12 2 4 5.3 O=C(O)CCCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
6436053 98711 13 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 484 11 2 4 4.9 O=C(O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL277689 98711 13 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 484 11 2 4 4.9 O=C(O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
6436053 98711 13 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration against thromboxane A2 receptorInhibitory concentration against thromboxane A2 receptor
ChEMBL 484 11 2 4 4.9 O=C(O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm058225d
CHEMBL277689 98711 13 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration against thromboxane A2 receptorInhibitory concentration against thromboxane A2 receptor
ChEMBL 484 11 2 4 4.9 O=C(O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm058225d
9930816 116981 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 399 11 1 7 3.7 O=C(O)CCCCO/N=C(\C1CCCCC1)C(Cc1cnccn1)n1ccnc1 10.1021/jm00047a016
CHEMBL338741 116981 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 399 11 1 7 3.7 O=C(O)CCCCO/N=C(\C1CCCCC1)C(Cc1cnccn1)n1ccnc1 10.1021/jm00047a016
10024132 12395 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 403 11 1 5 5.6 O=C(O)CCCCO/N=C(\C1CCCCC1)C(CC1CCCCC1)n1ccnc1 10.1021/jm00047a016
CHEMBL118568 12395 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 403 11 1 5 5.6 O=C(O)CCCCO/N=C(\C1CCCCC1)C(CC1CCCCC1)n1ccnc1 10.1021/jm00047a016
10018213 15285 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 309 13 1 5 3.5 CCCCCC/C(Cn1ccnc1)=N\OCCCCC(=O)O 10.1021/jm00047a016
CHEMBL121306 15285 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 309 13 1 5 3.5 CCCCCC/C(Cn1ccnc1)=N\OCCCCC(=O)O 10.1021/jm00047a016
11697902 78351 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 440 11 3 6 4.3 CCCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1021/jm060108a
CHEMBL211008 78351 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 440 11 3 6 4.3 CCCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1021/jm060108a
10007859 166489 0 None - 2 Human 8.6 pIC50 = 8.6 Binding
Inhibition of TP receptorInhibition of TP receptor
ChEMBL 554 7 2 4 6.7 CC(=O)Nc1cc(C(=O)O)cc(-n2c(C)ccc2-c2cc(Br)ccc2OCc2ccc(F)cc2F)c1 10.1016/j.bmcl.2006.10.078
CHEMBL427844 166489 0 None - 2 Human 8.6 pIC50 = 8.6 Binding
Inhibition of TP receptorInhibition of TP receptor
ChEMBL 554 7 2 4 6.7 CC(=O)Nc1cc(C(=O)O)cc(-n2c(C)ccc2-c2cc(Br)ccc2OCc2ccc(F)cc2F)c1 10.1016/j.bmcl.2006.10.078
11502680 98240 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
CHEMBL274415 98240 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 421 9 2 6 3.9 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Oc1ccc(C)cc1 10.1021/jm060108a
11676121 78322 4 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(C)cc1 10.1021/jm060108a
CHEMBL210964 78322 4 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ29,548 from TPalpha receptor (short isoform) expressed in COS7 cells at 1 uM
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(C)cc1 10.1021/jm060108a
11697902 78351 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 440 11 3 6 4.3 CCCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1021/jm060108a
CHEMBL211008 78351 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 440 11 3 6 4.3 CCCCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1NC1CCCCC1 10.1021/jm060108a
44310390 102144 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Compound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membraneCompound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membrane
ChEMBL 368 9 2 3 5.3 Cc1c(C)c(C=O)c(C)c(C(CCCCCC(=O)O)c2ccccc2)c1O 10.1021/jm00090a009
CHEMBL302514 102144 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Compound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membraneCompound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membrane
ChEMBL 368 9 2 3 5.3 Cc1c(C)c(C=O)c(C)c(C(CCCCCC(=O)O)c2ccccc2)c1O 10.1021/jm00090a009
6366701 14417 7 None - 0 Human 7.7 pIC50 = 7.7 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 415 11 1 5 5.0 O=C(O)CCCCO/N=C(\C1CCCCC1)C(Cc1ccc(F)cc1)n1ccnc1 10.1021/jm00047a016
CHEMBL120041 14417 7 None - 0 Human 7.7 pIC50 = 7.7 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 415 11 1 5 5.0 O=C(O)CCCCO/N=C(\C1CCCCC1)C(Cc1ccc(F)cc1)n1ccnc1 10.1021/jm00047a016
44310394 204113 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Compound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membraneCompound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membrane
ChEMBL 374 8 3 3 5.3 Cc1c(C)c(O)c(C(CCCCCC(=O)O)c2ccc(F)cc2)c(C)c1O 10.1021/jm00090a009
CHEMBL70314 204113 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Compound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membraneCompound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membrane
ChEMBL 374 8 3 3 5.3 Cc1c(C)c(O)c(C(CCCCCC(=O)O)c2ccc(F)cc2)c(C)c1O 10.1021/jm00090a009
10347272 18639 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 540 11 1 5 6.2 CC(C)(C)OC(=O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL127682 18639 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 540 11 1 5 6.2 CC(C)(C)OC(=O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
59179260 103884 0 None - 1 Human 6.7 pIC50 = 6.7 Binding
Inhibition of TP receptor (unknown origin)Inhibition of TP receptor (unknown origin)
ChEMBL 362 4 2 6 3.9 Nc1c(-c2ccccc2)nn(-c2nc(C(=O)O)cs2)c1-c1ccccc1 10.1016/j.bmcl.2013.10.065
CHEMBL3092130 103884 0 None - 1 Human 6.7 pIC50 = 6.7 Binding
Inhibition of TP receptor (unknown origin)Inhibition of TP receptor (unknown origin)
ChEMBL 362 4 2 6 3.9 Nc1c(-c2ccccc2)nn(-c2nc(C(=O)O)cs2)c1-c1ccccc1 10.1016/j.bmcl.2013.10.065
1610 2347 95 None - 4 Human 4.7 pIC50 = 4.7 Binding
Modulation of TxA2 receptor in human platelets assessed as reduction in U46619-induced platelet aggregation preincubated for 5 min followed by U46619 stimulationModulation of TxA2 receptor in human platelets assessed as reduction in U46619-induced platelet aggregation preincubated for 5 min followed by U46619 stimulation
ChEMBL 422 8 2 6 4.3 CCCCc1nc(c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)CO)Cl 10.1021/acs.jmedchem.0c00262
3941 2347 95 None - 4 Human 4.7 pIC50 = 4.7 Binding
Modulation of TxA2 receptor in human platelets assessed as reduction in U46619-induced platelet aggregation preincubated for 5 min followed by U46619 stimulationModulation of TxA2 receptor in human platelets assessed as reduction in U46619-induced platelet aggregation preincubated for 5 min followed by U46619 stimulation
ChEMBL 422 8 2 6 4.3 CCCCc1nc(c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)CO)Cl 10.1021/acs.jmedchem.0c00262
3961 2347 95 None - 4 Human 4.7 pIC50 = 4.7 Binding
Modulation of TxA2 receptor in human platelets assessed as reduction in U46619-induced platelet aggregation preincubated for 5 min followed by U46619 stimulationModulation of TxA2 receptor in human platelets assessed as reduction in U46619-induced platelet aggregation preincubated for 5 min followed by U46619 stimulation
ChEMBL 422 8 2 6 4.3 CCCCc1nc(c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)CO)Cl 10.1021/acs.jmedchem.0c00262
590 2347 95 None - 4 Human 4.7 pIC50 = 4.7 Binding
Modulation of TxA2 receptor in human platelets assessed as reduction in U46619-induced platelet aggregation preincubated for 5 min followed by U46619 stimulationModulation of TxA2 receptor in human platelets assessed as reduction in U46619-induced platelet aggregation preincubated for 5 min followed by U46619 stimulation
ChEMBL 422 8 2 6 4.3 CCCCc1nc(c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)CO)Cl 10.1021/acs.jmedchem.0c00262
CHEMBL191 2347 95 None - 4 Human 4.7 pIC50 = 4.7 Binding
Modulation of TxA2 receptor in human platelets assessed as reduction in U46619-induced platelet aggregation preincubated for 5 min followed by U46619 stimulationModulation of TxA2 receptor in human platelets assessed as reduction in U46619-induced platelet aggregation preincubated for 5 min followed by U46619 stimulation
ChEMBL 422 8 2 6 4.3 CCCCc1nc(c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)CO)Cl 10.1021/acs.jmedchem.0c00262
DB00678 2347 95 None - 4 Human 4.7 pIC50 = 4.7 Binding
Modulation of TxA2 receptor in human platelets assessed as reduction in U46619-induced platelet aggregation preincubated for 5 min followed by U46619 stimulationModulation of TxA2 receptor in human platelets assessed as reduction in U46619-induced platelet aggregation preincubated for 5 min followed by U46619 stimulation
ChEMBL 422 8 2 6 4.3 CCCCc1nc(c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)CO)Cl 10.1021/acs.jmedchem.0c00262
44190762 176880 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of radioligand from TXA2 receptorDisplacement of radioligand from TXA2 receptor
ChEMBL 531 8 1 5 6.6 Cc1c(C(=O)c2ccc(Cl)cc2)c2ccc(OC(F)(F)F)cc2n1Cc1cccc(O[C@H](C)C(=O)O)c1 10.1016/j.bmcl.2008.07.103
CHEMBL461571 176880 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Displacement of radioligand from TXA2 receptorDisplacement of radioligand from TXA2 receptor
ChEMBL 531 8 1 5 6.6 Cc1c(C(=O)c2ccc(Cl)cc2)c2ccc(OC(F)(F)F)cc2n1Cc1cccc(O[C@H](C)C(=O)O)c1 10.1016/j.bmcl.2008.07.103
10479865 18640 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 470 10 2 4 4.9 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm00027a004
CHEMBL127683 18640 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 470 10 2 4 4.9 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(CNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm00027a004
10343670 18847 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 448 10 2 3 5.4 O=C(O)CCC/C=C(\c1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL128104 18847 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 448 10 2 3 5.4 O=C(O)CCC/C=C(\c1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
10345903 117102 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 500 13 2 4 5.4 O=C(O)CCCCCC(c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL339335 117102 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 500 13 2 4 5.4 O=C(O)CCCCCC(c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
10502508 14141 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 425 8 2 3 5.9 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3cccc4ccsc34)[C@@H]1C2 10.1021/jm970343g
CHEMBL119809 14141 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 425 8 2 3 5.9 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3cccc4ccsc34)[C@@H]1C2 10.1021/jm970343g
5362391 99096 25 None -1 2 Human 5.7 pIC50 = 5.7 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1021/jm00047a016
CHEMBL280728 99096 25 None -1 2 Human 5.7 pIC50 = 5.7 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1021/jm00047a016
10547489 163334 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 375 8 2 3 4.7 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3ccsc3)[C@@H]1C2 10.1021/jm970343g
CHEMBL419040 163334 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 375 8 2 3 4.7 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3ccsc3)[C@@H]1C2 10.1021/jm970343g
10050347 15272 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 469 12 1 7 3.7 CS(=O)(=O)c1ccc(/C(=N\OCCCCC(=O)O)C(Cc2ccccc2)n2ccnc2)cc1 10.1021/jm00047a016
CHEMBL121289 15272 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 469 12 1 7 3.7 CS(=O)(=O)c1ccc(/C(=N\OCCCCC(=O)O)C(Cc2ccccc2)n2ccnc2)cc1 10.1021/jm00047a016
11283 586 10 None - 1 Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at recombinant full-length human TP receptor expressed in HEK293 cells assessed as inhibition of U-44069-induced response measured after 30 mins by TR-FRET assayAntagonist activity at recombinant full-length human TP receptor expressed in HEK293 cells assessed as inhibition of U-44069-induced response measured after 30 mins by TR-FRET assay
ChEMBL 543 8 2 4 5.9 OC(=O)CC[C@H](c1ccccc1Cl)CNC(=O)c1c(C)c(nc2c1cc(Br)cc2)N1CCCC1 10.1021/acs.jmedchem.0c00834
146368333 586 10 None - 1 Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at recombinant full-length human TP receptor expressed in HEK293 cells assessed as inhibition of U-44069-induced response measured after 30 mins by TR-FRET assayAntagonist activity at recombinant full-length human TP receptor expressed in HEK293 cells assessed as inhibition of U-44069-induced response measured after 30 mins by TR-FRET assay
ChEMBL 543 8 2 4 5.9 OC(=O)CC[C@H](c1ccccc1Cl)CNC(=O)c1c(C)c(nc2c1cc(Br)cc2)N1CCCC1 10.1021/acs.jmedchem.0c00834
CHEMBL4643852 586 10 None - 1 Human 5.7 pIC50 = 5.7 Binding
Antagonist activity at recombinant full-length human TP receptor expressed in HEK293 cells assessed as inhibition of U-44069-induced response measured after 30 mins by TR-FRET assayAntagonist activity at recombinant full-length human TP receptor expressed in HEK293 cells assessed as inhibition of U-44069-induced response measured after 30 mins by TR-FRET assay
ChEMBL 543 8 2 4 5.9 OC(=O)CC[C@H](c1ccccc1Cl)CNC(=O)c1c(C)c(nc2c1cc(Br)cc2)N1CCCC1 10.1021/acs.jmedchem.0c00834
10457484 117399 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 471 11 2 5 3.8 Cn1c(CCNS(=O)(=O)c2ccc(F)cc2)ccc1/C(=C\CCCC(=O)O)c1cccnc1 10.1021/jm00027a004
CHEMBL339812 117399 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 471 11 2 5 3.8 Cn1c(CCNS(=O)(=O)c2ccc(F)cc2)ccc1/C(=C\CCCC(=O)O)c1cccnc1 10.1021/jm00027a004
10367685 14533 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 475 12 1 7 4.3 CS(=O)(=O)c1ccc(CC(/C(=N/OCCCCC(=O)O)C2CCCCC2)n2ccnc2)cc1 10.1021/jm00047a016
CHEMBL120249 14533 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 475 12 1 7 4.3 CS(=O)(=O)c1ccc(CC(/C(=N/OCCCCC(=O)O)C2CCCCC2)n2ccnc2)cc1 10.1021/jm00047a016
10342027 16448 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 419 11 1 5 5.0 CC(C)(CCO/N=C(\c1ccccc1)C(Cc1ccccc1)n1ccnc1)CC(=O)O 10.1021/jm00047a016
CHEMBL123307 16448 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 419 11 1 5 5.0 CC(C)(CCO/N=C(\c1ccccc1)C(Cc1ccccc1)n1ccnc1)CC(=O)O 10.1021/jm00047a016
44159530 68384 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Displacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranesDisplacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranes
ChEMBL 501 9 1 4 6.2 CCN(Cc1cc(C(F)(F)F)ccc1-c1cc(CC(=O)O)ccc1OC)C(=O)OCc1ccccc1 10.1016/j.bmcl.2011.01.024
CHEMBL1916700 68384 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Displacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranesDisplacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranes
ChEMBL 501 9 1 4 6.2 CCN(Cc1cc(C(F)(F)F)ccc1-c1cc(CC(=O)O)ccc1OC)C(=O)OCc1ccccc1 10.1016/j.bmcl.2011.01.024
10087973 112839 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 329 10 1 5 3.3 C/C(=N\OCCCCC(=O)O)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
CHEMBL330837 112839 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 329 10 1 5 3.3 C/C(=N\OCCCCC(=O)O)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
10344641 15284 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 469 11 1 5 5.1 O=C(O)CCCCO/N=C(\c1ccc(Br)cc1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
CHEMBL121304 15284 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 469 11 1 5 5.1 O=C(O)CCCCO/N=C(\c1ccc(Br)cc1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
11723604 15289 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 321 10 1 5 3.5 O=C(O)CCCCCO/N=C(\Cn1ccnc1)C1CCCCC1 10.1021/jm00047a016
CHEMBL121314 15289 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 321 10 1 5 3.5 O=C(O)CCCCCO/N=C(\Cn1ccnc1)C1CCCCC1 10.1021/jm00047a016
10529261 205772 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 495 9 2 4 6.1 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NS(=O)(=O)c3ccc4oc5ccccc5c4c3)[C@@H]1C2 10.1021/jm970343g
CHEMBL82896 205772 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 495 9 2 4 6.1 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NS(=O)(=O)c3ccc4oc5ccccc5c4c3)[C@@H]1C2 10.1021/jm970343g
11755659 19406 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 498 11 1 4 5.3 CN(CCc1ccc(/C(=C\CCCC(=O)O)c2cccnc2)cc1)S(=O)(=O)c1ccc(Cl)cc1 10.1021/jm00027a004
CHEMBL129355 19406 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 498 11 1 4 5.3 CN(CCc1ccc(/C(=C\CCCC(=O)O)c2cccnc2)cc1)S(=O)(=O)c1ccc(Cl)cc1 10.1021/jm00027a004
44333604 4577 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Compound was evaluated for the competitive binding of [3H]U-46619 to washed human platelets at the Thromboxane A2 receptorCompound was evaluated for the competitive binding of [3H]U-46619 to washed human platelets at the Thromboxane A2 receptor
ChEMBL 337 13 2 3 4.0 CCCCCCNC[C@H]1C2CC(CO2)[C@@H]1C/C=C\CCCC(=O)O 10.1021/jm00094a017
CHEMBL102584 4577 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
Compound was evaluated for the competitive binding of [3H]U-46619 to washed human platelets at the Thromboxane A2 receptorCompound was evaluated for the competitive binding of [3H]U-46619 to washed human platelets at the Thromboxane A2 receptor
ChEMBL 337 13 2 3 4.0 CCCCCCNC[C@H]1C2CC(CO2)[C@@H]1C/C=C\CCCC(=O)O 10.1021/jm00094a017
10590325 129676 0 None - 1 Human 4.6 pIC50 = 4.6 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 300 3 3 5 2.4 O=[N+]([O-])c1ccc(CC2NCCc3cc(O)c(O)cc32)cc1 10.1021/jm950896w
CHEMBL367394 129676 0 None - 1 Human 4.6 pIC50 = 4.6 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 300 3 3 5 2.4 O=[N+]([O-])c1ccc(CC2NCCc3cc(O)c(O)cc32)cc1 10.1021/jm950896w
11755215 18042 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 487 11 2 6 3.5 O=C(O)CCO/N=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL126494 18042 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 487 11 2 6 3.5 O=C(O)CCO/N=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
10479578 18510 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 464 12 2 4 4.4 O=C(O)CCC/C=C(\c1ccc(CCNS(=O)(=O)Cc2ccccc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL127357 18510 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 464 12 2 4 4.4 O=C(O)CCC/C=C(\c1ccc(CCNS(=O)(=O)Cc2ccccc2)cc1)c1cccnc1 10.1021/jm00027a004
10072780 117289 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 456 9 2 4 5.2 O=C(O)CCC/C=C(\c1ccc(NS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL339568 117289 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 456 9 2 4 5.2 O=C(O)CCC/C=C(\c1ccc(NS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
10813802 13789 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 459 8 2 3 6.6 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3ccc4oc5ccccc5c4c3)[C@@H]1C2 10.1021/jm970343g
CHEMBL119550 13789 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 459 8 2 3 6.6 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3ccc4oc5ccccc5c4c3)[C@@H]1C2 10.1021/jm970343g
10244703 15286 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 307 9 1 5 3.1 O=C(O)CCCCO/N=C(/Cn1ccnc1)C1CCCCC1 10.1021/jm00047a016
CHEMBL121307 15286 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 307 9 1 5 3.1 O=C(O)CCCCO/N=C(/Cn1ccnc1)C1CCCCC1 10.1021/jm00047a016
10258317 18217 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 618 14 2 5 6.6 O=C(O)CCC/C=C(\c1ccc(CCN(Cc2ccc(C(=O)O)cc2)S(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL127008 18217 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 618 14 2 5 6.6 O=C(O)CCC/C=C(\c1ccc(CCN(Cc2ccc(C(=O)O)cc2)S(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
10075294 116896 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 518 11 2 4 5.3 O=C(O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(C(F)(F)F)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL338360 116896 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 518 11 2 4 5.3 O=C(O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(C(F)(F)F)cc2)cc1)c1cccnc1 10.1021/jm00027a004
10023102 14537 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 387 11 1 6 4.5 O=C(O)CCCCO/N=C(\C1CCCCC1)C(Cc1ccco1)n1ccnc1 10.1021/jm00047a016
CHEMBL120259 14537 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 387 11 1 6 4.5 O=C(O)CCCCO/N=C(\C1CCCCC1)C(Cc1ccco1)n1ccnc1 10.1021/jm00047a016
10552612 205716 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 477 9 2 3 5.0 O=C(O)CCC/C=C\C[C@@H]1[C@H]2CC[C@H](C2)[C@H]1NS(=O)(=O)c1ccc(C#Cc2ccccc2)cc1 10.1021/jm970343g
CHEMBL82489 205716 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 477 9 2 3 5.0 O=C(O)CCC/C=C\C[C@@H]1[C@H]2CC[C@H](C2)[C@H]1NS(=O)(=O)c1ccc(C#Cc2ccccc2)cc1 10.1021/jm970343g
11676121 78322 4 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(C)cc1 10.1021/jm060108a
CHEMBL210964 78322 4 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1ccc(C)cc1 10.1021/jm060108a
15125130 203831 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Compound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membraneCompound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membrane
ChEMBL 386 9 2 3 5.4 Cc1c(C)c(C(CCCCCC(=O)O)c2ccc(F)cc2)c(O)c(C)c1C=O 10.1021/jm00090a009
CHEMBL68512 203831 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Compound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membraneCompound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membrane
ChEMBL 386 9 2 3 5.4 Cc1c(C)c(C(CCCCCC(=O)O)c2ccc(F)cc2)c(O)c(C)c1C=O 10.1021/jm00090a009
10251282 114431 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 415 11 1 5 5.0 O=C(O)CCCCO/N=C(\C1CCCCC1)C(Cc1cccc(F)c1)n1ccnc1 10.1021/jm00047a016
CHEMBL333237 114431 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 415 11 1 5 5.0 O=C(O)CCCCO/N=C(\C1CCCCC1)C(Cc1cccc(F)c1)n1ccnc1 10.1021/jm00047a016
10075114 18638 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 511 11 1 4 4.9 CN(C)C(=O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL127681 18638 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 511 11 1 4 4.9 CN(C)C(=O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
10454526 114430 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 415 11 1 5 5.0 O=C(O)CCCCO/N=C(\C1CCCCC1)C(Cc1ccccc1F)n1ccnc1 10.1021/jm00047a016
CHEMBL333236 114430 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 415 11 1 5 5.0 O=C(O)CCCCO/N=C(\C1CCCCC1)C(Cc1ccccc1F)n1ccnc1 10.1021/jm00047a016
11754856 19192 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 479 10 3 5 2.5 Cc1ccc(S(=O)(=O)NCCc2ccc(/C(=C\C(=O)NCC(=O)O)c3cccnc3)cc2)cc1 10.1021/jm00027a004
CHEMBL128973 19192 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 479 10 3 5 2.5 Cc1ccc(S(=O)(=O)NCCc2ccc(/C(=C\C(=O)NCC(=O)O)c3cccnc3)cc2)cc1 10.1021/jm00027a004
10250339 14369 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 399 15 1 5 5.3 CCCCCC/C(=N\OCCCCC(=O)O)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
CHEMBL120019 14369 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 399 15 1 5 5.3 CCCCCC/C(=N\OCCCCC(=O)O)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
10483360 199228 28 None - 4 Human 4.5 pIC50 = 4.5 Binding
Displacement of [3H]SQ29548 from human TP receptor transfected in HEK 293 EBNA cellsDisplacement of [3H]SQ29548 from human TP receptor transfected in HEK 293 EBNA cells
ChEMBL 580 12 3 6 5.8 CCCCNC(=O)c1ccc(Oc2ccc(CC(=O)O)cc2OC)c(NS(=O)(=O)c2ccc(Cl)cc2Cl)c1 10.1016/j.bmcl.2009.09.052
CHEMBL589973 199228 28 None - 4 Human 4.5 pIC50 = 4.5 Binding
Displacement of [3H]SQ29548 from human TP receptor transfected in HEK 293 EBNA cellsDisplacement of [3H]SQ29548 from human TP receptor transfected in HEK 293 EBNA cells
ChEMBL 580 12 3 6 5.8 CCCCNC(=O)c1ccc(Oc2ccc(CC(=O)O)cc2OC)c(NS(=O)(=O)c2ccc(Cl)cc2Cl)c1 10.1016/j.bmcl.2009.09.052
16219283 121273 6 None - 0 Human 7.5 pIC50 = 7.5 Binding
In vitro concentration that reduced specific binding of [3H]U-440619 to guinea pig platelet receptor, Thromboxane A2 receptor by 50%In vitro concentration that reduced specific binding of [3H]U-440619 to guinea pig platelet receptor, Thromboxane A2 receptor by 50%
ChEMBL 350 12 2 3 4.3 CCCCC[C@H](O)/C=C/[C@H]1C2CC(CO2)[C@@H]1C/C=C\CCCC(=O)O 10.1021/jm00129a030
CHEMBL357834 121273 6 None - 0 Human 7.5 pIC50 = 7.5 Binding
In vitro concentration that reduced specific binding of [3H]U-440619 to guinea pig platelet receptor, Thromboxane A2 receptor by 50%In vitro concentration that reduced specific binding of [3H]U-440619 to guinea pig platelet receptor, Thromboxane A2 receptor by 50%
ChEMBL 350 12 2 3 4.3 CCCCC[C@H](O)/C=C/[C@H]1C2CC(CO2)[C@@H]1C/C=C\CCCC(=O)O 10.1021/jm00129a030
18944131 87195 0 None - 1 Human 6.5 pIC50 = 6.5 Binding
In vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparationIn vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparation
ChEMBL 484 10 2 6 4.0 O=C(O)CCc1ccccc1CC1OCOC1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
CHEMBL23273 87195 0 None - 1 Human 6.5 pIC50 = 6.5 Binding
In vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparationIn vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparation
ChEMBL 484 10 2 6 4.0 O=C(O)CCc1ccccc1CC1OCOC1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
18944131 87195 0 None - 1 Human 5.5 pIC50 = 5.5 Binding
In vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparationIn vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparation
ChEMBL 484 10 2 6 4.0 O=C(O)CCc1ccccc1CC1OCOC1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
CHEMBL23273 87195 0 None - 1 Human 5.5 pIC50 = 5.5 Binding
In vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparationIn vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparation
ChEMBL 484 10 2 6 4.0 O=C(O)CCc1ccccc1CC1OCOC1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
10594576 11011 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 358 8 3 2 4.0 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3ccc[nH]3)[C@@H]1C2 10.1021/jm970343g
CHEMBL117399 11011 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 358 8 3 2 4.0 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3ccc[nH]3)[C@@H]1C2 10.1021/jm970343g
16222207 7645 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Inhibition of thromboxane A2 receptorInhibition of thromboxane A2 receptor
ChEMBL 434 6 1 3 5.4 O=C(O)Cc1cnc(C(c2ccc(F)cc2)c2ccc(F)cc2)nc1-c1cccc(F)c1 10.1016/j.bmcl.2010.01.092
CHEMBL1088284 7645 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Inhibition of thromboxane A2 receptorInhibition of thromboxane A2 receptor
ChEMBL 434 6 1 3 5.4 O=C(O)Cc1cnc(C(c2ccc(F)cc2)c2ccc(F)cc2)nc1-c1cccc(F)c1 10.1016/j.bmcl.2010.01.092
9978202 14531 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 398 11 1 6 4.3 O=C(O)CCCCO/N=C(\C1CCCCC1)C(Cc1ccccn1)n1ccnc1 10.1021/jm00047a016
CHEMBL120228 14531 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 398 11 1 6 4.3 O=C(O)CCCCO/N=C(\C1CCCCC1)C(Cc1ccccn1)n1ccnc1 10.1021/jm00047a016
10095993 19460 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 464 11 2 4 4.6 Cc1ccc(S(=O)(=O)NCCc2ccc(/C(=C\CCCC(=O)O)c3cccnc3)cc2)cc1 10.1021/jm00027a004
CHEMBL129734 19460 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 464 11 2 4 4.6 Cc1ccc(S(=O)(=O)NCCc2ccc(/C(=C\CCCC(=O)O)c3cccnc3)cc2)cc1 10.1021/jm00027a004
10436457 20174 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 512 12 1 4 5.7 CCN(CCc1ccc(/C(=C\CCCC(=O)O)c2cccnc2)cc1)S(=O)(=O)c1ccc(Cl)cc1 10.1021/jm00027a004
CHEMBL130470 20174 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 512 12 1 4 5.7 CCN(CCc1ccc(/C(=C\CCCC(=O)O)c2cccnc2)cc1)S(=O)(=O)c1ccc(Cl)cc1 10.1021/jm00027a004
9979675 116938 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 422 11 2 4 4.1 O=C(O)CCC/C=C(\CCCNS(=O)(=O)c1ccc(Cl)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL338546 116938 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 422 11 2 4 4.1 O=C(O)CCC/C=C(\CCCNS(=O)(=O)c1ccc(Cl)cc1)c1cccnc1 10.1021/jm00027a004
44210947 99116 0 None - 1 Human 6.5 pIC50 = 6.5 Binding
In vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparationIn vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparation
ChEMBL 498 10 2 6 4.2 O=C(O)CCc1ccccc1CC1COCOC1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
CHEMBL280890 99116 0 None - 1 Human 6.5 pIC50 = 6.5 Binding
In vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparationIn vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparation
ChEMBL 498 10 2 6 4.2 O=C(O)CCc1ccccc1CC1COCOC1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
10052055 19452 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 510 13 2 6 4.3 COc1ccc(S(=O)(=O)NCCc2ccc(/C(=C\CCCC(=O)O)c3cccnc3)cc2)cc1OC 10.1021/jm00027a004
CHEMBL129635 19452 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 510 13 2 6 4.3 COc1ccc(S(=O)(=O)NCCc2ccc(/C(=C\CCCC(=O)O)c3cccnc3)cc2)cc1OC 10.1021/jm00027a004
73354171 93254 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity towards Thromboxane A2 receptor/Prostaglandin receptor in human platelet membranes using [125I]- as the radioligandBinding affinity towards Thromboxane A2 receptor/Prostaglandin receptor in human platelet membranes using [125I]- as the radioligand
ChEMBL 387 10 4 4 3.3 O=C(O)CCC/C=C\C[C@H]1[C@H]2CC[C@@H](O2)[C@H]1CNNC(=O)Nc1ccccc1 10.1021/jm00108a042
CHEMBL2448578 93254 1 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity towards Thromboxane A2 receptor/Prostaglandin receptor in human platelet membranes using [125I]- as the radioligandBinding affinity towards Thromboxane A2 receptor/Prostaglandin receptor in human platelet membranes using [125I]- as the radioligand
ChEMBL 387 10 4 4 3.3 O=C(O)CCC/C=C\C[C@H]1[C@H]2CC[C@@H](O2)[C@H]1CNNC(=O)Nc1ccccc1 10.1021/jm00108a042
10074653 18012 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 498 11 1 5 5.0 COC(=O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL126337 18012 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 498 11 1 5 5.0 COC(=O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
44364273 42227 8 None - 1 Human 7.4 pIC50 = 7.4 Binding
Displacement of radiolabeled U44069 from human TXA2 receptorDisplacement of radiolabeled U44069 from human TXA2 receptor
ChEMBL 350 12 2 3 4.3 CCCCC[C@H](O)/C=C/[C@H]1C2COC(C2)[C@@H]1C/C=C\CCCC(=O)O 10.1021/jm8007618
CHEMBL149724 42227 8 None - 1 Human 7.4 pIC50 = 7.4 Binding
Displacement of radiolabeled U44069 from human TXA2 receptorDisplacement of radiolabeled U44069 from human TXA2 receptor
ChEMBL 350 12 2 3 4.3 CCCCC[C@H](O)/C=C/[C@H]1C2COC(C2)[C@@H]1C/C=C\CCCC(=O)O 10.1021/jm8007618
6537211 17126 6 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 484 11 2 4 4.9 O=C(O)CCC/C=C(/c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL125519 17126 6 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 484 11 2 4 4.9 O=C(O)CCC/C=C(/c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
10025456 113995 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 425 8 2 3 5.9 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3csc4ccccc34)[C@@H]1C2 10.1021/jm970343g
CHEMBL332635 113995 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 425 8 2 3 5.9 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3csc4ccccc34)[C@@H]1C2 10.1021/jm970343g
15125138 163471 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Compound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membraneCompound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membrane
ChEMBL 386 9 2 3 5.4 Cc1c(C)c(C=O)c(C)c(C(CCCCCC(=O)O)c2ccc(F)cc2)c1O 10.1021/jm00090a009
CHEMBL420002 163471 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Compound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membraneCompound was evaluated for its ability to inhibit specific binding of [3H]U-46619 to Thromboxane A2/ Prostaglandin H2 receptor in guinea pig platelet membrane
ChEMBL 386 9 2 3 5.4 Cc1c(C)c(C=O)c(C)c(C(CCCCCC(=O)O)c2ccc(F)cc2)c1O 10.1021/jm00090a009
11510008 77282 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1cccc(C)c1 10.1021/jm060108a
CHEMBL208115 77282 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uMDisplacement of [3H]SQ-29548 from TPbeta receptor (long isoform) expressed in COS7 cells at 1 uM
ChEMBL 420 9 3 6 3.8 CCCCCNC(=O)NS(=O)(=O)c1cc([N+](=O)[O-])ccc1Nc1cccc(C)c1 10.1021/jm060108a
10092922 11798 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 409 11 1 5 4.5 O=C(O)CCCCO/N=C(\c1ccccc1)C(Cc1ccc(F)cc1)n1ccnc1 10.1021/jm00047a016
CHEMBL118188 11798 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 409 11 1 5 4.5 O=C(O)CCCCO/N=C(\c1ccccc1)C(Cc1ccc(F)cc1)n1ccnc1 10.1021/jm00047a016
10365109 117458 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 425 11 1 5 5.0 O=C(O)CCCCO/N=C(\c1ccccc1)C(Cc1ccc(Cl)cc1)n1ccnc1 10.1021/jm00047a016
CHEMBL339877 117458 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 425 11 1 5 5.0 O=C(O)CCCCO/N=C(\c1ccccc1)C(Cc1ccc(Cl)cc1)n1ccnc1 10.1021/jm00047a016
10599289 14142 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 441 8 3 4 5.6 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3csc4cc(O)ccc34)[C@@H]1C2 10.1021/jm970343g
CHEMBL119810 14142 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 441 8 3 4 5.6 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3csc4cc(O)ccc34)[C@@H]1C2 10.1021/jm970343g
10409839 14921 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 419 11 1 5 5.0 CC(C)(CCCO/N=C(\c1ccccc1)C(Cc1ccccc1)n1ccnc1)C(=O)O 10.1021/jm00047a016
CHEMBL120811 14921 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 419 11 1 5 5.0 CC(C)(CCCO/N=C(\c1ccccc1)C(Cc1ccccc1)n1ccnc1)C(=O)O 10.1021/jm00047a016
10742144 59657 0 None - 1 Human 4.4 pIC50 = 4.4 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 449 8 2 6 4.5 COc1cc(CC2c3cc(O)c(O)cc3CCN2CCc2ccccc2)cc(OC)c1OC 10.1021/jm950896w
CHEMBL172163 59657 0 None - 1 Human 4.4 pIC50 = 4.4 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 449 8 2 6 4.5 COc1cc(CC2c3cc(O)c(O)cc3CCN2CCc2ccccc2)cc(OC)c1OC 10.1021/jm950896w
10051348 116948 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 492 11 2 4 5.2 Cc1cc(C)c(S(=O)(=O)NCCc2ccc(/C(=C\CCCC(=O)O)c3cccnc3)cc2)c(C)c1 10.1021/jm00027a004
CHEMBL338588 116948 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 492 11 2 4 5.2 Cc1cc(C)c(S(=O)(=O)NCCc2ccc(/C(=C\CCCC(=O)O)c3cccnc3)cc2)c(C)c1 10.1021/jm00027a004
10254162 163437 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 470 10 2 4 4.6 O=C(O)CC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL419774 163437 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 470 10 2 4 4.6 O=C(O)CC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
10741899 10518 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 443 8 2 3 6.0 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3csc4ccc(F)cc34)[C@@H]1C2 10.1021/jm970343g
CHEMBL116836 10518 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 443 8 2 3 6.0 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3csc4ccc(F)cc34)[C@@H]1C2 10.1021/jm970343g
44344457 110513 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 467 10 1 4 5.3 COC(=O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(-c3ccccc3)cc2)[C@H]2CC[C@@H]1C2 10.1021/jm970343g
CHEMBL325026 110513 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 467 10 1 4 5.3 COC(=O)CCC/C=C\C[C@@H]1[C@@H](NS(=O)(=O)c2ccc(-c3ccccc3)cc2)[C@H]2CC[C@@H]1C2 10.1021/jm970343g
65772 60403 8 None -9 6 Human 6.4 pIC50 = 6.4 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm950896w
CHEMBL174984 60403 8 None -9 6 Human 6.4 pIC50 = 6.4 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm950896w
10402602 15076 0 None - 0 Human 4.3 pIC50 = 4.3 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 301 9 1 5 2.6 O=C(O)CCCCO/N=C(/Cn1ccnc1)c1ccccc1 10.1021/jm00047a016
CHEMBL120947 15076 0 None - 0 Human 4.3 pIC50 = 4.3 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 301 9 1 5 2.6 O=C(O)CCCCO/N=C(/Cn1ccnc1)c1ccccc1 10.1021/jm00047a016
10370098 17984 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 541 13 2 5 4.1 NC(=O)CN(CCc1ccc(/C(=C\CCCC(=O)O)c2cccnc2)cc1)S(=O)(=O)c1ccc(Cl)cc1 10.1021/jm00027a004
CHEMBL126196 17984 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 541 13 2 5 4.1 NC(=O)CN(CCc1ccc(/C(=C\CCCC(=O)O)c2cccnc2)cc1)S(=O)(=O)c1ccc(Cl)cc1 10.1021/jm00027a004
10424476 12468 0 None - 0 Human 4.3 pIC50 = 4.3 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 293 8 1 5 2.7 O=C(O)CCCO/N=C(/Cn1ccnc1)C1CCCCC1 10.1021/jm00047a016
CHEMBL118619 12468 0 None - 0 Human 4.3 pIC50 = 4.3 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 293 8 1 5 2.7 O=C(O)CCCO/N=C(/Cn1ccnc1)C1CCCCC1 10.1021/jm00047a016
1938 1969 18 None -1 4 Human 7.3 pIC50 = 7.3 Binding
Binding affinity towards Thromboxane A2 receptor/Prostaglandin receptor in human platelet membranes using [125I]- as the radioligandBinding affinity towards Thromboxane A2 receptor/Prostaglandin receptor in human platelet membranes using [125I]- as the radioligand
ChEMBL 512 11 2 4 4.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1/C=C/[C@H](COc1ccc(cc1)I)O)O2 10.1021/jm00108a042
5311175 1969 18 None -1 4 Human 7.3 pIC50 = 7.3 Binding
Binding affinity towards Thromboxane A2 receptor/Prostaglandin receptor in human platelet membranes using [125I]- as the radioligandBinding affinity towards Thromboxane A2 receptor/Prostaglandin receptor in human platelet membranes using [125I]- as the radioligand
ChEMBL 512 11 2 4 4.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1/C=C/[C@H](COc1ccc(cc1)I)O)O2 10.1021/jm00108a042
CHEMBL2113346 1969 18 None -1 4 Human 7.3 pIC50 = 7.3 Binding
Binding affinity towards Thromboxane A2 receptor/Prostaglandin receptor in human platelet membranes using [125I]- as the radioligandBinding affinity towards Thromboxane A2 receptor/Prostaglandin receptor in human platelet membranes using [125I]- as the radioligand
ChEMBL 512 11 2 4 4.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1/C=C/[C@H](COc1ccc(cc1)I)O)O2 10.1021/jm00108a042
10096033 98365 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 465 11 1 5 5.9 O=C(O)CCCCO/N=C(\C1CCCCC1)C(Cc1ccc(C(F)(F)F)cc1)n1ccnc1 10.1021/jm00047a016
CHEMBL275256 98365 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 465 11 1 5 5.9 O=C(O)CCCCO/N=C(\C1CCCCC1)C(Cc1ccc(C(F)(F)F)cc1)n1ccnc1 10.1021/jm00047a016
10052612 163440 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 526 12 1 4 6.1 CC(C)N(CCc1ccc(/C(=C\CCCC(=O)O)c2cccnc2)cc1)S(=O)(=O)c1ccc(Cl)cc1 10.1021/jm00027a004
CHEMBL419790 163440 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 526 12 1 4 6.1 CC(C)N(CCc1ccc(/C(=C\CCCC(=O)O)c2cccnc2)cc1)S(=O)(=O)c1ccc(Cl)cc1 10.1021/jm00027a004
10096697 116875 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 480 12 2 5 4.3 COc1ccc(S(=O)(=O)NCCc2ccc(/C(=C\CCCC(=O)O)c3cccnc3)cc2)cc1 10.1021/jm00027a004
CHEMBL338241 116875 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 480 12 2 5 4.3 COc1ccc(S(=O)(=O)NCCc2ccc(/C(=C\CCCC(=O)O)c3cccnc3)cc2)cc1 10.1021/jm00027a004
10364364 16291 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 412 11 2 6 4.3 O=C(CCCCO/N=C(\C1CCCCC1)C(Cc1ccccc1)n1ccnc1)NO 10.1021/jm00047a016
CHEMBL122472 16291 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 412 11 2 6 4.3 O=C(CCCCO/N=C(\C1CCCCC1)C(Cc1ccccc1)n1ccnc1)NO 10.1021/jm00047a016
5362391 99096 25 None -1 2 Human 5.3 pIC50 = 5.3 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1021/jm00027a004
CHEMBL280728 99096 25 None -1 2 Human 5.3 pIC50 = 5.3 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 366 8 1 4 4.1 O=C(O)CCCCO/N=C(/c1cccnc1)c1cccc(C(F)(F)F)c1 10.1021/jm00027a004
9931330 15562 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 409 11 1 5 4.5 O=C(O)CCCCO/N=C(/c1ccccc1)C(Cc1ccc(F)cc1)n1ccnc1 10.1021/jm00047a016
CHEMBL122008 15562 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 409 11 1 5 4.5 O=C(O)CCCCO/N=C(/c1ccccc1)C(Cc1ccc(F)cc1)n1ccnc1 10.1021/jm00047a016
10244704 169084 0 None - 0 Human 4.3 pIC50 = 4.3 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 307 9 1 5 3.1 O=C(O)CCCCO/N=C(\Cn1ccnc1)C1CCCCC1 10.1021/jm00047a016
CHEMBL439790 169084 0 None - 0 Human 4.3 pIC50 = 4.3 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 307 9 1 5 3.1 O=C(O)CCCCO/N=C(\Cn1ccnc1)C1CCCCC1 10.1021/jm00047a016
10254161 118047 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 470 10 2 4 4.9 O=C(O)CCC/C=C(\c1ccc(CNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL340396 118047 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 470 10 2 4 4.9 O=C(O)CCC/C=C(\c1ccc(CNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
10371334 116912 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 597 14 1 6 5.0 O=C(O)CCC/C=C(\c1ccc(CCN(CCN2CCOCC2)S(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL338419 116912 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 597 14 1 6 5.0 O=C(O)CCC/C=C(\c1ccc(CCN(CCN2CCOCC2)S(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
131717 203389 6 None - 1 Human 8.2 pIC50 = 8.2 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 452 14 2 4 4.7 O=C(O)CCC(CCCCNS(=O)(=O)c1ccc(Cl)cc1)CCCc1cccnc1 10.1021/jm00027a004
CHEMBL65414 203389 6 None - 1 Human 8.2 pIC50 = 8.2 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 452 14 2 4 4.7 O=C(O)CCC(CCCCNS(=O)(=O)c1ccc(Cl)cc1)CCCc1cccnc1 10.1021/jm00027a004
10434230 18831 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 456 9 2 4 5.2 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(NS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm00027a004
CHEMBL128022 18831 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 456 9 2 4 5.2 O=C(O)CCC/C=C(/c1cccnc1)c1cccc(NS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm00027a004
10256828 18701 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 542 13 2 5 4.7 O=C(O)CCC/C=C(\c1ccc(CCN(CC(=O)O)S(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL127738 18701 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 542 13 2 5 4.7 O=C(O)CCC/C=C(\c1ccc(CCN(CC(=O)O)S(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
10483231 19222 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 574 13 1 4 6.9 O=C(O)CCC/C=C(\c1ccc(CCN(Cc2ccccc2)S(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL129000 19222 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 574 13 1 4 6.9 O=C(O)CCC/C=C(\c1ccc(CCN(Cc2ccccc2)S(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
56924869 68381 0 None - 0 Human 4.2 pIC50 = 4.2 Binding
Displacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranesDisplacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranes
ChEMBL 487 8 1 4 5.8 COC(=O)N(Cc1ccccc1)Cc1cc(C(F)(F)F)ccc1-c1cc(CC(=O)O)ccc1OC 10.1016/j.bmcl.2011.01.024
CHEMBL1916697 68381 0 None - 0 Human 4.2 pIC50 = 4.2 Binding
Displacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranesDisplacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranes
ChEMBL 487 8 1 4 5.8 COC(=O)N(Cc1ccccc1)Cc1cc(C(F)(F)F)ccc1-c1cc(CC(=O)O)ccc1OC 10.1016/j.bmcl.2011.01.024
45270144 195351 33 None - 0 Human 4.2 pIC50 = 4.2 Binding
Displacement of [3H]SQ-29548 from thromboxane receptor in human platelet membraneDisplacement of [3H]SQ-29548 from thromboxane receptor in human platelet membrane
ChEMBL 501 8 2 6 4.1 CN(C)c1nc(Cc2ccc(NC(=O)c3ccc(C(F)(F)F)cc3)cc2)nc(N(C)C)c1CC(=O)O 10.1016/j.bmcl.2009.06.085
CHEMBL551813 195351 33 None - 0 Human 4.2 pIC50 = 4.2 Binding
Displacement of [3H]SQ-29548 from thromboxane receptor in human platelet membraneDisplacement of [3H]SQ-29548 from thromboxane receptor in human platelet membrane
ChEMBL 501 8 2 6 4.1 CN(C)c1nc(Cc2ccc(NC(=O)c3ccc(C(F)(F)F)cc3)cc2)nc(N(C)C)c1CC(=O)O 10.1016/j.bmcl.2009.06.085
44205724 68369 0 None - 0 Human 4.2 pIC50 = 4.2 Binding
Displacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranesDisplacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranes
ChEMBL 499 7 1 4 6.1 COc1ccc(CC(=O)O)cc1-c1ccc(C(F)(F)F)cc1CN1C(=O)O[C@H](c2ccccc2)[C@@H]1C 10.1016/j.bmcl.2011.01.024
CHEMBL1916686 68369 0 None - 0 Human 4.2 pIC50 = 4.2 Binding
Displacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranesDisplacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranes
ChEMBL 499 7 1 4 6.1 COc1ccc(CC(=O)O)cc1-c1ccc(C(F)(F)F)cc1CN1C(=O)O[C@H](c2ccccc2)[C@@H]1C 10.1016/j.bmcl.2011.01.024
10050297 118442 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 468 11 2 4 4.4 O=C(O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(F)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL341094 118442 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 468 11 2 4 4.4 O=C(O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(F)cc2)cc1)c1cccnc1 10.1021/jm00027a004
10502610 163718 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 427 9 2 3 4.7 O=C(O)CCC/C=C\C[C@@H]1[C@H]2CC[C@H](C2)[C@H]1NS(=O)(=O)c1ccc2ccccc2c1 10.1021/jm970343g
CHEMBL420507 163718 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 427 9 2 3 4.7 O=C(O)CCC/C=C\C[C@@H]1[C@H]2CC[C@H](C2)[C@H]1NS(=O)(=O)c1ccc2ccccc2c1 10.1021/jm970343g
44159411 68388 0 None - 0 Human 4.2 pIC50 = 4.2 Binding
Displacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranesDisplacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranes
ChEMBL 425 7 1 4 4.6 CCN(Cc1cc(C(F)(F)F)ccc1-c1cc(CC(=O)O)ccc1OC)C(=O)OC 10.1016/j.bmcl.2011.01.024
CHEMBL1916704 68388 0 None - 0 Human 4.2 pIC50 = 4.2 Binding
Displacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranesDisplacement of [3H]-SQ-29,548 from human TP receptor expressed in human platelet membranes
ChEMBL 425 7 1 4 4.6 CCN(Cc1cc(C(F)(F)F)ccc1-c1cc(CC(=O)O)ccc1OC)C(=O)OC 10.1016/j.bmcl.2011.01.024
15486805 166053 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Affinity for Prostanoid TP receptor expressed in CHO cellsAffinity for Prostanoid TP receptor expressed in CHO cells
ChEMBL 394 13 4 5 3.0 O=C(O)CCCCCC[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)COc1ccccc1 10.1021/jm990542v
CHEMBL425681 166053 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Affinity for Prostanoid TP receptor expressed in CHO cellsAffinity for Prostanoid TP receptor expressed in CHO cells
ChEMBL 394 13 4 5 3.0 O=C(O)CCCCCC[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)COc1ccccc1 10.1021/jm990542v
19097508 98772 0 None - 1 Human 8.2 pIC50 = 8.2 Binding
In vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparationIn vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparation
ChEMBL 508 10 2 5 4.8 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
CHEMBL278159 98772 0 None - 1 Human 8.2 pIC50 = 8.2 Binding
In vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparationIn vitro inhibition against TXA2/PGH2 receptor using [3H]-SQ 29,548 as radioligand in human platelet membrane preparation
ChEMBL 508 10 2 5 4.8 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
2449 204230 94 None - 0 Human 8.1 pIC50 = 8.1 Binding
In vitro concentration that reduced specific binding of [3H]U-440619 to guinea pig platelet receptor, TXA2 by 50%In vitro concentration that reduced specific binding of [3H]U-440619 to guinea pig platelet receptor, TXA2 by 50%
ChEMBL 354 8 1 3 4.6 CC1=C(C)C(=O)C(C(CCCCCC(=O)O)c2ccccc2)=C(C)C1=O 10.1021/jm00129a030
CHEMBL70972 204230 94 None - 0 Human 8.1 pIC50 = 8.1 Binding
In vitro concentration that reduced specific binding of [3H]U-440619 to guinea pig platelet receptor, TXA2 by 50%In vitro concentration that reduced specific binding of [3H]U-440619 to guinea pig platelet receptor, TXA2 by 50%
ChEMBL 354 8 1 3 4.6 CC1=C(C)C(=O)C(C(CCCCCC(=O)O)c2ccccc2)=C(C)C1=O 10.1021/jm00129a030
9801735 14535 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 411 11 1 5 5.2 Cc1ccc(CC(/C(=N/OCCCCC(=O)O)C2CCCCC2)n2ccnc2)cc1 10.1021/jm00047a016
CHEMBL120250 14535 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 411 11 1 5 5.2 Cc1ccc(CC(/C(=N/OCCCCC(=O)O)C2CCCCC2)n2ccnc2)cc1 10.1021/jm00047a016
10071192 113073 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 427 12 1 6 4.9 COc1ccc(CC(/C(=N/OCCCCC(=O)O)C2CCCCC2)n2ccnc2)cc1 10.1021/jm00047a016
CHEMBL331218 113073 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 427 12 1 6 4.9 COc1ccc(CC(/C(=N/OCCCCC(=O)O)C2CCCCC2)n2ccnc2)cc1 10.1021/jm00047a016
46202376 63754 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibition of thromboxane A2 receptorInhibition of thromboxane A2 receptor
ChEMBL 394 4 0 4 5.1 COc1ccc2c(c1)C(CC1CCOCC1)(c1ccc(Cl)cc1)n1ccnc1-2 10.1016/j.bmcl.2010.04.016
CHEMBL1801358 63754 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibition of thromboxane A2 receptorInhibition of thromboxane A2 receptor
ChEMBL 394 4 0 4 5.1 COc1ccc2c(c1)C(CC1CCOCC1)(c1ccc(Cl)cc1)n1ccnc1-2 10.1016/j.bmcl.2010.04.016
9973005 114740 0 None - 0 Human 4.1 pIC50 = 4.1 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 315 9 1 5 3.1 CC(/C(=N/OCCCCC(=O)O)c1ccccc1)n1ccnc1 10.1021/jm00047a016
CHEMBL333868 114740 0 None - 0 Human 4.1 pIC50 = 4.1 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 315 9 1 5 3.1 CC(/C(=N/OCCCCC(=O)O)c1ccccc1)n1ccnc1 10.1021/jm00047a016
10096378 18020 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 472 11 2 4 4.6 O=C(O)CCCC(c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL126373 18020 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 472 11 2 4 4.6 O=C(O)CCCC(c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
10529683 163644 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 509 11 2 5 6.6 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NS(=O)(=O)c3ccc(/N=N/c4ccccc4)cc3)[C@@H]1C2 10.1021/jm970343g
CHEMBL420404 163644 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 509 11 2 5 6.6 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NS(=O)(=O)c3ccc(/N=N/c4ccccc4)cc3)[C@@H]1C2 10.1021/jm970343g
10380987 14555 0 None - 0 Human 4.1 pIC50 = 4.1 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 315 10 1 5 2.9 O=C(O)CCCCCO/N=C(\Cn1ccnc1)c1ccccc1 10.1021/jm00047a016
CHEMBL120370 14555 0 None - 0 Human 4.1 pIC50 = 4.1 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 315 10 1 5 2.9 O=C(O)CCCCCO/N=C(\Cn1ccnc1)c1ccccc1 10.1021/jm00047a016
10320883 13949 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 437 12 1 6 5.1 CSc1ccc(/C(=N\OCCCCC(=O)O)C(Cc2ccccc2)n2ccnc2)cc1 10.1021/jm00047a016
CHEMBL119661 13949 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 437 12 1 6 5.1 CSc1ccc(/C(=N\OCCCCC(=O)O)C(Cc2ccccc2)n2ccnc2)cc1 10.1021/jm00047a016
53358921 64441 0 None - 6 Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]-SQ29548 from human TP receptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]-SQ29548 from human TP receptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 482 7 1 5 5.4 CCN1c2ccccc2C[C@@H]1COc1ccc(C(=O)n2c(C)c(CC(=O)O)c3ccccc32)c(C)c1 10.1016/j.bmc.2011.06.014
CHEMBL1813287 64441 0 None - 6 Human 5.1 pIC50 = 5.1 Binding
Displacement of [3H]-SQ29548 from human TP receptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]-SQ29548 from human TP receptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 482 7 1 5 5.4 CCN1c2ccccc2C[C@@H]1COc1ccc(C(=O)n2c(C)c(CC(=O)O)c3ccccc32)c(C)c1 10.1016/j.bmc.2011.06.014
6366700 14520 7 None - 0 Human 7.1 pIC50 = 7.1 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 397 11 1 5 4.9 O=C(O)CCCCO/N=C(\C1CCCCC1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
CHEMBL120181 14520 7 None - 0 Human 7.1 pIC50 = 7.1 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 397 11 1 5 4.9 O=C(O)CCCCO/N=C(\C1CCCCC1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
10411480 18090 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 450 11 2 4 4.3 O=C(O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccccc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL126761 18090 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 450 11 2 4 4.3 O=C(O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccccc2)cc1)c1cccnc1 10.1021/jm00027a004
10595288 205318 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 369 8 2 2 4.7 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3ccccc3)[C@@H]1C2 10.1021/jm970343g
CHEMBL79413 205318 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 369 8 2 2 4.7 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3ccccc3)[C@@H]1C2 10.1021/jm970343g
3077003 117086 3 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 486 12 2 4 5.0 O=C(O)CCCCC(c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL339269 117086 3 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 486 12 2 4 5.0 O=C(O)CCCCC(c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
10495597 59283 0 None - 1 Human 6.1 pIC50 = 6.1 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 316 3 4 6 2.1 O=[N+]([O-])c1cc(CC2NCCc3cc(O)c(O)cc32)ccc1O 10.1021/jm950896w
CHEMBL170451 59283 0 None - 1 Human 6.1 pIC50 = 6.1 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 316 3 4 6 2.1 O=[N+]([O-])c1cc(CC2NCCc3cc(O)c(O)cc32)ccc1O 10.1021/jm950896w
10453182 15068 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 393 11 1 6 3.2 O=C(O)COCCO/N=C(\c1ccccc1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
CHEMBL120943 15068 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 393 11 1 6 3.2 O=C(O)COCCO/N=C(\c1ccccc1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
10683471 59897 0 None - 1 Human 4.1 pIC50 = 4.1 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 270 2 4 4 2.1 Nc1ccc(CC2NCCc3cc(O)c(O)cc32)cc1 10.1021/jm950896w
CHEMBL173039 59897 0 None - 1 Human 4.1 pIC50 = 4.1 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 270 2 4 4 2.1 Nc1ccc(CC2NCCc3cc(O)c(O)cc32)cc1 10.1021/jm950896w
22901615 116913 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 480 9 2 4 4.4 O=C(O)CCC/C=C(/c1cccnc1)c1ccc2c(c1)CC(NS(=O)(=O)c1ccc(F)cc1)C2 10.1021/jm00027a004
CHEMBL338420 116913 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 480 9 2 4 4.4 O=C(O)CCC/C=C(/c1cccnc1)c1ccc2c(c1)CC(NS(=O)(=O)c1ccc(F)cc1)C2 10.1021/jm00027a004
10254733 18468 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 483 11 2 4 4.3 NC(=O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
CHEMBL127212 18468 0 None - 0 Human 7.0 pIC50 = 7.0 Binding
Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.Displacement of the high affinity radiolabeled ligand [3H]- SQ-29548 from the PGH-2/TXA-2 receptor in human gel-filtered platelets.
ChEMBL 483 11 2 4 4.3 NC(=O)CCC/C=C(\c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)c1cccnc1 10.1021/jm00027a004
9867949 10519 24 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 441 8 3 4 5.6 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3csc4ccc(O)cc34)[C@@H]1C2 10.1021/jm970343g
CHEMBL116837 10519 24 None - 0 Human 7.0 pIC50 = 7.0 Binding
Inhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assayInhibition of [3H]- (+)-S-145 specific binding to human platelet membranes in TXA2 receptor (TP) assay
ChEMBL 441 8 3 4 5.6 CC1(C)[C@H]2C[C@H](C/C=C\CCCC(=O)O)[C@@H](NC(=O)c3csc4ccc(O)cc34)[C@@H]1C2 10.1021/jm970343g
10431401 11704 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 405 12 1 5 4.7 O=C(O)CCCCCO/N=C(/c1ccccc1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
CHEMBL118124 11704 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 405 12 1 5 4.7 O=C(O)CCCCCO/N=C(/c1ccccc1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
5747298 170435 1 None - 0 Human 6.0 pIC50 = 6.0 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 397 11 1 5 4.9 O=C(O)CCCCO/N=C(/C1CCCCC1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
CHEMBL444856 170435 1 None - 0 Human 6.0 pIC50 = 6.0 Binding
In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human plateletsIn vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets
ChEMBL 397 11 1 5 4.9 O=C(O)CCCCO/N=C(/C1CCCCC1)C(Cc1ccccc1)n1ccnc1 10.1021/jm00047a016
19884707 105203 0 None - 1 Human 10.3 pKd = 10.3 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 507 13 1 5 6.9 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)CCCCCC2CCCCC2)co1 10.1021/jm00062a013
CHEMBL31146 105203 0 None - 1 Human 10.3 pKd = 10.3 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 507 13 1 5 6.9 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)CCCCCC2CCCCC2)co1 10.1021/jm00062a013
14952347 107351 0 None - 1 Human 10.0 pKd = 10 Binding
Compound was evaluated for the receptor binding studies with Thromboxane A2 receptor using [3H]-SQ 29548 as radioligand in human platelet membranes.Compound was evaluated for the receptor binding studies with Thromboxane A2 receptor using [3H]-SQ 29548 as radioligand in human platelet membranes.
ChEMBL 508 12 2 5 5.7 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/S0960-894X(01)81106-9
CHEMBL31765 107351 0 None - 1 Human 10.0 pKd = 10 Binding
Compound was evaluated for the receptor binding studies with Thromboxane A2 receptor using [3H]-SQ 29548 as radioligand in human platelet membranes.Compound was evaluated for the receptor binding studies with Thromboxane A2 receptor using [3H]-SQ 29548 as radioligand in human platelet membranes.
ChEMBL 508 12 2 5 5.7 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/S0960-894X(01)81106-9
14952347 107351 0 None - 1 Human 10.0 pKd = 10 Binding
Dissociation constant was determined from radioligand binding studies in human platelet membranes using Thromboxane A2 receptor radioligand [3H]-SQ 29,548.Dissociation constant was determined from radioligand binding studies in human platelet membranes using Thromboxane A2 receptor radioligand [3H]-SQ 29,548.
ChEMBL 508 12 2 5 5.7 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/S0960-894X(00)80592-2
CHEMBL31765 107351 0 None - 1 Human 10.0 pKd = 10 Binding
Dissociation constant was determined from radioligand binding studies in human platelet membranes using Thromboxane A2 receptor radioligand [3H]-SQ 29,548.Dissociation constant was determined from radioligand binding studies in human platelet membranes using Thromboxane A2 receptor radioligand [3H]-SQ 29,548.
ChEMBL 508 12 2 5 5.7 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/S0960-894X(00)80592-2
14952347 107351 0 None - 1 Human 10.0 pKd = 10 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 508 12 2 5 5.7 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1021/jm00062a013
CHEMBL31765 107351 0 None - 1 Human 10.0 pKd = 10 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 508 12 2 5 5.7 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1021/jm00062a013
14952443 102921 0 None - 1 Human 9.7 pKd = 9.7 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 536 12 2 5 5.6 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCc2ccc(Cl)cc2)co1 10.1021/jm00062a013
CHEMBL30615 102921 0 None - 1 Human 9.7 pKd = 9.7 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 536 12 2 5 5.6 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCc2ccc(Cl)cc2)co1 10.1021/jm00062a013
14952423 103077 0 None - 1 Human 9.7 pKd = 9.7 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 468 13 2 5 4.9 CCCCCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
CHEMBL30743 103077 0 None - 1 Human 9.7 pKd = 9.7 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 468 13 2 5 4.9 CCCCCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
19875349 99286 0 None - 1 Human 9.5 pKd = 9.5 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 532 13 2 6 5.0 COc1ccc(CCCCNC(=O)c2coc(C3C4CCC(O4)C3Cc3ccccc3CCC(=O)O)n2)cc1 10.1021/jm00062a013
CHEMBL281959 99286 0 None - 1 Human 9.5 pKd = 9.5 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 532 13 2 6 5.0 COc1ccc(CCCCNC(=O)c2coc(C3C4CCC(O4)C3Cc3ccccc3CCC(=O)O)n2)cc1 10.1021/jm00062a013
19875370 99594 0 None - 1 Human 9.5 pKd = 9.5 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 502 12 2 5 4.9 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCc2ccccc2)co1 10.1021/jm00062a013
CHEMBL283923 99594 0 None - 1 Human 9.5 pKd = 9.5 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 502 12 2 5 4.9 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCc2ccccc2)co1 10.1021/jm00062a013
52935553 77969 0 None - 1 Human 9.4 pKd = 9.4 Binding
Compound was evaluated for inhibition of specific binding of HSQ (5,6-di-3H-SQ 29,548) in washed plateletsCompound was evaluated for inhibition of specific binding of HSQ (5,6-di-3H-SQ 29,548) in washed platelets
ChEMBL 352 12 1 3 5.1 CC/C=C\CCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL2096756 77969 0 None - 1 Human 9.4 pKd = 9.4 Binding
Compound was evaluated for inhibition of specific binding of HSQ (5,6-di-3H-SQ 29,548) in washed plateletsCompound was evaluated for inhibition of specific binding of HSQ (5,6-di-3H-SQ 29,548) in washed platelets
ChEMBL 352 12 1 3 5.1 CC/C=C\CCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
44458593 95331 0 None - 1 Human 9.3 pKd = 9.3 Binding
Binding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligandBinding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligand
ChEMBL 466 9 2 4 5.4 O=C(O)CCc1ccccc1C[C@@H]1CCC[C@H]1c1nc(C(=O)NCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80329-7
CHEMBL25657 95331 0 None - 1 Human 9.3 pKd = 9.3 Binding
Binding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligandBinding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligand
ChEMBL 466 9 2 4 5.4 O=C(O)CCc1ccccc1C[C@@H]1CCC[C@H]1c1nc(C(=O)NCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80329-7
19875466 100986 0 None - 1 Human 9.3 pKd = 9.3 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 518 12 3 6 4.7 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCc2ccc(O)cc2)co1 10.1021/jm00062a013
CHEMBL29429 100986 0 None - 1 Human 9.3 pKd = 9.3 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 518 12 3 6 4.7 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCc2ccc(O)cc2)co1 10.1021/jm00062a013
19875479 104179 0 None - 1 Human 9.2 pKd = 9.2 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 482 11 2 5 5.1 CC(C)(C)CCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
CHEMBL30972 104179 0 None - 1 Human 9.2 pKd = 9.2 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 482 11 2 5 5.1 CC(C)(C)CCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
19875360 107823 0 None - 1 Human 9.2 pKd = 9.2 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 480 10 2 5 4.9 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCC2CCCCC2)co1 10.1021/jm00062a013
CHEMBL31922 107823 0 None - 1 Human 9.2 pKd = 9.2 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 480 10 2 5 4.9 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCC2CCCCC2)co1 10.1021/jm00062a013
19875435 159947 0 None - 1 Human 9.2 pKd = 9.2 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 474 10 2 5 4.2 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCc2ccccc2)co1 10.1021/jm00062a013
CHEMBL410732 159947 0 None - 1 Human 9.2 pKd = 9.2 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 474 10 2 5 4.2 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCc2ccccc2)co1 10.1021/jm00062a013
19875423 99244 0 None - 1 Human 9.1 pKd = 9.1 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 440 9 2 5 4.1 CCC(C)(C)NC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
CHEMBL281726 99244 0 None - 1 Human 9.1 pKd = 9.1 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 440 9 2 5 4.1 CCC(C)(C)NC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
44279917 105292 0 None - 1 Human 9.1 pKd = 9.1 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 522 13 2 5 6.1 O=C(O)CCCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1021/jm00062a013
CHEMBL31154 105292 0 None - 1 Human 9.1 pKd = 9.1 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 522 13 2 5 6.1 O=C(O)CCCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1021/jm00062a013
44279871 100040 0 None - 1 Human 9.0 pKd = 9 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 509 12 1 6 6.1 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)OCCCCC2CCCCC2)co1 10.1021/jm00062a013
CHEMBL286978 100040 0 None - 1 Human 9.0 pKd = 9 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 509 12 1 6 6.1 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)OCCCCC2CCCCC2)co1 10.1021/jm00062a013
20844482 207755 0 None - 1 Human 9.0 pKd = 9 Binding
The compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranesThe compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranes
ChEMBL 421 8 3 4 3.8 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1/C=N/NC(=O)Nc1ccccc1 10.1021/jm00113a030
CHEMBL95872 207755 0 None - 1 Human 9.0 pKd = 9 Binding
The compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranesThe compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranes
ChEMBL 421 8 3 4 3.8 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1/C=N/NC(=O)Nc1ccccc1 10.1021/jm00113a030
13799378 104457 0 None - 1 Human 9.0 pKd = 9.0 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 462 14 3 4 4.0 O=C(O)CCC/C=C/CC1C2CCC(O2)C1CNC(=O)CNC(=O)CCCC1CCCCC1 10.1021/jm00171a021
CHEMBL310406 104457 0 None - 1 Human 9.0 pKd = 9.0 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 462 14 3 4 4.0 O=C(O)CCC/C=C/CC1C2CCC(O2)C1CNC(=O)CNC(=O)CCCC1CCCCC1 10.1021/jm00171a021
18675848 99834 0 None - 1 Human 8.9 pKd = 8.9 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 494 11 2 5 5.3 O=C(O)Cc1cccc(CC2C3CCC(O3)C2c2nc(C(=O)NCCCCC3CCCCC3)co2)c1 10.1021/jm00062a013
CHEMBL285596 99834 0 None - 1 Human 8.9 pKd = 8.9 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 494 11 2 5 5.3 O=C(O)Cc1cccc(CC2C3CCC(O3)C2c2nc(C(=O)NCCCCC3CCCCC3)co2)c1 10.1021/jm00062a013
19097508 98772 0 None - 1 Human 8.9 pKd = 8.9 Binding
In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548
ChEMBL 508 10 2 5 4.8 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
CHEMBL278159 98772 0 None - 1 Human 8.9 pKd = 8.9 Binding
In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548
ChEMBL 508 10 2 5 4.8 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
19097508 98772 0 None - 1 Human 8.9 pKd = 8.9 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 508 10 2 5 4.8 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1021/jm00062a013
CHEMBL278159 98772 0 None - 1 Human 8.9 pKd = 8.9 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 508 10 2 5 4.8 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1021/jm00062a013
118718127 115276 0 None - 1 Human 8.8 pKd = 8.8 Binding
Compound was evaluated for inhibition of specific binding of HSQ (5,6-di-3H-SQ 29,548) in washed plateletsCompound was evaluated for inhibition of specific binding of HSQ (5,6-di-3H-SQ 29,548) in washed platelets
ChEMBL 354 13 1 3 5.3 CCCCCCSC[C@H]1C2CC[C@@H](O2)[C@H]1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL3349042 115276 0 None - 1 Human 8.8 pKd = 8.8 Binding
Compound was evaluated for inhibition of specific binding of HSQ (5,6-di-3H-SQ 29,548) in washed plateletsCompound was evaluated for inhibition of specific binding of HSQ (5,6-di-3H-SQ 29,548) in washed platelets
ChEMBL 354 13 1 3 5.3 CCCCCCSC[C@H]1C2CC[C@@H](O2)[C@H]1C/C=C\CCCC(=O)O 10.1021/jm00125a009
19875425 102411 0 None - 1 Human 8.8 pKd = 8.8 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 585 13 2 7 4.7 CS(=O)(=O)NC(=O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1021/jm00062a013
CHEMBL30398 102411 0 None - 1 Human 8.8 pKd = 8.8 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 585 13 2 7 4.7 CS(=O)(=O)NC(=O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1021/jm00062a013
19973038 168204 0 None - 1 Human 8.0 pKd = 8 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 412 9 2 5 3.3 CCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
CHEMBL433435 168204 0 None - 1 Human 8.0 pKd = 8 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 412 9 2 5 3.3 CCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
19097519 162273 0 None - 1 Human 8.0 pKd = 8.0 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 524 12 2 5 6.6 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(/C(S)=N/CCCCC2CCCCC2)co1 10.1021/jm00062a013
CHEMBL416395 162273 0 None - 1 Human 8.0 pKd = 8.0 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 524 12 2 5 6.6 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(/C(S)=N/CCCCC2CCCCC2)co1 10.1021/jm00062a013
3356 2280 73 None -38 8 Human 8.0 pKd = 8.0 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1021/jm0603668
4326 2280 73 None -38 8 Human 8.0 pKd = 8.0 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1021/jm0603668
9867642 2280 73 None -38 8 Human 8.0 pKd = 8.0 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1021/jm0603668
CHEMBL426559 2280 73 None -38 8 Human 8.0 pKd = 8.0 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1021/jm0603668
DB11629 2280 73 None -38 8 Human 8.0 pKd = 8.0 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1021/jm0603668
54757965 65280 0 None - 1 Mouse 5.0 pKd = 5 Binding
Displacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 353 8 2 3 2.8 O=S(=O)(NCCc1cccc(CCCO)c1)c1ccc(Cl)cc1 10.1021/jm200980u
CHEMBL1828642 65280 0 None - 1 Mouse 5.0 pKd = 5 Binding
Displacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 353 8 2 3 2.8 O=S(=O)(NCCc1cccc(CCCO)c1)c1ccc(Cl)cc1 10.1021/jm200980u
19838931 208339 0 None - 1 Human 6.0 pKd = 6.0 Binding
The compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranesThe compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranes
ChEMBL 421 8 3 4 3.8 O=C(O)Cc1cccc(CCC2C3CCC(O3)C2/C=N/NC(=O)Nc2ccccc2)c1 10.1021/jm00113a030
CHEMBL99348 208339 0 None - 1 Human 6.0 pKd = 6.0 Binding
The compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranesThe compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranes
ChEMBL 421 8 3 4 3.8 O=C(O)Cc1cccc(CCC2C3CCC(O3)C2/C=N/NC(=O)Nc2ccccc2)c1 10.1021/jm00113a030
19104215 87960 0 None - 1 Human 8.0 pKd = 8.0 Binding
Binding affinity was determined for Thromboxane A2 receptor in human platelet membrane in presence of [3H]-SQ-29,548 radioligandBinding affinity was determined for Thromboxane A2 receptor in human platelet membrane in presence of [3H]-SQ-29,548 radioligand
ChEMBL 481 12 2 5 5.5 O=C(O)CCc1ccccc1CN1CCCC1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/S0960-894X(00)80328-5
CHEMBL23414 87960 0 None - 1 Human 8.0 pKd = 8.0 Binding
Binding affinity was determined for Thromboxane A2 receptor in human platelet membrane in presence of [3H]-SQ-29,548 radioligandBinding affinity was determined for Thromboxane A2 receptor in human platelet membrane in presence of [3H]-SQ-29,548 radioligand
ChEMBL 481 12 2 5 5.5 O=C(O)CCc1ccccc1CN1CCCC1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/S0960-894X(00)80328-5
54669847 65453 0 None 18 2 Mouse 8.0 pKd = 8.0 Binding
Displacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 405 7 2 4 3.4 O=C1C=C(O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1 10.1021/jm200980u
CHEMBL1829805 65453 0 None 18 2 Mouse 8.0 pKd = 8.0 Binding
Displacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 405 7 2 4 3.4 O=C1C=C(O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1 10.1021/jm200980u
19875443 163260 0 None - 1 Human 8.0 pKd = 8.0 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 454 11 1 5 4.5 CCCCCN(C)C(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
CHEMBL418583 163260 0 None - 1 Human 8.0 pKd = 8.0 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 454 11 1 5 4.5 CCCCCN(C)C(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
23302977 202639 0 None - 1 Human 7.0 pKd = 7.0 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 543 15 2 5 7.7 O=C(O)CCCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
CHEMBL61306 202639 0 None - 1 Human 7.0 pKd = 7.0 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 543 15 2 5 7.7 O=C(O)CCCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
44301139 102047 0 None - 1 Human 6.0 pKd = 6.0 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 531 14 2 5 6.2 O=C(O)CCCC/C=C(\c1cccnc1)c1ccccc1C1=N[C@@H](C(=O)NCCCCC2CCCCC2)CO1 10.1016/s0960-894x(98)00353-9
CHEMBL301904 102047 0 None - 1 Human 6.0 pKd = 6.0 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 531 14 2 5 6.2 O=C(O)CCCC/C=C(\c1cccnc1)c1ccccc1C1=N[C@@H](C(=O)NCCCCC2CCCCC2)CO1 10.1016/s0960-894x(98)00353-9
19813455 99380 0 None - 1 Human 7.0 pKd = 7.0 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 494 12 2 5 5.6 O=C(NCCCCC1CCCCC1)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCCO)n1 10.1021/jm00062a013
CHEMBL282601 99380 0 None - 1 Human 7.0 pKd = 7.0 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 494 12 2 5 5.6 O=C(NCCCCC1CCCCC1)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCCO)n1 10.1021/jm00062a013
15462459 101671 0 None - 1 Human 6.0 pKd = 6.0 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 447 11 2 5 3.8 O=C(O)CCCC/C=C(\c1ccc(C2=N[C@H](C(=O)NCC3CC3)CO2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
CHEMBL299280 101671 0 None - 1 Human 6.0 pKd = 6.0 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 447 11 2 5 3.8 O=C(O)CCCC/C=C(\c1ccc(C2=N[C@H](C(=O)NCC3CC3)CO2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
54757867 65451 0 None -9 2 Human 4.9 pKd = 4.9 Binding
Displacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 405 7 2 4 3.6 O=C1CCC(O)=C1Cc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm200980u
CHEMBL1829803 65451 0 None -9 2 Human 4.9 pKd = 4.9 Binding
Displacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 405 7 2 4 3.6 O=C1CCC(O)=C1Cc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm200980u
54757867 65451 0 None 9 2 Mouse 5.9 pKd = 5.9 Binding
Displacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 405 7 2 4 3.6 O=C1CCC(O)=C1Cc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm200980u
CHEMBL1829803 65451 0 None 9 2 Mouse 5.9 pKd = 5.9 Binding
Displacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 405 7 2 4 3.6 O=C1CCC(O)=C1Cc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm200980u
14673099 107518 0 None - 1 Human 5.9 pKd = 5.9 Binding
The compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranesThe compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranes
ChEMBL 423 8 3 5 3.3 O=C(O)COc1cccc(CC2C3CCC(O3)C2/C=N/NC(=O)Nc2ccccc2)c1 10.1021/jm00113a030
CHEMBL318673 107518 0 None - 1 Human 5.9 pKd = 5.9 Binding
The compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranesThe compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranes
ChEMBL 423 8 3 5 3.3 O=C(O)COc1cccc(CC2C3CCC(O3)C2/C=N/NC(=O)Nc2ccccc2)c1 10.1021/jm00113a030
10369704 100893 0 None - 1 Human 7.9 pKd = 7.9 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 529 14 2 5 7.3 O=C(O)CCCC/C=C(/c1cccnc1)c1cccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)c1 10.1016/s0960-894x(98)00353-9
CHEMBL293764 100893 0 None - 1 Human 7.9 pKd = 7.9 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 529 14 2 5 7.3 O=C(O)CCCC/C=C(/c1cccnc1)c1cccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)c1 10.1016/s0960-894x(98)00353-9
14885216 205305 0 None - 1 Human 7.9 pKd = 7.9 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 438 15 3 4 4.4 CCCCCC/C(S)=N/CC(=O)NCC1C2CCC(O2)C1C/C=C/CCCC(=O)O 10.1021/jm00171a021
CHEMBL79287 205305 0 None - 1 Human 7.9 pKd = 7.9 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 438 15 3 4 4.4 CCCCCC/C(S)=N/CC(=O)NCC1C2CCC(O2)C1C/C=C/CCCC(=O)O 10.1021/jm00171a021
15462462 198262 0 None - 1 Human 6.9 pKd = 6.9 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 481 11 2 5 5.7 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCc3ccccc3)co2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
CHEMBL57576 198262 0 None - 1 Human 6.9 pKd = 6.9 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 481 11 2 5 5.7 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCc3ccccc3)co2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
71452805 79696 0 None - 1 Human 6.9 pKd = 6.9 Binding
Binding affinity of Thromboxane A2 (TXA2) receptor using [3H]-SQ 29,548 radioligand in washed human plateletsBinding affinity of Thromboxane A2 (TXA2) receptor using [3H]-SQ 29,548 radioligand in washed human platelets
ChEMBL 282 2 0 2 4.4 CC1(C)C2CC[C@H](Cc3cccc4ccc(=O)oc34)C1C2 10.1016/0960-894X(95)00284-Z
CHEMBL2115413 79696 0 None - 1 Human 6.9 pKd = 6.9 Binding
Binding affinity of Thromboxane A2 (TXA2) receptor using [3H]-SQ 29,548 radioligand in washed human plateletsBinding affinity of Thromboxane A2 (TXA2) receptor using [3H]-SQ 29,548 radioligand in washed human platelets
ChEMBL 282 2 0 2 4.4 CC1(C)C2CC[C@H](Cc3cccc4ccc(=O)oc34)C1C2 10.1016/0960-894X(95)00284-Z
10546960 203355 0 None -70 3 Human 6.9 pKd = 6.9 Binding
Displacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 367 8 2 3 2.9 O=C(O)CCc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm200980u
CHEMBL65121 203355 0 None -70 3 Human 6.9 pKd = 6.9 Binding
Displacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 367 8 2 3 2.9 O=C(O)CCc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm200980u
15852312 201503 0 None - 1 Human 6.8 pKd = 6.8 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 529 14 2 5 7.3 O=C(O)CCCC/C=C(/c1ccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
CHEMBL60516 201503 0 None - 1 Human 6.8 pKd = 6.8 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 529 14 2 5 7.3 O=C(O)CCCC/C=C(/c1ccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
44301318 197127 0 None - 1 Human 7.8 pKd = 7.8 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 531 14 2 5 6.2 O=C(O)CCCC/C=C(\c1ccc(C2=N[C@@H](C(=O)NCCCCC3CCCCC3)CO2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
CHEMBL56778 197127 0 None - 1 Human 7.8 pKd = 7.8 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 531 14 2 5 6.2 O=C(O)CCCC/C=C(\c1ccc(C2=N[C@@H](C(=O)NCCCCC3CCCCC3)CO2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
15852311 198796 0 None - 1 Human 7.8 pKd = 7.8 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 531 14 2 5 6.2 O=C(O)CCCC/C=C(\c1ccc(C2=N[C@H](C(=O)NCCCCC3CCCCC3)CO2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
CHEMBL58332 198796 0 None - 1 Human 7.8 pKd = 7.8 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 531 14 2 5 6.2 O=C(O)CCCC/C=C(\c1ccc(C2=N[C@H](C(=O)NCCCCC3CCCCC3)CO2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
15458912 100594 0 None - 1 Human 5.8 pKd = 5.8 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 529 14 2 5 7.3 O=C(O)CCCC/C=C(\c1cccnc1)c1ccccc1-c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/s0960-894x(98)00353-9
CHEMBL291789 100594 0 None - 1 Human 5.8 pKd = 5.8 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 529 14 2 5 7.3 O=C(O)CCCC/C=C(\c1cccnc1)c1ccccc1-c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/s0960-894x(98)00353-9
44301194 100563 0 None - 1 Human 6.8 pKd = 6.8 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 461 13 2 5 5.7 CCCCCNC(=O)c1coc(-c2ccc(/C(=C\CCCCC(=O)O)c3cccnc3)cc2)n1 10.1016/s0960-894x(98)00353-9
CHEMBL291539 100563 0 None - 1 Human 6.8 pKd = 6.8 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 461 13 2 5 5.7 CCCCCNC(=O)c1coc(-c2ccc(/C(=C\CCCCC(=O)O)c3cccnc3)cc2)n1 10.1016/s0960-894x(98)00353-9
19875405 99101 0 None - 1 Human 7.8 pKd = 7.8 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 508 12 2 5 5.7 O=C(O)Cc1cccc(CCC2C3CCC(O3)C2c2nc(C(=O)NCCCCC3CCCCC3)co2)c1 10.1021/jm00062a013
CHEMBL280786 99101 0 None - 1 Human 7.8 pKd = 7.8 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 508 12 2 5 5.7 O=C(O)Cc1cccc(CCC2C3CCC(O3)C2c2nc(C(=O)NCCCCC3CCCCC3)co2)c1 10.1021/jm00062a013
54758054 65450 0 None 20 2 Mouse 7.8 pKd = 7.8 Binding
Displacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 420 8 3 6 1.8 O=c1c(O)c(NCc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)c1=O 10.1021/jm200980u
CHEMBL1829802 65450 0 None 20 2 Mouse 7.8 pKd = 7.8 Binding
Displacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 420 8 3 6 1.8 O=c1c(O)c(NCc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)c1=O 10.1021/jm200980u
13799369 205568 0 None - 1 Human 7.8 pKd = 7.8 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 436 16 3 4 3.6 CCCCCCCC(=O)NCC(=O)NCC1C2CCC(O2)C1C/C=C/CCCC(=O)O 10.1021/jm00171a021
CHEMBL81263 205568 0 None - 1 Human 7.8 pKd = 7.8 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 436 16 3 4 3.6 CCCCCCCC(=O)NCC(=O)NCC1C2CCC(O2)C1C/C=C/CCCC(=O)O 10.1021/jm00171a021
44209494 208298 0 None - 1 Human 6.8 pKd = 6.8 Binding
The compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranesThe compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranes
ChEMBL 407 7 3 4 3.5 O=C(O)Cc1cccc(CC2C3CCC(O3)C2/C=N/NC(=O)Nc2ccccc2)c1 10.1021/jm00113a030
CHEMBL99041 208298 0 None - 1 Human 6.8 pKd = 6.8 Binding
The compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranesThe compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranes
ChEMBL 407 7 3 4 3.5 O=C(O)Cc1cccc(CC2C3CCC(O3)C2/C=N/NC(=O)Nc2ccccc2)c1 10.1021/jm00113a030
15052910 191926 1 None - 1 Human 6.8 pKd = 6.8 Binding
Tested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligandTested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligand
ChEMBL 313 11 2 3 2.8 O=C(O)CCCCCCCCNS(=O)(=O)c1ccccc1 10.1016/S0960-894X(01)80794-0
CHEMBL52003 191926 1 None - 1 Human 6.8 pKd = 6.8 Binding
Tested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligandTested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligand
ChEMBL 313 11 2 3 2.8 O=C(O)CCCCCCCCNS(=O)(=O)c1ccccc1 10.1016/S0960-894X(01)80794-0
19875358 99997 0 None - 1 Human 7.7 pKd = 7.7 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 494 11 2 5 5.7 O=C(O)c1cccc(CCC2C3CCC(O3)C2c2nc(C(=O)NCCCCC3CCCCC3)co2)c1 10.1021/jm00062a013
CHEMBL286708 99997 0 None - 1 Human 7.7 pKd = 7.7 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 494 11 2 5 5.7 O=C(O)c1cccc(CCC2C3CCC(O3)C2c2nc(C(=O)NCCCCC3CCCCC3)co2)c1 10.1021/jm00062a013
44301250 202292 0 None - 1 Human 5.7 pKd = 5.7 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 531 14 2 5 6.2 O=C(O)CCCC/C=C(/c1cccnc1)c1ccccc1C1=N[C@@H](C(=O)NCCCCC2CCCCC2)CO1 10.1016/s0960-894x(98)00353-9
CHEMBL61021 202292 0 None - 1 Human 5.7 pKd = 5.7 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 531 14 2 5 6.2 O=C(O)CCCC/C=C(/c1cccnc1)c1ccccc1C1=N[C@@H](C(=O)NCCCCC2CCCCC2)CO1 10.1016/s0960-894x(98)00353-9
54758053 65449 0 None 17 2 Mouse 7.7 pKd = 7.7 Binding
Displacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 391 8 2 5 2.2 O=S(=O)(NCCc1cccc(CCc2nn[nH]n2)c1)c1ccc(Cl)cc1 10.1021/jm200980u
CHEMBL1829801 65449 0 None 17 2 Mouse 7.7 pKd = 7.7 Binding
Displacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 391 8 2 5 2.2 O=S(=O)(NCCc1cccc(CCc2nn[nH]n2)c1)c1ccc(Cl)cc1 10.1021/jm200980u
18944178 59354 0 None - 1 Human 7.7 pKd = 7.7 Binding
Dissociation constant was determined from radioligand binding studies in human platelet membranes using Thromboxane A2 receptor radioligand [3H]-SQ 29,548.Dissociation constant was determined from radioligand binding studies in human platelet membranes using Thromboxane A2 receptor radioligand [3H]-SQ 29,548.
ChEMBL 488 12 2 4 6.4 O=C(O)CCc1ccccc1Cc1ccccc1-c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/S0960-894X(00)80592-2
CHEMBL170747 59354 0 None - 1 Human 7.7 pKd = 7.7 Binding
Dissociation constant was determined from radioligand binding studies in human platelet membranes using Thromboxane A2 receptor radioligand [3H]-SQ 29,548.Dissociation constant was determined from radioligand binding studies in human platelet membranes using Thromboxane A2 receptor radioligand [3H]-SQ 29,548.
ChEMBL 488 12 2 4 6.4 O=C(O)CCc1ccccc1Cc1ccccc1-c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/S0960-894X(00)80592-2
19875392 100095 0 None - 1 Human 7.7 pKd = 7.7 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 426 7 2 5 3.7 CC(C)(C)NC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
CHEMBL287421 100095 0 None - 1 Human 7.7 pKd = 7.7 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 426 7 2 5 3.7 CC(C)(C)NC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
19813457 104540 0 None - 1 Human 7.7 pKd = 7.7 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 494 11 2 5 5.3 O=C(O)Cc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1021/jm00062a013
CHEMBL31043 104540 0 None - 1 Human 7.7 pKd = 7.7 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 494 11 2 5 5.3 O=C(O)Cc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1021/jm00062a013
44461598 105853 0 None - 1 Human 8.6 pKd = 8.6 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 476 15 3 4 4.4 O=C(O)CCC/C=C/CC1C2CCC(O2)C1CNC(=O)CNC(=O)CCCCC1CCCCC1 10.1021/jm00171a021
CHEMBL312732 105853 0 None - 1 Human 8.6 pKd = 8.6 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 476 15 3 4 4.4 O=C(O)CCC/C=C/CC1C2CCC(O2)C1CNC(=O)CNC(=O)CCCCC1CCCCC1 10.1021/jm00171a021
19875446 100052 0 None - 1 Human 8.5 pKd = 8.5 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 548 13 2 6 5.7 CSc1ccc(CCCCNC(=O)c2coc(C3C4CCC(O4)C3Cc3ccccc3CCC(=O)O)n2)cc1 10.1021/jm00062a013
CHEMBL287068 100052 0 None - 1 Human 8.5 pKd = 8.5 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 548 13 2 6 5.7 CSc1ccc(CCCCNC(=O)c2coc(C3C4CCC(O4)C3Cc3ccccc3CCC(=O)O)n2)cc1 10.1021/jm00062a013
44279758 107486 0 None - 1 Human 8.5 pKd = 8.5 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 454 9 2 5 4.4 CC(C)(C)CCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
CHEMBL31850 107486 0 None - 1 Human 8.5 pKd = 8.5 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 454 9 2 5 4.4 CC(C)(C)CCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
6913677 185331 1 None - 1 Human 8.5 pKd = 8.5 Binding
Tested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligandTested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligand
ChEMBL 377 9 2 3 3.6 O=C(O)CCC/C=C\CC1C2CCC(C2)C1NS(=O)(=O)c1ccccc1 10.1016/S0960-894X(01)80794-0
CHEMBL48597 185331 1 None - 1 Human 8.5 pKd = 8.5 Binding
Tested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligandTested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligand
ChEMBL 377 9 2 3 3.6 O=C(O)CCC/C=C\CC1C2CCC(C2)C1NS(=O)(=O)c1ccccc1 10.1016/S0960-894X(01)80794-0
44279913 103054 0 None - 1 Human 7.7 pKd = 7.7 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 456 12 3 6 3.1 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCCO)co1 10.1021/jm00062a013
CHEMBL30727 103054 0 None - 1 Human 7.7 pKd = 7.7 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 456 12 3 6 3.1 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCCO)co1 10.1021/jm00062a013
54669847 65453 0 None -18 2 Human 6.7 pKd = 6.7 Binding
Displacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 405 7 2 4 3.4 O=C1C=C(O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1 10.1021/jm200980u
CHEMBL1829805 65453 0 None -18 2 Human 6.7 pKd = 6.7 Binding
Displacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 405 7 2 4 3.4 O=C1C=C(O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)C1 10.1021/jm200980u
44329879 207753 0 None - 1 Human 7.7 pKd = 7.7 Binding
The compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranesThe compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranes
ChEMBL 435 9 3 4 4.2 O=C(O)CCCc1ccccc1CC1C2CCC(O2)C1/C=N/NC(=O)Nc1ccccc1 10.1021/jm00113a030
CHEMBL95867 207753 0 None - 1 Human 7.7 pKd = 7.7 Binding
The compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranesThe compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranes
ChEMBL 435 9 3 4 4.2 O=C(O)CCCc1ccccc1CC1C2CCC(O2)C1/C=N/NC(=O)Nc1ccccc1 10.1021/jm00113a030
19875478 102353 0 None - 1 Human 7.7 pKd = 7.7 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 551 13 3 6 4.5 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC(=O)NC2CCCCC2)co1 10.1021/jm00062a013
CHEMBL30377 102353 0 None - 1 Human 7.7 pKd = 7.7 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 551 13 3 6 4.5 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC(=O)NC2CCCCC2)co1 10.1021/jm00062a013
19875474 109646 0 None - 1 Human 7.7 pKd = 7.7 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 509 12 2 6 4.2 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCN2CCCCC2)co1 10.1021/jm00062a013
CHEMBL2368531 109646 0 None - 1 Human 7.7 pKd = 7.7 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 509 12 2 6 4.2 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCN2CCCCC2)co1 10.1021/jm00062a013
CHEMBL32237 109646 0 None - 1 Human 7.7 pKd = 7.7 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 509 12 2 6 4.2 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCN2CCCCC2)co1 10.1021/jm00062a013
18666327 84660 0 None - 1 Human 7.6 pKd = 7.6 Binding
Binding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligandBinding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligand
ChEMBL 480 12 2 4 6.3 O=C(O)CCc1ccccc1C[C@@H]1CCC[C@@H]1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/S0960-894X(00)80329-7
CHEMBL22244 84660 0 None - 1 Human 7.6 pKd = 7.6 Binding
Binding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligandBinding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligand
ChEMBL 480 12 2 4 6.3 O=C(O)CCc1ccccc1C[C@@H]1CCC[C@@H]1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/S0960-894X(00)80329-7
44301207 101765 0 None - 1 Human 6.6 pKd = 6.6 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 463 13 2 5 4.6 CCCCCNC(=O)[C@@H]1COC(c2ccc(/C(=C\CCCCC(=O)O)c3cccnc3)cc2)=N1 10.1016/s0960-894x(98)00353-9
CHEMBL299886 101765 0 None - 1 Human 6.6 pKd = 6.6 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 463 13 2 5 4.6 CCCCCNC(=O)[C@@H]1COC(c2ccc(/C(=C\CCCCC(=O)O)c3cccnc3)cc2)=N1 10.1016/s0960-894x(98)00353-9
54669848 65454 0 None 12 2 Mouse 7.6 pKd = 7.6 Binding
Displacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 419 7 2 4 3.8 CC1=C(O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)CC1=O 10.1021/jm200980u
CHEMBL1829806 65454 0 None 12 2 Mouse 7.6 pKd = 7.6 Binding
Displacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 419 7 2 4 3.8 CC1=C(O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)CC1=O 10.1021/jm200980u
10546960 203355 0 None -13 3 Mouse 7.6 pKd = 7.6 Binding
Displacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 367 8 2 3 2.9 O=C(O)CCc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm200980u
CHEMBL65121 203355 0 None -13 3 Mouse 7.6 pKd = 7.6 Binding
Displacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from mouse prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 367 8 2 3 2.9 O=C(O)CCc1cccc(CCNS(=O)(=O)c2ccc(Cl)cc2)c1 10.1021/jm200980u
19875366 101704 0 None - 1 Human 7.6 pKd = 7.6 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 412 8 2 5 3.3 CC(C)NC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
CHEMBL29947 101704 0 None - 1 Human 7.6 pKd = 7.6 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 412 8 2 5 3.3 CC(C)NC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
44461401 105625 0 None - 1 Human 7.6 pKd = 7.6 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 454 15 3 4 5.6 CCCCCC/C(S)=N/C/C(S)=N/CC1C2CC[C@@H](O2)C1C/C=C/CCCC(=O)O 10.1021/jm00171a021
CHEMBL312360 105625 0 None - 1 Human 7.6 pKd = 7.6 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 454 15 3 4 5.6 CCCCCC/C(S)=N/C/C(S)=N/CC1C2CC[C@@H](O2)C1C/C=C/CCCC(=O)O 10.1021/jm00171a021
18675853 103195 0 None - 1 Human 8.5 pKd = 8.5 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 510 12 2 6 5.1 O=C(O)COc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1021/jm00062a013
CHEMBL30832 103195 0 None - 1 Human 8.5 pKd = 8.5 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 510 12 2 6 5.1 O=C(O)COc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1021/jm00062a013
44458568 89448 0 None - 1 Human 8.5 pKd = 8.5 Binding
Binding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligandBinding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligand
ChEMBL 466 9 2 4 5.4 O=C(O)CCc1ccccc1C[C@H]1CCC[C@@H]1c1nc(C(=O)NCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80329-7
CHEMBL23711 89448 0 None - 1 Human 8.5 pKd = 8.5 Binding
Binding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligandBinding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligand
ChEMBL 466 9 2 4 5.4 O=C(O)CCc1ccccc1C[C@H]1CCC[C@@H]1c1nc(C(=O)NCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80329-7
19875414 102809 0 None - 1 Human 8.4 pKd = 8.4 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 520 12 2 5 5.1 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCc2ccc(F)cc2)co1 10.1021/jm00062a013
CHEMBL30537 102809 0 None - 1 Human 8.4 pKd = 8.4 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 520 12 2 5 5.1 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCc2ccc(F)cc2)co1 10.1021/jm00062a013
18944131 87195 0 None - 1 Human 7.5 pKd = 7.5 Binding
In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548
ChEMBL 484 10 2 6 4.0 O=C(O)CCc1ccccc1CC1OCOC1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
CHEMBL23273 87195 0 None - 1 Human 7.5 pKd = 7.5 Binding
In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548
ChEMBL 484 10 2 6 4.0 O=C(O)CCc1ccccc1CC1OCOC1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
54669848 65454 0 None -12 2 Human 6.5 pKd = 6.5 Binding
Displacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 419 7 2 4 3.8 CC1=C(O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)CC1=O 10.1021/jm200980u
CHEMBL1829806 65454 0 None -12 2 Human 6.5 pKd = 6.5 Binding
Displacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 419 7 2 4 3.8 CC1=C(O)C(Cc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)CC1=O 10.1021/jm200980u
15462454 197041 0 None - 1 Human 7.5 pKd = 7.5 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 515 13 2 5 6.9 O=C(O)CCC/C=C(\c1ccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
CHEMBL56722 197041 0 None - 1 Human 7.5 pKd = 7.5 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 515 13 2 5 6.9 O=C(O)CCC/C=C(\c1ccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
54758053 65449 0 None -17 2 Human 6.5 pKd = 6.5 Binding
Displacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 391 8 2 5 2.2 O=S(=O)(NCCc1cccc(CCc2nn[nH]n2)c1)c1ccc(Cl)cc1 10.1021/jm200980u
CHEMBL1829801 65449 0 None -17 2 Human 6.5 pKd = 6.5 Binding
Displacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 391 8 2 5 2.2 O=S(=O)(NCCc1cccc(CCc2nn[nH]n2)c1)c1ccc(Cl)cc1 10.1021/jm200980u
54758054 65450 0 None -20 2 Human 6.5 pKd = 6.5 Binding
Displacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 420 8 3 6 1.8 O=c1c(O)c(NCc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)c1=O 10.1021/jm200980u
CHEMBL1829802 65450 0 None -20 2 Human 6.5 pKd = 6.5 Binding
Displacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assayDisplacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in QBI-HEK 293A cells after 2 hrs by scintillation proximity assay
ChEMBL 420 8 3 6 1.8 O=c1c(O)c(NCc2cccc(CCNS(=O)(=O)c3ccc(Cl)cc3)c2)c1=O 10.1021/jm200980u
44280058 99325 0 None - 1 Human 7.4 pKd = 7.4 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 536 12 2 5 6.3 CC(C)(Cc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1)C(=O)O 10.1021/jm00062a013
CHEMBL282186 99325 0 None - 1 Human 7.4 pKd = 7.4 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 536 12 2 5 6.3 CC(C)(Cc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC2CCCCC2)co1)C(=O)O 10.1021/jm00062a013
44295187 188740 0 None - 1 Human 7.4 pKd = 7.4 Binding
Tested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligandTested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligand
ChEMBL 351 9 2 3 3.3 O=C(O)CCC/C=C\C[C@H]1CCC[C@H]1NS(=O)(=O)c1ccccc1 10.1016/S0960-894X(01)80794-0
CHEMBL50507 188740 0 None - 1 Human 7.4 pKd = 7.4 Binding
Tested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligandTested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligand
ChEMBL 351 9 2 3 3.3 O=C(O)CCC/C=C\C[C@H]1CCC[C@H]1NS(=O)(=O)c1ccccc1 10.1016/S0960-894X(01)80794-0
44458583 165717 0 None - 1 Human 7.4 pKd = 7.4 Binding
Binding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligandBinding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligand
ChEMBL 466 10 2 4 5.4 C/C(Cc1ccccc1CCC(=O)O)=C(\C)c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80329-7
CHEMBL424587 165717 0 None - 1 Human 7.4 pKd = 7.4 Binding
Binding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligandBinding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligand
ChEMBL 466 10 2 4 5.4 C/C(Cc1ccccc1CCC(=O)O)=C(\C)c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80329-7
15462461 201624 0 None - 1 Human 6.4 pKd = 6.4 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 483 11 2 5 4.6 O=C(O)CCCC/C=C(\c1ccc(C2=N[C@H](C(=O)NCc3ccccc3)CO2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
CHEMBL60587 201624 0 None - 1 Human 6.4 pKd = 6.4 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 483 11 2 5 4.6 O=C(O)CCCC/C=C(\c1ccc(C2=N[C@H](C(=O)NCc3ccccc3)CO2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
44329690 107478 0 None - 1 Human 7.4 pKd = 7.4 Binding
The compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranesThe compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranes
ChEMBL 385 9 3 4 3.8 O=C(O)CCC/C=C\CC1C2CCC(O2)C1/C=N/NC(=O)Nc1ccccc1 10.1021/jm00113a030
CHEMBL318426 107478 0 None - 1 Human 7.4 pKd = 7.4 Binding
The compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranesThe compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranes
ChEMBL 385 9 3 4 3.8 O=C(O)CCC/C=C\CC1C2CCC(O2)C1/C=N/NC(=O)Nc1ccccc1 10.1021/jm00113a030
21865528 99463 5 None - 1 Human 8.4 pKd = 8.4 Binding
In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548
ChEMBL 440 11 2 5 4.1 CCCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1016/S0960-894X(00)80330-3
CHEMBL283100 99463 5 None - 1 Human 8.4 pKd = 8.4 Binding
In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548
ChEMBL 440 11 2 5 4.1 CCCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1016/S0960-894X(00)80330-3
21865528 99463 5 None - 1 Human 8.4 pKd = 8.4 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 440 11 2 5 4.1 CCCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
CHEMBL283100 99463 5 None - 1 Human 8.4 pKd = 8.4 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 440 11 2 5 4.1 CCCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
1987 1989 19 None 1 2 Rat 8.4 pKd = 8.4 Binding
Inhibition of [3H]-SQ 29,548 radioligand binding to thromboxane A2 (TXA2) receptor of human platelet membranesInhibition of [3H]-SQ 29,548 radioligand binding to thromboxane A2 (TXA2) receptor of human platelet membranes
ChEMBL 440 11 2 5 4.1 CCCCCNC(=O)c1coc(n1)[C@@H]1[C@H]2CC[C@@H]([C@@H]1Cc1ccccc1CCC(=O)O)O2 10.1016/S0960-894X(00)80658-7
3037233 1989 19 None 1 2 Rat 8.4 pKd = 8.4 Binding
Inhibition of [3H]-SQ 29,548 radioligand binding to thromboxane A2 (TXA2) receptor of human platelet membranesInhibition of [3H]-SQ 29,548 radioligand binding to thromboxane A2 (TXA2) receptor of human platelet membranes
ChEMBL 440 11 2 5 4.1 CCCCCNC(=O)c1coc(n1)[C@@H]1[C@H]2CC[C@@H]([C@@H]1Cc1ccccc1CCC(=O)O)O2 10.1016/S0960-894X(00)80658-7
CHEMBL3301673 1989 19 None 1 2 Rat 8.4 pKd = 8.4 Binding
Inhibition of [3H]-SQ 29,548 radioligand binding to thromboxane A2 (TXA2) receptor of human platelet membranesInhibition of [3H]-SQ 29,548 radioligand binding to thromboxane A2 (TXA2) receptor of human platelet membranes
ChEMBL 440 11 2 5 4.1 CCCCCNC(=O)c1coc(n1)[C@@H]1[C@H]2CC[C@@H]([C@@H]1Cc1ccccc1CCC(=O)O)O2 10.1016/S0960-894X(00)80658-7
DB12321 1989 19 None 1 2 Rat 8.4 pKd = 8.4 Binding
Inhibition of [3H]-SQ 29,548 radioligand binding to thromboxane A2 (TXA2) receptor of human platelet membranesInhibition of [3H]-SQ 29,548 radioligand binding to thromboxane A2 (TXA2) receptor of human platelet membranes
ChEMBL 440 11 2 5 4.1 CCCCCNC(=O)c1coc(n1)[C@@H]1[C@H]2CC[C@@H]([C@@H]1Cc1ccccc1CCC(=O)O)O2 10.1016/S0960-894X(00)80658-7
44461226 205827 0 None - 1 Human 8.4 pKd = 8.4 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 516 13 3 5 4.3 CC(C)(C)c1ccc(SCC(=O)NCC(=O)NCC2C3CCC(O3)C2C/C=C/CCCC(=O)O)cc1 10.1021/jm00171a021
CHEMBL83366 205827 0 None - 1 Human 8.4 pKd = 8.4 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 516 13 3 5 4.3 CC(C)(C)c1ccc(SCC(=O)NCC(=O)NCC2C3CCC(O3)C2C/C=C/CCCC(=O)O)cc1 10.1021/jm00171a021
44458582 165492 0 None - 1 Human 8.4 pKd = 8.4 Binding
Binding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligandBinding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligand
ChEMBL 480 12 2 4 6.3 O=C(O)CCc1ccccc1CC1CCC[C@H]1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/S0960-894X(00)80329-7
CHEMBL424031 165492 0 None - 1 Human 8.4 pKd = 8.4 Binding
Binding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligandBinding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligand
ChEMBL 480 12 2 4 6.3 O=C(O)CCc1ccccc1CC1CCC[C@H]1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/S0960-894X(00)80329-7
14952432 106065 0 None - 1 Human 8.4 pKd = 8.4 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 452 8 2 5 4.3 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NC2CCCCC2)co1 10.1021/jm00062a013
CHEMBL31334 106065 0 None - 1 Human 8.4 pKd = 8.4 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 452 8 2 5 4.3 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NC2CCCCC2)co1 10.1021/jm00062a013
44279724 162620 0 None - 1 Human 8.3 pKd = 8.3 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 464 12 2 5 4.1 C#CCCCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
CHEMBL416943 162620 0 None - 1 Human 8.3 pKd = 8.3 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 464 12 2 5 4.1 C#CCCCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
44279891 99173 0 None - 1 Human 8.3 pKd = 8.3 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 494 11 2 5 4.7 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC(F)(F)F)co1 10.1021/jm00062a013
CHEMBL281293 99173 0 None - 1 Human 8.3 pKd = 8.3 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 494 11 2 5 4.7 O=C(O)CCc1ccccc1CC1C2CCC(O2)C1c1nc(C(=O)NCCCCC(F)(F)F)co1 10.1021/jm00062a013
13799389 205304 0 None - 1 Human 7.4 pKd = 7.4 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 460 13 3 5 3.0 O=C(O)CCC/C=C/CC1C2CCC(O2)C1CNC(=O)CNC(=O)CSc1ccccc1 10.1021/jm00171a021
CHEMBL79278 205304 0 None - 1 Human 7.4 pKd = 7.4 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 460 13 3 5 3.0 O=C(O)CCC/C=C/CC1C2CCC(O2)C1CNC(=O)CNC(=O)CSc1ccccc1 10.1021/jm00171a021
71450971 79617 0 None - 1 Human 6.4 pKd = 6.4 Binding
Binding affinity of Thromboxane A2 (TXA2) receptor using [3H]-SQ 29,548 radioligand in washed human plateletsBinding affinity of Thromboxane A2 (TXA2) receptor using [3H]-SQ 29,548 radioligand in washed human platelets
ChEMBL 282 2 0 2 4.4 CC1(C)C2CC[C@@H](Cc3cccc4ccc(=O)oc34)C1C2 10.1016/0960-894X(95)00284-Z
CHEMBL2114959 79617 0 None - 1 Human 6.4 pKd = 6.4 Binding
Binding affinity of Thromboxane A2 (TXA2) receptor using [3H]-SQ 29,548 radioligand in washed human plateletsBinding affinity of Thromboxane A2 (TXA2) receptor using [3H]-SQ 29,548 radioligand in washed human platelets
ChEMBL 282 2 0 2 4.4 CC1(C)C2CC[C@@H](Cc3cccc4ccc(=O)oc34)C1C2 10.1016/0960-894X(95)00284-Z
18944131 87195 0 None - 1 Human 7.4 pKd = 7.4 Binding
In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548
ChEMBL 484 10 2 6 4.0 O=C(O)CCc1ccccc1CC1OCOC1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
CHEMBL23273 87195 0 None - 1 Human 7.4 pKd = 7.4 Binding
In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548
ChEMBL 484 10 2 6 4.0 O=C(O)CCc1ccccc1CC1OCOC1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
14952419 116529 0 None - 1 Human 7.4 pKd = 7.4 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 384 7 2 5 2.6 CNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
CHEMBL33621 116529 0 None - 1 Human 7.4 pKd = 7.4 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 384 7 2 5 2.6 CNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
44387219 60526 0 None - 1 Human 7.3 pKd = 7.3 Binding
Inhibition of specific binding of HSQ(5,6-di-3H-SQ 29,548) in washed plateletsInhibition of specific binding of HSQ(5,6-di-3H-SQ 29,548) in washed platelets
ChEMBL 324 11 1 3 4.3 C=CCCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL175751 60526 0 None - 1 Human 7.3 pKd = 7.3 Binding
Inhibition of specific binding of HSQ(5,6-di-3H-SQ 29,548) in washed plateletsInhibition of specific binding of HSQ(5,6-di-3H-SQ 29,548) in washed platelets
ChEMBL 324 11 1 3 4.3 C=CCCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
13799369 205568 0 None - 1 Human 7.3 pKd = 7.3 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 436 16 3 4 3.6 CCCCCCCC(=O)NCC(=O)NCC1C2CCC(O2)C1C/C=C/CCCC(=O)O 10.1021/jm00171a021
CHEMBL81263 205568 0 None - 1 Human 7.3 pKd = 7.3 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 436 16 3 4 3.6 CCCCCCCC(=O)NCC(=O)NCC1C2CCC(O2)C1C/C=C/CCCC(=O)O 10.1021/jm00171a021
14952425 163261 0 None - 1 Human 8.2 pKd = 8.2 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 510 16 2 5 6.1 CCCCCCCCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
CHEMBL418585 163261 0 None - 1 Human 8.2 pKd = 8.2 Binding
Inhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligandInhibitory binding activity against TXA2 receptor in human platelet membrane, using [3H]-SQ 29548 as the radioligand
ChEMBL 510 16 2 5 6.1 CCCCCCCCCCNC(=O)c1coc(C2C3CCC(O3)C2Cc2ccccc2CCC(=O)O)n1 10.1021/jm00062a013
44301170 200029 0 None - 1 Human 7.3 pKd = 7.3 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 531 14 2 5 6.2 O=C(O)CCCC/C=C(/c1ccc(C2=N[C@@H](C(=O)NCCCCC3CCCCC3)CO2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
CHEMBL59547 200029 0 None - 1 Human 7.3 pKd = 7.3 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 531 14 2 5 6.2 O=C(O)CCCC/C=C(/c1ccc(C2=N[C@@H](C(=O)NCCCCC3CCCCC3)CO2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
15458911 100930 0 None - 1 Human 6.3 pKd = 6.3 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 529 14 2 5 7.3 O=C(O)CCCC/C=C(/c1cccnc1)c1ccccc1-c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/s0960-894x(98)00353-9
CHEMBL293971 100930 0 None - 1 Human 6.3 pKd = 6.3 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 529 14 2 5 7.3 O=C(O)CCCC/C=C(/c1cccnc1)c1ccccc1-c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/s0960-894x(98)00353-9
19838907 207758 0 None - 1 Human 8.2 pKd = 8.2 Binding
The compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranesThe compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranes
ChEMBL 423 8 3 5 3.3 O=C(O)COc1ccccc1CC1C2CCC(O2)C1/C=N/NC(=O)Nc1ccccc1 10.1021/jm00113a030
CHEMBL95884 207758 0 None - 1 Human 8.2 pKd = 8.2 Binding
The compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranesThe compound was tested for inhibition of specific binding of [3H]-SQ 29,548 to thromboxane A2 receptor in human platelet membranes
ChEMBL 423 8 3 5 3.3 O=C(O)COc1ccccc1CC1C2CCC(O2)C1/C=N/NC(=O)Nc1ccccc1 10.1021/jm00113a030
18944163 85051 0 None - 1 Human 7.2 pKd = 7.2 Binding
Binding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligandBinding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligand
ChEMBL 492 10 2 4 5.9 O=C(O)CCc1ccccc1CC1=C(c2nc(C(=O)NCCc3ccc(Cl)cc3)co2)CCCC1 10.1016/S0960-894X(00)80329-7
CHEMBL22418 85051 0 None - 1 Human 7.2 pKd = 7.2 Binding
Binding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligandBinding affinity was determined for Thromboxane A2 receptor in human platelet membrane using [3H]SQ-29,548 radioligand
ChEMBL 492 10 2 4 5.9 O=C(O)CCc1ccccc1CC1=C(c2nc(C(=O)NCCc3ccc(Cl)cc3)co2)CCCC1 10.1016/S0960-894X(00)80329-7
15462456 197990 0 None - 1 Human 6.2 pKd = 6.2 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 529 14 2 5 7.3 O=C(O)CCCC/C=C(\c1cccnc1)c1cccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)c1 10.1016/s0960-894x(98)00353-9
CHEMBL57359 197990 0 None - 1 Human 6.2 pKd = 6.2 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 529 14 2 5 7.3 O=C(O)CCCC/C=C(\c1cccnc1)c1cccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)c1 10.1016/s0960-894x(98)00353-9
44295061 188921 0 None - 1 Human 7.2 pKd = 7.2 Binding
Tested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligandTested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligand
ChEMBL 311 10 2 3 2.6 O=C(O)CCC/C=C/CCCNS(=O)(=O)c1ccccc1 10.1016/S0960-894X(01)80794-0
CHEMBL50785 188921 0 None - 1 Human 7.2 pKd = 7.2 Binding
Tested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligandTested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligand
ChEMBL 311 10 2 3 2.6 O=C(O)CCC/C=C/CCCNS(=O)(=O)c1ccccc1 10.1016/S0960-894X(01)80794-0
44295209 101868 0 None - 1 Human 8.1 pKd = 8.1 Binding
Tested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligandTested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligand
ChEMBL 351 9 2 3 3.3 O=C(O)CCC/C=C\C[C@H]1CCC[C@@H]1NS(=O)(=O)c1ccccc1 10.1016/S0960-894X(01)80794-0
CHEMBL300681 101868 0 None - 1 Human 8.1 pKd = 8.1 Binding
Tested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligandTested for binding affinity against platelet TXA2 receptor in washed human platelets using [125I]BOP as radioligand
ChEMBL 351 9 2 3 3.3 O=C(O)CCC/C=C\C[C@H]1CCC[C@@H]1NS(=O)(=O)c1ccccc1 10.1016/S0960-894X(01)80794-0
71454591 79713 0 None - 1 Human 8.1 pKd = 8.1 Binding
Binding affinity was determined for Thromboxane A2 receptor in human platelet membrane in presence of [3H]-SQ-29,548 radioligandBinding affinity was determined for Thromboxane A2 receptor in human platelet membrane in presence of [3H]-SQ-29,548 radioligand
ChEMBL 509 11 2 6 4.7 O=C(O)CCc1ccccc1C(=O)N1C(=O)CCC1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/S0960-894X(00)80328-5
CHEMBL2115542 79713 0 None - 1 Human 8.1 pKd = 8.1 Binding
Binding affinity was determined for Thromboxane A2 receptor in human platelet membrane in presence of [3H]-SQ-29,548 radioligandBinding affinity was determined for Thromboxane A2 receptor in human platelet membrane in presence of [3H]-SQ-29,548 radioligand
ChEMBL 509 11 2 6 4.7 O=C(O)CCc1ccccc1C(=O)N1C(=O)CCC1c1nc(C(=O)NCCCCC2CCCCC2)co1 10.1016/S0960-894X(00)80328-5
44387220 62392 0 None - 1 Human 7.1 pKd = 7.1 Binding
Inhibition of specific binding of HSQ(5,6-di-3H-SQ 29,548) in washed plateletsInhibition of specific binding of HSQ(5,6-di-3H-SQ 29,548) in washed platelets
ChEMBL 310 10 1 3 3.9 C=CCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL177949 62392 0 None - 1 Human 7.1 pKd = 7.1 Binding
Inhibition of specific binding of HSQ(5,6-di-3H-SQ 29,548) in washed plateletsInhibition of specific binding of HSQ(5,6-di-3H-SQ 29,548) in washed platelets
ChEMBL 310 10 1 3 3.9 C=CCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
15462460 201844 0 None - 1 Human 6.1 pKd = 6.1 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 445 11 2 5 5.0 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCC3CC3)co2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
CHEMBL60710 201844 0 None - 1 Human 6.1 pKd = 6.1 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 445 11 2 5 5.0 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCC3CC3)co2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
44210947 99116 0 None - 1 Human 8.1 pKd = 8.1 Binding
In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548
ChEMBL 498 10 2 6 4.2 O=C(O)CCc1ccccc1CC1COCOC1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
CHEMBL280890 99116 0 None - 1 Human 8.1 pKd = 8.1 Binding
In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548
ChEMBL 498 10 2 6 4.2 O=C(O)CCc1ccccc1CC1COCOC1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
18944131 87195 0 None - 1 Human 8.1 pKd = 8.1 Binding
In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548
ChEMBL 484 10 2 6 4.0 O=C(O)CCc1ccccc1CC1OCOC1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
CHEMBL23273 87195 0 None - 1 Human 8.1 pKd = 8.1 Binding
In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548In vitro binding affinity was determined for platelet thromboxane receptor in presence of [3H]-SQ 29548
ChEMBL 484 10 2 6 4.0 O=C(O)CCc1ccccc1CC1OCOC1c1nc(C(=O)NCCc2ccc(Cl)cc2)co1 10.1016/S0960-894X(00)80330-3
13799367 205673 0 None - 1 Human 8.1 pKd = 8.1 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 450 17 3 4 4.0 CCCCCCCCC(=O)NCC(=O)NCC1C2CCC(O2)C1C/C=C/CCCC(=O)O 10.1021/jm00171a021
CHEMBL82146 205673 0 None - 1 Human 8.1 pKd = 8.1 Binding
Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.Binding affinity was determined from the inhibition of [3H]-SQ 29,548 binding to Thromboxane A2 receptor in human platelet membranes.
ChEMBL 450 17 3 4 4.0 CCCCCCCCC(=O)NCC(=O)NCC1C2CCC(O2)C1C/C=C/CCCC(=O)O 10.1021/jm00171a021
5284442 97175 30 None -1 2 Human 5.1 pKd = 5.1 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 281 7 1 2 4.2 O=C(O)CCCC/C=C(\c1ccccc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
CHEMBL26820 97175 30 None -1 2 Human 5.1 pKd = 5.1 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 281 7 1 2 4.2 O=C(O)CCCC/C=C(\c1ccccc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
44301140 101080 0 None - 1 Human 6.1 pKd = 6.1 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 531 14 2 5 6.2 O=C(O)CCCC/C=C(\c1cccnc1)c1cccc(C2=N[C@@H](C(=O)NCCCCC3CCCCC3)CO2)c1 10.1016/s0960-894x(98)00353-9
CHEMBL294850 101080 0 None - 1 Human 6.1 pKd = 6.1 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 531 14 2 5 6.2 O=C(O)CCCC/C=C(\c1cccnc1)c1cccc(C2=N[C@@H](C(=O)NCCCCC3CCCCC3)CO2)c1 10.1016/s0960-894x(98)00353-9
9958626 101703 0 None - 1 Human 8.0 pKd = 8 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 529 14 2 5 7.3 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
CHEMBL299467 101703 0 None - 1 Human 8.0 pKd = 8 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 529 14 2 5 7.3 O=C(O)CCCC/C=C(\c1ccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
15852309 163216 0 None - 1 Human 7.0 pKd = 7.0 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 501 12 2 5 6.5 O=C(O)CC/C=C(\c1ccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
CHEMBL418323 163216 0 None - 1 Human 7.0 pKd = 7.0 Binding
In vitro thromboxane receptor antagonism was determined using a human platelet binding assayIn vitro thromboxane receptor antagonism was determined using a human platelet binding assay
ChEMBL 501 12 2 5 6.5 O=C(O)CC/C=C(\c1ccc(-c2nc(C(=O)NCCCCC3CCCCC3)co2)cc1)c1cccnc1 10.1016/s0960-894x(98)00353-9
44385711 60457 0 None - 1 Human 7.0 pKd = 7.0 Binding
Inhibition of specific binding of HSQ(5,6-di-3H-SQ 29,548) in washed plateletsInhibition of specific binding of HSQ(5,6-di-3H-SQ 29,548) in washed platelets
ChEMBL 312 10 1 3 4.1 CCCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
CHEMBL175303 60457 0 None - 1 Human 7.0 pKd = 7.0 Binding
Inhibition of specific binding of HSQ(5,6-di-3H-SQ 29,548) in washed plateletsInhibition of specific binding of HSQ(5,6-di-3H-SQ 29,548) in washed platelets
ChEMBL 312 10 1 3 4.1 CCCSCC1C2CCC(O2)C1C/C=C\CCCC(=O)O 10.1021/jm00125a009
123879 3287 82 None 3 4 Human 9.2 pKi = 9.2 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2010.11.015
1910 3287 82 None 3 4 Human 9.2 pKi = 9.2 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2010.11.015
1911 3287 82 None 3 4 Human 9.2 pKi = 9.2 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2010.11.015
2354 3287 82 None 3 4 Human 9.2 pKi = 9.2 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2010.11.015
CHEMBL361812 3287 82 None 3 4 Human 9.2 pKi = 9.2 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2010.11.015
DB13036 3287 82 None 3 4 Human 9.2 pKi = 9.2 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1016/j.bmcl.2010.11.015
11597294 166176 4 None 1 8 Human 9.1 pKi = 9.1 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 435 4 1 2 5.7 O=C(O)C[C@H]1CCc2c1n(Cc1ccc(Cl)cc1)c1c(Br)cc(F)cc21 10.1021/jm0603668
CHEMBL426387 166176 4 None 1 8 Human 9.1 pKi = 9.1 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 435 4 1 2 5.7 O=C(O)C[C@H]1CCc2c1n(Cc1ccc(Cl)cc1)c1c(Br)cc(F)cc21 10.1021/jm0603668
10369249 167872 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 515 6 2 5 5.7 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc(C(=O)NCc4ccccc4)ccc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL431075 167872 0 None - 1 Human 9.0 pKi = 9.0 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 515 6 2 5 5.7 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc(C(=O)NCc4ccccc4)ccc31)c1ccccc1CO2 10.1021/jm00096a017
14372497 77306 0 None 6 2 Human 8.8 pKi = 8.8 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 389 4 1 2 5.5 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1c(F)cc(F)cc21 10.1016/j.bmcl.2006.02.062
CHEMBL208260 77306 0 None 6 2 Human 8.8 pKi = 8.8 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 389 4 1 2 5.5 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1c(F)cc(F)cc21 10.1016/j.bmcl.2006.02.062
10365193 165733 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 427 4 1 6 4.7 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc([N+](=O)[O-])ccc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL424621 165733 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 427 4 1 6 4.7 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc([N+](=O)[O-])ccc31)c1ccccc1CO2 10.1021/jm00096a017
10094735 10167 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 439 6 2 5 4.9 Cc1ccsc1C(=O)NCCSC1c2ccccc2COc2ccc(C(=O)O)cc21 10.1021/jm00096a016
CHEMBL115924 10167 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 439 6 2 5 4.9 Cc1ccsc1C(=O)NCCSC1c2ccccc2COc2ccc(C(=O)O)cc21 10.1021/jm00096a016
9984004 11327 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 515 6 2 5 5.7 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ccc(C(=O)NCc4ccccc4)cc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL117943 11327 0 None - 1 Human 8.0 pKi = 8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 515 6 2 5 5.7 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ccc(C(=O)NCc4ccccc4)cc31)c1ccccc1CO2 10.1021/jm00096a017
11495634 14905 13 None -1 4 Human 8.0 pKi = 8 Binding
Inhibition of TP receptorInhibition of TP receptor
ChEMBL 405 6 1 3 5.4 O=C(O)c1cccc(Cc2cc(Cl)ccc2OCc2ccc(Cl)cc2F)n1 10.1016/j.bmcl.2009.02.112
CHEMBL1207972 14905 13 None -1 4 Human 8.0 pKi = 8 Binding
Inhibition of TP receptorInhibition of TP receptor
ChEMBL 405 6 1 3 5.4 O=C(O)c1cccc(Cc2cc(Cl)ccc2OCc2ccc(Cl)cc2F)n1 10.1016/j.bmcl.2009.02.112
CHEMBL467114 14905 13 None -1 4 Human 8.0 pKi = 8 Binding
Inhibition of TP receptorInhibition of TP receptor
ChEMBL 405 6 1 3 5.4 O=C(O)c1cccc(Cc2cc(Cl)ccc2OCc2ccc(Cl)cc2F)n1 10.1016/j.bmcl.2009.02.112
10094735 10167 0 None - 1 Human 8.0 pKi = 8 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 439 6 2 5 4.9 Cc1ccsc1C(=O)NCCSC1c2ccccc2COc2ccc(C(=O)O)cc21 10.1021/jm00096a016
CHEMBL115924 10167 0 None - 1 Human 8.0 pKi = 8 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 439 6 2 5 4.9 Cc1ccsc1C(=O)NCCSC1c2ccccc2COc2ccc(C(=O)O)cc21 10.1021/jm00096a016
53323267 56824 0 None -1 2 Human 8.0 pKi = 8.0 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 402 5 2 4 2.7 O=C(O)Cc1c2n(c3ccccc13)C[C@H](NS(=O)(=O)c1ccc(F)cc1)CC2 10.1016/j.bmcl.2010.11.015
CHEMBL1643785 56824 0 None -1 2 Human 8.0 pKi = 8.0 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 402 5 2 4 2.7 O=C(O)Cc1c2n(c3ccccc13)C[C@H](NS(=O)(=O)c1ccc(F)cc1)CC2 10.1016/j.bmcl.2010.11.015
9868012 123849 0 None -50 2 Human 7.0 pKi = 7 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 420 6 1 3 7.0 O=C(O)c1cccc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)c1 10.1016/j.bmcl.2004.12.005
CHEMBL362543 123849 0 None -50 2 Human 7.0 pKi = 7 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 420 6 1 3 7.0 O=C(O)c1cccc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)c1 10.1016/j.bmcl.2004.12.005
44411552 77086 0 None -24 2 Human 7.0 pKi = 7 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 524 6 1 4 4.9 CN(C)S(=O)(=O)c1cc(Br)c2c(c1)c1c(n2Cc2ccc(Cl)cc2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
CHEMBL207451 77086 0 None -24 2 Human 7.0 pKi = 7 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 524 6 1 4 4.9 CN(C)S(=O)(=O)c1cc(Br)c2c(c1)c1c(n2Cc2ccc(Cl)cc2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
10548754 16383 0 None -154 2 Human 6.0 pKi = 6 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 396 2 4 4 2.7 Nc1ccc(CC2NCCc3cc(O)c(O)cc32)cc1I 10.1021/jm960208o
CHEMBL122990 16383 0 None -154 2 Human 6.0 pKi = 6 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 396 2 4 4 2.7 Nc1ccc(CC2NCCc3cc(O)c(O)cc32)cc1I 10.1021/jm960208o
53321924 56835 0 None -190 3 Human 6.0 pKi = 6.0 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 432 5 1 4 3.6 CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(Cl)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL1643796 56835 0 None -190 3 Human 6.0 pKi = 6.0 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 432 5 1 4 3.6 CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(Cl)cc1 10.1016/j.bmcl.2010.11.015
35028115 141999 5 None -109 2 Human 6.0 pKi = 6.0 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 435 5 1 4 4.4 CS(=O)(=O)c1cc(F)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@H](CC(=O)O)CC3 10.1021/jm0603668
CHEMBL387477 141999 5 None -109 2 Human 6.0 pKi = 6.0 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 435 5 1 4 4.4 CS(=O)(=O)c1cc(F)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@H](CC(=O)O)CC3 10.1021/jm0603668
3078930 164902 5 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 449 7 2 5 4.5 COc1ccccc1C(=O)NCCSC1c2ccccc2COc2ccc(C(=O)O)cc21 10.1021/jm00096a016
CHEMBL422253 164902 5 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 449 7 2 5 4.5 COc1ccccc1C(=O)NCCSC1c2ccccc2COc2ccc(C(=O)O)cc21 10.1021/jm00096a016
10047807 9793 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 421 5 2 4 3.7 O=C(O)c1ccc2c(c1)/C(=C/CNS(=O)(=O)c1ccccc1)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL113670 9793 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 421 5 2 4 3.7 O=C(O)c1ccc2c(c1)/C(=C/CNS(=O)(=O)c1ccccc1)c1ccccc1CO2 10.1021/jm00096a017
3078930 164902 5 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 449 7 2 5 4.5 COc1ccccc1C(=O)NCCSC1c2ccccc2COc2ccc(C(=O)O)cc21 10.1021/jm00096a016
CHEMBL422253 164902 5 None - 1 Human 8.0 pKi = 8.0 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 449 7 2 5 4.5 COc1ccccc1C(=O)NCCSC1c2ccccc2COc2ccc(C(=O)O)cc21 10.1021/jm00096a016
14953108 98215 0 None - 1 Human 8.0 pKi = 8.0 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 418 6 1 3 5.0 CC(C)(CC(=O)O)Cc1nc2ccccc2n1Cc1ccc(Br)cc1F 10.1021/jm00061a008
CHEMBL274287 98215 0 None - 1 Human 8.0 pKi = 8.0 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 418 6 1 3 5.0 CC(C)(CC(=O)O)Cc1nc2ccccc2n1Cc1ccc(Br)cc1F 10.1021/jm00061a008
10181442 96339 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 435 5 1 4 4.4 CS(=O)(=O)c1cc(F)cc2c1c(Cc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL261501 96339 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 435 5 1 4 4.4 CS(=O)(=O)c1cc(F)cc2c1c(Cc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
44411606 77153 0 None -112 2 Human 6.0 pKi = 6.0 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 442 5 1 5 4.1 CS(=O)(=O)c1cc(C#N)c2c(c1)c1c(n2Cc2ccc(Cl)cc2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
CHEMBL207805 77153 0 None -112 2 Human 6.0 pKi = 6.0 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 442 5 1 5 4.1 CS(=O)(=O)c1cc(C#N)c2c(c1)c1c(n2Cc2ccc(Cl)cc2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
9895436 107016 0 None -61 7 Human 6.0 pKi = 6.0 Binding
Compound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assayCompound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assay
ChEMBL 628 8 1 4 7.4 CC(C)(Cc1ccccc1)C(=O)NS(=O)(=O)c1ccccc1-c1ccc(CN2C(=O)c3ccccc3CCc3ccccc32)cc1 10.1016/s0960-894x(99)00465-5
CHEMBL315391 107016 0 None -61 7 Human 6.0 pKi = 6.0 Binding
Compound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assayCompound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assay
ChEMBL 628 8 1 4 7.4 CC(C)(Cc1ccccc1)C(=O)NS(=O)(=O)c1ccccc1-c1ccc(CN2C(=O)c3ccccc3CCc3ccccc32)cc1 10.1016/s0960-894x(99)00465-5
44338286 6230 0 None -85 2 Human 4.9 pKi = 4.9 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 422 6 1 4 6.3 CC(C)(O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
CHEMBL108146 6230 0 None -85 2 Human 4.9 pKi = 4.9 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 422 6 1 4 6.3 CC(C)(O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
10024655 110596 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 412 4 1 5 4.8 COc1ccc2ncn(C/C=C3\c4ccccc4COc4ccc(C(=O)O)cc43)c2c1 10.1021/jm00096a017
CHEMBL325523 110596 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 412 4 1 5 4.8 COc1ccc2ncn(C/C=C3\c4ccccc4COc4ccc(C(=O)O)cc43)c2c1 10.1021/jm00096a017
14953092 60450 0 None - 1 Human 7.9 pKi = 7.9 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 424 6 1 3 6.1 CC(C)(CC(=O)O)Cc1nc2cc(Cl)ccc2n1Cc1ccc(Cl)c(Cl)c1 10.1021/jm00061a008
CHEMBL17528 60450 0 None - 1 Human 7.9 pKi = 7.9 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 424 6 1 3 6.1 CC(C)(CC(=O)O)Cc1nc2cc(Cl)ccc2n1Cc1ccc(Cl)c(Cl)c1 10.1021/jm00061a008
14953089 61062 0 None - 1 Human 7.9 pKi = 7.9 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 418 6 1 3 5.0 CC(C)(CC(=O)O)Cc1nc2cc(F)ccc2n1Cc1ccc(Br)cc1 10.1021/jm00061a008
CHEMBL17640 61062 0 None - 1 Human 7.9 pKi = 7.9 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 418 6 1 3 5.0 CC(C)(CC(=O)O)Cc1nc2cc(F)ccc2n1Cc1ccc(Br)cc1 10.1021/jm00061a008
10207799 65075 0 None -28 2 Human 6.9 pKi = 6.9 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 475 6 1 4 7.3 OC(c1cncc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)c1)C(F)(F)F 10.1016/j.bmcl.2004.12.005
CHEMBL182368 65075 0 None -28 2 Human 6.9 pKi = 6.9 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 475 6 1 4 7.3 OC(c1cncc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)c1)C(F)(F)F 10.1016/j.bmcl.2004.12.005
44392527 122901 0 None -97 2 Human 5.9 pKi = 5.9 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 524 8 1 4 8.2 CC(NC(=O)c1cccc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)c1)c1cccnc1 10.1016/j.bmcl.2004.12.005
CHEMBL360592 122901 0 None -97 2 Human 5.9 pKi = 5.9 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 524 8 1 4 8.2 CC(NC(=O)c1cccc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)c1)c1cccnc1 10.1016/j.bmcl.2004.12.005
11408533 141327 0 None -467 3 Human 5.9 pKi = 5.9 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 459 6 1 5 4.5 CC(=O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1016/j.bmcl.2006.02.062
CHEMBL383484 141327 0 None -467 3 Human 5.9 pKi = 5.9 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 459 6 1 5 4.5 CC(=O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1016/j.bmcl.2006.02.062
11408533 141327 0 None -467 3 Human 5.9 pKi = 5.9 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 459 6 1 5 4.5 CC(=O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1021/jm0603668
CHEMBL383484 141327 0 None -467 3 Human 5.9 pKi = 5.9 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 459 6 1 5 4.5 CC(=O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1021/jm0603668
11189801 189612 0 None -5888 2 Human 4.9 pKi = 4.9 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 436 5 1 6 4.2 CS(=O)(=O)c1nccc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL514802 189612 0 None -5888 2 Human 4.9 pKi = 4.9 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 436 5 1 6 4.2 CS(=O)(=O)c1nccc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
53323268 56827 0 None -251 3 Human 5.9 pKi = 5.9 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 456 7 1 4 3.8 O=C(O)Cc1c2n(c3ccccc13)C[C@H](N(CC1CC1)S(=O)(=O)c1ccc(F)cc1)CC2 10.1016/j.bmcl.2010.11.015
CHEMBL1643788 56827 0 None -251 3 Human 5.9 pKi = 5.9 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 456 7 1 4 3.8 O=C(O)Cc1c2n(c3ccccc13)C[C@H](N(CC1CC1)S(=O)(=O)c1ccc(F)cc1)CC2 10.1016/j.bmcl.2010.11.015
14953096 64270 0 None - 1 Human 7.9 pKi = 7.9 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 434 6 1 3 5.5 CC(C)(CC(=O)O)Cc1nc2cc(Cl)ccc2n1Cc1ccc(Br)cc1 10.1021/jm00061a008
CHEMBL18093 64270 0 None - 1 Human 7.9 pKi = 7.9 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 434 6 1 3 5.5 CC(C)(CC(=O)O)Cc1nc2cc(Cl)ccc2n1Cc1ccc(Br)cc1 10.1021/jm00061a008
44591807 192567 0 None -6 2 Human 7.9 pKi = 7.9 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 448 5 1 4 7.0 CC(C)c1ccnc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL521290 192567 0 None -6 2 Human 7.9 pKi = 7.9 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 448 5 1 4 7.0 CC(C)c1ccnc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
16049493 78270 0 None -75 2 Human 6.9 pKi = 6.9 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 415 5 1 3 5.0 C[S@+]([O-])c1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
CHEMBL210707 78270 0 None -75 2 Human 6.9 pKi = 6.9 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 415 5 1 3 5.0 C[S@+]([O-])c1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
10409291 163866 0 None - 1 Human 5.9 pKi = 5.9 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 410 3 1 4 5.4 Cc1cc2ncn(C/C=C3\c4cc(C(=O)O)ccc4COc4ccccc43)c2cc1C 10.1021/jm00096a017
CHEMBL420678 163866 0 None - 1 Human 5.9 pKi = 5.9 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 410 3 1 4 5.4 Cc1cc2ncn(C/C=C3\c4cc(C(=O)O)ccc4COc4ccccc43)c2cc1C 10.1021/jm00096a017
51550 205750 14 None -11 2 Human 5.9 pKi = 5.9 Binding
Compound was tested for its binding affinity at Thromboxane A2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets at 0.1 uMCompound was tested for its binding affinity at Thromboxane A2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets at 0.1 uM
ChEMBL 335 8 2 4 1.7 O=C(O)COc1ccc(CCNS(=O)(=O)c2ccccc2)cc1 10.1021/jm00096a016
CHEMBL8273 205750 14 None -11 2 Human 5.9 pKi = 5.9 Binding
Compound was tested for its binding affinity at Thromboxane A2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets at 0.1 uMCompound was tested for its binding affinity at Thromboxane A2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets at 0.1 uM
ChEMBL 335 8 2 4 1.7 O=C(O)COc1ccc(CCNS(=O)(=O)c2ccccc2)cc1 10.1021/jm00096a016
51550 205750 14 None -11 2 Human 5.9 pKi = 5.9 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 335 8 2 4 1.7 O=C(O)COc1ccc(CCNS(=O)(=O)c2ccccc2)cc1 10.1021/jm00096a016
CHEMBL8273 205750 14 None -11 2 Human 5.9 pKi = 5.9 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 335 8 2 4 1.7 O=C(O)COc1ccc(CCNS(=O)(=O)c2ccccc2)cc1 10.1021/jm00096a016
53321923 56820 0 None -234 3 Human 5.9 pKi = 5.9 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 484 5 1 4 4.4 CN([C@@H]1CCc2c(CC(=O)O)c3c(Cl)cc(Cl)cc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL1643781 56820 0 None -234 3 Human 5.9 pKi = 5.9 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 484 5 1 4 4.4 CN([C@@H]1CCc2c(CC(=O)O)c3c(Cl)cc(Cl)cc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
53322785 56829 0 None -363 3 Human 5.9 pKi = 5.9 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 484 6 1 4 4.0 O=C(O)Cc1c2n(c3ccccc13)C[C@H](N(CC(F)(F)F)S(=O)(=O)c1ccc(F)cc1)CC2 10.1016/j.bmcl.2010.11.015
CHEMBL1643790 56829 0 None -363 3 Human 5.9 pKi = 5.9 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 484 6 1 4 4.0 O=C(O)Cc1c2n(c3ccccc13)C[C@H](N(CC(F)(F)F)S(=O)(=O)c1ccc(F)cc1)CC2 10.1016/j.bmcl.2010.11.015
10136631 161234 1 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 415 5 1 3 6.4 O=C(O)CC1CCn2c1c(Sc1ccc(Cl)cc1)c1c(C3CC3)cc(F)cc12 10.1016/j.bmcl.2008.03.015
CHEMBL411847 161234 1 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 415 5 1 3 6.4 O=C(O)CC1CCn2c1c(Sc1ccc(Cl)cc1)c1c(C3CC3)cc(F)cc12 10.1016/j.bmcl.2008.03.015
11384493 3837 38 None -1071 3 Human 5.9 pKi = 5.9 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 416 5 1 4 3.0 OC(=O)Cn1c2CCC(Cc2c2c1cccc2)N(S(=O)(=O)c1ccc(cc1)F)C 10.1016/j.bmcl.2010.11.015
1905 3837 38 None -1071 3 Human 5.9 pKi = 5.9 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 416 5 1 4 3.0 OC(=O)Cn1c2CCC(Cc2c2c1cccc2)N(S(=O)(=O)c1ccc(cc1)F)C 10.1016/j.bmcl.2010.11.015
CHEMBL1643768 3837 38 None -1071 3 Human 5.9 pKi = 5.9 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 416 5 1 4 3.0 OC(=O)Cn1c2CCC(Cc2c2c1cccc2)N(S(=O)(=O)c1ccc(cc1)F)C 10.1016/j.bmcl.2010.11.015
11755897 9989 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 505 7 2 5 5.2 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccc3ccccc3c1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL114838 9989 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 505 7 2 5 5.2 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccc3ccccc3c1)c1ccccc1CO2 10.1021/jm00096a016
10028935 111331 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 500 8 2 7 4.0 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1cccc([N+](=O)[O-])c1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL326808 111331 0 None - 1 Human 7.9 pKi = 7.9 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 500 8 2 7 4.0 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1cccc([N+](=O)[O-])c1)c1ccccc1CO2 10.1021/jm00096a016
11269563 141610 0 None -12 5 Human 7.9 pKi = 7.9 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 399 5 1 3 5.2 CC(=O)c1cc(F)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1021/jm0603668
CHEMBL385126 141610 0 None -12 5 Human 7.9 pKi = 7.9 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 399 5 1 3 5.2 CC(=O)c1cc(F)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1021/jm0603668
11755897 9989 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 505 7 2 5 5.2 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccc3ccccc3c1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL114838 9989 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 505 7 2 5 5.2 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccc3ccccc3c1)c1ccccc1CO2 10.1021/jm00096a016
10028935 111331 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 500 8 2 7 4.0 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1cccc([N+](=O)[O-])c1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL326808 111331 0 None - 1 Human 7.9 pKi = 7.9 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 500 8 2 7 4.0 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1cccc([N+](=O)[O-])c1)c1ccccc1CO2 10.1021/jm00096a016
44392460 123945 0 None -11 3 Human 6.9 pKi = 6.9 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 421 6 1 4 6.4 O=C(O)c1cccc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)n1 10.1016/j.bmcl.2004.12.005
CHEMBL362851 123945 0 None -11 3 Human 6.9 pKi = 6.9 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 421 6 1 4 6.4 O=C(O)c1cccc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)n1 10.1016/j.bmcl.2004.12.005
44411890 77277 0 None -36 2 Human 6.9 pKi = 6.9 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 491 7 1 3 6.5 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1c([S+]([O-])Cc3ccccc3)cccc21 10.1016/j.bmcl.2006.02.062
CHEMBL208083 77277 0 None -36 2 Human 6.9 pKi = 6.9 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 491 7 1 3 6.5 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1c([S+]([O-])Cc3ccccc3)cccc21 10.1016/j.bmcl.2006.02.062
14953120 59570 0 None - 1 Human 6.9 pKi = 6.9 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 372 4 1 3 4.8 O=C(O)[C@H]1CCC[C@@H]1c1nc2cc(F)ccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
CHEMBL17178 59570 0 None - 1 Human 6.9 pKi = 6.9 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 372 4 1 3 4.8 O=C(O)[C@H]1CCC[C@@H]1c1nc2cc(F)ccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
10789142 114194 0 None -190 2 Human 5.8 pKi = 5.8 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 438 3 4 4 3.1 CC(=O)Nc1ccc(CC2NCCc3cc(O)c(O)cc32)cc1I 10.1021/jm960208o
CHEMBL332964 114194 0 None -190 2 Human 5.8 pKi = 5.8 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 438 3 4 4 3.1 CC(=O)Nc1ccc(CC2NCCc3cc(O)c(O)cc32)cc1I 10.1021/jm960208o
10074701 170078 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 500 8 2 7 4.0 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1[N+](=O)[O-])c1ccccc1CO2 10.1021/jm00096a016
CHEMBL444330 170078 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 500 8 2 7 4.0 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1[N+](=O)[O-])c1ccccc1CO2 10.1021/jm00096a016
9978044 10103 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 396 3 1 4 5.1 Cc1ccc2c(c1)ncn2C/C=C1\c2ccccc2COc2ccc(C(=O)O)cc21 10.1021/jm00096a017
CHEMBL115536 10103 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 396 3 1 4 5.1 Cc1ccc2c(c1)ncn2C/C=C1\c2ccccc2COc2ccc(C(=O)O)cc21 10.1021/jm00096a017
15025390 14799 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 382 3 1 4 4.8 O=C(O)c1ccc2c(c1)/C(=C\Cn1cnc3ccccc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL1206916 14799 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 382 3 1 4 4.8 O=C(O)c1ccc2c(c1)/C(=C\Cn1cnc3ccccc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL324972 14799 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 382 3 1 4 4.8 O=C(O)c1ccc2c(c1)/C(=C\Cn1cnc3ccccc31)c1ccccc1CO2 10.1021/jm00096a017
10093386 113395 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 416 3 1 4 5.4 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ccc(Cl)cc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL331833 113395 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 416 3 1 4 5.4 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ccc(Cl)cc31)c1ccccc1CO2 10.1021/jm00096a017
71460870 82573 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to TXA2 receptor receptorBinding affinity to TXA2 receptor receptor
ChEMBL 396 4 1 4 4.7 O=C(O)Cc1ccc2c(c1)/C(=C/Cn1cnc3ccccc31)c1ccccc1CO2 10.1021/jm300682j
CHEMBL2178581 82573 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to TXA2 receptor receptorBinding affinity to TXA2 receptor receptor
ChEMBL 396 4 1 4 4.7 O=C(O)Cc1ccc2c(c1)/C(=C/Cn1cnc3ccccc31)c1ccccc1CO2 10.1021/jm300682j
10249316 72216 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition constant against thromboxane A2 receptor to prostaglandin H2 receptorInhibition constant against thromboxane A2 receptor to prostaglandin H2 receptor
ChEMBL 382 3 1 4 4.8 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ccccc31)c1ccccc1CO2 10.1021/jm058225d
CHEMBL198104 72216 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition constant against thromboxane A2 receptor to prostaglandin H2 receptorInhibition constant against thromboxane A2 receptor to prostaglandin H2 receptor
ChEMBL 382 3 1 4 4.8 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ccccc31)c1ccccc1CO2 10.1021/jm058225d
10074701 170078 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 500 8 2 7 4.0 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1[N+](=O)[O-])c1ccccc1CO2 10.1021/jm00096a016
CHEMBL444330 170078 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 500 8 2 7 4.0 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1[N+](=O)[O-])c1ccccc1CO2 10.1021/jm00096a016
14953088 98682 0 None - 1 Human 7.8 pKi = 7.8 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 436 6 1 3 5.2 CC(C)(CC(=O)O)Cc1nc2cc(F)ccc2n1Cc1ccc(Br)cc1F 10.1021/jm00061a008
CHEMBL277516 98682 0 None - 1 Human 7.8 pKi = 7.8 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 436 6 1 3 5.2 CC(C)(CC(=O)O)Cc1nc2cc(F)ccc2n1Cc1ccc(Br)cc1F 10.1021/jm00061a008
10406932 99016 1 None - 1 Human 7.8 pKi = 7.8 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 371 4 1 2 5.4 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1ccc(F)cc21 10.1021/jm00061a008
CHEMBL280107 99016 1 None - 1 Human 7.8 pKi = 7.8 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 371 4 1 2 5.4 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1ccc(F)cc21 10.1021/jm00061a008
9910826 66292 0 None -2 2 Human 6.8 pKi = 6.8 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 434 7 1 3 6.9 O=C(O)Cc1cccc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)c1 10.1016/j.bmcl.2004.12.005
CHEMBL184779 66292 0 None -2 2 Human 6.8 pKi = 6.8 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 434 7 1 3 6.9 O=C(O)Cc1cccc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)c1 10.1016/j.bmcl.2004.12.005
11318288 67951 0 None 5 2 Human 6.8 pKi = 6.8 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 516 10 2 5 6.2 O=C(O)COc1cccc2c(CCSC(c3ccccc3)(c3ccccc3)C(F)(F)F)c(CO)oc12 10.1021/jm050194z
CHEMBL191118 67951 0 None 5 2 Human 6.8 pKi = 6.8 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 516 10 2 5 6.2 O=C(O)COc1cccc2c(CCSC(c3ccccc3)(c3ccccc3)C(F)(F)F)c(CO)oc12 10.1021/jm050194z
44338263 7327 0 None -5 2 Human 5.8 pKi = 5.8 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 408 6 1 4 6.1 CC(O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
CHEMBL108616 7327 0 None -5 2 Human 5.8 pKi = 5.8 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 408 6 1 4 6.1 CC(O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
44338272 7849 0 None -4 2 Human 5.8 pKi = 5.8 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 436 7 0 5 5.7 COC(=O)Cc1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
CHEMBL108979 7849 0 None -4 2 Human 5.8 pKi = 5.8 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 436 7 0 5 5.7 COC(=O)Cc1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
9939791 161918 0 None -125 8 Human 5.8 pKi = 5.8 Binding
Compound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assayCompound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assay
ChEMBL 684 8 1 5 7.2 CO[C@](C(=O)NS(=O)(=O)c1ccccc1-c1ccc(CN2C(=O)c3ccccc3CCc3ccccc32)cc1)(c1ccccc1)C(F)(F)F 10.1016/s0960-894x(99)00465-5
CHEMBL415310 161918 0 None -125 8 Human 5.8 pKi = 5.8 Binding
Compound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assayCompound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assay
ChEMBL 684 8 1 5 7.2 CO[C@](C(=O)NS(=O)(=O)c1ccccc1-c1ccc(CN2C(=O)c3ccccc3CCc3ccccc32)cc1)(c1ccccc1)C(F)(F)F 10.1016/s0960-894x(99)00465-5
53324589 56813 0 None -891 3 Human 5.8 pKi = 5.8 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 484 5 1 4 4.1 CN([C@@H]1CCc2c(CC(=O)O)c3ccc(C(F)(F)F)cc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL1643775 56813 0 None -891 3 Human 5.8 pKi = 5.8 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 484 5 1 4 4.1 CN([C@@H]1CCc2c(CC(=O)O)c3ccc(C(F)(F)F)cc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
53317718 56828 0 None -1122 3 Human 5.8 pKi = 5.8 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 510 7 1 4 4.8 O=C(O)Cc1c2n(c3ccccc13)C[C@H](N(Cc1ccc(F)cc1)S(=O)(=O)c1ccc(F)cc1)CC2 10.1016/j.bmcl.2010.11.015
CHEMBL1643789 56828 0 None -1122 3 Human 5.8 pKi = 5.8 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 510 7 1 4 4.8 O=C(O)Cc1c2n(c3ccccc13)C[C@H](N(Cc1ccc(F)cc1)S(=O)(=O)c1ccc(F)cc1)CC2 10.1016/j.bmcl.2010.11.015
44364273 42227 8 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of radiolabeled U44069 from human TXA2 receptorDisplacement of radiolabeled U44069 from human TXA2 receptor
ChEMBL 350 12 2 3 4.3 CCCCC[C@H](O)/C=C/[C@H]1C2COC(C2)[C@@H]1C/C=C\CCCC(=O)O 10.1021/jm8007618
CHEMBL149724 42227 8 None - 1 Human 7.8 pKi = 7.8 Binding
Displacement of radiolabeled U44069 from human TXA2 receptorDisplacement of radiolabeled U44069 from human TXA2 receptor
ChEMBL 350 12 2 3 4.3 CCCCC[C@H](O)/C=C/[C@H]1C2COC(C2)[C@@H]1C/C=C\CCCC(=O)O 10.1021/jm8007618
14953104 98390 0 None - 1 Human 7.8 pKi = 7.8 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 400 6 1 3 4.9 CC(C)(CC(=O)O)Cc1nc2ccccc2n1Cc1ccc(Br)cc1 10.1021/jm00061a008
CHEMBL275382 98390 0 None - 1 Human 7.8 pKi = 7.8 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 400 6 1 3 4.9 CC(C)(CC(=O)O)Cc1nc2ccccc2n1Cc1ccc(Br)cc1 10.1021/jm00061a008
14953080 60271 0 None - 1 Human 6.8 pKi = 6.8 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 384 8 1 3 5.6 CCC(CC)(CC(=O)O)Cc1nc2ccccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
CHEMBL17418 60271 0 None - 1 Human 6.8 pKi = 6.8 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 384 8 1 3 5.6 CCC(CC)(CC(=O)O)Cc1nc2ccccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
22083972 139174 0 None -1862 2 Human 4.8 pKi = 4.8 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 461 6 2 5 4.3 CC(O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CC3 10.1016/j.bmcl.2006.02.062
CHEMBL378744 139174 0 None -1862 2 Human 4.8 pKi = 4.8 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 461 6 2 5 4.3 CC(O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CC3 10.1016/j.bmcl.2006.02.062
65772 60403 8 None -9 6 Human 6.8 pKi = 6.8 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm960208o
CHEMBL174984 60403 8 None -9 6 Human 6.8 pKi = 6.8 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm960208o
10742144 59657 0 None - 1 Human 4.8 pKi = 4.8 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 449 8 2 6 4.5 COc1cc(CC2c3cc(O)c(O)cc3CCN2CCc2ccccc2)cc(OC)c1OC 10.1021/jm950896w
CHEMBL172163 59657 0 None - 1 Human 4.8 pKi = 4.8 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 449 8 2 6 4.5 COc1cc(CC2c3cc(O)c(O)cc3CCN2CCc2ccccc2)cc(OC)c1OC 10.1021/jm950896w
10074062 9951 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 484 5 1 4 6.9 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc(-c3ccccc3)c1-c1ccccc1)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL114666 9951 0 None - 1 Human 6.8 pKi = 6.8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 484 5 1 4 6.9 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc(-c3ccccc3)c1-c1ccccc1)c1ccccc1CO2 10.1021/jm00096a017
11476788 161274 0 None -1 6 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 463 5 1 5 4.4 CS(=O)(=O)c1cc(F)cc2c1c(C(=O)c1ccc(Cl)cc1)c1n2CCC[C@@H]1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL412070 161274 0 None -1 6 Human 6.8 pKi = 6.8 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 463 5 1 5 4.4 CS(=O)(=O)c1cc(F)cc2c1c(C(=O)c1ccc(Cl)cc1)c1n2CCC[C@@H]1CC(=O)O 10.1016/j.bmcl.2008.03.015
44591513 184097 0 None -1862 2 Human 5.8 pKi = 5.8 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 420 5 1 4 6.0 CCc1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL482550 184097 0 None -1862 2 Human 5.8 pKi = 5.8 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 420 5 1 4 6.0 CCc1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
10458078 110434 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 485 8 2 6 4.1 COc1ccc(S(=O)(=O)NCCSC2c3ccccc3COc3ccc(C(=O)O)cc32)cc1 10.1021/jm00096a016
CHEMBL324583 110434 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 485 8 2 6 4.1 COc1ccc(S(=O)(=O)NCCSC2c3ccccc3COc3ccc(C(=O)O)cc32)cc1 10.1021/jm00096a016
10023647 10867 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 396 3 1 4 5.1 Cc1cccc2c1ncn2C/C=C1\c2ccccc2COc2ccc(C(=O)O)cc21 10.1021/jm00096a017
CHEMBL117242 10867 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 396 3 1 4 5.1 Cc1cccc2c1ncn2C/C=C1\c2ccccc2COc2ccc(C(=O)O)cc21 10.1021/jm00096a017
10051178 110658 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 488 5 2 5 5.8 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ccc(C(O)c4ccccc4)cc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL325868 110658 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 488 5 2 5 5.8 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ccc(C(O)c4ccccc4)cc31)c1ccccc1CO2 10.1021/jm00096a017
1880 2262 41 None 2 3 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 375 4 1 3 5.5 OC(=O)CC1CCn2c1c(Sc1ccc(cc1)Cl)c1c2cc(cc1)F 10.1016/j.bmcl.2008.03.015
44450494 2262 41 None 2 3 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 375 4 1 3 5.5 OC(=O)CC1CCn2c1c(Sc1ccc(cc1)Cl)c1c2cc(cc1)F 10.1016/j.bmcl.2008.03.015
CHEMBL264421 2262 41 None 2 3 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 375 4 1 3 5.5 OC(=O)CC1CCn2c1c(Sc1ccc(cc1)Cl)c1c2cc(cc1)F 10.1016/j.bmcl.2008.03.015
10226143 95843 1 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 453 4 1 3 6.3 O=C(O)CC1CCn2c1c(Sc1ccc(Cl)cc1)c1c(Br)cc(F)cc12 10.1016/j.bmcl.2008.03.015
CHEMBL258968 95843 1 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 453 4 1 3 6.3 O=C(O)CC1CCn2c1c(Sc1ccc(Cl)cc1)c1c(Br)cc(F)cc12 10.1016/j.bmcl.2008.03.015
10458078 110434 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 485 8 2 6 4.1 COc1ccc(S(=O)(=O)NCCSC2c3ccccc3COc3ccc(C(=O)O)cc32)cc1 10.1021/jm00096a016
CHEMBL324583 110434 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 485 8 2 6 4.1 COc1ccc(S(=O)(=O)NCCSC2c3ccccc3COc3ccc(C(=O)O)cc32)cc1 10.1021/jm00096a016
10480515 184333 0 None -9 2 Human 7.8 pKi = 7.8 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 484 5 1 6 5.3 CS(=O)(=O)c1ccnc2c1c(Sc1cccc(Cl)c1Cl)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL484327 184333 0 None -9 2 Human 7.8 pKi = 7.8 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 484 5 1 6 5.3 CS(=O)(=O)c1ccnc2c1c(Sc1cccc(Cl)c1Cl)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
14953077 65171 0 None - 1 Human 5.8 pKi = 5.8 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 360 5 1 3 4.5 CC(C)(Cc1nc2cc(F)ccc2n1Cc1ccc(Cl)cc1)C(=O)O 10.1021/jm00061a008
CHEMBL18245 65171 0 None - 1 Human 5.8 pKi = 5.8 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 360 5 1 3 4.5 CC(C)(Cc1nc2cc(F)ccc2n1Cc1ccc(Cl)cc1)C(=O)O 10.1021/jm00061a008
10342667 185048 0 None -28 2 Human 6.8 pKi = 6.8 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 430 5 1 6 4.3 Cc1ccc(Sc2c3n(c4nccc(S(C)(=O)=O)c24)CCCC3CC(=O)O)cc1 10.1016/j.bmcl.2009.03.010
CHEMBL485535 185048 0 None -28 2 Human 6.8 pKi = 6.8 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 430 5 1 6 4.3 Cc1ccc(Sc2c3n(c4nccc(S(C)(=O)=O)c24)CCCC3CC(=O)O)cc1 10.1016/j.bmcl.2009.03.010
14372505 141282 0 None -61 2 Human 6.8 pKi = 6.8 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 415 5 1 3 5.0 C[S+]([O-])c1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
CHEMBL383224 141282 0 None -61 2 Human 6.8 pKi = 6.8 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 415 5 1 3 5.0 C[S+]([O-])c1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
65772 60403 8 None -9 6 Human 6.8 pKi = 6.8 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm950896w
CHEMBL174984 60403 8 None -9 6 Human 6.8 pKi = 6.8 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC 10.1021/jm950896w
10051943 16325 0 None -588 3 Human 6.8 pKi = 6.8 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 507 2 3 3 3.7 Oc1cc2c(cc1O)C(Cc1cc(I)cc(I)c1)NCC2 10.1021/jm960208o
CHEMBL122757 16325 0 None -588 3 Human 6.8 pKi = 6.8 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 507 2 3 3 3.7 Oc1cc2c(cc1O)C(Cc1cc(I)cc(I)c1)NCC2 10.1021/jm960208o
10097814 9975 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 509 9 2 7 4.6 COc1ccc(C(=O)NCCSC2c3ccccc3COc3ccc(C(=O)O)cc32)c(OC)c1OC 10.1021/jm00096a016
CHEMBL114785 9975 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 509 9 2 7 4.6 COc1ccc(C(=O)NCCSC2c3ccccc3COc3ccc(C(=O)O)cc32)c(OC)c1OC 10.1021/jm00096a016
10319482 110595 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 412 4 1 4 5.5 Cc1cc2ncn(CCC3c4ccccc4COc4ccc(C(=O)O)cc43)c2cc1C 10.1021/jm00096a017
CHEMBL325521 110595 0 None - 1 Human 7.8 pKi = 7.8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 412 4 1 4 5.5 Cc1cc2ncn(CCC3c4ccccc4COc4ccc(C(=O)O)cc43)c2cc1C 10.1021/jm00096a017
10097814 9975 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 509 9 2 7 4.6 COc1ccc(C(=O)NCCSC2c3ccccc3COc3ccc(C(=O)O)cc32)c(OC)c1OC 10.1021/jm00096a016
CHEMBL114785 9975 0 None - 1 Human 7.8 pKi = 7.8 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 509 9 2 7 4.6 COc1ccc(C(=O)NCCSC2c3ccccc3COc3ccc(C(=O)O)cc32)c(OC)c1OC 10.1021/jm00096a016
44411555 77044 0 None -177 2 Human 6.8 pKi = 6.8 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 546 5 1 5 5.6 CS(=O)(=O)c1cc(Br)c2c(c1)c1c(n2Cc2ccc3ccc(Cl)cc3n2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
CHEMBL207201 77044 0 None -177 2 Human 6.8 pKi = 6.8 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 546 5 1 5 5.6 CS(=O)(=O)c1cc(Br)c2c(c1)c1c(n2Cc2ccc3ccc(Cl)cc3n2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
11260506 67540 0 None 19 2 Human 6.8 pKi = 6.8 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 476 11 2 5 6.0 CCC(SCCc1c(CO)oc2c(OCC(=O)O)cccc12)(c1ccccc1)c1ccccc1 10.1021/jm050194z
CHEMBL189694 67540 0 None 19 2 Human 6.8 pKi = 6.8 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 476 11 2 5 6.0 CCC(SCCc1c(CO)oc2c(OCC(=O)O)cccc12)(c1ccccc1)c1ccccc1 10.1021/jm050194z
10024547 110487 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 410 3 1 4 5.4 Cc1cc2ncn(C/C=C3\c4ccccc4COc4cc(C(=O)O)ccc43)c2cc1C 10.1021/jm00096a017
CHEMBL324816 110487 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 410 3 1 4 5.4 Cc1cc2ncn(C/C=C3\c4ccccc4COc4cc(C(=O)O)ccc43)c2cc1C 10.1021/jm00096a017
44411798 139061 0 None -77 2 Human 5.8 pKi = 5.8 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 443 6 1 3 5.8 CC(C)[S+]([O-])c1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
CHEMBL378628 139061 0 None -77 2 Human 5.8 pKi = 5.8 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 443 6 1 3 5.8 CC(C)[S+]([O-])c1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
53317569 56821 0 None -489 3 Human 5.7 pKi = 5.7 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 468 5 1 4 3.8 CN([C@@H]1CCc2c(CC(=O)O)c3cc(F)c(Cl)cc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL1643782 56821 0 None -489 3 Human 5.7 pKi = 5.7 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 468 5 1 4 3.8 CN([C@@H]1CCc2c(CC(=O)O)c3cc(F)c(Cl)cc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
44591563 191908 0 None -478 2 Human 6.7 pKi = 6.7 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 468 5 1 4 7.2 CC(C)c1nccc2c1c(Sc1cc(Cl)c(Cl)cc1Cl)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL520007 191908 0 None -478 2 Human 6.7 pKi = 6.7 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 468 5 1 4 7.2 CC(C)c1nccc2c1c(Sc1cc(Cl)c(Cl)cc1Cl)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
10414389 16497 0 None -120 2 Human 6.7 pKi = 6.7 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 522 2 4 4 3.3 Nc1c(I)cc(CC2NCCc3cc(O)c(O)cc32)cc1I 10.1021/jm960208o
CHEMBL123596 16497 0 None -120 2 Human 6.7 pKi = 6.7 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 522 2 4 4 3.3 Nc1c(I)cc(CC2NCCc3cc(O)c(O)cc32)cc1I 10.1021/jm960208o
53320595 56809 0 None -407 3 Human 5.7 pKi = 5.7 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 434 5 1 4 3.2 CN([C@@H]1CCc2c(CC(=O)O)c3cc(F)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL1643771 56809 0 None -407 3 Human 5.7 pKi = 5.7 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 434 5 1 4 3.2 CN([C@@H]1CCc2c(CC(=O)O)c3cc(F)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
10477535 110346 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 426 4 2 5 4.5 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ccc(C(=O)O)cc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL324046 110346 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 426 4 2 5 4.5 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ccc(C(=O)O)cc31)c1ccccc1CO2 10.1021/jm00096a017
9806791 15555 0 None -1621 2 Human 4.7 pKi = 4.7 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 523 2 4 4 3.4 Oc1cc2c(cc1O)C(Cc1cc(I)c(O)c(I)c1)NCC2 10.1021/jm960208o
CHEMBL121964 15555 0 None -1621 2 Human 4.7 pKi = 4.7 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 523 2 4 4 3.4 Oc1cc2c(cc1O)C(Cc1cc(I)c(O)c(I)c1)NCC2 10.1021/jm960208o
44450427 95760 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 471 5 1 5 5.1 CS(=O)(=O)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1F)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL258498 95760 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 471 5 1 5 5.1 CS(=O)(=O)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1F)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
10026771 114421 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 450 3 1 4 5.8 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc(C(F)(F)F)ccc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL333159 114421 0 None - 1 Human 8.7 pKi = 8.7 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 450 3 1 4 5.8 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc(C(F)(F)F)ccc31)c1ccccc1CO2 10.1021/jm00096a017
15157538 138825 0 None 1 2 Human 8.7 pKi = 8.7 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 431 4 1 2 6.0 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1c(Br)cccc21 10.1016/j.bmcl.2006.02.062
CHEMBL378125 138825 0 None 1 2 Human 8.7 pKi = 8.7 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 431 4 1 2 6.0 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1c(Br)cccc21 10.1016/j.bmcl.2006.02.062
15157534 76731 0 None 15 2 Human 8.6 pKi = 8.6 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 353 4 1 2 5.2 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1ccccc21 10.1016/j.bmcl.2006.02.062
CHEMBL206631 76731 0 None 15 2 Human 8.6 pKi = 8.6 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 353 4 1 2 5.2 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1ccccc21 10.1016/j.bmcl.2006.02.062
14372504 138286 0 None -2 2 Human 8.6 pKi = 8.6 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 399 5 1 3 6.0 CSc1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
CHEMBL377072 138286 0 None -2 2 Human 8.6 pKi = 8.6 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 399 5 1 3 6.0 CSc1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
10251861 10055 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 426 3 1 6 4.5 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc4c(cc31)OCO4)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL115241 10055 0 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 426 3 1 6 4.5 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc4c(cc31)OCO4)c1ccccc1CO2 10.1021/jm00096a017
5311396 165250 3 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 410 3 1 4 5.4 Cc1cc2ncn(C/C=C3\c4ccccc4COc4ccc(C(=O)O)cc43)c2cc1C 10.1021/jm00096a017
CHEMBL422964 165250 3 None - 1 Human 8.6 pKi = 8.6 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 410 3 1 4 5.4 Cc1cc2ncn(C/C=C3\c4ccccc4COc4ccc(C(=O)O)cc43)c2cc1C 10.1021/jm00096a017
3356 2280 73 None -38 8 Human 8.5 pKi = 8.5 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1021/jm0603668
4326 2280 73 None -38 8 Human 8.5 pKi = 8.5 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1021/jm0603668
9867642 2280 73 None -38 8 Human 8.5 pKi = 8.5 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1021/jm0603668
CHEMBL426559 2280 73 None -38 8 Human 8.5 pKi = 8.5 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1021/jm0603668
DB11629 2280 73 None -38 8 Human 8.5 pKi = 8.5 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 10.1021/jm0603668
11756528 9906 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 523 7 2 5 5.1 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccc(C(F)(F)F)cc1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL114363 9906 0 None - 1 Human 7.7 pKi = 7.7 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 523 7 2 5 5.1 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccc(C(F)(F)F)cc1)c1ccccc1CO2 10.1021/jm00096a016
11756528 9906 0 None - 1 Human 7.7 pKi = 7.7 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 523 7 2 5 5.1 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccc(C(F)(F)F)cc1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL114363 9906 0 None - 1 Human 7.7 pKi = 7.7 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 523 7 2 5 5.1 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccc(C(F)(F)F)cc1)c1ccccc1CO2 10.1021/jm00096a016
14953097 163256 0 None - 1 Human 7.7 pKi = 7.7 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 386 7 1 4 4.8 COc1ccc(Cn2c(CC(C)(C)CC(=O)O)nc3cc(Cl)ccc32)cc1 10.1021/jm00061a008
CHEMBL418552 163256 0 None - 1 Human 7.7 pKi = 7.7 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 386 7 1 4 4.8 COc1ccc(Cn2c(CC(C)(C)CC(=O)O)nc3cc(Cl)ccc32)cc1 10.1021/jm00061a008
44392477 65074 0 None 1 2 Human 6.7 pKi = 6.7 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 543 6 1 4 8.0 OC(c1cncc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)c1)(C(F)(F)F)C(F)(F)F 10.1016/j.bmcl.2004.12.005
CHEMBL182367 65074 0 None 1 2 Human 6.7 pKi = 6.7 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 543 6 1 4 8.0 OC(c1cncc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)c1)(C(F)(F)F)C(F)(F)F 10.1016/j.bmcl.2004.12.005
18476686 76526 0 None -117 2 Human 6.7 pKi = 6.7 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 495 5 1 4 5.0 CS(=O)(=O)c1cc(Br)c2c(c1)c1c(n2Cc2ccc(Cl)cc2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
CHEMBL206040 76526 0 None -117 2 Human 6.7 pKi = 6.7 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 495 5 1 4 5.0 CS(=O)(=O)c1cc(Br)c2c(c1)c1c(n2Cc2ccc(Cl)cc2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
10297505 159280 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 447 7 1 4 6.6 CCC(OC)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL409939 159280 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 447 7 1 4 6.6 CCC(OC)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
44338237 8164 0 None -2 2 Human 5.7 pKi = 5.7 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 435 6 0 4 5.7 CN(C)C(=O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
CHEMBL109189 8164 0 None -2 2 Human 5.7 pKi = 5.7 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 435 6 0 4 5.7 CN(C)C(=O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
44338236 109141 0 None -1 2 Human 5.7 pKi = 5.7 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 442 6 0 5 5.4 CS(=O)(=O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
CHEMBL321405 109141 0 None -1 2 Human 5.7 pKi = 5.7 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 442 6 0 5 5.4 CS(=O)(=O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
11743676 184189 0 None -3981 2 Human 5.7 pKi = 5.7 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 434 5 1 4 6.6 CC(C)c1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL483159 184189 0 None -3981 2 Human 5.7 pKi = 5.7 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 434 5 1 4 6.6 CC(C)c1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
3086644 64831 7 None - 1 Human 7.7 pKi = 7.7 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 391 6 1 4 4.8 CC(C)(CC(=O)O)Cc1nc2cc(Cl)cnc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
CHEMBL18197 64831 7 None - 1 Human 7.7 pKi = 7.7 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 391 6 1 4 4.8 CC(C)(CC(=O)O)Cc1nc2cc(Cl)cnc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
44411896 76979 0 None -6 2 Human 5.7 pKi = 5.7 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 417 5 1 4 4.3 CS(=O)(=O)c1ccc2c(c1)c1c(n2Cc2ccc(Cl)cc2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
CHEMBL207104 76979 0 None -6 2 Human 5.7 pKi = 5.7 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 417 5 1 4 4.3 CS(=O)(=O)c1ccc2c(c1)c1c(n2Cc2ccc(Cl)cc2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
9874010 207190 0 None -123 8 Human 5.7 pKi = 5.7 Binding
Compound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assayCompound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assay
ChEMBL 629 8 1 4 6.9 CN(CCc1ccccc1)C(=O)NS(=O)(=O)c1ccccc1-c1ccc(CN2C(=O)c3ccccc3CCc3ccccc32)cc1 10.1016/s0960-894x(99)00465-5
CHEMBL92539 207190 0 None -123 8 Human 5.7 pKi = 5.7 Binding
Compound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assayCompound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assay
ChEMBL 629 8 1 4 6.9 CN(CCc1ccccc1)C(=O)NS(=O)(=O)c1ccccc1-c1ccc(CN2C(=O)c3ccccc3CCc3ccccc32)cc1 10.1016/s0960-894x(99)00465-5
53324111 56836 0 None -52 3 Human 5.7 pKi = 5.7 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 466 5 1 4 3.9 CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(C(F)(F)F)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL1643797 56836 0 None -52 3 Human 5.7 pKi = 5.7 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 466 5 1 4 3.9 CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(C(F)(F)F)cc1 10.1016/j.bmcl.2010.11.015
53319321 56825 0 None -1174 3 Human 5.7 pKi = 5.7 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 430 6 1 4 3.4 CCN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL1643786 56825 0 None -1174 3 Human 5.7 pKi = 5.7 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 430 6 1 4 3.4 CCN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
53325908 56822 0 None -1348 3 Human 5.7 pKi = 5.7 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 434 5 1 4 3.2 CN([C@@H]1CCc2c(CC(=O)O)c3cccc(F)c3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL1643783 56822 0 None -1348 3 Human 5.7 pKi = 5.7 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 434 5 1 4 3.2 CN([C@@H]1CCc2c(CC(=O)O)c3cccc(F)c3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
10161062 158818 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 449 6 1 4 4.6 CS(=O)(=O)c1cc(F)cc2c1c(CCc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL409451 158818 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 449 6 1 4 4.6 CS(=O)(=O)c1cc(F)cc2c1c(CCc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
11306423 2525 8 None -52 2 Human 6.7 pKi = 6.7 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 491 6 2 5 6.4 Clc1ccc(c(c1)c1ccsc1c1cncc(c1)C(C(F)(F)F)(O)O)OCc1ccccc1 10.1016/j.bmcl.2004.12.005
6068 2525 8 None -52 2 Human 6.7 pKi = 6.7 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 491 6 2 5 6.4 Clc1ccc(c(c1)c1ccsc1c1cncc(c1)C(C(F)(F)F)(O)O)OCc1ccccc1 10.1016/j.bmcl.2004.12.005
CHEMBL185346 2525 8 None -52 2 Human 6.7 pKi = 6.7 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 491 6 2 5 6.4 Clc1ccc(c(c1)c1ccsc1c1cncc(c1)C(C(F)(F)F)(O)O)OCc1ccccc1 10.1016/j.bmcl.2004.12.005
44411799 78285 0 None -50 2 Human 6.7 pKi = 6.7 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 586 5 1 6 6.3 CS(=O)(=O)c1cc(Br)c2c(c1)c1c(n2Cc2ccc3sc(Cl)c(Cl)c3n2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
CHEMBL210744 78285 0 None -50 2 Human 6.7 pKi = 6.7 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 586 5 1 6 6.3 CS(=O)(=O)c1cc(Br)c2c(c1)c1c(n2Cc2ccc3sc(Cl)c(Cl)c3n2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
44338326 6542 0 None -38 2 Human 5.7 pKi = 5.7 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 404 6 0 4 5.3 COC(=O)c1ccc(CCc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
CHEMBL108289 6542 0 None -38 2 Human 5.7 pKi = 5.7 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 404 6 0 4 5.3 COC(=O)c1ccc(CCc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
10204462 96537 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 453 5 1 5 5.0 CS(=O)(=O)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL262869 96537 0 None - 1 Human 6.7 pKi = 6.7 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 453 5 1 5 5.0 CS(=O)(=O)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
10363348 10035 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 396 3 1 4 5.1 Cc1ccc2ncn(C/C=C3\c4ccccc4COc4ccc(C(=O)O)cc43)c2c1 10.1021/jm00096a017
CHEMBL115111 10035 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 396 3 1 4 5.1 Cc1ccc2ncn(C/C=C3\c4ccccc4COc4ccc(C(=O)O)cc43)c2c1 10.1021/jm00096a017
14953067 61355 0 None - 1 Human 7.6 pKi = 7.6 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 388 7 1 3 5.3 CC(C)(CCC(=O)O)Cc1nc2cc(F)ccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
CHEMBL17677 61355 0 None - 1 Human 7.6 pKi = 7.6 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 388 7 1 3 5.3 CC(C)(CCC(=O)O)Cc1nc2cc(F)ccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
14953084 163138 0 None - 1 Human 7.6 pKi = 7.6 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 390 6 1 3 5.4 CC(C)(CC(=O)O)Cc1nc2cc(Cl)ccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
CHEMBL417820 163138 0 None - 1 Human 7.6 pKi = 7.6 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 390 6 1 3 5.4 CC(C)(CC(=O)O)Cc1nc2cc(Cl)ccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
10254794 192217 0 None -17 2 Human 7.6 pKi = 7.6 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 484 5 1 6 5.3 CS(=O)(=O)c1ccnc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL520480 192217 0 None -17 2 Human 7.6 pKi = 7.6 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 484 5 1 6 5.3 CS(=O)(=O)c1ccnc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
9953978 66319 0 None -14 2 Human 6.6 pKi = 6.6 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 421 6 1 4 6.4 O=C(O)c1cncc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)c1 10.1016/j.bmcl.2004.12.005
CHEMBL184947 66319 0 None -14 2 Human 6.6 pKi = 6.6 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 421 6 1 4 6.4 O=C(O)c1cncc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)c1 10.1016/j.bmcl.2004.12.005
22083975 138397 0 None -2 2 Human 5.6 pKi = 5.6 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 446 6 1 4 4.1 CN(C)S(=O)(=O)c1ccc2c(c1)c1c(n2Cc2ccc(Cl)cc2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
CHEMBL377297 138397 0 None -2 2 Human 5.6 pKi = 5.6 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 446 6 1 4 4.1 CN(C)S(=O)(=O)c1ccc2c(c1)c1c(n2Cc2ccc(Cl)cc2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
10073359 184303 0 None -6 2 Human 7.6 pKi = 7.6 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 468 5 1 6 4.7 CS(=O)(=O)c1ccnc2c1c(Sc1ccc(F)cc1Cl)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL484130 184303 0 None -6 2 Human 7.6 pKi = 7.6 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 468 5 1 6 4.7 CS(=O)(=O)c1ccnc2c1c(Sc1ccc(F)cc1Cl)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
10478975 161908 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 451 7 2 4 4.7 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1C=C2 10.1021/jm00096a016
CHEMBL415239 161908 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 451 7 2 4 4.7 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1C=C2 10.1021/jm00096a016
10478975 161908 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 451 7 2 4 4.7 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1C=C2 10.1021/jm00096a016
CHEMBL415239 161908 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 451 7 2 4 4.7 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1C=C2 10.1021/jm00096a016
10162132 96224 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 467 6 1 5 5.3 CCS(=O)(=O)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL260854 96224 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 467 6 1 5 5.3 CCS(=O)(=O)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
10480363 110397 0 None - 1 Human 6.6 pKi = 6.6 Binding
Compound was tested for its binding affinity at Thromboxane A2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsCompound was tested for its binding affinity at Thromboxane A2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 481 8 2 5 4.7 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)/C=C/c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL324364 110397 0 None - 1 Human 6.6 pKi = 6.6 Binding
Compound was tested for its binding affinity at Thromboxane A2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsCompound was tested for its binding affinity at Thromboxane A2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 481 8 2 5 4.7 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)/C=C/c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
10480363 110397 0 None - 1 Human 6.6 pKi = 6.6 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 481 8 2 5 4.7 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)/C=C/c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL324364 110397 0 None - 1 Human 6.6 pKi = 6.6 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 481 8 2 5 4.7 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)/C=C/c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
11166017 67139 0 None -3 2 Human 5.6 pKi = 5.6 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 418 9 1 4 6.0 O=C(O)COc1cccc2c(CSCC(c3ccccc3)c3ccccc3)coc12 10.1021/jm050194z
CHEMBL187544 67139 0 None -3 2 Human 5.6 pKi = 5.6 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 418 9 1 4 6.0 O=C(O)COc1cccc2c(CSCC(c3ccccc3)c3ccccc3)coc12 10.1021/jm050194z
11201307 67890 0 None 21 2 Human 7.6 pKi = 7.6 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 432 9 1 4 6.1 CC(SCCc1coc2c(OCC(=O)O)cccc12)(c1ccccc1)c1ccccc1 10.1021/jm050194z
CHEMBL191056 67890 0 None 21 2 Human 7.6 pKi = 7.6 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 432 9 1 4 6.1 CC(SCCc1coc2c(OCC(=O)O)cccc12)(c1ccccc1)c1ccccc1 10.1021/jm050194z
44411851 77746 0 None -64 2 Human 6.6 pKi = 6.6 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 545 6 1 5 5.3 CS(=O)(=O)c1cc(Br)c2c(c1)c1c(n2Cc2cccc(OC(F)(F)F)c2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
CHEMBL209033 77746 0 None -64 2 Human 6.6 pKi = 6.6 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 545 6 1 5 5.3 CS(=O)(=O)c1cc(Br)c2c(c1)c1c(n2Cc2cccc(OC(F)(F)F)c2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
10116114 125886 0 None -75 8 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-SQ29548 from human TP receptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]-SQ29548 from human TP receptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 470 6 1 6 4.5 Cc1cc2c(CC(=O)O)cccc2n1C(=O)c1ccc(OC[C@@H]2CN(C)c3ccccc3O2)cc1 10.1016/j.bmc.2011.06.014
CHEMBL364841 125886 0 None -75 8 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-SQ29548 from human TP receptor expressed in CHO cells after 30 mins by liquid scintillation countingDisplacement of [3H]-SQ29548 from human TP receptor expressed in CHO cells after 30 mins by liquid scintillation counting
ChEMBL 470 6 1 6 4.5 Cc1cc2c(CC(=O)O)cccc2n1C(=O)c1ccc(OC[C@@H]2CN(C)c3ccccc3O2)cc1 10.1016/j.bmc.2011.06.014
10116114 125886 0 None -75 8 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-SQ29548 from human prostanoid TP receptor expressed in CHO cells after 60 mins by liquid scintillation countingDisplacement of [3H]-SQ29548 from human prostanoid TP receptor expressed in CHO cells after 60 mins by liquid scintillation counting
ChEMBL 470 6 1 6 4.5 Cc1cc2c(CC(=O)O)cccc2n1C(=O)c1ccc(OC[C@@H]2CN(C)c3ccccc3O2)cc1 10.1016/j.bmc.2011.08.007
CHEMBL364841 125886 0 None -75 8 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-SQ29548 from human prostanoid TP receptor expressed in CHO cells after 60 mins by liquid scintillation countingDisplacement of [3H]-SQ29548 from human prostanoid TP receptor expressed in CHO cells after 60 mins by liquid scintillation counting
ChEMBL 470 6 1 6 4.5 Cc1cc2c(CC(=O)O)cccc2n1C(=O)c1ccc(OC[C@@H]2CN(C)c3ccccc3O2)cc1 10.1016/j.bmc.2011.08.007
10322452 9986 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 469 7 2 5 4.4 Cc1ccc(S(=O)(=O)NCCSC2c3ccccc3COc3ccc(C(=O)O)cc32)cc1 10.1021/jm00096a016
CHEMBL114826 9986 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 469 7 2 5 4.4 Cc1ccc(S(=O)(=O)NCCSC2c3ccccc3COc3ccc(C(=O)O)cc32)cc1 10.1021/jm00096a016
10322452 9986 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 469 7 2 5 4.4 Cc1ccc(S(=O)(=O)NCCSC2c3ccccc3COc3ccc(C(=O)O)cc32)cc1 10.1021/jm00096a016
CHEMBL114826 9986 0 None - 1 Human 7.6 pKi = 7.6 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 469 7 2 5 4.4 Cc1ccc(S(=O)(=O)NCCSC2c3ccccc3COc3ccc(C(=O)O)cc32)cc1 10.1021/jm00096a016
10297616 96391 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 449 6 1 4 7.0 CSC(C)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL261811 96391 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 449 6 1 4 7.0 CSC(C)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
44411635 78227 0 None -1 2 Human 5.6 pKi = 5.6 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 539 6 1 6 3.8 CS(=O)(=O)c1ccc(Cn2c3c(c4cc(S(C)(=O)=O)cc(Br)c42)CCC3CC(=O)O)cc1 10.1016/j.bmcl.2006.02.062
CHEMBL210588 78227 0 None -1 2 Human 5.6 pKi = 5.6 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 539 6 1 6 3.8 CS(=O)(=O)c1ccc(Cn2c3c(c4cc(S(C)(=O)=O)cc(Br)c42)CCC3CC(=O)O)cc1 10.1016/j.bmcl.2006.02.062
10112823 96128 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 419 5 2 4 5.6 CC(O)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL260400 96128 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 419 5 2 4 5.6 CC(O)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
10410551 110395 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 432 3 1 4 5.9 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc4ccccc4cc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL324331 110395 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 432 3 1 4 5.9 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc4ccccc4cc31)c1ccccc1CO2 10.1021/jm00096a017
9938626 206833 0 None -177 7 Human 5.6 pKi = 5.6 Binding
Compound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assayCompound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assay
ChEMBL 600 7 1 4 6.9 CC(C(=O)NS(=O)(=O)c1ccccc1-c1ccc(CN2C(=O)c3ccccc3CCc3ccccc32)cc1)c1ccccc1 10.1016/s0960-894x(99)00465-5
CHEMBL90491 206833 0 None -177 7 Human 5.6 pKi = 5.6 Binding
Compound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assayCompound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assay
ChEMBL 600 7 1 4 6.9 CC(C(=O)NS(=O)(=O)c1ccccc1-c1ccc(CN2C(=O)c3ccccc3CCc3ccccc32)cc1)c1ccccc1 10.1016/s0960-894x(99)00465-5
11741746 184213 0 None -3981 2 Human 5.6 pKi = 5.6 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 400 5 1 4 5.9 CC(C)c1nccc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL483346 184213 0 None -3981 2 Human 5.6 pKi = 5.6 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 400 5 1 4 5.9 CC(C)c1nccc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
53320618 56840 0 None -446 3 Human 5.6 pKi = 5.6 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 438 5 1 5 3.6 CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(Cl)s1 10.1016/j.bmcl.2010.11.015
CHEMBL1643801 56840 0 None -446 3 Human 5.6 pKi = 5.6 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 438 5 1 5 3.6 CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(Cl)s1 10.1016/j.bmcl.2010.11.015
44450410 156399 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 487 5 1 5 5.3 CS(=O)(=O)c1cc(F)cc2c1c(Sc1ccc(C(F)(F)F)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL406649 156399 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 487 5 1 5 5.3 CS(=O)(=O)c1cc(F)cc2c1c(Sc1ccc(C(F)(F)F)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
53320616 56816 0 None -1202 3 Human 5.5 pKi = 5.5 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 492 6 1 4 4.7 CN([C@@H]1CCc2c(CC(=O)O)c3ccc(-c4ccccc4)cc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL1643778 56816 0 None -1202 3 Human 5.5 pKi = 5.5 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 492 6 1 4 4.7 CN([C@@H]1CCc2c(CC(=O)O)c3ccc(-c4ccccc4)cc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
10407599 10647 0 None - 1 Human 4.5 pKi = 4.5 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 383 3 1 5 4.2 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ncccc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL117036 10647 0 None - 1 Human 4.5 pKi = 4.5 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 383 3 1 5 4.2 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ncccc31)c1ccccc1CO2 10.1021/jm00096a017
44591458 179999 0 None -213 2 Human 5.5 pKi = 5.5 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 392 4 1 4 5.5 O=C(O)CC1CCn2c1c(Sc1ccc(Cl)c(Cl)c1)c1cnccc12 10.1016/j.bmcl.2009.03.010
CHEMBL474702 179999 0 None -213 2 Human 5.5 pKi = 5.5 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 392 4 1 4 5.5 O=C(O)CC1CCn2c1c(Sc1ccc(Cl)c(Cl)c1)c1cnccc12 10.1016/j.bmcl.2009.03.010
10454345 9901 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 412 4 1 5 4.8 COc1ccc2c(c1)ncn2C/C=C1\c2ccccc2COc2ccc(C(=O)O)cc21 10.1021/jm00096a017
CHEMBL114335 9901 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 412 4 1 5 4.8 COc1ccc2c(c1)ncn2C/C=C1\c2ccccc2COc2ccc(C(=O)O)cc21 10.1021/jm00096a017
11744062 9878 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 442 5 1 6 4.8 COc1cc2ncn(C/C=C3\c4ccccc4COc4ccc(C(=O)O)cc43)c2cc1OC 10.1021/jm00096a017
CHEMBL114213 9878 0 None - 1 Human 8.5 pKi = 8.5 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 442 5 1 6 4.8 COc1cc2ncn(C/C=C3\c4ccccc4COc4ccc(C(=O)O)cc43)c2cc1OC 10.1021/jm00096a017
9978920 10050 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 410 3 1 4 5.4 Cc1ccc2c(ncn2C/C=C2\c3ccccc3COc3ccc(C(=O)O)cc32)c1C 10.1021/jm00096a017
CHEMBL115224 10050 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 410 3 1 4 5.4 Cc1ccc2c(ncn2C/C=C2\c3ccccc3COc3ccc(C(=O)O)cc32)c1C 10.1021/jm00096a017
10050461 9998 1 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 471 7 2 5 4.8 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1CS2 10.1021/jm00096a016
CHEMBL114901 9998 1 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 471 7 2 5 4.8 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1CS2 10.1021/jm00096a016
10050461 9998 1 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 471 7 2 5 4.8 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1CS2 10.1021/jm00096a016
CHEMBL114901 9998 1 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 471 7 2 5 4.8 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1CS2 10.1021/jm00096a016
10074101 184095 0 None -2 2 Human 8.4 pKi = 8.4 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 484 5 1 6 5.3 CS(=O)(=O)c1ccnc2c1c(Sc1ccc(Cl)cc1Cl)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL482547 184095 0 None -2 2 Human 8.4 pKi = 8.4 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 484 5 1 6 5.3 CS(=O)(=O)c1ccnc2c1c(Sc1ccc(Cl)cc1Cl)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
10364232 110509 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 410 3 1 4 5.4 Cc1cc(C)c2ncn(C/C=C3\c4ccccc4COc4ccc(C(=O)O)cc43)c2c1 10.1021/jm00096a017
CHEMBL324965 110509 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 410 3 1 4 5.4 Cc1cc(C)c2ncn(C/C=C3\c4ccccc4COc4ccc(C(=O)O)cc43)c2c1 10.1021/jm00096a017
10026942 9938 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 453 7 2 4 4.3 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1CC2 10.1021/jm00096a016
CHEMBL114588 9938 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 453 7 2 4 4.3 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1CC2 10.1021/jm00096a016
10071103 10506 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 426 4 2 5 4.5 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc(C(=O)O)ccc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL116721 10506 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 426 4 2 5 4.5 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc(C(=O)O)ccc31)c1ccccc1CO2 10.1021/jm00096a017
10026942 9938 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 453 7 2 4 4.3 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1CC2 10.1021/jm00096a016
CHEMBL114588 9938 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 453 7 2 4 4.3 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1CC2 10.1021/jm00096a016
9809136 106889 0 None -301 8 Human 5.5 pKi = 5.5 Binding
Compound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assayCompound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assay
ChEMBL 614 7 1 4 7.1 CC(C)(C(=O)NS(=O)(=O)c1ccccc1-c1ccc(CN2C(=O)c3ccccc3CCc3ccccc32)cc1)c1ccccc1 10.1016/s0960-894x(99)00465-5
CHEMBL314533 106889 0 None -301 8 Human 5.5 pKi = 5.5 Binding
Compound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assayCompound was evaluated for its secondary binding affinity to human TP receptors by using Aequorin luminescence-based functional calcium assay
ChEMBL 614 7 1 4 7.1 CC(C)(C(=O)NS(=O)(=O)c1ccccc1-c1ccc(CN2C(=O)c3ccccc3CCc3ccccc32)cc1)c1ccccc1 10.1016/s0960-894x(99)00465-5
9802748 135923 0 None -1584 3 Human 5.5 pKi = 5.5 Binding
Inhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptorInhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptor
ChEMBL 430 6 1 4 3.4 CN([C@@H]1CCc2c(c3ccccc3n2CCC(=O)O)C1)S(=O)(=O)c1ccc(F)cc1 10.1021/jm049036i
CHEMBL373118 135923 0 None -1584 3 Human 5.5 pKi = 5.5 Binding
Inhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptorInhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptor
ChEMBL 430 6 1 4 3.4 CN([C@@H]1CCc2c(c3ccccc3n2CCC(=O)O)C1)S(=O)(=O)c1ccc(F)cc1 10.1021/jm049036i
14953103 63178 0 None - 1 Human 7.5 pKi = 7.5 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 352 7 1 4 4.1 COc1ccc(Cn2c(CC(C)(C)CC(=O)O)nc3ccccc32)cc1 10.1021/jm00061a008
CHEMBL17899 63178 0 None - 1 Human 7.5 pKi = 7.5 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 352 7 1 4 4.1 COc1ccc(Cn2c(CC(C)(C)CC(=O)O)nc3ccccc32)cc1 10.1021/jm00061a008
14953078 98721 0 None - 1 Human 7.5 pKi = 7.5 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 356 6 1 3 4.8 CC(C)(CC(=O)O)Cc1nc2ccccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
CHEMBL277826 98721 0 None - 1 Human 7.5 pKi = 7.5 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 356 6 1 3 4.8 CC(C)(CC(=O)O)Cc1nc2ccccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
44450397 96136 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 463 5 1 4 5.5 CS(=O)(=O)c1cc(F)cc2c1c(-c1cccc(-c3ccccc3)c1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL260468 96136 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 463 5 1 4 5.5 CS(=O)(=O)c1cc(F)cc2c1c(-c1cccc(-c3ccccc3)c1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
11316066 67310 0 None 1 2 Human 6.5 pKi = 6.5 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 418 9 1 4 6.0 O=C(O)COc1cccc2c(CCSC(c3ccccc3)c3ccccc3)coc12 10.1021/jm050194z
CHEMBL188384 67310 0 None 1 2 Human 6.5 pKi = 6.5 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 418 9 1 4 6.0 O=C(O)COc1cccc2c(CCSC(c3ccccc3)c3ccccc3)coc12 10.1021/jm050194z
44338291 6432 0 None -3 2 Human 5.5 pKi = 5.5 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 438 6 0 5 4.8 COC(=O)c1ccc(C[S+]([O-])c2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
CHEMBL108242 6432 0 None -3 2 Human 5.5 pKi = 5.5 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 438 6 0 5 4.8 COC(=O)c1ccc(C[S+]([O-])c2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
11350967 67187 0 None -11 2 Human 5.5 pKi = 5.5 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 432 10 1 4 6.4 O=C(O)COc1cccc2c(CCCSC(c3ccccc3)c3ccccc3)coc12 10.1021/jm050194z
CHEMBL187758 67187 0 None -11 2 Human 5.5 pKi = 5.5 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 432 10 1 4 6.4 O=C(O)COc1cccc2c(CCCSC(c3ccccc3)c3ccccc3)coc12 10.1021/jm050194z
11750835 67449 0 None -5 2 Human 5.5 pKi = 5.5 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 432 10 1 4 6.4 O=C(O)COc1cccc2c(CSCCC(c3ccccc3)c3ccccc3)coc12 10.1021/jm050194z
CHEMBL189063 67449 0 None -5 2 Human 5.5 pKi = 5.5 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 432 10 1 4 6.4 O=C(O)COc1cccc2c(CSCCC(c3ccccc3)c3ccccc3)coc12 10.1021/jm050194z
11407826 123646 0 None -38 2 Human 5.5 pKi = 5.5 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 432 10 1 4 6.0 O=C(O)COc1cccc2c(CCSCC(c3ccccc3)c3ccccc3)coc12 10.1021/jm050194z
CHEMBL361939 123646 0 None -38 2 Human 5.5 pKi = 5.5 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 432 10 1 4 6.0 O=C(O)COc1cccc2c(CCSCC(c3ccccc3)c3ccccc3)coc12 10.1021/jm050194z
11545879 14906 3 None -125 3 Human 6.5 pKi = 6.5 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 381 6 1 3 5.8 CC(C)COc1ccc(Cl)cc1-c1ccccc1-c1cccc(C(=O)O)n1 10.1016/j.bmcl.2008.11.032
CHEMBL1207973 14906 3 None -125 3 Human 6.5 pKi = 6.5 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 381 6 1 3 5.8 CC(C)COc1ccc(Cl)cc1-c1ccccc1-c1cccc(C(=O)O)n1 10.1016/j.bmcl.2008.11.032
CHEMBL467510 14906 3 None -125 3 Human 6.5 pKi = 6.5 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 381 6 1 3 5.8 CC(C)COc1ccc(Cl)cc1-c1ccccc1-c1cccc(C(=O)O)n1 10.1016/j.bmcl.2008.11.032
10225820 156398 1 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 449 5 1 4 5.0 CC(c1ccc(Cl)cc1)c1c2n(c3cc(F)cc(S(C)(=O)=O)c13)CCC2CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL406648 156398 1 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 449 5 1 4 5.0 CC(c1ccc(Cl)cc1)c1c2n(c3cc(F)cc(S(C)(=O)=O)c13)CCC2CC(=O)O 10.1016/j.bmcl.2008.03.015
3078928 110365 1 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 455 7 2 5 4.1 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL324130 110365 1 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 455 7 2 5 4.1 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
3078928 110365 1 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 455 7 2 5 4.1 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL324130 110365 1 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 455 7 2 5 4.1 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1CO2 10.1021/jm00096a017
3078928 110365 1 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 455 7 2 5 4.1 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL324130 110365 1 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 455 7 2 5 4.1 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
10412393 9919 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 469 7 1 5 4.4 CN(CCSC1c2ccccc2COc2ccc(C(=O)O)cc21)S(=O)(=O)c1ccccc1 10.1021/jm00096a016
CHEMBL114424 9919 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 469 7 1 5 4.4 CN(CCSC1c2ccccc2COc2ccc(C(=O)O)cc21)S(=O)(=O)c1ccccc1 10.1021/jm00096a016
10412393 9919 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 469 7 1 5 4.4 CN(CCSC1c2ccccc2COc2ccc(C(=O)O)cc21)S(=O)(=O)c1ccccc1 10.1021/jm00096a016
CHEMBL114424 9919 0 None - 1 Human 7.5 pKi = 7.5 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 469 7 1 5 4.4 CN(CCSC1c2ccccc2COc2ccc(C(=O)O)cc21)S(=O)(=O)c1ccccc1 10.1021/jm00096a016
44411605 77198 0 None -117 2 Human 6.5 pKi = 6.5 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 499 6 1 4 6.3 CS(=O)(=O)c1cc(C2CCCCC2)c2c(c1)c1c(n2Cc2ccc(Cl)cc2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
CHEMBL207916 77198 0 None -117 2 Human 6.5 pKi = 6.5 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 499 6 1 4 6.3 CS(=O)(=O)c1cc(C2CCCCC2)c2c(c1)c1c(n2Cc2ccc(Cl)cc2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
10495597 59283 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 316 3 4 6 2.1 O=[N+]([O-])c1cc(CC2NCCc3cc(O)c(O)cc32)ccc1O 10.1021/jm950896w
CHEMBL170451 59283 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 316 3 4 6 2.1 O=[N+]([O-])c1cc(CC2NCCc3cc(O)c(O)cc32)ccc1O 10.1021/jm950896w
44591806 184154 0 None -3 2 Human 6.5 pKi = 6.5 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 402 5 1 5 5.2 COc1ccnc2c1c(Sc1ccc(Cl)cc1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL482953 184154 0 None -3 2 Human 6.5 pKi = 6.5 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 402 5 1 5 5.2 COc1ccnc2c1c(Sc1ccc(Cl)cc1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
44411797 139515 0 None -85 2 Human 6.5 pKi = 6.5 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 429 6 1 3 5.4 CC[S+]([O-])c1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
CHEMBL379491 139515 0 None -85 2 Human 6.5 pKi = 6.5 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 429 6 1 3 5.4 CC[S+]([O-])c1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
46890180 6676 0 None -97 2 Human 5.5 pKi = 5.5 Binding
Binding affinity to human thromboxane A2 receptor by radioligand displacement assayBinding affinity to human thromboxane A2 receptor by radioligand displacement assay
ChEMBL 510 7 1 5 4.9 Cc1c(C2c3ccccc3S(=O)(=O)N2CCOc2ccc(Cl)cc2)c2ccccc2n1CC(=O)O 10.1016/j.bmcl.2010.04.046
CHEMBL1083446 6676 0 None -97 2 Human 5.5 pKi = 5.5 Binding
Binding affinity to human thromboxane A2 receptor by radioligand displacement assayBinding affinity to human thromboxane A2 receptor by radioligand displacement assay
ChEMBL 510 7 1 5 4.9 Cc1c(C2c3ccccc3S(=O)(=O)N2CCOc2ccc(Cl)cc2)c2ccccc2n1CC(=O)O 10.1016/j.bmcl.2010.04.046
44591535 184188 0 None -4677 2 Human 5.5 pKi = 5.5 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 446 6 1 4 6.4 O=C(O)CC1CCn2c1c(Sc1ccc(Cl)c(Cl)c1)c1c(CC3CC3)nccc12 10.1016/j.bmcl.2009.03.010
CHEMBL483154 184188 0 None -4677 2 Human 5.5 pKi = 5.5 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 446 6 1 4 6.4 O=C(O)CC1CCn2c1c(Sc1ccc(Cl)c(Cl)c1)c1c(CC3CC3)nccc12 10.1016/j.bmcl.2009.03.010
10683471 59897 0 None - 1 Human 4.5 pKi = 4.5 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 270 2 4 4 2.1 Nc1ccc(CC2NCCc3cc(O)c(O)cc32)cc1 10.1021/jm950896w
CHEMBL173039 59897 0 None - 1 Human 4.5 pKi = 4.5 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 270 2 4 4 2.1 Nc1ccc(CC2NCCc3cc(O)c(O)cc32)cc1 10.1021/jm950896w
10345671 184279 0 None -10 2 Human 7.5 pKi = 7.5 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 494 5 1 6 4.7 CS(=O)(=O)c1ccnc2c1c(Sc1ccc(Br)cc1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL483939 184279 0 None -10 2 Human 7.5 pKi = 7.5 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 494 5 1 6 4.7 CS(=O)(=O)c1ccnc2c1c(Sc1ccc(Br)cc1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
10349225 16384 0 None -40 2 Human 6.5 pKi = 6.5 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 564 3 4 4 3.7 CC(=O)Nc1c(I)cc(CC2NCCc3cc(O)c(O)cc32)cc1I 10.1021/jm960208o
CHEMBL122992 16384 0 None -40 2 Human 6.5 pKi = 6.5 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 564 3 4 4 3.7 CC(=O)Nc1c(I)cc(CC2NCCc3cc(O)c(O)cc32)cc1I 10.1021/jm960208o
44392512 65224 0 None -6 2 Human 6.4 pKi = 6.4 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 432 6 1 5 6.3 N#CC(O)c1cncc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)c1 10.1016/j.bmcl.2004.12.005
CHEMBL182623 65224 0 None -6 2 Human 6.4 pKi = 6.4 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 432 6 1 5 6.3 N#CC(O)c1cncc(-c2sccc2-c2cc(Cl)ccc2OCc2ccccc2)c1 10.1016/j.bmcl.2004.12.005
9933925 139561 0 None -380 2 Human 5.4 pKi = 5.4 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 459 6 1 5 4.5 CC(=O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CC3 10.1016/j.bmcl.2006.02.062
CHEMBL379711 139561 0 None -380 2 Human 5.4 pKi = 5.4 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 459 6 1 5 4.5 CC(=O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CC3 10.1016/j.bmcl.2006.02.062
10114504 95793 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 445 7 1 3 7.5 CCC(CC)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL258714 95793 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 445 7 1 3 7.5 CCC(CC)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
10409168 111146 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 408 4 1 4 5.3 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc(-c3ccccc3)c1)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL326393 111146 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 408 4 1 4 5.3 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc(-c3ccccc3)c1)c1ccccc1CO2 10.1021/jm00096a017
14953098 163163 0 None - 1 Human 7.4 pKi = 7.4 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 418 7 1 5 3.7 CC(C)(CC(=O)O)Cc1nc2cc(F)ccc2n1Cc1ccc(S(C)(=O)=O)cc1 10.1021/jm00061a008
CHEMBL418000 163163 0 None - 1 Human 7.4 pKi = 7.4 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 418 7 1 5 3.7 CC(C)(CC(=O)O)Cc1nc2cc(F)ccc2n1Cc1ccc(S(C)(=O)=O)cc1 10.1021/jm00061a008
44411889 77276 0 None -131 2 Human 5.4 pKi = 5.4 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 424 5 1 3 4.9 CN(C)C(=O)c1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
CHEMBL208082 77276 0 None -131 2 Human 5.4 pKi = 5.4 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 424 5 1 3 4.9 CN(C)C(=O)c1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
44338285 7475 0 None -12 2 Human 5.4 pKi = 5.4 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 406 6 0 4 6.2 CC(=O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
CHEMBL108698 7475 0 None -12 2 Human 5.4 pKi = 5.4 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 406 6 0 4 6.2 CC(=O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
45268455 196137 48 None -1513 4 Human 5.4 pKi = 5.4 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 416 5 1 4 3.0 CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL561132 196137 48 None -1513 4 Human 5.4 pKi = 5.4 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 416 5 1 4 3.0 CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
45268455 196137 48 None -1513 4 Human 5.4 pKi = 5.4 Binding
Displacement of radioligand from prostanoid TP receptor expressed in HEK293 cells by competitive binding assayDisplacement of radioligand from prostanoid TP receptor expressed in HEK293 cells by competitive binding assay
ChEMBL 416 5 1 4 3.0 CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.084
CHEMBL561132 196137 48 None -1513 4 Human 5.4 pKi = 5.4 Binding
Displacement of radioligand from prostanoid TP receptor expressed in HEK293 cells by competitive binding assayDisplacement of radioligand from prostanoid TP receptor expressed in HEK293 cells by competitive binding assay
ChEMBL 416 5 1 4 3.0 CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.084
45268455 196137 48 None -1513 4 Human 5.4 pKi = 5.4 Binding
Selectivity interaction (Prostanoid receptor binding assay) EUB0000297b TBXA2RSelectivity interaction (Prostanoid receptor binding assay) EUB0000297b TBXA2R
ChEMBL 416 5 1 4 3.0 CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.6019/CHEMBL5212743
CHEMBL561132 196137 48 None -1513 4 Human 5.4 pKi = 5.4 Binding
Selectivity interaction (Prostanoid receptor binding assay) EUB0000297b TBXA2RSelectivity interaction (Prostanoid receptor binding assay) EUB0000297b TBXA2R
ChEMBL 416 5 1 4 3.0 CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.6019/CHEMBL5212743
10433093 184530 0 None -1000 2 Human 6.4 pKi = 6.4 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 434 5 1 4 6.6 CC(C)c1nccc2c1c(Sc1ccc(Cl)cc1Cl)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL484779 184530 0 None -1000 2 Human 6.4 pKi = 6.4 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 434 5 1 4 6.6 CC(C)c1nccc2c1c(Sc1ccc(Cl)cc1Cl)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
15947857 155513 7 None -34 7 Human 7.4 pKi = 7.4 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 767 12 1 9 6.3 COc1cccc(OC)c1C1(C(=O)NS(=O)(=O)Cc2ccc(N3Cc4c(c(OCC(F)(F)F)c5cccnc5c4OCC(F)(F)F)C3=O)c(C)c2)CC1 10.1016/j.bmcl.2008.01.103
CHEMBL404199 155513 7 None -34 7 Human 7.4 pKi = 7.4 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 767 12 1 9 6.3 COc1cccc(OC)c1C1(C(=O)NS(=O)(=O)Cc2ccc(N3Cc4c(c(OCC(F)(F)F)c5cccnc5c4OCC(F)(F)F)C3=O)c(C)c2)CC1 10.1016/j.bmcl.2008.01.103
14953114 63482 0 None - 1 Human 7.4 pKi = 7.4 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 357 6 1 4 4.2 CC(C)(CC(=O)O)Cc1nc2cccnc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
CHEMBL17990 63482 0 None - 1 Human 7.4 pKi = 7.4 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 357 6 1 4 4.2 CC(C)(CC(=O)O)Cc1nc2cccnc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
9825028 184369 0 None -9 2 Human 7.4 pKi = 7.4 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 450 5 1 6 4.6 CS(=O)(=O)c1ccnc2c1c(Sc1ccc(Cl)cc1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL484525 184369 0 None -9 2 Human 7.4 pKi = 7.4 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 450 5 1 6 4.6 CS(=O)(=O)c1ccnc2c1c(Sc1ccc(Cl)cc1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
11374485 78969 0 None -32 2 Human 6.4 pKi = 6.4 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 455 6 1 4 6.0 NS(=O)(=O)c1cccc(-c2ccsc2-c2cc(Cl)ccc2OCc2ccccc2)c1 10.1016/j.bmcl.2004.12.005
CHEMBL2113029 78969 0 None -32 2 Human 6.4 pKi = 6.4 Binding
Binding affinity against human Prostanoid TP receptorBinding affinity against human Prostanoid TP receptor
ChEMBL 455 6 1 4 6.0 NS(=O)(=O)c1cccc(-c2ccsc2-c2cc(Cl)ccc2OCc2ccccc2)c1 10.1016/j.bmcl.2004.12.005
53317958 56812 0 None -3630 3 Human 5.4 pKi = 5.4 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 450 5 1 4 3.7 CN([C@@H]1CCc2c(CC(=O)O)c3ccc(Cl)cc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL1643774 56812 0 None -3630 3 Human 5.4 pKi = 5.4 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 450 5 1 4 3.7 CN([C@@H]1CCc2c(CC(=O)O)c3ccc(Cl)cc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
10386146 9840 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 398 3 2 5 4.5 O=C(O)c1ccc2c(c1)/C(=C/Cn1c(O)nc3ccccc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL114034 9840 0 None - 1 Human 8.4 pKi = 8.4 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 398 3 2 5 4.5 O=C(O)c1ccc2c(c1)/C(=C/Cn1c(O)nc3ccccc31)c1ccccc1CO2 10.1021/jm00096a017
14953090 98626 0 None - 1 Human 8.4 pKi = 8.4 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 370 7 1 4 4.3 COc1ccc(Cn2c(CC(C)(C)CC(=O)O)nc3cc(F)ccc32)cc1 10.1021/jm00061a008
CHEMBL277065 98626 0 None - 1 Human 8.4 pKi = 8.4 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 370 7 1 4 4.3 COc1ccc(Cn2c(CC(C)(C)CC(=O)O)nc3cc(F)ccc32)cc1 10.1021/jm00061a008
10480363 110397 0 None - 1 Human 8.4 pKi = 8.4 Binding
Compound was tested for its binding affinity at Thromboxane A2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsCompound was tested for its binding affinity at Thromboxane A2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 481 8 2 5 4.7 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)/C=C/c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL324364 110397 0 None - 1 Human 8.4 pKi = 8.4 Binding
Compound was tested for its binding affinity at Thromboxane A2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsCompound was tested for its binding affinity at Thromboxane A2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 481 8 2 5 4.7 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)/C=C/c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
10480363 110397 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 481 8 2 5 4.7 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)/C=C/c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL324364 110397 0 None - 1 Human 8.4 pKi = 8.4 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 481 8 2 5 4.7 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)/C=C/c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
11237257 67607 0 None 446 2 Human 8.4 pKi = 8.4 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 494 10 2 6 4.3 CC(c1ccccc1)(c1ccccc1)S(=O)(=O)CCc1c(CO)oc2c(OCC(=O)O)cccc12 10.1021/jm050194z
CHEMBL190288 67607 0 None 446 2 Human 8.4 pKi = 8.4 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 494 10 2 6 4.3 CC(c1ccccc1)(c1ccccc1)S(=O)(=O)CCc1c(CO)oc2c(OCC(=O)O)cccc12 10.1021/jm050194z
123879 3287 82 None 3 4 Human 8.4 pKi = 8.4 Binding
Inhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptorInhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
1910 3287 82 None 3 4 Human 8.4 pKi = 8.4 Binding
Inhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptorInhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
1911 3287 82 None 3 4 Human 8.4 pKi = 8.4 Binding
Inhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptorInhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
2354 3287 82 None 3 4 Human 8.4 pKi = 8.4 Binding
Inhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptorInhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
CHEMBL361812 3287 82 None 3 4 Human 8.4 pKi = 8.4 Binding
Inhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptorInhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
DB13036 3287 82 None 3 4 Human 8.4 pKi = 8.4 Binding
Inhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptorInhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptor
ChEMBL 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 10.1021/jm049036i
11261579 67599 0 None 117 2 Human 8.4 pKi = 8.4 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 462 10 2 5 5.6 CC(SCCc1c(CO)oc2c(OCC(=O)O)cccc12)(c1ccccc1)c1ccccc1 10.1021/jm050194z
CHEMBL190236 67599 0 None 117 2 Human 8.4 pKi = 8.4 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 462 10 2 5 5.6 CC(SCCc1c(CO)oc2c(OCC(=O)O)cccc12)(c1ccccc1)c1ccccc1 10.1021/jm050194z
11743212 17164 0 None -131 7 Human 6.4 pKi = 6.4 Binding
Ability to inhibit the binding of human Thromboxane A2 receptor to TXA2Ability to inhibit the binding of human Thromboxane A2 receptor to TXA2
ChEMBL 426 7 1 3 6.8 O=C(O)C1CC1c1ccccc1-c1csc(-c2ccccc2OCc2ccccc2)c1 10.1016/s0960-894x(03)00794-7
CHEMBL125588 17164 0 None -131 7 Human 6.4 pKi = 6.4 Binding
Ability to inhibit the binding of human Thromboxane A2 receptor to TXA2Ability to inhibit the binding of human Thromboxane A2 receptor to TXA2
ChEMBL 426 7 1 3 6.8 O=C(O)C1CC1c1ccccc1-c1csc(-c2ccccc2OCc2ccccc2)c1 10.1016/s0960-894x(03)00794-7
44338297 108640 0 None 1 2 Human 5.4 pKi = 5.4 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 390 5 0 4 5.1 COC(=O)c1ccc(Cc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
CHEMBL320734 108640 0 None 1 2 Human 5.4 pKi = 5.4 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 390 5 0 4 5.1 COC(=O)c1ccc(Cc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
44591762 191819 0 None -26 2 Human 7.4 pKi = 7.4 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 466 5 1 6 5.1 CS(=O)(=O)c1ccnc2c1c(Sc1cccc3ccccc13)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL519862 191819 0 None -26 2 Human 7.4 pKi = 7.4 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 466 5 1 6 5.1 CS(=O)(=O)c1ccnc2c1c(Sc1cccc3ccccc13)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
44591515 184130 0 None -524 2 Human 6.4 pKi = 6.4 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 432 5 1 4 6.3 O=C(O)CC1CCn2c1c(Sc1ccc(Cl)c(Cl)c1)c1c(C3CC3)nccc12 10.1016/j.bmcl.2009.03.010
CHEMBL482744 184130 0 None -524 2 Human 6.4 pKi = 6.4 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 432 5 1 4 6.3 O=C(O)CC1CCn2c1c(Sc1ccc(Cl)c(Cl)c1)c1c(C3CC3)nccc12 10.1016/j.bmcl.2009.03.010
15680093 64846 0 None - 1 Human 7.4 pKi = 7.4 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 400 6 1 3 5.5 O=C(O)CC1(Cc2nc3cc(F)ccc3n2Cc2ccc(Cl)cc2)CCCC1 10.1021/jm00061a008
CHEMBL18206 64846 0 None - 1 Human 7.4 pKi = 7.4 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 400 6 1 3 5.5 O=C(O)CC1(Cc2nc3cc(F)ccc3n2Cc2ccc(Cl)cc2)CCCC1 10.1021/jm00061a008
40517075 9257 1 None 1 2 Human 5.4 pKi = 5.4 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 364 5 0 3 6.0 Clc1ccc(Cn2c(SCc3ccccc3)nc3ccccc32)cc1 10.1016/j.bmcl.2004.04.005
CHEMBL110774 9257 1 None 1 2 Human 5.4 pKi = 5.4 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 364 5 0 3 6.0 Clc1ccc(Cn2c(SCc3ccccc3)nc3ccccc32)cc1 10.1016/j.bmcl.2004.04.005
53323266 56823 0 None -107 3 Human 6.4 pKi = 6.4 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 452 5 1 4 3.3 CN([C@@H]1CCc2c(CC(=O)O)c3cc(F)cc(F)c3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL1643784 56823 0 None -107 3 Human 6.4 pKi = 6.4 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 452 5 1 4 3.3 CN([C@@H]1CCc2c(CC(=O)O)c3cc(F)cc(F)c3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
10364780 110634 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 419 6 2 4 4.5 O=C(O)c1ccc2c(c1)C(SCCNC(=O)c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL325743 110634 0 None - 1 Human 7.4 pKi = 7.4 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 419 6 2 4 4.5 O=C(O)c1ccc2c(c1)C(SCCNC(=O)c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
10364780 110634 0 None - 1 Human 7.4 pKi = 7.4 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 419 6 2 4 4.5 O=C(O)c1ccc2c(c1)C(SCCNC(=O)c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL325743 110634 0 None - 1 Human 7.4 pKi = 7.4 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 419 6 2 4 4.5 O=C(O)c1ccc2c(c1)C(SCCNC(=O)c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
10092137 110327 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 396 3 1 4 5.1 Cc1cccc2ncn(C/C=C3\c4ccccc4COc4ccc(C(=O)O)cc43)c12 10.1021/jm00096a017
CHEMBL323926 110327 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 396 3 1 4 5.1 Cc1cccc2ncn(C/C=C3\c4ccccc4COc4ccc(C(=O)O)cc43)c12 10.1021/jm00096a017
10430971 165331 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 398 3 2 5 4.5 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3c(O)cccc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL423511 165331 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 398 3 2 5 4.5 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3c(O)cccc31)c1ccccc1CO2 10.1021/jm00096a017
10136760 159621 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 417 5 1 3 6.7 CC(C)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL410338 159621 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 417 5 1 3 6.7 CC(C)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
9871887 103200 0 None -22 4 Human 7.3 pKi = 7.3 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 537 3 3 4 3.7 COc1c(I)cc(CC2NCCc3cc(O)c(O)cc32)cc1I 10.1021/jm960208o
CHEMBL308351 103200 0 None -22 4 Human 7.3 pKi = 7.3 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 537 3 3 4 3.7 COc1c(I)cc(CC2NCCc3cc(O)c(O)cc32)cc1I 10.1021/jm960208o
44591537 191228 0 None -537 2 Human 6.3 pKi = 6.3 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 448 5 1 4 7.0 CC(C)c1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL518988 191228 0 None -537 2 Human 6.3 pKi = 6.3 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 448 5 1 4 7.0 CC(C)c1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
10095579 101331 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 456 7 2 6 3.5 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1cccnc1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL296720 101331 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 456 7 2 6 3.5 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1cccnc1)c1ccccc1CO2 10.1021/jm00096a016
9801972 78138 0 None -25 2 Human 7.3 pKi = 7.3 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 415 5 1 3 5.0 C[S@@+]([O-])c1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
CHEMBL210356 78138 0 None -25 2 Human 7.3 pKi = 7.3 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 415 5 1 3 5.0 C[S@@+]([O-])c1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
10095579 101331 0 None - 1 Human 7.3 pKi = 7.3 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 456 7 2 6 3.5 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1cccnc1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL296720 101331 0 None - 1 Human 7.3 pKi = 7.3 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 456 7 2 6 3.5 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1cccnc1)c1ccccc1CO2 10.1021/jm00096a016
10476586 8146 0 None -1 2 Human 5.3 pKi = 5.3 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 408 6 1 4 5.7 O=C(O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
CHEMBL109179 8146 0 None -1 2 Human 5.3 pKi = 5.3 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 408 6 1 4 5.7 O=C(O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
10204113 95999 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 447 6 2 4 6.2 CC(C)C(O)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL259650 95999 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 447 6 2 4 6.2 CC(C)C(O)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
14953087 163289 0 None - 1 Human 8.3 pKi = 8.3 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 386 7 1 4 5.0 CSc1ccc(Cn2c(CC(C)(C)CC(=O)O)nc3cc(F)ccc32)cc1 10.1021/jm00061a008
CHEMBL418730 163289 0 None - 1 Human 8.3 pKi = 8.3 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 386 7 1 4 5.0 CSc1ccc(Cn2c(CC(C)(C)CC(=O)O)nc3cc(F)ccc32)cc1 10.1021/jm00061a008
9980414 110380 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 435 6 3 5 4.2 O=C(O)c1ccc2c(c1)C(SCCNC(=O)c1ccccc1O)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL324256 110380 0 None - 1 Human 8.3 pKi = 8.3 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 435 6 3 5 4.2 O=C(O)c1ccc2c(c1)C(SCCNC(=O)c1ccccc1O)c1ccccc1CO2 10.1021/jm00096a016
44411688 78180 0 None -2 2 Human 8.3 pKi = 8.3 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 431 5 1 4 4.6 CS(=O)(=O)c1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
CHEMBL210471 78180 0 None -2 2 Human 8.3 pKi = 8.3 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 431 5 1 4 4.6 CS(=O)(=O)c1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
9980414 110380 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 435 6 3 5 4.2 O=C(O)c1ccc2c(c1)C(SCCNC(=O)c1ccccc1O)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL324256 110380 0 None - 1 Human 8.3 pKi = 8.3 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 435 6 3 5 4.2 O=C(O)c1ccc2c(c1)C(SCCNC(=O)c1ccccc1O)c1ccccc1CO2 10.1021/jm00096a016
1888 3900 29 None 2 17 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]SQ29548 from thromboxane A2 receptorDisplacement of [3H]SQ29548 from thromboxane A2 receptor
ChEMBL 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 10.1021/np50094a001
1974 3900 29 None 2 17 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]SQ29548 from thromboxane A2 receptorDisplacement of [3H]SQ29548 from thromboxane A2 receptor
ChEMBL 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 10.1021/np50094a001
5311493 3900 29 None 2 17 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]SQ29548 from thromboxane A2 receptorDisplacement of [3H]SQ29548 from thromboxane A2 receptor
ChEMBL 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 10.1021/np50094a001
CHEMBL521784 3900 29 None 2 17 Human 8.3 pKi = 8.3 Binding
Displacement of [3H]SQ29548 from thromboxane A2 receptorDisplacement of [3H]SQ29548 from thromboxane A2 receptor
ChEMBL 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 10.1021/np50094a001
3078925 110736 6 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 461 7 2 6 4.1 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1cccs1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL326047 110736 6 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 461 7 2 6 4.1 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1cccs1)c1ccccc1CO2 10.1021/jm00096a016
3078925 110736 6 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 461 7 2 6 4.1 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1cccs1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL326047 110736 6 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 461 7 2 6 4.1 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1cccs1)c1ccccc1CO2 10.1021/jm00096a016
24765153 184529 0 None -7762 8 Human 5.3 pKi = 5.3 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 434 5 1 4 6.6 CC(C)c1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CC[C@H]1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL484778 184529 0 None -7762 8 Human 5.3 pKi = 5.3 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 434 5 1 4 6.6 CC(C)c1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CC[C@H]1CC(=O)O 10.1016/j.bmcl.2009.03.010
11202399 126835 0 None - 1 Human 7.3 pKi = 7.3 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 478 10 2 5 4.6 CC(c1ccccc1)(c1ccccc1)[S+]([O-])CCc1c(CO)oc2c(OCC(=O)O)cccc12 10.1021/jm050194z
CHEMBL365501 126835 0 None - 1 Human 7.3 pKi = 7.3 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 478 10 2 5 4.6 CC(c1ccccc1)(c1ccccc1)[S+]([O-])CCc1c(CO)oc2c(OCC(=O)O)cccc12 10.1021/jm050194z
44271957 63875 0 None - 1 Human 6.3 pKi = 6.3 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 384 4 1 3 5.0 O=C(O)[C@@H]1CC=CC[C@@H]1c1nc2cc(F)ccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
CHEMBL18037 63875 0 None - 1 Human 6.3 pKi = 6.3 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 384 4 1 3 5.0 O=C(O)[C@@H]1CC=CC[C@@H]1c1nc2cc(F)ccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
11292620 69192 0 None -1 2 Human 5.3 pKi = 5.3 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 404 8 1 4 5.9 O=C(O)COc1cccc2c(CSC(c3ccccc3)c3ccccc3)coc12 10.1021/jm050194z
CHEMBL192661 69192 0 None -1 2 Human 5.3 pKi = 5.3 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 404 8 1 4 5.9 O=C(O)COc1cccc2c(CSC(c3ccccc3)c3ccccc3)coc12 10.1021/jm050194z
10276571 159086 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 463 5 1 5 4.4 CS(=O)(=O)c1cc(F)cc2c1c(C(=O)c1ccc(Cl)cc1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL409737 159086 0 None - 1 Human 6.3 pKi = 6.3 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 463 5 1 5 4.4 CS(=O)(=O)c1cc(F)cc2c1c(C(=O)c1ccc(Cl)cc1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
14953073 65012 0 None - 1 Human 7.3 pKi = 7.3 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 372 6 1 3 4.7 O=C(O)CC1(Cc2nc3cc(F)ccc3n2Cc2ccc(Cl)cc2)CC1 10.1021/jm00061a008
CHEMBL18232 65012 0 None - 1 Human 7.3 pKi = 7.3 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 372 6 1 3 4.7 O=C(O)CC1(Cc2nc3cc(F)ccc3n2Cc2ccc(Cl)cc2)CC1 10.1021/jm00061a008
11270709 138264 0 None -144 2 Human 6.3 pKi = 6.3 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 443 6 1 4 4.9 C=Cc1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CC3 10.1016/j.bmcl.2006.02.062
CHEMBL377055 138264 0 None -144 2 Human 6.3 pKi = 6.3 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 443 6 1 4 4.9 C=Cc1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CC3 10.1016/j.bmcl.2006.02.062
10456444 9942 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 450 3 1 4 6.1 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc(Cl)c(Cl)cc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL114614 9942 0 None - 1 Human 7.3 pKi = 7.3 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 450 3 1 4 6.1 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc(Cl)c(Cl)cc31)c1ccccc1CO2 10.1021/jm00096a017
5036 101565 26 None -9 3 Human 7.3 pKi = 7.3 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 416 6 2 4 3.1 O=C(O)CCn1c2c(c3ccccc31)CC(NS(=O)(=O)c1ccc(F)cc1)CC2 10.1016/j.bmcl.2010.11.015
CHEMBL298483 101565 26 None -9 3 Human 7.3 pKi = 7.3 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 416 6 2 4 3.1 O=C(O)CCn1c2c(c3ccccc31)CC(NS(=O)(=O)c1ccc(F)cc1)CC2 10.1016/j.bmcl.2010.11.015
10577317 15512 0 None -2691 2 Human 5.3 pKi = 5.3 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 500 4 4 4 4.4 O=C(Nc1ccc(CC2NCCc3cc(O)c(O)cc32)cc1I)c1ccccc1 10.1021/jm960208o
CHEMBL121704 15512 0 None -2691 2 Human 5.3 pKi = 5.3 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 500 4 4 4 4.4 O=C(Nc1ccc(CC2NCCc3cc(O)c(O)cc32)cc1I)c1ccccc1 10.1021/jm960208o
11545850 70236 0 None -1047 3 Human 6.3 pKi = 6.3 Binding
Inhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptorInhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptor
ChEMBL 402 5 2 4 2.7 O=C(O)Cn1c2c(c3ccccc31)C[C@H](NS(=O)(=O)c1ccc(F)cc1)CC2 10.1021/jm049036i
CHEMBL194085 70236 0 None -1047 3 Human 6.3 pKi = 6.3 Binding
Inhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptorInhibition of [3H]SQ-29,548 binding to human Thromboxane A2 receptor
ChEMBL 402 5 2 4 2.7 O=C(O)Cn1c2c(c3ccccc31)C[C@H](NS(=O)(=O)c1ccc(F)cc1)CC2 10.1021/jm049036i
14953076 98290 0 None - 1 Human 5.3 pKi = 5.3 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 332 5 1 3 3.9 O=C(O)CCc1nc2cc(F)ccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
CHEMBL274749 98290 0 None - 1 Human 5.3 pKi = 5.3 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 332 5 1 3 3.9 O=C(O)CCc1nc2cc(F)ccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
10276868 158819 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 469 5 1 5 5.5 CS(=O)(=O)c1cc(F)cc2c1c(Sc1ccc3ccccc3c1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL409452 158819 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 469 5 1 5 5.5 CS(=O)(=O)c1cc(F)cc2c1c(Sc1ccc3ccccc3c1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
44591516 184186 0 None -588 2 Human 6.2 pKi = 6.2 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 460 6 1 4 6.8 O=C(O)CC1CCCn2c1c(Sc1ccc(Cl)c(Cl)c1)c1c(CC3CC3)nccc12 10.1016/j.bmcl.2009.03.010
CHEMBL483152 184186 0 None -588 2 Human 6.2 pKi = 6.2 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 460 6 1 4 6.8 O=C(O)CC1CCCn2c1c(Sc1ccc(Cl)c(Cl)c1)c1c(CC3CC3)nccc12 10.1016/j.bmcl.2009.03.010
11742673 110514 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 416 3 1 4 5.4 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc(Cl)ccc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL325032 110514 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 416 3 1 4 5.4 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc(Cl)ccc31)c1ccccc1CO2 10.1021/jm00096a017
14953093 63506 0 None - 1 Human 8.2 pKi = 8.2 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 402 7 1 4 5.5 CSc1ccc(Cn2c(CC(C)(C)CC(=O)O)nc3cc(Cl)ccc32)cc1 10.1021/jm00061a008
CHEMBL18000 63506 0 None - 1 Human 8.2 pKi = 8.2 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 402 7 1 4 5.5 CSc1ccc(Cn2c(CC(C)(C)CC(=O)O)nc3cc(Cl)ccc32)cc1 10.1021/jm00061a008
14953086 65213 0 None - 1 Human 8.2 pKi = 8.2 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 408 6 1 3 5.6 CC(C)(CC(=O)O)Cc1nc2cc(F)ccc2n1Cc1ccc(Cl)c(Cl)c1 10.1021/jm00061a008
CHEMBL18257 65213 0 None - 1 Human 8.2 pKi = 8.2 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 408 6 1 3 5.6 CC(C)(CC(=O)O)Cc1nc2cc(F)ccc2n1Cc1ccc(Cl)c(Cl)c1 10.1021/jm00061a008
10253895 9898 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 464 7 3 4 5.2 O=C(O)c1ccc2c(c1)C(SCC/N=C(\S)NCc1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL114324 9898 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 464 7 3 4 5.2 O=C(O)c1ccc2c(c1)C(SCC/N=C(\S)NCc1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
11744063 9826 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 442 5 1 6 4.8 COc1cc(OC)c2c(c1)ncn2C/C=C1\c2ccccc2COc2ccc(C(=O)O)cc21 10.1021/jm00096a017
CHEMBL113944 9826 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 442 5 1 6 4.8 COc1cc(OC)c2c(c1)ncn2C/C=C1\c2ccccc2COc2ccc(C(=O)O)cc21 10.1021/jm00096a017
10480645 11138 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 488 5 2 5 5.8 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc(C(O)c4ccccc4)ccc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL117821 11138 0 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 488 5 2 5 5.8 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc(C(O)c4ccccc4)ccc31)c1ccccc1CO2 10.1021/jm00096a017
10253895 9898 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 464 7 3 4 5.2 O=C(O)c1ccc2c(c1)C(SCC/N=C(\S)NCc1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL114324 9898 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 464 7 3 4 5.2 O=C(O)c1ccc2c(c1)C(SCC/N=C(\S)NCc1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
10480363 110397 0 None - 1 Human 8.2 pKi = 8.2 Binding
Compound was tested for its binding affinity at Thromboxane A2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets at 0.1 uMCompound was tested for its binding affinity at Thromboxane A2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets at 0.1 uM
ChEMBL 481 8 2 5 4.7 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)/C=C/c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL324364 110397 0 None - 1 Human 8.2 pKi = 8.2 Binding
Compound was tested for its binding affinity at Thromboxane A2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets at 0.1 uMCompound was tested for its binding affinity at Thromboxane A2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets at 0.1 uM
ChEMBL 481 8 2 5 4.7 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)/C=C/c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
10480363 110397 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 481 8 2 5 4.7 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)/C=C/c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
CHEMBL324364 110397 0 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 481 8 2 5 4.7 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)/C=C/c1ccccc1)c1ccccc1CO2 10.1021/jm00096a016
44411791 78071 0 None -1 2 Human 8.2 pKi = 8.2 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 381 5 1 3 5.1 O=Cc1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
CHEMBL210045 78071 0 None -1 2 Human 8.2 pKi = 8.2 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 381 5 1 3 5.1 O=Cc1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
3078923 9857 5 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 533 7 2 5 4.8 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1cc(Br)ccc1CO2 10.1021/jm00096a016
CHEMBL114102 9857 5 None - 1 Human 8.2 pKi = 8.2 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 533 7 2 5 4.8 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1cc(Br)ccc1CO2 10.1021/jm00096a016
3078923 9857 5 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 533 7 2 5 4.8 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1cc(Br)ccc1CO2 10.1021/jm00096a016
CHEMBL114102 9857 5 None - 1 Human 8.2 pKi = 8.2 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 533 7 2 5 4.8 O=C(O)c1ccc2c(c1)C(SCCNS(=O)(=O)c1ccccc1)c1cc(Br)ccc1CO2 10.1021/jm00096a016
10456399 9882 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 450 3 1 4 5.8 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ccc(C(F)(F)F)cc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL114257 9882 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 450 3 1 4 5.8 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ccc(C(F)(F)F)cc31)c1ccccc1CO2 10.1021/jm00096a017
14953106 63340 0 None - 1 Human 7.2 pKi = 7.2 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 367 7 1 5 4.0 CC(C)(CC(=O)O)Cc1nc2ccccc2n1Cc1ccc([N+](=O)[O-])cc1 10.1021/jm00061a008
CHEMBL17941 63340 0 None - 1 Human 7.2 pKi = 7.2 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 367 7 1 5 4.0 CC(C)(CC(=O)O)Cc1nc2ccccc2n1Cc1ccc([N+](=O)[O-])cc1 10.1021/jm00061a008
10359399 10524 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 332 3 1 4 3.6 O=C(O)c1ccc2c(c1)/C(=C/Cn1ccnc1)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL116869 10524 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 332 3 1 4 3.6 O=C(O)c1ccc2c(c1)/C(=C/Cn1ccnc1)c1ccccc1CO2 10.1021/jm00096a017
44338319 7207 0 None -5 2 Human 5.2 pKi = 5.2 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 405 6 1 5 5.1 COC(=O)c1ccc(CNc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
CHEMBL108564 7207 0 None -5 2 Human 5.2 pKi = 5.2 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 405 6 1 5 5.1 COC(=O)c1ccc(CNc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
9917280 14540 0 None -39810 2 Human 4.2 pKi = 4.2 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 633 2 3 3 4.3 Oc1cc2c(cc1O)C(Cc1cc(I)c(I)c(I)c1)NCC2 10.1021/jm960208o
CHEMBL120278 14540 0 None -39810 2 Human 4.2 pKi = 4.2 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 633 2 3 3 4.3 Oc1cc2c(cc1O)C(Cc1cc(I)c(I)c(I)c1)NCC2 10.1021/jm960208o
50898361 56873 0 None -48 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 549 7 2 5 5.4 Cc1ccc(S(=O)(=O)NC(=O)NCCc2ccc(-c3c(C(=O)N(C)C)sc4c(C)cc(C)cc34)cc2)cc1 10.1016/j.bmcl.2010.11.118
CHEMBL1644003 56873 0 None -48 4 Human 7.2 pKi = 7.2 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 549 7 2 5 5.4 Cc1ccc(S(=O)(=O)NC(=O)NCCc2ccc(-c3c(C(=O)N(C)C)sc4c(C)cc(C)cc34)cc2)cc1 10.1016/j.bmcl.2010.11.118
23964891 7455 0 None - 1 Human 5.2 pKi = 5.2 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 382 5 0 3 6.2 Fc1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
CHEMBL108678 7455 0 None - 1 Human 5.2 pKi = 5.2 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 382 5 0 3 6.2 Fc1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
44591562 184528 0 None -9120 2 Human 5.2 pKi = 5.2 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 434 5 1 4 6.3 CC(C)c1nccc2c1c(Sc1ccc(C(F)(F)F)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL484777 184528 0 None -9120 2 Human 5.2 pKi = 5.2 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 434 5 1 4 6.3 CC(C)c1nccc2c1c(Sc1ccc(C(F)(F)F)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
44331597 208401 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human platelet TXA2 receptors as ability to displace binding [3H]SQ-29,548Binding affinity to human platelet TXA2 receptors as ability to displace binding [3H]SQ-29,548
ChEMBL 737 20 6 8 4.0 [N-]=[N+]=Nc1ccc(CCCC(=O)NCC(=O)NCC2C3CCC(O3)C2C/C=C\CCCC(=O)NNC(=O)CCCC[C@H]2SC[C@H]3NC(=O)N[C@H]32)cc1 10.1016/s0960-894x(99)00511-9
CHEMBL99695 208401 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human platelet TXA2 receptors as ability to displace binding [3H]SQ-29,548Binding affinity to human platelet TXA2 receptors as ability to displace binding [3H]SQ-29,548
ChEMBL 737 20 6 8 4.0 [N-]=[N+]=Nc1ccc(CCCC(=O)NCC(=O)NCC2C3CCC(O3)C2C/C=C\CCCC(=O)NNC(=O)CCCC[C@H]2SC[C@H]3NC(=O)N[C@H]32)cc1 10.1016/s0960-894x(99)00511-9
44591536 191227 0 None -549 2 Human 6.2 pKi = 6.2 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 448 6 1 4 6.8 CCCc1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL518987 191227 0 None -549 2 Human 6.2 pKi = 6.2 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 448 6 1 4 6.8 CCCc1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
10251769 9977 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 424 4 1 4 5.3 Cc1cc2ncn(C/C=C3\c4ccccc4COc4ccc(CC(=O)O)cc43)c2cc1C 10.1021/jm00096a017
CHEMBL114798 9977 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 424 4 1 4 5.3 Cc1cc2ncn(C/C=C3\c4ccccc4COc4ccc(CC(=O)O)cc43)c2cc1C 10.1021/jm00096a017
1986 1312 50 None - 1 Human 7.2 pKi = 7.2 Binding
Compound was tested for its binding affinity at Thromboxane A2/ Prostaglandin H2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsCompound was tested for its binding affinity at Thromboxane A2/ Prostaglandin H2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 353 7 2 3 2.5 OC(=O)Cc1ccc(cc1)CCNS(=O)(=O)c1ccc(cc1)Cl 10.1021/jm00096a017
54343 1312 50 None - 1 Human 7.2 pKi = 7.2 Binding
Compound was tested for its binding affinity at Thromboxane A2/ Prostaglandin H2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsCompound was tested for its binding affinity at Thromboxane A2/ Prostaglandin H2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 353 7 2 3 2.5 OC(=O)Cc1ccc(cc1)CCNS(=O)(=O)c1ccc(cc1)Cl 10.1021/jm00096a017
CHEMBL71685 1312 50 None - 1 Human 7.2 pKi = 7.2 Binding
Compound was tested for its binding affinity at Thromboxane A2/ Prostaglandin H2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsCompound was tested for its binding affinity at Thromboxane A2/ Prostaglandin H2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 353 7 2 3 2.5 OC(=O)Cc1ccc(cc1)CCNS(=O)(=O)c1ccc(cc1)Cl 10.1021/jm00096a017
15948325 2526 45 None -512 6 Human 6.2 pKi = 6.2 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 603 11 1 8 4.7 CCOc1c2CN(C(=O)c2c(c2c1nccc2)OCC)c1ccc(cc1C)CS(=O)(=O)NC(=O)Cc1ccccc1OC 10.1016/j.bmcl.2008.01.103
5856 2526 45 None -512 6 Human 6.2 pKi = 6.2 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 603 11 1 8 4.7 CCOc1c2CN(C(=O)c2c(c2c1nccc2)OCC)c1ccc(cc1C)CS(=O)(=O)NC(=O)Cc1ccccc1OC 10.1016/j.bmcl.2008.01.103
CHEMBL402162 2526 45 None -512 6 Human 6.2 pKi = 6.2 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 603 11 1 8 4.7 CCOc1c2CN(C(=O)c2c(c2c1nccc2)OCC)c1ccc(cc1C)CS(=O)(=O)NC(=O)Cc1ccccc1OC 10.1016/j.bmcl.2008.01.103
10047167 78467 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 410 3 1 4 5.4 Cc1cc2ncn(C/C=C3/c4ccccc4COc4ccc(C(=O)O)cc43)c2cc1C 10.1021/jm00096a017
CHEMBL2111756 78467 0 None - 1 Human 7.2 pKi = 7.2 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 410 3 1 4 5.4 Cc1cc2ncn(C/C=C3/c4ccccc4COc4ccc(C(=O)O)cc43)c2cc1C 10.1021/jm00096a017
10458032 192219 0 None -17 2 Human 7.2 pKi = 7.2 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 484 5 1 6 5.0 CS(=O)(=O)c1ccnc2c1c(Sc1ccc(C(F)(F)F)cc1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL520481 192219 0 None -17 2 Human 7.2 pKi = 7.2 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 484 5 1 6 5.0 CS(=O)(=O)c1ccnc2c1c(Sc1ccc(C(F)(F)F)cc1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
11742649 184129 0 None -39 2 Human 6.2 pKi = 6.2 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 416 5 1 6 3.9 CS(=O)(=O)c1ccnc2c1c(Sc1ccccc1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL482743 184129 0 None -39 2 Human 6.2 pKi = 6.2 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 416 5 1 6 3.9 CS(=O)(=O)c1ccnc2c1c(Sc1ccccc1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
53326879 56810 0 None -5 2 Human 5.2 pKi = 5.2 Binding
Selectivity interaction (Prostanoid receptor binding assay) EUB0000334a TBXA2RSelectivity interaction (Prostanoid receptor binding assay) EUB0000334a TBXA2R
ChEMBL 494 6 1 6 2.4 CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.6019/CHEMBL5212743
CHEMBL1643772 56810 0 None -5 2 Human 5.2 pKi = 5.2 Binding
Selectivity interaction (Prostanoid receptor binding assay) EUB0000334a TBXA2RSelectivity interaction (Prostanoid receptor binding assay) EUB0000334a TBXA2R
ChEMBL 494 6 1 6 2.4 CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.6019/CHEMBL5212743
51550 205750 14 None -11 2 Human 6.2 pKi = 6.2 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 335 8 2 4 1.7 O=C(O)COc1ccc(CCNS(=O)(=O)c2ccccc2)cc1 10.1021/jm00061a008
CHEMBL8273 205750 14 None -11 2 Human 6.2 pKi = 6.2 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 335 8 2 4 1.7 O=C(O)COc1ccc(CCNS(=O)(=O)c2ccccc2)cc1 10.1021/jm00061a008
14953071 98253 0 None - 1 Human 6.2 pKi = 6.2 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 378 5 1 4 4.8 CC(C)(Sc1nc2cc(F)ccc2n1Cc1ccc(Cl)cc1)C(=O)O 10.1021/jm00061a008
CHEMBL274485 98253 0 None - 1 Human 6.2 pKi = 6.2 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 378 5 1 4 4.8 CC(C)(Sc1nc2cc(F)ccc2n1Cc1ccc(Cl)cc1)C(=O)O 10.1021/jm00061a008
25003075 6838 18 None -23988 7 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in HEK293-EBNA cells after 60 mins by scintillation countingDisplacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in HEK293-EBNA cells after 60 mins by scintillation counting
ChEMBL 478 6 2 3 5.8 O=C(O)c1ccc(C2(NC(=O)c3cccc4ccn(Cc5ccc(C(F)(F)F)cc5)c34)CC2)cc1 10.1016/j.bmcl.2010.04.065
CHEMBL1084009 6838 18 None -23988 7 Human 5.2 pKi = 5.2 Binding
Displacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in HEK293-EBNA cells after 60 mins by scintillation countingDisplacement of [3H]SQ-29548 from human prostanoid TP receptor expressed in HEK293-EBNA cells after 60 mins by scintillation counting
ChEMBL 478 6 2 3 5.8 O=C(O)c1ccc(C2(NC(=O)c3cccc4ccn(Cc5ccc(C(F)(F)F)cc5)c34)CC2)cc1 10.1016/j.bmcl.2010.04.065
10158956 96331 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 417 5 1 4 5.8 CC(=O)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL261471 96331 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 417 5 1 4 5.8 CC(=O)c1cc(F)cc2c1c(Sc1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
44450496 159950 1 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 477 5 1 5 4.8 CS(=O)(=O)c1cc(F)cc2c1c(C(=O)c1ccc(Cl)cc1)c1n2CCCCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL410736 159950 1 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 477 5 1 5 4.8 CS(=O)(=O)c1cc(F)cc2c1c(C(=O)c1ccc(Cl)cc1)c1n2CCCCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
25817650 63194 1 None -7244 3 Human 5.2 pKi = 5.2 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 416 5 1 4 3.0 CN([C@@H]1CCc2c(c3ccccc3n2CC(=O)O)C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL179036 63194 1 None -7244 3 Human 5.2 pKi = 5.2 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 416 5 1 4 3.0 CN([C@@H]1CCc2c(c3ccccc3n2CC(=O)O)C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
44591512 192550 0 None -691 2 Human 6.2 pKi = 6.2 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 434 5 1 4 6.4 CCc1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL521122 192550 0 None -691 2 Human 6.2 pKi = 6.2 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 434 5 1 4 6.4 CCc1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
10344683 188862 0 None -4897 2 Human 5.2 pKi = 5.2 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 470 5 1 6 4.9 CS(=O)(=O)c1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL506909 188862 0 None -4897 2 Human 5.2 pKi = 5.2 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 470 5 1 6 4.9 CS(=O)(=O)c1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
10225819 96249 0 None - 1 Human 5.2 pKi = 5.2 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 449 5 1 5 4.0 CS(=O)(=O)c1cc(F)cc2c1c(C(=O)c1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL261008 96249 0 None - 1 Human 5.2 pKi = 5.2 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 449 5 1 5 4.0 CS(=O)(=O)c1cc(F)cc2c1c(C(=O)c1ccc(Cl)cc1)c1n2CCC1CC(=O)O 10.1016/j.bmcl.2008.03.015
44591457 189068 0 None -8 2 Human 8.2 pKi = 8.2 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 414 5 1 4 6.3 CC(C)c1ccnc2c1c(Sc1ccc(Cl)cc1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL509685 189068 0 None -8 2 Human 8.2 pKi = 8.2 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 414 5 1 4 6.3 CC(C)c1ccnc2c1c(Sc1ccc(Cl)cc1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
14953115 98914 0 None - 1 Human 8.2 pKi = 8.2 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 403 7 1 5 4.9 CSc1ccc(Cn2c(CC(C)(C)CC(=O)O)nc3cc(Cl)cnc32)cc1 10.1021/jm00061a008
CHEMBL279348 98914 0 None - 1 Human 8.2 pKi = 8.2 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 403 7 1 5 4.9 CSc1ccc(Cn2c(CC(C)(C)CC(=O)O)nc3cc(Cl)cnc32)cc1 10.1021/jm00061a008
10251338 111335 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 416 5 2 4 5.2 O=C(O)c1ccc2c(c1)C(SCCc1nc3ccccc3[nH]1)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL326856 111335 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 416 5 2 4 5.2 O=C(O)c1ccc2c(c1)C(SCCc1nc3ccccc3[nH]1)c1ccccc1CO2 10.1021/jm00096a017
10366462 9928 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 449 7 2 5 5.0 O=C(NCCSC1c2ccccc2COc2ccc(C(=O)O)cc21)OCc1ccccc1 10.1021/jm00096a016
CHEMBL114473 9928 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 449 7 2 5 5.0 O=C(NCCSC1c2ccccc2COc2ccc(C(=O)O)cc21)OCc1ccccc1 10.1021/jm00096a016
10366462 9928 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 449 7 2 5 5.0 O=C(NCCSC1c2ccccc2COc2ccc(C(=O)O)cc21)OCc1ccccc1 10.1021/jm00096a016
CHEMBL114473 9928 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 449 7 2 5 5.0 O=C(NCCSC1c2ccccc2COc2ccc(C(=O)O)cc21)OCc1ccccc1 10.1021/jm00096a016
44411809 77371 0 None 2 2 Human 8.1 pKi = 8.1 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 383 5 2 3 4.7 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1c(CO)cccc21 10.1016/j.bmcl.2006.02.062
CHEMBL208596 77371 0 None 2 2 Human 8.1 pKi = 8.1 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 383 5 2 3 4.7 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1c(CO)cccc21 10.1016/j.bmcl.2006.02.062
14953072 98820 0 None - 1 Human 8.1 pKi = 8.1 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 374 6 1 3 4.9 CC(C)(CC(=O)O)Cc1nc2cc(F)ccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
CHEMBL278653 98820 0 None - 1 Human 8.1 pKi = 8.1 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 374 6 1 3 4.9 CC(C)(CC(=O)O)Cc1nc2cc(F)ccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
44338292 6433 0 None -2 2 Human 5.2 pKi = 5.2 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 376 4 0 4 5.2 COC(=O)c1ccc(-c2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
CHEMBL108243 6433 0 None -2 2 Human 5.2 pKi = 5.2 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 376 4 0 4 5.2 COC(=O)c1ccc(-c2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
11294166 77045 0 None -3890 3 Human 5.2 pKi = 5.2 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 461 6 2 5 4.3 CC(O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1016/j.bmcl.2006.02.062
CHEMBL207203 77045 0 None -3890 3 Human 5.2 pKi = 5.2 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 461 6 2 5 4.3 CC(O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1016/j.bmcl.2006.02.062
11294166 77045 0 None -3890 3 Human 5.2 pKi = 5.2 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 461 6 2 5 4.3 CC(O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1021/jm0603668
CHEMBL207203 77045 0 None -3890 3 Human 5.2 pKi = 5.2 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
ChEMBL 461 6 2 5 4.3 CC(O)c1cc(S(C)(=O)=O)cc2c3c(n(Cc4ccc(Cl)cc4)c12)[C@@H](CC(=O)O)CC3 10.1021/jm0603668
44450497 160554 0 None -3 2 Human 5.1 pKi = 5.1 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 463 5 1 5 4.4 CS(=O)(=O)c1cc(F)cc2c1c(C(=O)c1ccc(Cl)cc1)c1n2CCC[C@H]1CC(=O)O 10.1016/j.bmcl.2008.03.015
CHEMBL411255 160554 0 None -3 2 Human 5.1 pKi = 5.1 Binding
Binding affinity to human recombinant TP receptor by radioligand competition binding assayBinding affinity to human recombinant TP receptor by radioligand competition binding assay
ChEMBL 463 5 1 5 4.4 CS(=O)(=O)c1cc(F)cc2c1c(C(=O)c1ccc(Cl)cc1)c1n2CCC[C@H]1CC(=O)O 10.1016/j.bmcl.2008.03.015
53316671 56817 0 None -288 3 Human 6.1 pKi = 6.1 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 452 5 1 4 3.3 CN([C@@H]1CCc2c(CC(=O)O)c3cc(F)c(F)cc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL1643779 56817 0 None -288 3 Human 6.1 pKi = 6.1 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 452 5 1 4 3.3 CN([C@@H]1CCc2c(CC(=O)O)c3cc(F)c(F)cc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
11454655 67774 0 None 79 2 Human 7.1 pKi = 7.1 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 490 12 2 5 6.1 CC(SCCc1c(CCCO)oc2c(OCC(=O)O)cccc12)(c1ccccc1)c1ccccc1 10.1021/jm050194z
CHEMBL190840 67774 0 None 79 2 Human 7.1 pKi = 7.1 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 490 12 2 5 6.1 CC(SCCc1c(CCCO)oc2c(OCC(=O)O)cccc12)(c1ccccc1)c1ccccc1 10.1021/jm050194z
53317957 56811 0 None -660 3 Human 6.1 pKi = 6.1 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 434 5 1 4 3.2 CN([C@@H]1CCc2c(CC(=O)O)c3ccc(F)cc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL1643773 56811 0 None -660 3 Human 6.1 pKi = 6.1 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 434 5 1 4 3.2 CN([C@@H]1CCc2c(CC(=O)O)c3ccc(F)cc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
22083978 77126 0 None -162 2 Human 6.1 pKi = 6.1 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 499 6 1 5 6.0 CS(=O)(=O)c1cc(-c2cccs2)c2c(c1)c1c(n2Cc2ccc(Cl)cc2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
CHEMBL207689 77126 0 None -162 2 Human 6.1 pKi = 6.1 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 499 6 1 5 6.0 CS(=O)(=O)c1cc(-c2cccs2)c2c(c1)c1c(n2Cc2ccc(Cl)cc2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
71450058 82574 0 None -37 2 Human 6.1 pKi = 6.1 Binding
Binding affinity to TXA2 receptor receptorBinding affinity to TXA2 receptor receptor
ChEMBL 453 6 1 3 5.6 O=C(O)Cc1ccc2c(c1)/C(=C/CN1CCCC(Cc3ccccc3)C1)c1ccccc1CO2 10.1021/jm300682j
CHEMBL2178582 82574 0 None -37 2 Human 6.1 pKi = 6.1 Binding
Binding affinity to TXA2 receptor receptorBinding affinity to TXA2 receptor receptor
ChEMBL 453 6 1 3 5.6 O=C(O)Cc1ccc2c(c1)/C(=C/CN1CCCC(Cc3ccccc3)C1)c1ccccc1CO2 10.1021/jm300682j
44404954 135265 0 None -48 3 Human 6.1 pKi = 6.1 Binding
Inhibition constant against thromboxane A2 receptor to prostaglandin H2 receptorInhibition constant against thromboxane A2 receptor to prostaglandin H2 receptor
ChEMBL 453 6 1 3 5.6 O=C(O)Cc1ccc2c(c1)/C(=C\CN1CCC(Cc3ccccc3)CC1)c1ccccc1CO2 10.1021/jm058225d
CHEMBL372588 135265 0 None -48 3 Human 6.1 pKi = 6.1 Binding
Inhibition constant against thromboxane A2 receptor to prostaglandin H2 receptorInhibition constant against thromboxane A2 receptor to prostaglandin H2 receptor
ChEMBL 453 6 1 3 5.6 O=C(O)Cc1ccc2c(c1)/C(=C\CN1CCC(Cc3ccccc3)CC1)c1ccccc1CO2 10.1021/jm058225d
44411814 78237 0 None -218 2 Human 6.1 pKi = 6.1 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 495 5 1 4 5.0 CS(=O)(=O)c1cc(Br)c2c(c1)c1c(n2Cc2cccc(Cl)c2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
CHEMBL210615 78237 0 None -218 2 Human 6.1 pKi = 6.1 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 495 5 1 4 5.0 CS(=O)(=O)c1cc(Br)c2c(c1)c1c(n2Cc2cccc(Cl)c2)C(CC(=O)O)CC1 10.1016/j.bmcl.2006.02.062
10455224 10467 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 427 9 2 4 4.2 O=C(O)c1cccc(C(SCCNS(=O)(=O)c2ccccc2)c2ccccc2)c1 10.1021/jm00096a016
CHEMBL116465 10467 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 427 9 2 4 4.2 O=C(O)c1cccc(C(SCCNS(=O)(=O)c2ccccc2)c2ccccc2)c1 10.1021/jm00096a016
10455224 10467 0 None - 1 Human 7.1 pKi = 7.1 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 427 9 2 4 4.2 O=C(O)c1cccc(C(SCCNS(=O)(=O)c2ccccc2)c2ccccc2)c1 10.1021/jm00096a016
CHEMBL116465 10467 0 None - 1 Human 7.1 pKi = 7.1 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 427 9 2 4 4.2 O=C(O)c1cccc(C(SCCNS(=O)(=O)c2ccccc2)c2ccccc2)c1 10.1021/jm00096a016
11374965 69193 0 None 2 2 Human 7.1 pKi = 7.1 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 476 11 2 5 5.7 CC(SCCc1c(CCO)oc2c(OCC(=O)O)cccc12)(c1ccccc1)c1ccccc1 10.1021/jm050194z
CHEMBL192662 69193 0 None 2 2 Human 7.1 pKi = 7.1 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 476 11 2 5 5.7 CC(SCCc1c(CCO)oc2c(OCC(=O)O)cccc12)(c1ccccc1)c1ccccc1 10.1021/jm050194z
10432190 184096 0 None -6 2 Human 7.1 pKi = 7.1 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 418 5 1 5 5.9 CSc1ccnc2c1c(Sc1ccc(Cl)cc1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL482548 184096 0 None -6 2 Human 7.1 pKi = 7.1 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 418 5 1 5 5.9 CSc1ccnc2c1c(Sc1ccc(Cl)cc1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
46890179 7057 0 None -269 2 Human 5.1 pKi = 5.1 Binding
Binding affinity to human thromboxane A2 receptor by radioligand displacement assayBinding affinity to human thromboxane A2 receptor by radioligand displacement assay
ChEMBL 476 7 1 5 4.2 Cc1c(C2c3ccccc3S(=O)(=O)N2CCOc2ccccc2)c2ccccc2n1CC(=O)O 10.1016/j.bmcl.2010.04.046
CHEMBL1084903 7057 0 None -269 2 Human 5.1 pKi = 5.1 Binding
Binding affinity to human thromboxane A2 receptor by radioligand displacement assayBinding affinity to human thromboxane A2 receptor by radioligand displacement assay
ChEMBL 476 7 1 5 4.2 Cc1c(C2c3ccccc3S(=O)(=O)N2CCOc2ccccc2)c2ccccc2n1CC(=O)O 10.1016/j.bmcl.2010.04.046
10431100 168084 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 400 3 1 4 4.9 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc(F)ccc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL432602 168084 0 None - 1 Human 8.1 pKi = 8.1 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 400 3 1 4 4.9 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3cc(F)ccc31)c1ccccc1CO2 10.1021/jm00096a017
44271646 62991 0 None - 1 Human 6.1 pKi = 6.1 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 358 4 1 3 4.5 O=C(O)[C@H]1CC[C@@H]1c1nc2cc(F)ccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
CHEMBL17861 62991 0 None - 1 Human 6.1 pKi = 6.1 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 358 4 1 3 4.5 O=C(O)[C@H]1CC[C@@H]1c1nc2cc(F)ccc2n1Cc1ccc(Cl)cc1 10.1021/jm00061a008
44411984 77320 0 None -107 2 Human 6.1 pKi = 6.1 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 517 5 1 4 5.7 CC(C)(C)c1ccc(Cn2c3c(c4cc(S(C)(=O)=O)cc(Br)c42)CCC3CC(=O)O)cc1 10.1016/j.bmcl.2006.02.062
CHEMBL208319 77320 0 None -107 2 Human 6.1 pKi = 6.1 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 517 5 1 4 5.7 CC(C)(C)c1ccc(Cn2c3c(c4cc(S(C)(=O)=O)cc(Br)c42)CCC3CC(=O)O)cc1 10.1016/j.bmcl.2006.02.062
10834286 114460 0 None -19 2 Human 4.1 pKi = 4.1 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 391 2 3 3 4.6 Oc1cc2c(cc1O)C(Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1)NCC2 10.1021/jm960208o
CHEMBL333438 114460 0 None -19 2 Human 4.1 pKi = 4.1 Binding
Binding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligandBinding affinity for human Platelet Thromboxane A2 / Prostaglandin (TP), by radioligand competition binding assays using [3H]-SQ 29548 as radioligand
ChEMBL 391 2 3 3 4.6 Oc1cc2c(cc1O)C(Cc1cc(C(F)(F)F)cc(C(F)(F)F)c1)NCC2 10.1021/jm960208o
14953075 98441 0 None - 1 Human 6.1 pKi = 6.1 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 414 6 1 3 5.8 O=C(O)CC1(Cc2nc3cc(F)ccc3n2Cc2ccc(Cl)cc2)CCCCC1 10.1021/jm00061a008
CHEMBL275651 98441 0 None - 1 Human 6.1 pKi = 6.1 Binding
Tested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human plateletsTested in vitro for inhibition constant against TXA2 / PGH-2 receptor using [125I]PTA-OH binding affinity to human platelets
ChEMBL 414 6 1 3 5.8 O=C(O)CC1(Cc2nc3cc(F)ccc3n2Cc2ccc(Cl)cc2)CCCCC1 10.1021/jm00061a008
10456019 163491 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 442 5 1 6 4.8 COc1cc(OC)c2ncn(C/C=C3\c4ccccc4COc4ccc(C(=O)O)cc43)c2c1 10.1021/jm00096a017
CHEMBL420136 163491 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 442 5 1 6 4.8 COc1cc(OC)c2ncn(C/C=C3\c4ccccc4COc4ccc(C(=O)O)cc43)c2c1 10.1021/jm00096a017
44411567 138843 0 None 1 2 Human 7.1 pKi = 7.1 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 472 6 2 3 6.5 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1c(C(=O)Nc3ccccc3)cccc21 10.1016/j.bmcl.2006.02.062
CHEMBL378151 138843 0 None 1 2 Human 7.1 pKi = 7.1 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 472 6 2 3 6.5 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1c(C(=O)Nc3ccccc3)cccc21 10.1016/j.bmcl.2006.02.062
11282319 67664 0 None 8 2 Human 7.1 pKi = 7.1 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 448 10 2 5 5.5 O=C(O)COc1cccc2c(CCSC(c3ccccc3)c3ccccc3)c(CO)oc12 10.1021/jm050194z
CHEMBL190708 67664 0 None 8 2 Human 7.1 pKi = 7.1 Binding
Inhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membraneInhibition of [3H]SQ-29,548 binding to thromboxane A2 receptors (TP) of human platelet membrane
ChEMBL 448 10 2 5 5.5 O=C(O)COc1cccc2c(CCSC(c3ccccc3)c3ccccc3)c(CO)oc12 10.1021/jm050194z
53323246 56808 0 None -81 3 Human 6.1 pKi = 6.1 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 434 5 1 4 3.2 CN([C@@H]1CCc2c(CC(=O)O)c3c(F)cccc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL1643770 56808 0 None -81 3 Human 6.1 pKi = 6.1 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 434 5 1 4 3.2 CN([C@@H]1CCc2c(CC(=O)O)c3c(F)cccc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
15157541 97138 0 None -5 2 Human 8.0 pKi = 8.0 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 395 5 1 2 6.4 CC(C)c1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
CHEMBL267820 97138 0 None -5 2 Human 8.0 pKi = 8.0 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 395 5 1 2 6.4 CC(C)c1cccc2c3c(n(Cc4ccc(Cl)cc4)c12)C(CC(=O)O)CCC3 10.1016/j.bmcl.2006.02.062
10365194 10427 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 427 4 1 6 4.7 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ccc([N+](=O)[O-])cc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL116342 10427 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 427 4 1 6 4.7 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ccc([N+](=O)[O-])cc31)c1ccccc1CO2 10.1021/jm00096a017
10001037 10054 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 400 3 1 4 4.9 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ccc(F)cc31)c1ccccc1CO2 10.1021/jm00096a017
CHEMBL115238 10054 0 None - 1 Human 8.0 pKi = 8.0 Binding
Binding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2/PGH2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 400 3 1 4 4.9 O=C(O)c1ccc2c(c1)/C(=C/Cn1cnc3ccc(F)cc31)c1ccccc1CO2 10.1021/jm00096a017
44338308 9151 0 None 3 2 Human 6.1 pKi = 6.1 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 391 5 1 5 5.3 COC(=O)c1ccc(Nc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
CHEMBL110063 9151 0 None 3 2 Human 6.1 pKi = 6.1 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 391 5 1 5 5.3 COC(=O)c1ccc(Nc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
53320617 56826 0 None -575 3 Human 6.0 pKi = 6.0 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 472 9 1 4 4.6 CCCCCN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL1643787 56826 0 None -575 3 Human 6.0 pKi = 6.0 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 472 9 1 4 4.6 CCCCCN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
44338387 110438 1 None -61 2 Human 5.0 pKi = 5.0 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 422 6 0 5 5.8 COC(=O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
CHEMBL324619 110438 1 None -61 2 Human 5.0 pKi = 5.0 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 422 6 0 5 5.8 COC(=O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
10029290 9883 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 509 9 2 7 4.6 COc1cc(C(=O)NCCSC2c3ccccc3COc3ccc(C(=O)O)cc32)cc(OC)c1OC 10.1021/jm00096a016
CHEMBL114260 9883 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig plateletsBinding affinity at TXA2 receptor by measuring its ability to displace [3H]U-46619 from guinea pig platelets
ChEMBL 509 9 2 7 4.6 COc1cc(C(=O)NCCSC2c3ccccc3COc3ccc(C(=O)O)cc32)cc(OC)c1OC 10.1021/jm00096a016
10029290 9883 0 None - 1 Human 7.0 pKi = 7.0 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 509 9 2 7 4.6 COc1cc(C(=O)NCCSC2c3ccccc3COc3ccc(C(=O)O)cc32)cc(OC)c1OC 10.1021/jm00096a016
CHEMBL114260 9883 0 None - 1 Human 7.0 pKi = 7.0 Binding
Inhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligandInhibition of the thromboxane A2 receptor assayed by binding to guinea pig platelets using [3H]U-46619 as radioligand
ChEMBL 509 9 2 7 4.6 COc1cc(C(=O)NCCSC2c3ccccc3COc3ccc(C(=O)O)cc32)cc(OC)c1OC 10.1021/jm00096a016
11519006 102486 0 None -151 6 Human 6.0 pKi = 6.0 Binding
Inhibition of [3H]SQ-29,548 binding to human Prostanoid TP receptorInhibition of [3H]SQ-29,548 binding to human Prostanoid TP receptor
ChEMBL 481 8 1 5 6.1 O=C(O)COc1cccc(C[C@@H]2CCC[C@H]3O[C@]23c2nc(-c3ccccc3)c(-c3ccccc3)o2)c1 10.1016/j.bmcl.2005.04.076
CHEMBL2373410 102486 0 None -151 6 Human 6.0 pKi = 6.0 Binding
Inhibition of [3H]SQ-29,548 binding to human Prostanoid TP receptorInhibition of [3H]SQ-29,548 binding to human Prostanoid TP receptor
ChEMBL 481 8 1 5 6.1 O=C(O)COc1cccc(C[C@@H]2CCC[C@H]3O[C@]23c2nc(-c3ccccc3)c(-c3ccccc3)o2)c1 10.1016/j.bmcl.2005.04.076
CHEMBL3040272 102486 0 None -151 6 Human 6.0 pKi = 6.0 Binding
Inhibition of [3H]SQ-29,548 binding to human Prostanoid TP receptorInhibition of [3H]SQ-29,548 binding to human Prostanoid TP receptor
ChEMBL 481 8 1 5 6.1 O=C(O)COc1cccc(C[C@@H]2CCC[C@H]3O[C@]23c2nc(-c3ccccc3)c(-c3ccccc3)o2)c1 10.1016/j.bmcl.2005.04.076
44338389 5957 0 None -8 2 Human 5.0 pKi = 5.0 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 422 6 0 5 5.8 COC(=O)c1cccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)c1 10.1016/j.bmcl.2004.04.005
CHEMBL107988 5957 0 None -8 2 Human 5.0 pKi = 5.0 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 422 6 0 5 5.8 COC(=O)c1cccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)c1 10.1016/j.bmcl.2004.04.005
44138108 184285 0 None -2884 6 Human 6.0 pKi = 6.0 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 434 5 1 4 6.6 CC(C)c1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CC[C@@H]1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL483991 184285 0 None -2884 6 Human 6.0 pKi = 6.0 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 434 5 1 4 6.6 CC(C)c1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CC[C@@H]1CC(=O)O 10.1016/j.bmcl.2009.03.010
44338257 9309 0 None 4 2 Human 6.0 pKi = 6.0 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 389 5 0 4 5.9 N#Cc1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
CHEMBL111006 9309 0 None 4 2 Human 6.0 pKi = 6.0 Binding
Binding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assayBinding affinity against human recombinant Thromboxane A2 receptor was determined using radioligand competition binding assay
ChEMBL 389 5 0 4 5.9 N#Cc1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1 10.1016/j.bmcl.2004.04.005
10590325 129676 0 None - 1 Human 5.0 pKi = 5.0 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 300 3 3 5 2.4 O=[N+]([O-])c1ccc(CC2NCCc3cc(O)c(O)cc32)cc1 10.1021/jm950896w
CHEMBL367394 129676 0 None - 1 Human 5.0 pKi = 5.0 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
ChEMBL 300 3 3 5 2.4 O=[N+]([O-])c1ccc(CC2NCCc3cc(O)c(O)cc32)cc1 10.1021/jm950896w
44411813 139246 0 None -3 2 Human 7.0 pKi = 7.0 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 477 6 1 3 6.4 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1c([S+]([O-])c3ccccc3)cccc21 10.1016/j.bmcl.2006.02.062
CHEMBL378929 139246 0 None -3 2 Human 7.0 pKi = 7.0 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 477 6 1 3 6.4 O=C(O)CC1CCCc2c1n(Cc1ccc(Cl)cc1)c1c([S+]([O-])c3ccccc3)cccc21 10.1016/j.bmcl.2006.02.062
53319320 56819 0 None -954 3 Human 6.0 pKi = 6.0 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 452 5 1 4 3.3 CN([C@@H]1CCc2c(CC(=O)O)c3ccc(F)c(F)c3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
CHEMBL1643780 56819 0 None -954 3 Human 6.0 pKi = 6.0 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
ChEMBL 452 5 1 4 3.3 CN([C@@H]1CCc2c(CC(=O)O)c3ccc(F)c(F)c3n2C1)S(=O)(=O)c1ccc(F)cc1 10.1016/j.bmcl.2010.11.015
14372503 78301 0 None -12 2 Human 6.0 pKi = 6 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 431 5 1 4 4.6 CS(=O)(=O)c1ccc2c(c1)c1c(n2Cc2ccc(Cl)cc2)C(CC(=O)O)CCC1 10.1016/j.bmcl.2006.02.062
CHEMBL210807 78301 0 None -12 2 Human 6.0 pKi = 6 Binding
Binding affinity to TP receptorBinding affinity to TP receptor
ChEMBL 431 5 1 4 4.6 CS(=O)(=O)c1ccc2c(c1)c1c(n2Cc2ccc(Cl)cc2)C(CC(=O)O)CCC1 10.1016/j.bmcl.2006.02.062
44591514 191779 0 None -398 2 Human 6.0 pKi = 6 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 446 5 1 4 6.7 O=C(O)CC1CCCn2c1c(Sc1ccc(Cl)c(Cl)c1)c1c(C3CC3)nccc12 10.1016/j.bmcl.2009.03.010
CHEMBL519803 191779 0 None -398 2 Human 6.0 pKi = 6 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 446 5 1 4 6.7 O=C(O)CC1CCCn2c1c(Sc1ccc(Cl)c(Cl)c1)c1c(C3CC3)nccc12 10.1016/j.bmcl.2009.03.010
10028338 179820 0 None -776 2 Human 6.0 pKi = 6 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 484 5 1 6 5.3 CS(=O)(=O)c1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
CHEMBL474502 179820 0 None -776 2 Human 6.0 pKi = 6 Binding
Displacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assayDisplacement of radioligand from human recombinant TP receptor expressed in HEK293 cells by scintillation proximity assay
ChEMBL 484 5 1 6 5.3 CS(=O)(=O)c1nccc2c1c(Sc1ccc(Cl)c(Cl)c1)c1n2CCCC1CC(=O)O 10.1016/j.bmcl.2009.03.010
65772 60403 8 None -9 6 Human 8.2 pIC50 = 8.2 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
Drug Central 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC None
CHEMBL174984 60403 8 None -9 6 Human 8.2 pIC50 = 8.2 Binding
Inhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human plateletsInhibitory concentration against radioligand [3H]SQ-29,548 (5 nM) binding to TP receptors in human platelets
Drug Central 345 5 3 6 2.6 COc1cc(C[C@@H]2NCCc3cc(O)c(O)cc32)cc(OC)c1OC None
2449 204230 94 None - 0 Human 8.1 pIC50 = 8.1 Binding
In vitro concentration that reduced specific binding of [3H]U-440619 to guinea pig platelet receptor, TXA2 by 50%In vitro concentration that reduced specific binding of [3H]U-440619 to guinea pig platelet receptor, TXA2 by 50%
Drug Central 354 8 1 3 4.6 CC1=C(C)C(=O)C(C(CCCCCC(=O)O)c2ccccc2)=C(C)C1=O None
CHEMBL70972 204230 94 None - 0 Human 8.1 pIC50 = 8.1 Binding
In vitro concentration that reduced specific binding of [3H]U-440619 to guinea pig platelet receptor, TXA2 by 50%In vitro concentration that reduced specific binding of [3H]U-440619 to guinea pig platelet receptor, TXA2 by 50%
Drug Central 354 8 1 3 4.6 CC1=C(C)C(=O)C(C(CCCCCC(=O)O)c2ccccc2)=C(C)C1=O None
6069 1 0 None -8 8 Human 7.0 pKd = 7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 386 12 2 3 4.7 CCCCC[C@@H](/C=C/[C@H]1C[C@@H]2O[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2(F)F)O 2748606
73755171 1 0 None -8 8 Human 7.0 pKd = 7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 386 12 2 3 4.7 CCCCC[C@@H](/C=C/[C@H]1C[C@@H]2O[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2(F)F)O 2748606
1980 3662 0 None -8 9 Human 7.8 pKd = 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 10634944
1980 3662 0 None -8 9 Human 7.8 pKd = 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 16604093
1985 3662 0 None -8 9 Human 7.8 pKd = 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 10634944
1985 3662 0 None -8 9 Human 7.8 pKd = 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 16604093
6437074 3662 0 None -8 9 Human 7.8 pKd = 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 10634944
6437074 3662 0 None -8 9 Human 7.8 pKd = 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 16604093
1938 1969 18 None -1 4 Human 9.1 pKd = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 512 11 2 4 4.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1/C=C/[C@H](COc1ccc(cc1)I)O)O2 1830308
5311175 1969 18 None -1 4 Human 9.1 pKd = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 512 11 2 4 4.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1/C=C/[C@H](COc1ccc(cc1)I)O)O2 1830308
CHEMBL2113346 1969 18 None -1 4 Human 9.1 pKd = 9.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 512 11 2 4 4.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1/C=C/[C@H](COc1ccc(cc1)I)O)O2 1830308
22524604 2078 0 None - 1 Human 9.3 pKd = 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 531 9 2 3 4.8 OC(=O)CCC/C=C\C[C@@H]1[C@H](C[C@@H]2C[C@H]1C2(C)C)NS(=O)(=O)c1ccc(cc1)I 1386885
3332 2078 0 None - 1 Human 9.3 pKd = 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 531 9 2 3 4.8 OC(=O)CCC/C=C\C[C@@H]1[C@H](C[C@@H]2C[C@H]1C2(C)C)NS(=O)(=O)c1ccc(cc1)I 1386885
1888 3900 29 None 2 17 Human 7.8 pKd None 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 10634944
1974 3900 29 None 2 17 Human 7.8 pKd None 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 10634944
5311493 3900 29 None 2 17 Human 7.8 pKd None 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 10634944
CHEMBL521784 3900 29 None 2 17 Human 7.8 pKd None 7.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 10634944
134694160 1461 0 None -1 2 Mouse 8.5 pKd None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1375456
1979 1461 0 None -1 2 Mouse 8.5 pKd None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1375456
1984 1461 0 None -1 2 Mouse 8.5 pKd None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1375456
3165 1461 0 None -1 2 Mouse 8.5 pKd None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1375456
5312138 1461 0 None -1 2 Mouse 8.5 pKd None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1375456
CHEMBL3301671 1461 0 None -1 2 Mouse 8.5 pKd None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1375456
134694160 1461 0 None 1 2 Human 8.9 pKd None 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1825698
1979 1461 0 None 1 2 Human 8.9 pKd None 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1825698
1984 1461 0 None 1 2 Human 8.9 pKd None 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1825698
3165 1461 0 None 1 2 Human 8.9 pKd None 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1825698
5312138 1461 0 None 1 2 Human 8.9 pKd None 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1825698
CHEMBL3301671 1461 0 None 1 2 Human 8.9 pKd None 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1825698
1980 3662 0 None 8 9 Rat 9.0 pKd None 9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 7635958
1985 3662 0 None 8 9 Rat 9.0 pKd None 9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 7635958
6437074 3662 0 None 8 9 Rat 9.0 pKd None 9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 7635958
135398737 958 93 3H-SQ 29548 -416 89 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
38 958 93 3H-SQ 29548 -416 89 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
722 958 93 3H-SQ 29548 -416 89 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
CHEMBL42 958 93 3H-SQ 29548 -416 89 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
DB00363 958 93 3H-SQ 29548 -416 89 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 326 0 1 4 3.7 CN1CCN(CC1)C1=Nc2cc(Cl)ccc2Nc2c1cccc2 None
1222 1664 49 3H-SQ 29548 -1659 33 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
3396 1664 49 3H-SQ 29548 -1659 33 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
85 1664 49 3H-SQ 29548 -1659 33 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
CHEMBL46516 1664 49 3H-SQ 29548 -1659 33 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
DB04842 1664 49 3H-SQ 29548 -1659 33 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 475 7 1 3 5.3 Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1 None
1353 1911 93 3H-SQ 29548 -691 83 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
3559 1911 93 3H-SQ 29548 -691 83 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
86 1911 93 3H-SQ 29548 -691 83 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
CHEMBL54 1911 93 3H-SQ 29548 -691 83 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
DB00502 1911 93 3H-SQ 29548 -691 83 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 375 6 1 3 4.4 Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl None
135398745 2914 112 3H-SQ 29548 -512 65 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
47 2914 112 3H-SQ 29548 -512 65 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
CHEMBL715 2914 112 3H-SQ 29548 -512 65 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
DB00334 2914 112 3H-SQ 29548 -512 65 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 312 1 1 5 1.7 CN1CCN(CC1)C1=c2cc(sc2=Nc2c(N1)cccc2)C None
2181 3128 46 3H-SQ 29548 -831 35 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
4830 3128 46 3H-SQ 29548 -831 35 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
92 3128 46 3H-SQ 29548 -831 35 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
CHEMBL440294 3128 46 3H-SQ 29548 -831 35 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
DB09286 3128 46 3H-SQ 29548 -831 35 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 375 7 1 4 2.6 O=C(c1ccc(cc1)F)CCCN1CCC(CC1)(N1CCCCC1)C(=O)N None
2337 3256 77 3H-SQ 29548 -112 62 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
50 3256 77 3H-SQ 29548 -112 62 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
5002 3256 77 3H-SQ 29548 -112 62 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
CHEMBL716 3256 77 3H-SQ 29548 -112 62 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
DB01224 3256 77 3H-SQ 29548 -112 62 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 383 5 1 6 2.9 OCCOCCN1CCN(CC1)C1=Nc2ccccc2Sc2c1cccc2 None
2389 3331 118 3H-SQ 29548 -2691 67 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
5073 3331 118 3H-SQ 29548 -2691 67 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
96 3331 118 3H-SQ 29548 -2691 67 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
CHEMBL85 3331 118 3H-SQ 29548 -2691 67 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
DB00734 3331 118 3H-SQ 29548 -2691 67 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 410 4 0 6 3.6 Fc1ccc2c(c1)onc2C1CCN(CC1)CCc1c(C)nc2n(c1=O)CCCC2 None
2435 3590 83 3H-SQ 29548 -1949 48 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
60149 3590 83 3H-SQ 29548 -1949 48 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
98 3590 83 3H-SQ 29548 -1949 48 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
CHEMBL12713 3590 83 3H-SQ 29548 -1949 48 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
DB06144 3590 83 3H-SQ 29548 -1949 48 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 440 5 1 3 4.6 Clc1ccc2c(c1)c(cn2c1ccc(cc1)F)C1CCN(CC1)CCN1CCNC1=O None
2865 4143 73 3H-SQ 29548 -2041 53 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
59 4143 73 3H-SQ 29548 -2041 53 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
60854 4143 73 3H-SQ 29548 -2041 53 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
CHEMBL708 4143 73 3H-SQ 29548 -2041 53 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
DB00246 4143 73 3H-SQ 29548 -2041 53 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 412 4 1 5 3.8 O=C1Nc2c(C1)cc(c(c2)Cl)CCN1CCN(CC1)c1nsc2c1cccc2 None
103 4153 61 3H-SQ 29548 -831 53 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
2875 4153 61 3H-SQ 29548 -831 53 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
5736 4153 61 3H-SQ 29548 -831 53 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
CHEMBL285802 4153 61 3H-SQ 29548 -831 53 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
DB09225 4153 61 3H-SQ 29548 -831 53 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 331 4 0 3 4.9 CN(CCOC1=Cc2ccccc2Sc2c1cc(Cl)cc2)C None
115237 55585 119 3H-SQ 29548 -4265 54 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
CHEMBL1621 55585 119 3H-SQ 29548 -4265 54 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 426 4 1 7 3.1 Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O None
46780481 107531 20 3H-SQ 29548 -5888 53 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
9903970 107531 20 3H-SQ 29548 -5888 53 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL3187365 107531 20 3H-SQ 29548 -5888 53 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
CHEMBL3544974 107531 20 3H-SQ 29548 -5888 53 Human 6.0 pKi = 6 Binding
NoneNone
PDSP KiDatabase 285 0 0 2 4.3 CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1 None
1881 3079 0 3H-15(S)9,11-epoxymethano PGH2 -4570 21 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O None
1891 3079 0 3H-15(S)9,11-epoxymethano PGH2 -4570 21 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O None
448457 3079 0 3H-15(S)9,11-epoxymethano PGH2 -4570 21 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O None
CHEMBL1235252 3079 0 3H-15(S)9,11-epoxymethano PGH2 -4570 21 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O None
DB02056 3079 0 3H-15(S)9,11-epoxymethano PGH2 -4570 21 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1C(=O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O None
138 3081 88 3H-15(S)9,11-epoxymethano PGH2 -10000 18 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 354 13 3 4 3.5 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O None
1882 3081 88 3H-15(S)9,11-epoxymethano PGH2 -10000 18 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 354 13 3 4 3.5 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O None
5280723 3081 88 3H-15(S)9,11-epoxymethano PGH2 -10000 18 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 354 13 3 4 3.5 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O None
CHEMBL495 3081 88 3H-15(S)9,11-epoxymethano PGH2 -10000 18 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 354 13 3 4 3.5 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O None
DB00770 3081 88 3H-15(S)9,11-epoxymethano PGH2 -10000 18 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 354 13 3 4 3.5 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O None
1883 3082 75 3H-15(S)9,11-epoxymethano PGH2 -10000 24 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O None
1916 3082 75 3H-15(S)9,11-epoxymethano PGH2 -10000 24 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O None
5280360 3082 75 3H-15(S)9,11-epoxymethano PGH2 -10000 24 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O None
913 3082 75 3H-15(S)9,11-epoxymethano PGH2 -10000 24 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O None
CHEMBL548 3082 75 3H-15(S)9,11-epoxymethano PGH2 -10000 24 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O None
DB00917 3082 75 3H-15(S)9,11-epoxymethano PGH2 -10000 24 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O None
1884 3083 52 3H-15(S)9,11-epoxymethano PGH2 -3019 22 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O None
5280363 3083 52 3H-15(S)9,11-epoxymethano PGH2 -3019 22 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O None
912 3083 52 3H-15(S)9,11-epoxymethano PGH2 -3019 22 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O None
CHEMBL815 3083 52 3H-15(S)9,11-epoxymethano PGH2 -3019 22 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O None
DB12789 3083 52 3H-15(S)9,11-epoxymethano PGH2 -3019 22 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O None
243 3202 91 3H-SQ 29548 -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
3052762 3202 91 3H-SQ 29548 -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
3502 3202 91 3H-SQ 29548 -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
CHEMBL117287 3202 91 3H-SQ 29548 -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
DB06480 3202 91 3H-SQ 29548 -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
44208932 140707 7 UNDEFINED -89125 36 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 475 5 1 3 6.8 Cc1ccc(Cn2nc(C(=O)NC3C4(C)CCC(C4)C3(C)C)cc2-c2ccc(Cl)c(C)c2)cc1 None
CHEMBL381689 140707 7 UNDEFINED -89125 36 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 475 5 1 3 6.8 Cc1ccc(Cn2nc(C(=O)NC3C4(C)CCC(C4)C3(C)C)cc2-c2ccc(Cl)c(C)c2)cc1 None
None 216437 0 3H-15(S)9,11-epoxymethano PGH2 - 1 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 368 12 4 4 3.4 CCCCCC(C)(C=CC1C(CC(C1CC=CCCCC(=O)O)O)O)O None
None 216439 0 3H-15(S)9,11-epoxymethano PGH2 - 1 Mouse 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 304 14 1 1 6.2 CCCCCC=CCC=CCC=CCC=CCCCC(=O)O None
None 216493 0 3H-SQ 29548 -10471285 17 Rat 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 372 2 1 3 4.4 CC(C)(C)C1=CC=C(C=C1)NC(=O)N2CCN(CC2)C3=C(C=CC=N3)Cl None
None 216434 0 3H-15(S)9,11-epoxymethano PGH2 - 1 Mouse 6.0 pKi = 6.0 Binding
NoneNone
PDSP KiDatabase 348 12 2 4 4.5 CCCCCC(C=CC1C2CC(C1CC=CCCCC(=O)O)N=N2)O None
None 216125 0 125I-BOP - 1 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 541 11 4 4 4.7 CC1(C2CC1C(C(C2)NCC(CC3=CC(=C(C=C3)O)I)O)CC=CCCCC(=O)O)C None
None 216125 0 125I-BOP - 1 Human 6.9 pKi = 6.9 Binding
NoneNone
PDSP KiDatabase 541 11 4 4 4.7 CC1(C2CC1C(C(C2)NCC(CC3=CC(=C(C=C3)O)I)O)CC=CCCCC(=O)O)C None
None 216438 0 3H-15(S)9,11-epoxymethano PGH2 - 1 Mouse 5.9 pKi = 5.9 Binding
NoneNone
PDSP KiDatabase 388 12 2 4 4.1 CCCCCC(C=CC1C(C2C(C(O1)O2)(F)F)CC=CCCCC(=O)O)O None
1980 3662 0 125I-BOP -8 9 Human 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
1985 3662 0 125I-BOP -8 9 Human 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
6437074 3662 0 125I-BOP -8 9 Human 7.9 pKi = 7.9 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
1980 3662 0 125I-BOP -8 9 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
1985 3662 0 125I-BOP -8 9 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
6437074 3662 0 125I-BOP -8 9 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
None 216219 0 125I-BOP - 1 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 373 4 1 2 5.2 C1CC(C2C(C1)C3=C(N2CC4=CC=C(C=C4)Cl)C=CC(=C3)F)CC(=O)O None
1980 3662 0 125I-BOP -8 9 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
1985 3662 0 125I-BOP -8 9 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
6437074 3662 0 125I-BOP -8 9 Human 7.8 pKi = 7.8 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
None 216433 0 3H-15(S)9,11-epoxymethano PGH2 - 1 Mouse 5.8 pKi = 5.8 Binding
NoneNone
PDSP KiDatabase 352 12 2 4 4.0 CCCCCC(C=CC1C2CC(C1CC=CCCCC(=O)O)OO2)O None
1888 3900 29 3H-SQ 29548 2 17 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
1974 3900 29 3H-SQ 29548 2 17 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
5311493 3900 29 3H-SQ 29548 2 17 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
CHEMBL521784 3900 29 3H-SQ 29548 2 17 Human 7.7 pKi = 7.7 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
None 216433 0 3H-15(S)9,11-epoxymethano PGH2 - 1 Mouse 6.7 pKi = 6.7 Binding
NoneNone
PDSP KiDatabase 352 12 2 4 4.0 CCCCCC(C=CC1C2CC(C1CC=CCCCC(=O)O)OO2)O None
None 216226 0 3H-SQ 29548 - 1 Human 7.6 pKi = 7.6 Binding
NoneNone
PDSP KiDatabase 422 15 3 4 3.2 CCCCCCC(=O)NCC(=O)NCC1C2CCC(C1CC=CCCCC(=O)O)O2 None
1888 3900 29 3H-SQ 29548 2 17 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
1974 3900 29 3H-SQ 29548 2 17 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
5311493 3900 29 3H-SQ 29548 2 17 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
CHEMBL521784 3900 29 3H-SQ 29548 2 17 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
None 216225 0 3H-SQ 29548 - 1 Human 7.5 pKi = 7.5 Binding
NoneNone
PDSP KiDatabase 384 10 2 3 4.7 CC(C1=CC=CC=C1)C(C=CC2C3CCC(C2CC=CCCCC(=O)O)O3)O None
None 216435 0 3H-15(S)9,11-epoxymethano PGH2 - 1 Mouse 6.5 pKi = 6.5 Binding
NoneNone
PDSP KiDatabase 408 11 4 5 2.7 C1C(C(C(C1O)C=CC(COC2=CC=C(C=C2)F)O)CC=CCCCC(=O)O)O None
None 216124 0 125I-BOP - 1 Human 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCCC(C=CC1C2CC(C1CC=CCCCC(=O)O)OC2)O None
None 216124 0 3H-SQ 29548 - 1 Human 8.4 pKi = 8.4 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCCC(C=CC1C2CC(C1CC=CCCCC(=O)O)OC2)O None
1883 3082 75 None -380 24 Human 8.4 pKi = 8.4 Binding
NoneNone
Drug Central 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O None
1916 3082 75 None -380 24 Human 8.4 pKi = 8.4 Binding
NoneNone
Drug Central 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O None
5280360 3082 75 None -380 24 Human 8.4 pKi = 8.4 Binding
NoneNone
Drug Central 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O None
913 3082 75 None -380 24 Human 8.4 pKi = 8.4 Binding
NoneNone
Drug Central 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O None
CHEMBL548 3082 75 None -380 24 Human 8.4 pKi = 8.4 Binding
NoneNone
Drug Central 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O None
DB00917 3082 75 None -380 24 Human 8.4 pKi = 8.4 Binding
NoneNone
Drug Central 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O None
1980 3662 0 125I-BOP -8 9 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
1985 3662 0 125I-BOP -8 9 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
6437074 3662 0 125I-BOP -8 9 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
None 216125 0 125I-BOP - 1 Human 6.4 pKi = 6.4 Binding
NoneNone
PDSP KiDatabase 541 11 4 4 4.7 CC1(C2CC1C(C(C2)NCC(CC3=CC(=C(C=C3)O)I)O)CC=CCCCC(=O)O)C None
None 216124 0 125I-BOP - 1 Human 7.4 pKi = 7.4 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCCC(C=CC1C2CC(C1CC=CCCCC(=O)O)OC2)O None
None 216440 0 3H-15(S)9,11-epoxymethano PGH2 - 1 Mouse 6.3 pKi = 6.3 Binding
NoneNone
PDSP KiDatabase 383 9 3 3 4.7 C1CC2CC1C(C2C=NNC(=O)NC3=CC=CC=C3)CC=CCCCC(=O)O None
None 216226 0 3H-SQ 29548 - 1 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 422 15 3 4 3.2 CCCCCCC(=O)NCC(=O)NCC1C2CCC(C1CC=CCCCC(=O)O)O2 None
1884 3083 52 None -61 22 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O None
5280363 3083 52 None -61 22 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O None
912 3083 52 None -61 22 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O None
CHEMBL815 3083 52 None -61 22 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O None
DB12789 3083 52 None -61 22 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O None
138107701 187464 46 None -5 15 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 360 8 3 3 3.5 CC#CCC(C)[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)O)C[C@H]2C[C@H]1O None
5311181 187464 46 None -5 15 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 360 8 3 3 3.5 CC#CCC(C)[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)O)C[C@H]2C[C@H]1O None
CHEMBL494 187464 46 None -5 15 Human 8.3 pKi = 8.3 Binding
NoneNone
Drug Central 360 8 3 3 3.5 CC#CCC(C)[C@H](O)/C=C/[C@@H]1[C@H]2C/C(=C/CCCC(=O)O)C[C@H]2C[C@H]1O None
1980 3662 0 3H-SQ 29548 -8 9 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
1985 3662 0 3H-SQ 29548 -8 9 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
6437074 3662 0 3H-SQ 29548 -8 9 Human 8.3 pKi = 8.3 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
1888 3900 29 125I-BOP 2 17 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
1974 3900 29 125I-BOP 2 17 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
5311493 3900 29 125I-BOP 2 17 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
CHEMBL521784 3900 29 125I-BOP 2 17 Human 7.3 pKi = 7.3 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
1888 3900 29 125I-BOP 2 17 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
1974 3900 29 125I-BOP 2 17 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
5311493 3900 29 125I-BOP 2 17 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
CHEMBL521784 3900 29 125I-BOP 2 17 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
None 216124 0 125I-BOP - 1 Human 7.2 pKi = 7.2 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCCC(C=CC1C2CC(C1CC=CCCCC(=O)O)OC2)O None
None 216124 0 3H-SQ 29548 - 1 Human 8.2 pKi = 8.2 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCCC(C=CC1C2CC(C1CC=CCCCC(=O)O)OC2)O None
1980 3662 0 3H-SQ 29548 -8 9 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
1985 3662 0 3H-SQ 29548 -8 9 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
6437074 3662 0 3H-SQ 29548 -8 9 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 None
None 216143 0 3H-SQ 29548 - 1 Human 8.1 pKi = 8.1 Binding
NoneNone
PDSP KiDatabase 477 11 2 4 5.7 C1CCN(CC1)C2C(CC(C2CCC=CCCC(=O)O)OCC3=CC=C(C=C3)C4=CC=CC=C4)O None
None 216225 0 3H-SQ 29548 - 1 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 384 10 2 3 4.7 CC(C1=CC=CC=C1)C(C=CC2C3CCC(C2CC=CCCCC(=O)O)O3)O None
1888 3900 29 125I-BOP 2 17 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
1974 3900 29 125I-BOP 2 17 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
5311493 3900 29 125I-BOP 2 17 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
CHEMBL521784 3900 29 125I-BOP 2 17 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
None 216436 0 3H-15(S)9,11-epoxymethano PGH2 - 1 Mouse 6.1 pKi = 6.1 Binding
NoneNone
PDSP KiDatabase 382 12 4 4 3.7 CCCCC(C)(C)C(C=CC1C(CC(C1CC=CCCCC(=O)O)O)O)O None
3356 2280 73 None -38 8 Human 8.1 pKi = 8.1 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
Drug Central 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F None
4326 2280 73 None -38 8 Human 8.1 pKi = 8.1 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
Drug Central 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F None
9867642 2280 73 None -38 8 Human 8.1 pKi = 8.1 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
Drug Central 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F None
CHEMBL426559 2280 73 None -38 8 Human 8.1 pKi = 8.1 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
Drug Central 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F None
DB11629 2280 73 None -38 8 Human 8.1 pKi = 8.1 Binding
Binding affinity to human TP receptor expressed in HEK293 cellsBinding affinity to human TP receptor expressed in HEK293 cells
Drug Central 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F None
1888 3900 29 125I-BOP 2 17 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
1974 3900 29 125I-BOP 2 17 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
5311493 3900 29 125I-BOP 2 17 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
CHEMBL521784 3900 29 125I-BOP 2 17 Human 7.1 pKi = 7.1 Binding
NoneNone
PDSP KiDatabase 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O None
134694160 1461 0 None -1 2 Mouse 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 None
1979 1461 0 None -1 2 Mouse 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 None
1984 1461 0 None -1 2 Mouse 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 None
3165 1461 0 None -1 2 Mouse 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 None
5312138 1461 0 None -1 2 Mouse 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 None
CHEMBL3301671 1461 0 None -1 2 Mouse 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 None
123879 3287 82 None 3 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
Drug Central 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F None
1910 3287 82 None 3 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
Drug Central 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F None
1911 3287 82 None 3 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
Drug Central 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F None
2354 3287 82 None 3 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
Drug Central 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F None
CHEMBL361812 3287 82 None 3 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
Drug Central 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F None
DB13036 3287 82 None 3 4 Human 8.0 pKi = 8.0 Binding
Binding affinity to thromboxane receptorBinding affinity to thromboxane receptor
Drug Central 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F None
134694160 1461 0 None 1 2 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 None
1979 1461 0 None 1 2 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 None
1984 1461 0 None 1 2 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 None
3165 1461 0 None 1 2 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 None
5312138 1461 0 None 1 2 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 None
CHEMBL3301671 1461 0 None 1 2 Human 8.0 pKi = 8.0 Binding
NoneNone
Drug Central 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 None
3356 2280 73 None -38 8 Human 6.1 pKi = 6.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 17882161
4326 2280 73 None -38 8 Human 6.1 pKi = 6.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 17882161
9867642 2280 73 None -38 8 Human 6.1 pKi = 6.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 17882161
CHEMBL426559 2280 73 None -38 8 Human 6.1 pKi = 6.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 17882161
DB11629 2280 73 None -38 8 Human 6.1 pKi = 6.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 435 5 1 4 4.4 OC(=O)C[C@H]1CCc2c1n(Cc1ccc(cc1)Cl)c1c2cc(cc1S(=O)(=O)C)F 17882161
1888 3900 29 None 2 17 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 10634944
1974 3900 29 None 2 17 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 10634944
5311493 3900 29 None 2 17 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 10634944
CHEMBL521784 3900 29 None 2 17 Human 7.5 pKi = 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 10634944
123879 3287 82 None 3 4 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 1387312
1910 3287 82 None 3 4 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 1387312
1911 3287 82 None 3 4 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 1387312
2354 3287 82 None 3 4 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 1387312
CHEMBL361812 3287 82 None 3 4 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 1387312
DB13036 3287 82 None 3 4 Human 8.0 pKi = 8 Binding
UnclassifiedUnclassified
Guide to Pharmacology 416 6 2 4 3.1 OC(=O)CCn1c2CC[C@H](Cc2c2c1cccc2)NS(=O)(=O)c1ccc(cc1)F 1387312
1978 2933 0 None - 1 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 391 9 3 3 3.9 OC(=O)CCC/C=C\C[C@@H]1[C@@H](NC(=O)[C@@H](C2CCCC2)O)C[C@H]2C[C@@H]1C2(C)C 3008368
5311334 2933 0 None - 1 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 391 9 3 3 3.9 OC(=O)CCC/C=C\C[C@@H]1[C@@H](NC(=O)[C@@H](C2CCCC2)O)C[C@H]2C[C@@H]1C2(C)C 3008368
CHEMBL266243 2933 0 None - 1 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 391 9 3 3 3.9 OC(=O)CCC/C=C\C[C@@H]1[C@@H](NC(=O)[C@@H](C2CCCC2)O)C[C@H]2C[C@@H]1C2(C)C 3008368
1987 1989 19 None -1 2 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 440 11 2 5 4.1 CCCCCNC(=O)c1coc(n1)[C@@H]1[C@H]2CC[C@@H]([C@@H]1Cc1ccccc1CCC(=O)O)O2 8437108
3037233 1989 19 None -1 2 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 440 11 2 5 4.1 CCCCCNC(=O)c1coc(n1)[C@@H]1[C@H]2CC[C@@H]([C@@H]1Cc1ccccc1CCC(=O)O)O2 8437108
CHEMBL3301673 1989 19 None -1 2 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 440 11 2 5 4.1 CCCCCNC(=O)c1coc(n1)[C@@H]1[C@H]2CC[C@@H]([C@@H]1Cc1ccccc1CCC(=O)O)O2 8437108
DB12321 1989 19 None -1 2 Human 8.2 pKi = 8.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 440 11 2 5 4.1 CCCCCNC(=O)c1coc(n1)[C@@H]1[C@H]2CC[C@@H]([C@@H]1Cc1ccccc1CCC(=O)O)O2 8437108
1980 3662 0 None -8 9 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 10634944
1980 3662 0 None -8 9 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 16604093
1980 3662 0 None -8 9 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 2975605
1985 3662 0 None -8 9 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 10634944
1985 3662 0 None -8 9 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 16604093
1985 3662 0 None -8 9 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 2975605
6437074 3662 0 None -8 9 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 10634944
6437074 3662 0 None -8 9 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 16604093
6437074 3662 0 None -8 9 Human 8.6 pKi = 8.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 2975605
1976 3973 18 None 8 2 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 477 11 2 4 5.7 OC(=O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)C[C@@H]([C@@H]1N1CCCCC1)O 2527074
1976 3973 18 None 8 2 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 477 11 2 4 5.7 OC(=O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)C[C@@H]([C@@H]1N1CCCCC1)O 8242228
6918030 3973 18 None 8 2 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 477 11 2 4 5.7 OC(=O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)C[C@@H]([C@@H]1N1CCCCC1)O 2527074
6918030 3973 18 None 8 2 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 477 11 2 4 5.7 OC(=O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)C[C@@H]([C@@H]1N1CCCCC1)O 8242228
CHEMBL65030 3973 18 None 8 2 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 477 11 2 4 5.7 OC(=O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)C[C@@H]([C@@H]1N1CCCCC1)O 2527074
CHEMBL65030 3973 18 None 8 2 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 477 11 2 4 5.7 OC(=O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)C[C@@H]([C@@H]1N1CCCCC1)O 8242228
1940 1663 41 None -20892 10 Human 4.3 pKi None 4.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 458 11 4 5 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)C(F)(F)F)O)O 10634944
3417 1663 41 None -20892 10 Human 4.3 pKi None 4.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 458 11 4 5 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)C(F)(F)F)O)O 10634944
5311100 1663 41 None -20892 10 Human 4.3 pKi None 4.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 458 11 4 5 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)C(F)(F)F)O)O 10634944
CHEMBL1201379 1663 41 None -20892 10 Human 4.3 pKi None 4.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 458 11 4 5 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)C(F)(F)F)O)O 10634944
DB11519 1663 41 None -20892 10 Human 4.3 pKi None 4.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 458 11 4 5 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)C(F)(F)F)O)O 10634944
1883 3082 75 None -380 24 Human 4.5 pKi None 4.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O 10634944
1916 3082 75 None -380 24 Human 4.5 pKi None 4.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O 10634944
5280360 3082 75 None -380 24 Human 4.5 pKi None 4.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O 10634944
913 3082 75 None -380 24 Human 4.5 pKi None 4.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O 10634944
CHEMBL548 3082 75 None -380 24 Human 4.5 pKi None 4.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O 10634944
DB00917 3082 75 None -380 24 Human 4.5 pKi None 4.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 352 12 3 4 3.3 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O 10634944
1892 747 20 None -316 9 Human 4.7 pKi None 4.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 394 13 3 4 4.3 CCCC1(CCC1)[C@H](C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O 10634944
25886893 747 20 None -316 9 Human 4.7 pKi None 4.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 394 13 3 4 4.3 CCCC1(CCC1)[C@H](C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O 10634944
CHEMBL1628262 747 20 None -316 9 Human 4.7 pKi None 4.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 394 13 3 4 4.3 CCCC1(CCC1)[C@H](C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O)O 10634944
1893 795 0 None -1412 13 Human 4.7 pKi None 4.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 350 10 3 3 4.1 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=C\CCCC(=O)O)/C2)O 10634944
5311242 795 0 None -1412 13 Human 4.7 pKi None 4.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 350 10 3 3 4.1 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=C\CCCC(=O)O)/C2)O 10634944
CHEMBL148319 795 0 None -1412 13 Human 4.7 pKi None 4.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 350 10 3 3 4.1 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@H]2[C@@H]1C/C(=C\CCCC(=O)O)/C2)O 10634944
1884 3083 52 None -61 22 Human 5.1 pKi None 5.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O 10634944
5280363 3083 52 None -61 22 Human 5.1 pKi None 5.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O 10634944
912 3083 52 None -61 22 Human 5.1 pKi None 5.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O 10634944
CHEMBL815 3083 52 None -61 22 Human 5.1 pKi None 5.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O 10634944
DB12789 3083 52 None -61 22 Human 5.1 pKi None 5.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 354 12 4 4 3.0 CCCCC[C@@H](/C=C/[C@H]1[C@H](O)C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)O)O 10634944
1894 957 41 None -1621 5 Human 5.2 pKi None 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 424 11 4 5 3.2 OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)Cl)O)O 10634944
5311053 957 41 None -1621 5 Human 5.2 pKi None 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 424 11 4 5 3.2 OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)Cl)O)O 10634944
CHEMBL37853 957 41 None -1621 5 Human 5.2 pKi None 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 424 11 4 5 3.2 OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)Cl)O)O 10634944
DB11507 957 41 None -1621 5 Human 5.2 pKi None 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 424 11 4 5 3.2 OC(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@H]([C@@H]1/C=C/[C@H](COc1cccc(c1)Cl)O)O 10634944
1895 2007 0 None -630 16 Human 5.2 pKi None 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 360 8 3 3 3.5 CC#CCC([C@@H](/C=C/C1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)C 10634944
6435378 2007 0 None -630 16 Human 5.2 pKi None 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 360 8 3 3 3.5 CC#CCC([C@@H](/C=C/C1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)C 10634944
CHEMBL236025 2007 0 None -630 16 Human 5.2 pKi None 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 360 8 3 3 3.5 CC#CCC([C@@H](/C=C/C1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)C 10634944
DB01088 2007 0 None -630 16 Human 5.2 pKi None 5.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 360 8 3 3 3.5 CC#CCC([C@@H](/C=C/C1[C@H](O)C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)C 10634944
1949 318 0 None 12 3 Human 6.2 pKi None 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 477 11 1 5 4.7 OC(=O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)CC(=O)[C@@H]1N1CCOCC1 10634944
5310999 318 0 None 12 3 Human 6.2 pKi None 6.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 477 11 1 5 4.7 OC(=O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)CC(=O)[C@@H]1N1CCOCC1 10634944
1970 798 0 None - 1 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 348 12 2 2 5.3 CCCCC[C@@H](/C=C/[C@H]1CC2CC([C@@H]1C/C=C\CCCC(=O)O)C2)O 1434130
5311387 798 0 None - 1 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 348 12 2 2 5.3 CCCCC[C@@H](/C=C/[C@H]1CC2CC([C@@H]1C/C=C\CCCC(=O)O)C2)O 1434130
1913 2464 0 None -2238 15 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 374 12 2 4 4.0 OC(=O)CCCCCC[C@@H]1[C@@H](/C=C/[C@H](COc2ccccc2)O)CCC1=O 10634944
5311223 2464 0 None -2238 15 Human 6.5 pKi None 6.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 374 12 2 4 4.0 OC(=O)CCCCCC[C@@H]1[C@@H](/C=C/[C@H](COc2ccccc2)O)CCC1=O 10634944
1920 2937 0 None -125 4 Human 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 439 9 2 3 4.8 OC(=O)CCC/C=C\[C@H]1C2CCC([C@@H]1CNS(=O)(=O)c1ccc(cc1C)Cl)CC2 10537280
9824507 2937 0 None -125 4 Human 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 439 9 2 3 4.8 OC(=O)CCC/C=C\[C@H]1C2CCC([C@@H]1CNS(=O)(=O)c1ccc(cc1C)Cl)CC2 10537280
CHEMBL1628612 2937 0 None -125 4 Human 7.1 pKi None 7.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 439 9 2 3 4.8 OC(=O)CCC/C=C\[C@H]1C2CCC([C@@H]1CNS(=O)(=O)c1ccc(cc1C)Cl)CC2 10537280
1888 3900 29 None -2 17 Mouse 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 9313928
1974 3900 29 None -2 17 Mouse 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 9313928
5311493 3900 29 None -2 17 Mouse 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 9313928
CHEMBL521784 3900 29 None -2 17 Mouse 7.2 pKi None 7.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 350 12 2 3 4.3 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OC[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 9313928
1898 3450 0 None -15 2 Human 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 441 8 3 4 5.6 OC(=O)CCC/C=C\C[C@@H]1C[C@H]2C[C@@H]([C@@H]1NC(=O)c1csc3c1cc(O)cc3)C2(C)C 11454901
5311213 3450 0 None -15 2 Human 7.6 pKi None 7.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 441 8 3 4 5.6 OC(=O)CCC/C=C\C[C@@H]1C[C@H]2C[C@@H]([C@@H]1NC(=O)c1csc3c1cc(O)cc3)C2(C)C 11454901
1986 1312 50 None - 1 Human 7.7 pKi None 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 353 7 2 3 2.5 OC(=O)Cc1ccc(cc1)CCNS(=O)(=O)c1ccc(cc1)Cl 1434130
54343 1312 50 None - 1 Human 7.7 pKi None 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 353 7 2 3 2.5 OC(=O)Cc1ccc(cc1)CCNS(=O)(=O)c1ccc(cc1)Cl 1434130
CHEMBL71685 1312 50 None - 1 Human 7.7 pKi None 7.7 Binding
UnclassifiedUnclassified
Guide to Pharmacology 353 7 2 3 2.5 OC(=O)Cc1ccc(cc1)CCNS(=O)(=O)c1ccc(cc1)Cl 1434130
1980 3662 0 None -12 9 Mouse 7.9 pKi None 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 9313928
1985 3662 0 None -12 9 Mouse 7.9 pKi None 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 9313928
6437074 3662 0 None -12 9 Mouse 7.9 pKi None 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 387 10 4 4 3.3 O=C(Nc1ccccc1)NNC[C@@H]1[C@@H]2CC[C@H]([C@@H]1C/C=C\CCCC(=O)O)O2 9313928
1939 3688 0 None 1 2 Mouse 7.9 pKi None 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 366 12 2 3 5.2 CCCCC[C@H](/C=C/[C@H]1C[C@H]2C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)S2)O 9313928
5311453 3688 0 None 1 2 Mouse 7.9 pKi None 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 366 12 2 3 5.2 CCCCC[C@H](/C=C/[C@H]1C[C@H]2C[C@@H]([C@@H]1C/C=C\CCCC(=O)O)S2)O 9313928
1976 3973 18 None -8 2 Mouse 7.9 pKi None 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 477 11 2 4 5.7 OC(=O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)C[C@@H]([C@@H]1N1CCCCC1)O 9313928
6918030 3973 18 None -8 2 Mouse 7.9 pKi None 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 477 11 2 4 5.7 OC(=O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)C[C@@H]([C@@H]1N1CCCCC1)O 9313928
CHEMBL65030 3973 18 None -8 2 Mouse 7.9 pKi None 7.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 477 11 2 4 5.7 OC(=O)CC/C=C\CC[C@H]1[C@@H](OCc2ccc(cc2)c2ccccc2)C[C@@H]([C@@H]1N1CCCCC1)O 9313928
1972 3084 0 None - 1 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 352 12 2 4 4.0 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OO[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 1434130
445049 3084 0 None - 1 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 352 12 2 4 4.0 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OO[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 1434130
4483 3084 0 None - 1 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 352 12 2 4 4.0 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OO[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 1434130
91898397 3084 0 None - 1 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 352 12 2 4 4.0 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OO[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 1434130
CHEMBL2074582 3084 0 None - 1 Human 8.4 pKi None 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 352 12 2 4 4.0 CCCCC[C@@H](/C=C/[C@H]1[C@@H]2OO[C@H]([C@@H]1C/C=C\CCCC(=O)O)C2)O 1434130
1971 1569 0 None - 1 Human 8.5 pKi None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 404 11 2 4 4.1 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1/C=C/[C@@H](COc1ccc(cc1)F)O)O2 2743082
5311384 1569 0 None - 1 Human 8.5 pKi None 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 404 11 2 4 4.1 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1/C=C/[C@@H](COc1ccc(cc1)F)O)O2 2743082
19088577 2203 0 None - 1 Human 8.9 pKi None 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 409 3 0 5 4.0 [O-]C(=O)c1ccc2c(c1)/C(=C/Cn1cnc3c1cc(C)c(c3)C)/c1ccccc1CO2 1434130
1977 2203 0 None - 1 Human 8.9 pKi None 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology 409 3 0 5 4.0 [O-]C(=O)c1ccc2c(c1)/C(=C/Cn1cnc3c1cc(C)c(c3)C)/c1ccccc1CO2 1434130
134694160 1461 0 None -1 2 Mouse 9.2 pKi None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 9313928
1979 1461 0 None -1 2 Mouse 9.2 pKi None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 9313928
1984 1461 0 None -1 2 Mouse 9.2 pKi None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 9313928
3165 1461 0 None -1 2 Mouse 9.2 pKi None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 9313928
5312138 1461 0 None -1 2 Mouse 9.2 pKi None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 9313928
CHEMBL3301671 1461 0 None -1 2 Mouse 9.2 pKi None 9.2 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 9313928
1938 1969 18 None 1 4 Mouse 9.3 pKi None 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 512 11 2 4 4.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1/C=C/[C@H](COc1ccc(cc1)I)O)O2 9313928
5311175 1969 18 None 1 4 Mouse 9.3 pKi None 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 512 11 2 4 4.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1/C=C/[C@H](COc1ccc(cc1)I)O)O2 9313928
CHEMBL2113346 1969 18 None 1 4 Mouse 9.3 pKi None 9.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 512 11 2 4 4.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1/C=C/[C@H](COc1ccc(cc1)I)O)O2 9313928
134694160 1461 0 None 1 2 Human 9.6 pKi None 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1833018
1979 1461 0 None 1 2 Human 9.6 pKi None 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1833018
1984 1461 0 None 1 2 Human 9.6 pKi None 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1833018
3165 1461 0 None 1 2 Human 9.6 pKi None 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1833018
5312138 1461 0 None 1 2 Human 9.6 pKi None 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1833018
CHEMBL3301671 1461 0 None 1 2 Human 9.6 pKi None 9.6 Binding
UnclassifiedUnclassified
Guide to Pharmacology 377 9 2 3 3.6 OC(=O)CCC/C=C\C[C@H]1[C@@H]2CC[C@H]([C@@H]1NS(=O)(=O)c1ccccc1)C2 1833018